Aminoff: Neurology and General Medicine: Breathing and the Nervou...
1 / 20
Return to Previous Page
http://www.merck...
177 downloads
2814 Views
24MB Size
Report
This content was uploaded by our users and we assume good faith they have the permission to share this book. If you own the copyright to this book and it is wrongfully on our website, we offer a simple DMCA procedure to remove your content from our site. Start by pressing the button below!
Report copyright / DMCA form
Aminoff: Neurology and General Medicine: Breathing and the Nervou...
1 / 20
Return to Previous Page
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Print this page
This information has been developed and provided by an independent third party source. Merck & Co., Inc., does not endorse and is not responsible for the accuracy of the content, or for practices or standards of non-Merck sources. This resource may discuss regimens that have not been approved by the FDA. For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences please see the appropriate manufacturer's product circular. View Prescribing Information for Merck products.
Table of Contents This Chapter by Chapters
Keyword Index
Michael J. Aminoff
NEUROLOGY and GENERAL MEDICINE 1 Breathing and the Nervous System ROGER P. SIMON •
Previous
Next
RESPIRATORY EFFECTS OF NERVOUS SYSTEM DYSFUNCTION Alteration of Gas Exchange Pulmonary Hydrostatic Pressure Capillary Permeability Central Effects on Ventilation Autonomic Dysfunction Extrapyramidal Disorders Forebrain Influences on Ventilation Apraxia of Ventilatory Movements Posthyperventilation Apnea Hindbrain Control of Ventilation Other Ventilatory Patterns Cheyne–Stokes Breathing Central Hyperventilation Alveolar Hypoventilation NERVOUS SYSTEM EFFECTS OF RESPIRATORY DYSFUNCTION Hypoxia Acute Hypoxia Hypercapnia Chronic Hypercapnia Acute Hypercapnia Hypocapnia Acute Hypocapnia Chronic Hypocapnia HICCUP SNEEZING YAWNING
The relationship between breathing and the nervous system can be considered from two perspectives, both of which are important to neurologists as well as to general physicians. First, neurological dysfunction can have effects on respiration that may be the most disturbing aspects of the underlying neurological disease. Second, primary respiratory dysfunction may affect the nervous system and lead to a request for neurological consultation. Both interactions are considered in this chapter. In revising this chapter for the current edition,
2009.01.05. 11:50
Aminoff: Neurology and General Medicine: Breathing and the Nervou...
2 / 20
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
many old but classic references were removed, but interested readers will find these cited in earlier editions, to which they are referred. RESPIRATORY EFFECTS OF NERVOUS SYSTEM DYSFUNCTION
Alteration of Gas Exchange One of the most dramatic and life-threatening effects of nervous system dysfunction on respiration is the impairment of alveolar gas exchange by a neurologically induced increase in pulmonary interstitial and alveolar fluid: the phenomenon of acute pulmonary edema. The fluid producing pulmonary edema originates in the pulmonary capillaries. Fluid movement from the pulmonary capillary bed into the alveolar air space is governed by the variables in the classic Starling equation. In its simplest form, the Starling equation expresses transcapillary fluid flux as a balance between intravascular pressures (tending to push fluid out of the vascular lumen) 1and plasma osmotic forces (which tend to retain fluid within the by which neurogenically induced vascular lumen) (Fig. 1-1). Although the mechanisms 2 pulmonary edema occurs remain uncertain, the major recognized factors are discussed in the following sections.
FIGURE 1-1 Relationships between microvascular hydrostatic pressure (PMV); perimicrovascular hydrostatic pressure, that is, within the interstitial space (PPMV); plasma colloid osmotic pressure (πMV); and perimicrovascular pericolloid osmotic pressure (πMv). Under normal conditions, the sum of forces is slightly positive, producing a small vascular fluid flux into the pericapillary interstitium of the lung, which is drained as lymph. (From Fein A, Grossman RF, Jones JG, et al: The value of edema fluid protein measurement in patients with pulmonary edema. Am J Med 67:32, 1979, with permission.)
Pulmonary Hydrostatic Pressure The main variable under the control of the nervous system affecting pulmonary capillary fluid flux is pulmonary intravascular pressure. A marked increase in this pressure can force fluid from the vascular compartment, flood the interstitial space (Fig. 1-1), produce pulmonary edema, and impair oxygenation. can unbalance the Starling equation and result in An elevation in intracranial pressure 2 neurogenic pulmonary edema. This early experimental observation in animals has been 3 confirmed in patients with traumatic head injury. Experimental studies have demonstrated that the effect of increased intracranial pressure on pulmonary vascular pressure and transcapillary fluid flux occurs as intracranial pressure approaches systemic pressure. An
2009.01.05. 11:50
Aminoff: Neurology and General Medicine: Breathing and the Nervou...
3 / 20
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
increase in systemic pressure (the Cushing response) then occurs to protect cerebral perfusion. In most studies, an increase in intracranial pressure alone, in the absence of the Cushing response, has no effect on transcapillary fluid flux in the lung. During the Cushing response, pulmonary vascular pressure increases in concert with systemic pressure, with a 4 resultant increase in pulmonary transcapillary fluid flux. Only one experimental study has shown an increase5in pulmonary transcapillary fluid flux in the absence of elevated pulmonary vascular pressure. Other classic models of induction of neurogenic pulmonary edema also appear to be those of centrally induced pulmonary vascular hypertension. These models include “sympathetic activation” induced by intracisternal veratrine and intracisternally 6–8 administered thrombin and fibrinogen with or without vagotomy in rabbits. Focal central nervous system (CNS) lesions can cause both an elevation of systemic vascular pressure and pulmonary edema. Although hemodynamic data in humans are lacking, there are many reports that the brainstem, particularly the medulla, is the site of focal 2,9–11 In unanesthetized small animals, brainstem CNS injuries that result in pulmonary edema. lesions in the region of the nucleus tractus solitarius produce marked systemic hypertension and fulminant pulmonary edema; pulmonary vascular pressure cannot be measured in these small animals. Following bilateral lesion placement in the ventral lateral nucleus tractus solitarius in sheep, however, pulmonary arterial pressures and transcapillary fluid flux in the lung can be measured and may increase significantly without a change in systemic or left 12 to a CNS injury is similar to that reported for atrial pressures. This pattern of response 2 neurogenic pulmonary edema in humans. Furthermore, a patient has been reported in whom a unilateral injury occurred to the tractus solitarius during a neurosurgical procedure and in whom the contralateral tractus solitarius was absent because of a congenital brainstem9 syrinx. The patient died of pulmonary edema and hypoxemia 34 hours postoperatively. The localization by magnetic resonance imaging (MRI) of a lesion at the obex (Fig. 1-2) in patients with recently diagnosed multiple sclerosis (MS) and acute pulmonary edema supports this 13,14 Recent corroborative data anatomical site as that inducing neurogenic pulmonary edema. come from a subset of patients with EV71 encephalitis in whom brainstem encephalitis and a polio-like acute flaccid paresis picture occur associated with neurogenic pulmonary edema. Brain MRI performed within hours of onset of pulmonary edema showed restricted diffusion in 15 the posterior medulla, anterior to the inferior aspect of the fourth ventricle (Fig. 1-3).
FIGURE 1-2 Rostral to caudal (A to C) schematic reconstruction of the medullary lesion in a patient with multiple sclerosis and pulmonary edema, based on magnetic resonance imaging, illustrating the major nuclear groups and tracts involved. AP, area postrema; 4th, fourth ventricle; LRN, lateral reticular nucleus; MLF, medial longitudinal fasciculus; MRN, medial reticular nucleus; NA, nucleus ambiguus; NTS, nucleus of the solitary tract; Ob, obex; ST, solitary tract; V, spinal trigeminal nucleus; X, dorsal motor nucleus of the vagus; XII, hypoglossal nucleus. (From Simon RP: Respiratory manifestations of neurologic diseases. p. 496. In Goetz CG, Tanner CM, Aminoff MJ [eds]: Handbook of Clinical Neurology. Vol 63. Elsevier, Amsterdam, 1993, with permission.)
2009.01.05. 11:50
Aminoff: Neurology and General Medicine: Breathing and the Nervou...
4 / 20
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 1-3 A, Diffusion magnetic resonance image at the level of the fourth ventricle, performed within hours of onset of neurogenic pulmonary edema, showing paired areas of restricted diffusion paracentrally in the region of the dorsal motor nucleus of the vagus, nucleus tractus solitarius, and medial reticular formation. Axial (B) and sagittal (C) T1-weighted images of same patient performed 4 weeks after onset of neurogenic pulmonary edema. Note the well-defined signal abnormality anterior to the inferior aspect of the fourth ventricle consistent with encephalomyelomalacia. (A kindly provided by Dr. P. Ian Andrews; B and C modified from Nolan MA, Craig ME, Lahra MM, et al: Survival after pulmonary edema due to enterovirus 71 encephalitis. Neurology 60:1651, 2003.)
Generalized seizures produce an abrupt, marked increase in sympathetic outflow from the 16 brain, and both systemic and pulmonary vascular pressures increase. The degree of systemic pressure elevation cor relates with the number of seizures and is maximal during status epilepticus. The magnitude of the pressure elevation in the pulmonary vasculature is independent of the number of seizures, however, although the duration of the elevation is maximal with status epilepticus (Fig. 1-4). The increase in transcapillary fluid flux resulting from this17transient pulmonary vascular hypertension persists for hours after the pressure transient and probably explains the phenomenon of pulmonary edema following seizures in humans.
2009.01.05. 11:50
Aminoff: Neurology and General Medicine: Breathing and the Nervou...
5 / 20
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 1-4 Vascular pressure changes that occur during seizures in sheep. Mean values have been plotted at 10-second intervals. Spinal cord refers to animals with cervical spinal cord transection prior to seizures. Single, 5, and 20 shocks refer to the number of electroconvulsive seizures induced; bicuculline refers to bicuculline-induced status epilepticus. LA, left atrial; PA, pulmonary arterial. (From Bayne LL, Simon RP: Systemic and pulmonary vascular pressures during generalized seizures in sheep. Ann Neurol 10:566, 1981, with permission.)
The development of postictal pulmonary edema requires an increase in pulmonary vascular pressures. If these pressure transients are aborted by a diversion of blood from the pulmonary artery and left atrium during experimental status epilepticus, pulmonary edema does not occur. As these peripheral vascular manipulations do not alter central sympathetic output during the seizure, the studies support a hydrodynamic mechanism for postictal pulmonary edema rather than the pulmonary edema being a manifestation of increased 18 activity of the sympathetic nervous system. Capillary Permeability Fulminant neurogenic pulmonary edema occurs in the setting of an alteration in pulmonary 5 19 capillary permeability, possibly independent of or in association with an imbalance of the forces in the Starling equation. The classic explanation for the pathogenesis of the altered permeability is that the rapid elevation of pulmonary vascular pressures and blood flow mechanically disrupts the pulmonary capillary bed, resulting in a pulmonary capillary leak 20 phenomenon and noncardiogenic pulmonary edema. Although this explanation is likely, some studies indicate the possibility that altered capillary permeability occurs in the absence 5 of altered intravascular pressure. Other studies in animals have demonstrated an inverse correlation between maximal pulmonary vascular pressures and altered capillary permeability, suggesting that a combination of “cardiogenic” and “noncardiogenic” factors 19 may be the most common cause of neurogenic pulmonary edema. A similar conclusion has been reached from the study of patients in whom the ratio of the protein concentration of edema fluid to plasma protein concentration has been used as an index of altered capillary 21 permeability.
2009.01.05. 11:50
Aminoff: Neurology and General Medicine: Breathing and the Nervou...
6 / 20
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Central Effects on Ventilation Autonomic Dysfunction Neural pathways subserving volitional ventilation descend from cortex through the brainstem and spinal cord in the region of the corticospinal tract. The neuronal pools subserving rhythmic involuntary ventilation originate in the caudal medulla and give rise to descending pathways in the ventrolateral brainstem and spinal cord. Accordingly, appropriately placed focal lesions may interfere with voluntary or involuntary ventilation independently. Impairment of autonomic but not volitional ventilation produces the phenomenon of sleep apnea, or “Ondine's curse.” This term was taken from a 1956 play by Jean Giraudoux, who recreated a German mythical legend. The sea nymph Ondine cursed the unfaithful knight Hans with the necessity of voluntary control over all of his autonomic functions: “He died, they will say, because it was a nuisance to breathe.” In the brainstem, bilateral medullary 22 infarctions (Fig. 1-5A) have resulted in sleep apnea, as has unilateral medullary infarction (Fig. 1-5B). In the latter case, the lesion depicted in Figure 1-5B will have destroyed primary ventilatory nuclei in and about the nucleus retroambigualis and the nucleus tractus solitarius as well as fibers from these nuclear groups, which descend contralaterally. Transient 23 vertebrobasilar ischemia has also resulted in transient episodes of Ondine's curse. Congenital disorders of central alveolar hypoventilation may represent a primary defect in neural crest cell migration and function, resulting in altered central chemoreceptors. Accordingly neuroblastoma formation and Hirschsprung's disease sometimes occur in these 24 have lost patients. Patients with myotonic dystrophy and alveolar hypoventilation 25 catecholaminergic neurons in the medullary reticular formation. Incomplete and asymmetric involvement in the region of the dorsal and ventral ventilatory complex of the medulla at about the obex has been described in two patients with multiple sclerosis who died of sleep 26 apnea.
FIGURE 1-5 A, Location of bilateral brainstem infarcts in a patient with automatic respiratory failure. B, Brainstem section showing a unilateral lesion that resulted in failure of autonomic respiration. (A from Devereaux MW, Keane JR, Davis RL: Automatic respiratory failure associated with infarction of the medulla. Arch Neurol 29:46, 1973, with permission. B from Levin BE, Margolis G: Acute failure of automatic respirations secondary to a unilateral brain stem infarct. Ann Neurol 1:583, 1977, with permission.)
2009.01.05. 11:50
Aminoff: Neurology and General Medicine: Breathing and the Nervou...
7 / 20
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Primary involvement of autonomic ventilatory nuclei was a common consequence of bulbar poliomyelitis (Fig. 1-6). As with lesions of the descending pathways from these nuclear groups, these lesions led to temporary or permanent sleep apnea. There are rare reports of 27,28 and pathological material from hypoventilation in patients with systems degeneration, such cases suggests that the causal abnormalities are located in the region of the solitary tracts in the caudal medulla. Vertebral artery dissection involving the dorsal medulla and 29 anterior spinal artery with resultant central ventilatory failure has been reported.
FIGURE 1-6 Medullary lesions found in 17 patients with bulbar poliomyelitis who died of respiratory failure. (From Baker AB, Matzke HA, Brown JR: Poliomyelitis. III: Bulbar poliomyelitis: a study of medullary function. Arch Neurol Psychiatry 63:257, 1950, with permission.)
Iatrogenic sleep apnea occurs in some patients following bilateral cervical tractotomy30 performed for intractable pain (6 of 112 patients reported by Tranmer and associates ). Figure 1-7 shows the most common site of the cordotomy lesion and the descending autonomic pathways in the reticulospinal tract. Descending pathways for voluntary ventilation are located in the corticospinal tract and thus are distant from the lesion site (Fig. 1-7).
FIGURE 1-7 Cervical spinal cord at the C1–C2 level showing the area commonly damaged in cervical cordotomies and the site of the descending autonomic pathway subserving ventilation. (From Tranmer BI, Tucker WS, Bilbao JM: Sleep apnea following percutaneous cervical cordotomy. Can J
2009.01.05. 11:50
Aminoff: Neurology and General Medicine: Breathing and the Nervou...
8 / 20
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Neurol Sci 14:262, 1987, with permission.) Sleep apnea also occurs on an obstructive or mixed basis. Such patients are usually obese, hypertensive men older than 40 years. Excessive daytime sleepiness and sleep attacks are associated symptoms. Nocturnal breath cessation is associated with prominent snoring, snorting, and gasping sounds. Obstructive sleep apnea has been associated with neurodegenerative diseases, such as syringobulbia and olivopontocerebellar degeneration, 31 and miscellaneous unilateral lesions of the rostrolateral medulla, which may produce 32 oropharyngeal weakness. Nonobstructive ventilatory dysfunction may occur as well. 33 Treatment with continuous positive airway pressure (CPAP) during sleep is effective. Further discussion of this syndrome can be found in Chapter 32. Impairment of voluntary ventilatory efforts with preservation of autonomic ventilation may also occur. Cases have been reported from a demyelinating lesion in the high cervical cord and a bilateral pyramidal tract lesion in the medulla resulting from syphilitic arteritis. In another case, an infarct of the basal pons produced quadriplegia; autonomic ventilation was modulated normally by laughing, crying, and anxiety, supporting a nonpyramidal location of descending 27 pathways from limbic structures to medullary ventilatory nuclei. The most common cause, however, is a midpontine lesion that produces the “locked-in” syndrome. Patients may have a regular ventilatory pattern and a preserved response to CO2 stimulation, or a Cheyne–Stokes pattern that is volitionally unalterable. Extrapyramidal Disorders Symptomatic or asymptomatic ventilatory dysfunction is an infrequently recognized but relatively common manifestation of extrapyramidal syndromes34of multiple causes. Respiratory dysrhythmias were common in postencephalitic parkinsonism. Tachypnea, the most common abnormality, may be episodic or continuous during sleep or wakefulness; rates as high as 100 per minute are reported. Ventilatory dysrhythmias are less common and manifest as breath-holding spells, sighing, forced or noisy expiration, inversion of the inspiration/expiration ratio, or the Cheyne–Stokes pattern. Respiratory tics occur as well, manifesting as yawning, hiccupping, spasmodic coughing, and sniffing. In a study by Kim, all nine patients with postencephalitic parkinsonism had an increase in 35 respiratory rate, and the normal variation in respiratory amplitude did not occur. The most striking abnormality in these patients was their inability to alter the respiratory rhythm voluntarily so that, for instance, they were unable to hold their breath. Direct fiberoptic visualization of the upper airway in patients with extrapyramidal disease 36 (essential tremor, parkinsonian tremor, rigid parkinsonism, or dyskinesia) has disclosed rhythmic or irregular glottic and supraglottic involuntary movements. Symptomatic stridor and ventilatory failure that could be reversed by endotracheal intubation were described in a number of these patients and suggested upper airway obstruction. Abnormal flow-volume curves were commonly found. Such upper airway dysfunction may be a factor in the retention of secretions and respiratory infections that occur in many patients. Alternatively, a reduction in both maximal static inspiratory and expiratory pressures precluding the ability to rapidly 37 increase peak expiratory flow for maximally effective coughing may be an important factor. Respiratory distress and dyspnea are also described in patients with extrapyramidal dysfunction in whom no cardiopulmonary cause is found, but in whom respiratory rates are irregular owing to involuntary respiratory dyskinesias that are either levodopa induced or 38 related to a tardive dyskinesia. Respiratory dyskinesias, then, may be an accompaniment of choreiform movement disorders and may account for subjective complaints of dyspnea in 39 Parkinson's disease and dystonia. Forebrain Influences on Ventilation That the forebrain influences both ventilatory rate and rhythm is documented by the volitional acts of overbreathing and breath-holding as well as by the coordinated semivoluntary or involuntary rhythmic alterations in ventilatory pattern that occur as part of speaking, singing, laughing, and crying. Furthermore, during sleep, normal ventilatory patterns become more irregular, total ventilatory volume decreases, Paco2 is elevated, and the CO2 response curve shifts to the right. Cortical “readiness potentials” originating from supplementary motor and primary motor cortex can40be recorded from humans prior to volitional but not automatic inspiration or expiration. Using positron emission tomography of changes in regional cerebral blood-flow, areas of cortical activation during volitional inspiration and expiration 41 have been identified. Inspiration is associated with increased cerebral blood-flow in primary
2009.01.05. 11:50
Aminoff: Neurology and General Medicine: Breathing and the Nervou...
9 / 20
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
motor cortex bilaterally, the right supplementary motor cortex, and left ventrolateral thalamus. In expiration, the structures implicated are similar and overlapping but extend beyond those in inspiration and include the cerebellum. In the cortex, the identified regions activated during ventilation conform to the homuncular regions of thoracic and abdominal muscles. Diaphragmatic contraction induced from these cortical regions with magnetic stimulation does 42 not, however, affect automatic breathing. Hemispheric stroke results in attenuation of diaphragmatic excursion on the hemiplegic side but only during 43 volitional breathing; thus, the diaphragm lacks bilateral cortical 44 representation. The intercostal muscles are similarly affected by hemispheric stroke. Sleep-disordered breathing is common in acute supra- and infratentorial stroke but rarely has 45 localizing value. The cortical areas effective in inducing apnea in humans are similar to those in primates (Fig. 1-8) and include the anterior portion of the hippocampal gyrus, the ventral and medial surfaces of the temporal lobe, the anterior portion of the insula, and the anterior portion of the limbic gyrus. An episode of partial seizures with ictal apnea following encephalitis in humans has been studied with ictal-interictal subtraction single-photon emission computed tomography (SPECT), showing an abnormality in the left posterior lateral temporal region 46 consistent with the ictal electroencephalographic (EEG) findings. Respiratory changes have also been associated with paroxysmal abnormalities on the electroencephalogram. Such 47 episodes have been implicated in epileptic sudden death.
FIGURE 1-8 Points on the anterior lateral (top) and ventromedial (bottom)
cerebral cortex of Macaca mulatta where electrical stimulation elicited inhibition of respiration. C, cingulate gyrus; CC, corpus callosum; CF, central fissure; HG, hippocampal gyrus; IN, insula; LO, lateral orbital gyrus; OLF, olfactory tract; OT, optic tract; PO, posterior orbital gyrus; R, gyrus rectus; ST, superior temporal gyrus. (From Kaada BR: Somato-motor, autonomic, and electrocorticographic responses to electrical stimulation of “rhinencephalic”
2009.01.05. 11:50
Aminoff: Neurology and General Medicine: Breathing and the Nervou...
10 / 20
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
and other structures in primates, cat, and dog. Acta Physiol Scand 24:1, 1951, with permission.) Apraxia of Ventilatory Movements The inability to take or hold a deep breath despite normal motor and sensory function is termed respiratory apraxia. This phenomenon is noted most often in elderly patients with evidence of mild or moderate cerebrovascular disease. For example, in a patient with progressive supranuclear palsy, rhythmic breathing movements persisted during planned 48 volitional inspiration or breath-holding. As cortical magnetic stimulation of primary motor cortex produces diaphragmatic contraction but does not affect ongoing nonvolitional ventilation, cortical or subcortical regions other than primary motor cortex must be the site of respiratory apraxia in such patients. Posthyperventilation Apnea In 1867, Hering observed that brief periods of apnea followed hyperventilation in anesthetized 49,50 animals, and in 1908, Haldane reported apnea after voluntary hyperventilation in humans. Modern reanalysis of posthyperventilation apnea in awake normal human subjects shows that both hyperpnea and apnea of 10 to 30 seconds may occur in an individual subject; apneic pauses occur about 1 minute after cessation of hyperventilation; the apnea's length and occurrence, although variable among subjects, was reproducible in individual subjects; and 51 the occurrence of apnea was unrelated to the Pco2 during hyperventilation. In patients with brain injury, apnea occurred for more than 1052seconds with equal frequency in patients with unilateral (67%) and bilateral (70%) damage. No correlation was found between the decrease in end-tidal CO2 and the occurrence of apnea. A depressed level of consciousness in normal subjects, as during drowsiness, sleep, or anesthesia, also leads to posthyperventilation apnea. Posthyperventilation apnea has also been described in normal 53 patients engaged in an intellectual task. Hindbrain Control of Ventilation The concept that the hindbrain controls ventilatory function, rate, and rhythm has grown from the experiments of Lumsden (Fig. 1-9). These studies in anesthetized cats localized the brainstem ventilatory centers to regions below the inferior colliculus because transection at this level did not alter the ventilatory pattern when the vagi were intact. Transection at the medullary-cervical junction produced the cessation of all ventilatory functions. Accordingly, the neuronal centers responsible for ventilation are located between these levels. Transection at the pontomedullary junction resulted in rhythmic breathing with a gasping quality unchanged by vagal transection, demonstrating that the most primitive respiratory oscillator is located within the medulla. The higher brainstem “centers” play a modulatory role. A modern example of such experiments in anesthetized cats is found in Figure 1-10.
2009.01.05. 11:50
Aminoff: Neurology and General Medicine: Breathing and the Nervou...
11 / 20
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 1-9 A, The original illustration from Lumsden (1923) showing the level of “crucial sections” producing ventilatory alteration in cats. Ventilatory effects produced with lesions: 1, no alteration; 2, apneusis; between 3 and 4, uncoordinated inspiratory spasms and gasping; 4, gasping; between 5 and 6, cessation of all respiratory movements. B, Respiratory tracings from Lumsden (1923). a, normal animal; b, after vagotomy; c, apneusis (transection 2); d, gasping (transection 4). (From Lumsden T: Observation on the respiratory centres in the cat. J Physiol [Lond] 57:153, 1923, with permission.)
2009.01.05. 11:50
Aminoff: Neurology and General Medicine: Breathing and the Nervou...
12 / 20
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 1-10 Effects of brainstem and vagal transection on the ventilatory
pattern in an unanesthetized cat. APC, apneustic center; CP, cerebellar peduncle; DRG, dorsal ventilatory group; IC, inferior colliculus; PNC, pneumotaxic center; VRG, ventral ventilatory groups. Transections at different levels are indicated by roman numerals. Tracings on right represent the tidal volume with inspiration upward. (From Berger AJ, Mitchell RA, Severinghaus JW: Regulation of respiration. N Engl J Med 297:139, 1977, with permission.) Cerebellum
Classic studies of the role of the cerebellum in ventilation focused on the inhibitory effects of the anterior lobe induced by stimulation. Modern studies have extended these observations to the posterior lobe, showing stimulation-induced ventilatory inhibition from the fastigial nucleus and uvula. Stimulation of large regions of the cerebellum, however, produced no ventilatory alteration. Stimulation of the fastigial nucleus produced early termination of bursting in both 54 the inspiratory and the expiratory medullary neurons in the cat. Functional magnetic resonance imaging and positron emission tomography studies have also shown activation of the cerebellum along with other brainstem and basal forebrain structures during volitional 41,55,56 A breathing in humans. In some studies, expiration particularly involved the cerebellum. congenital syndrome associated with hypoplastic posterior cerebellar vermis (Joubert's syndrome) is characterized by prominent ventilatory abnormalities: episodic hyperpnea and 57 apnea. Pneumotaxic Center
Lumsden named the pneumotaxic center (pneumotaxy: normal rhythmic ventilation) and 58 localized it to the rostral pons in the parabrachial complex. Transection at this level results in regular breathing, and the rate of this breathing, but not the rhythm, is slowed by vagotomy. Destruction of this region or transection below it produces the phenomenon of apneusis (Fig. 1-9B), which is discussed in the next section. Modern electrophysiological and cytoarchitectural studies have localized respiratory-related neuronal activity to multiple nuclei 59 in the dorsal and ventral pons and its connections. Electrical stimulation within this region produces premature switching of respiratory phases. This off-switching is modified at least in 60 part by the classic Hering–Breuer (and possibly other) afferents carried within the vagus. 61 Glycinergic and GABAergic input is critical for off-switching. Neuroanatomical and neurophysiological studies in animals support the belief that the pneumotaxic center functions as a relay station, finely tuning the ventilatory pattern generator. Stimulation by glutamate injection of the parabrachial complex Kolliker–Fuse nucleus to include the margins of the sensory and motor trigeminal nuclei have identified functionally distinct cell populations producing specific but sometimes opposing ventilatory responses, which include both 62 respiratory facilitation and inhibition.
2009.01.05. 11:50
Aminoff: Neurology and General Medicine: Breathing and the Nervou...
13 / 20
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Apneustic Center
The phenomenon of apneusis consists of prominent, prolonged end-inspiratory pauses that 58,63 Although the can be pro- duced by pontine transection in vagotomized animals (Fig. 1-9). phenomenon of apneusis is well recognized, anatomical definition of a neuronal aggregate that can reasonably be called the apneustic center is still lacking. Apneusis is defined operationally as a failure of activation of normal inspiratory off-switching. The phenomenon of apneusis may result from one of a number of lesions (Fig. 1-11) or pharmacological manipulations. Systemic, but not local, administration of antagonists of the N-methyl-d-aspartate (NMDA) subset of the glutamate receptor, but not non-NMDA 64 antagonism induces apneusis, thus defining the neurotransmitter system involved and the 65 lack of a specific inducing site. However, altered membrane66potentials in neurons of the ventral respiratory group are produced by NMDA antagonists.
FIGURE 1-11 Areas of the brainstem infarction in two patients with apneustic
breathing. (From Plum F, Alvord EC: Apneustic breathing in man. Arch Neurol 10:101, 1964, with permission.) Apneustic respiration is rare in humans. Children with brainstem damage from hypoxic-ischemic injury or other brainstem lesions may have apneustic breathing, with cyanosis during inspiratory pauses. Tandospirone or buspirone, serotonin-1A agonists, 67,68 Five patients with cervicomedullary compression from normalize breathing. achondroplasia had apneustic breathing patterns that were “reduced in the majority” following decompressive surgery. The absence of a compressive effect at the level of the pneumotaxic 69 center and the integrity of the vagus nerves are notable in this clinical description. Medullary Center
Rhythmic ventilatory excursions persist with brainstem transection at the pontomedullary level, and all ventilatory movements are abolished by transection at the medullary-cervical junction. Accordingly, attention has been focused on the medulla as the generator of rhythmic ventilatory movements. Medullary centers responsible for inspiration and expiration were identified and were held to explain both ventilatory function and ventilatory rhythmicity. Two major neuronal pools are responsible for ventilation. Primary inspiratory cells located in the ventrolateral nucleus tractus solitarius constitute the dorsal respiratory group, which receives all primary pulmonary afferents from the vagus nerves. GABAB receptors are the major 70 modulators. Inspiratory and expiratory neurons are found in a separate grouping within the nucleus ambiguus and the nucleus retroambigualis, which together constitute the ventral respiratory group (Fig. 1-12). Excitatory amino acid neurotransmitter function is necessary to modulate ventral respiratory group function. NMDA receptors are the major mediators of ventral respiratory group ventilatory drive, with modulation by non-NMDA glutamate 71 systems. Thus, ventilatory rhythmicity is mediated by the dorsal respiratory group, and projection to spinal respiratory motor neurons and vagally mediated auxiliary muscles of respiration occurs via the ventral respiratory group. Although rhythmic ventilatory responses occur from the medulla following ponto-medullary transection, this respiratory pattern has a rather gasping quality and is not normal rhythmic ventilation.72A gasping center has been found just rostral and ventral to the dorsal respiratory group. The primary ventilatory rhythm generator appears to reside in a limited region of the ventral medulla (the pre-Bötzinger
2009.01.05. 11:50
Aminoff: Neurology and General Medicine: Breathing and the Nervou...
14 / 20
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
complex) just rostral to the rostral ventilatory group (Fig. 1-12). Rhythm generation is eliminated by removal of this region, and medullary slices containing this region generate 73 complex responds to hypoxia, and this respiratory-related oscillations. The pre-Bötzinger 74 membrane response is modified by glutamate receptors. The network and intrinsic 75,76 properties of this region are an intensive area of current investigation.
FIGURE 1-12 A, Dorsal view of brainstem and cervical spinal cord indicating regions involved in control of breathing and progression of labeling with a viral tracer injected into the phrenic nerve. The percentage of labeled third-order neurons (propiobulbar neurons) in the pre-Bötzinger complex and adjacent regions is plotted in the set at right. Note that the pre-Bötzinger complex contains almost entirely third-order neurons, whereas adjacent regions, rVRG and BötC, contain 0 to 20 percent. BötC, Bötzinger complex; cVRG, caudal ventral respiratory group; KF, Kölliker-Fuse nucleus; NTS, nucleus tractus solitarius; PB, parabrachial nuclei; PGi, paragigantocellular reticular nucleus; preBötC, pre-Bötzinger complex; RTN, retrotrapezoid nucleus; rVRG, rostral ventral respiratory group. B, Sagittal and transverse view of the location of the pre-Bötzinger complex. cNA, caudal nucleus ambiguus; LRN, lateral reticular nucleus; rNA, rostral nucleus ambiguus; VII, facial nucleus. (From Rekling JC, Feldman JL: PreBötzinger complex and pacemaker neurons: hypothesized site and kernel for respiratory rhythm generation. Annu Rev Physiol 60:385, 1998, with permission.)
Other Ventilatory Patterns
2009.01.05. 11:50
Aminoff: Neurology and General Medicine: Breathing and the Nervou...
15 / 20
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Cheyne–Stokes Breathing Periodic, or 77 Cheyne–Stokes, breathing suggests left ventricular failure or nervous system dysfunction. Its original description by Cheyne was in a patient who died of heart failure, but both CNS and cardiac dysfunction (or a combination of the two) can produce this ventilatory 78 pattern. The Cheyne–Stokes pattern is that of escalating hyperventilation followed by decremental hypoventilation and finally apnea, which recurs in cycles. Cycle lengths of 40 to 100 seconds 79 have been reported in humans. Arterial blood gas assays during Cheyne–Stokes breathing indicate a rising pH and a falling Paco2, which become maximal at the apnea point and never 80 return to normal values (Fig. 1-13). Cheyne–Stokes patterns are seen in 30 to 40 percent of patients in congestive heart failure, and Cheyne–Stokes breathing is associated with an 81–83 This ventilatory pattern also occurs in normal premature infants, increased mortality. during normal sleep, in subjects at high80,84 altitude, and with equal frequency in association with 85 Associated changes in arousal, pupillary size, supratentorial and infratentorial stroke. 86 cardiac rhythm, heart rate, blood pressure, muscle tone, and consciousness may occur cyclically in patients with Cheyne–Stokes breathing. The alterations in Paco2 also affect the cerebral vasculature, producing changes in the intracerebral volume of the vascular compartment with associated alterations in cerebral blood-flow and intracranial pressure. The periodicity80 of ventilation can be eliminated by intravenous theophylline or by oxygen inhalation.
FIGURE 1-13 Periodicity of arterial oxygen saturation (Sao2; upper trace), chest
wall motion (middle trace), and CO2 concentration in the expired air (lower trace) in a stroke patient with Cheyne–Stokes respiration. The phase shift between the upper and middle traces is due to the sampling time of the pulse oximeter of approximately 40 seconds. The drops in CO2 concentration during hypopnea are due to dead space ventilation. (From Nachtmann MD, Siebler M, Rose G, et al: Cheyne-Stokes respiration in ischemic stroke. Neurology 45:820, 1995, with permission.) Based on studies in patients with heart failure, the ventilatory oscillations result from Pco2
2009.01.05. 11:50
Aminoff: Neurology and General Medicine: Breathing and the Nervou...
16 / 20
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
87
fluctuations about the apneic threshold. The reciprocal fall in Po2 results from attenuated ventilatory drive. Cheyne–Stokes breathing is abolished by inhalation of CO2 (increasing the 88 Pco2 over the apneic point) but not by inhalation of oxygen. A host of factors that might explain Cheyne–Stokes ventilatory oscillations has been addressed experimentally and clinically. The possibility that a prolonged circulation time may itself produce ventilatory oscillations by creating a feedback loop delay to central receptors was classically considered as the factor responsible for the Cheyne–Stokes ventilatory pattern. However, Hoffman and associates, studying patients with cardiogenic pulmonary edema, found no differences in left ventricular ejection fractions in patients with or without 89 delay did correlate Cheyne–Stokes breathing. Hall and colleagues found that circulatory 90 with Cheyne–Stokes cycle length, but not with apnea length. Lorenzi-Filho and co-workers showed that CO2 inhalation blocked Cheyne–Stokes breathing in patients with heart failure and argued that reduction in Paco2 sensed by peripheral chemoreceptors triggered central 88 apneas. The issue of an abnormal feedback to91the CNS in the genesis of respiratory oscillations was studied in animals by Cherniack who used the normal phrenic nerve stimulus to trigger a mechanical ventilator that had been modified so that the gain could be varied to amplify or retard the induced tidal volume triggered by the phrenic stimulus. This model produced periodic ventilations when the gain was increased. Supporting the concept of abnormal feedback loops generating Cheyne–Stokes breathing, ventilatory periodicity was eliminated by destruction of peripheral chemoreceptors but was unchanged by vagotomy. Furthermore, all animals had a persistent respiratory alkalosis. Duplicating observed clinical phenomena, the oscillations were enhanced by hypoxia and eliminated by increasing the oxygen or CO2 content of inspired air. Hypoxemia (during sleep) also induces 92 Cheyne–Stokes breathing in humans. Originally described as a variant of Cheyne–Stokes breathing, Biot breathing is characterized by clusters of breaths having equal and regular inspiratory and expiratory phases, rather than the spindle characteristics of Cheyne–Stokes breathing. The similarity to Cheyne–Stokes breathing is in the separation of the ventilatory periods by apnea, which in Biot breathing occurs in end-expiration. Although first described in patients with meningitis, a ganglioglioma 93 and bihemispheric involving the cerebellum and pons was responsible in one patient, 94 infarction in another. Central Hyperventilation Hyperventilation was thought, at one point, to be the 95 respiratory pattern characteristic of midbrain dysfunction during transtentorial herniation. The exhaustion resulting from such hyperventilation may be fatal; morphine or methadone will suppress the abnormal ventilatory 96 drive. A specific midbrain localization for lesions pro-ducing this ventilatory pattern cannot be supported any longer. Cases of isolated brainstem tumors and sustained tachypnea offered the possibility of an unambiguous anatomical localization of the source of this ventilatory pattern. In some instances the pons or medulla was involved. Extra-axial medullary 97 compression has also caused central hyperventilation. Central hyperventilation has been associated with CNS lymphoma,98,99 the infiltrating nature of which has been suggested as the Table 1-1 shows the incidence of various abnormal common feature in such cases. ventilatory patterns associated with lesions at different CNS sites. Click here to view this table.... The possibility of central stimulation of medullary chemoreceptors due to local lactate production from tumors or stroke has been suggested to explain the lack of correlation between anatomical lesion site and ventilatory pattern. However, a markedly alkaline cerebrospinal fluid (CSF) pH was reported in a patient with central hyperventilation and a 100 pontine tumor. Pulmonary congestion of neurogenic cause (neurogenic pulmonary edema) might induce this respiratory pattern via stimulation of pulmonary receptors in the pulmonary interstitial space. At the San Francisco General Hospital, the author saw three patients with sustained tachypnea following stroke. Their in vivo lung water content was measured with a double indicator dilution technique (by Dr. Frank Lewis), and no elevation was found.
Alveolar Hypoventilation Hypoventilation, hypoxia, and apnea are major risks in diseases of the anterior horn cells,
2009.01.05. 11:50
Aminoff: Neurology and General Medicine: Breathing and the Nervou...
17 / 20
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
peripheral nerves, myoneural junctions, and muscles. Motor neuron disease, polyneuropathy, myasthenia gravis, and the muscular dystrophies are, respectively, the most common 101 examples of such diseases that cause ventilatory disturbances. In part because of the decreased exercise demands induced by the disease processes, dyspnea is often absent and arterial blood gases may show little alteration immediately prior to fatal ventilatory compromise. Furthermore, the amount of muscle weakness in extremity and girdle muscles is often a poor predictor of ventilatory muscle function. Vincken and associates examined this point and documented that maximal inspiratory (diaphragmatic, intercostal, and accessory neck muscles) and expiratory (abdominal and intercostal muscles) pressure measurements were required to assess 102 the risk of respiratory compromise in patients with chronic neuromuscular disease. Unsuspected ventilatory dysfunction was found in one half of the 30 patients studied, and in one third of patients, it was severe. In no case was the ventilatory dysfunction clinically suspected. Traumatic myelopathies or myelopathies resulting from infiltrative tumors produce ventilatory insufficiency with lesions above the cervical roots innervating the phrenic nerve (C3, C4, C5). Such patients' ventilatory dysfunction has been successfully managed without mechanical ventilation by electrical pacing of the diaphragm. In patients with lesions between C3 and C5, this treatment is feasible if the C5 root is preserved below the level of the lesion. Each of eight patients with traumatic tetraplegia reported by Vanderlinden and co-workers were successfully weaned from ventilator support using this 103 have been used to assess diaphragm technique. Cervical and cortical magnetic stimulation 104 strength in patients proposed for phrenic pacing. Although ventilatory compromise is often the terminal event in advanced motor neuron disease, isolated respiratory insufficiency may be the presenting feature of the disease. In patients with primary bulbar disease, sleep apnea or nocturnal hypoventilation occurs, manifesting itself by both obstructive and central apnea. Orthopnea may be the presenting symptom of motor neuron disease. Such patients have predominantly diaphragmatic weakness, and this may be unilateral or bilateral. Paradoxical chest wall and abdominal movements are seen during inspiration, and vital capacity is reduced, especially when the patient is tested in the supine position. In this group of patients with diaphragmatic weakness in the absence of bulbar impairment), symptomatic relief is obtained with ventilatory support (CPAP or nocturnal105 intermittent positive pressure ventilation) without unwarranted positive airway pressure (BiPAP) is now an prolongation of life. Continuous bimodal 105,106 important alternative to tracheostomy. Ventilatory failure requiring mechanical assistance has been reported in 10 to 80 percent of were needed in 43 percent patients with Guillain–Barré syndrome. Intubation and ventilation 104 of the 111 patients from the French plasmapheresis study and in 47 percent of the 123 107 patients in the American study. The mean duration of the assisted ventilation was 31 days in the French study, and it was reduced to 18 days by plasmapheresis. Intubation is usually required when vital capacity falls below 18 ml/kg. Sunderrajan and Davenport analyzed the presenting and early stages of their patients' illness and were unable to identify any 108 characteristics or neurological features that would predict the need for assisted ventilation. While the mean hospital day on which intubation was required was 4.4, the range was broad (0 to 21 days). The hospital day on which the patient was extubated had an equally wide range: hospital days 5 to 90. Two unusual cases required ventilatory support for more than a year. This experience suggests that extubation will be successful when vital capacities exceed 1 liter. A detailed study of diaphragmatic performance in patients with Guillain–Barré syndrome suggested that improvement in the maximal transdiaphragmatic pressure was the best predictor of recovery, and this measure was correlated with maximal inspiratory force, 109 but not forced vital capacity. The duration of mechanical ventilatory support required in patients with the Guillain–Barré syndrome was nearly halved by treatment with plasma 110 exchange; treatment with intravenous gamma globulin is equivalent. An acute, primary axonal degeneration of motor and sensory fibers occurs in the setting of 111 prolonged sepsis (approximately 2 weeks) with multiple organ failure. This syndrome has been termed critical illness neuropathy and is described in detail in Chapter 52. The neuropathy is characterized clinically by distal weakness with reduced or absent tendon reflexes; when it is severe, there is paralysis with areflexia. The syndrome is frequently recognized only because of unexpected difficulty in weaning patients from assisted ventilation. Phrenic nerve conduction velocities have been abnormal, and autopsy studies have shown axonal degeneration of112 the phrenic nerve, with denervation atrophy in the intercostal muscles and diaphragm. Complete recovery over a period of 6 months is the rule in mild and moderate cases, but patients with severe polyneuropathy may fail to improve and have a fatal outcome. A similar syndrome of critical care myopathy is recognized, with a 113,114 Neuromuscular blockade and corticosteroid treatment may be risk similar prognosis. 113 factors, especially in transplant patients.
2009.01.05. 11:50
Aminoff: Neurology and General Medicine: Breathing and the Nervou...
18 / 20
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Temporary ventilatory support may be required in myasthenia gravis. Indications include the post-thymectomy period and failure of outpatient pharmacological therapy. Of 22 such patients seen at the Mayo Clinic, the duration of ventilatory support116required was 1 to 32 115 exchange days, with 1 to 41 days reported by O'Donohue and colleagues. Both plasma 117 and intravenous immunoglobulin treatments may be useful in myasthenic crisis. In patients with myopathy, ventilatory dysfunction may occur and may be disproportionate to the severity of the muscle weakness. Although the poor prognosis in the muscular dystrophies usually commits patients to ventilatory support for the remainder of their lives, two patients with Duchenne muscular dystrophy were weaned from39continual positive pressure ventilation with intermittent negative pressure techniques. Recurrent episodes of ventilatory failure independent of muscle weakness have been reported in patients with 118 mitochondrial myopathies. Patients have depressed respiratory responses to hypoxia and often to hypercapnia as well. Life-threatening hypoventilation often occurs in the setting of surgery, sedation, or infection. Reported cases include typical Kearns-Sayre syndrome, MERRF (myoclonic epilepsy and ragged-red fibers) syndrome, and familial mitochondrial myopathy. No specific biochemical defect has been found, although a defect in cytochrome-c 118 oxidase has been suggested. The cause of the hypoventilation may be central rather than 119 muscular. NERVOUS SYSTEM EFFECTS OF RESPIRATORY DYSFUNCTION
Hypoxia Acute Hypoxia The terms hypoxic and anoxic encephalopathy are frequently used to describe neurological syndromes that occur following cardiac arrest. The encephalopathy, however, is due primarily to cerebral ischemia. Acute hypoxia results in transient alterations of cognitive function similar to those due to intoxication with alcohol. Hallucinations and alterations in judgment and behavior are well known in mountain climbers at high altitudes. Climbers to the Mt. Everest summit, at 8,854 meters (29,000 feet) have been studied to determine the potential acute and long-term neurological deficits from hypoxia at these altitudes. The results of simple tests of short-term memory (number recall) and simple motor tasks (finger tapping) are shown in immediately after Figure 1-14. Significant reductions in performance in both tests were found 120 the expedition, and significant impairments persisted 12 months later.
2009.01.05. 11:50
Aminoff: Neurology and General Medicine: Breathing and the Nervou...
19 / 20
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 1-14 Results of finger-tapping and short-term memory tests performed
before, immediately after, and 1 year following an expedition to Mt. Everest. (From West JB: Do climbs to extreme altitude cause brain damage? Lancet 2:387, 1986, with permission.) Neuropathological studies of the CNS in primates subjected to hypoxia have revealed lesions only in the watershed distribution between major arterial territories. Thus, the effects of acute 121 Structural abnormalities do not hypoxia on the brain are those of cerebral hypoperfusion. 122,123 However, polymerase occur in the brain in the setting of hypoxia without ischemia, chain reaction (PCR) techniques to simultaneously amplify long random segments of DNA have shown that pure hypoxia for 30 minutes in vivo124 produces both nuclear and mitochondrial DNA damage, which have dissimilar repair kinetics.
Hypercapnia Chronic Hypercapnia A reversible syndrome of headache, papilledema, and impaired consciousness with “tremor 125 of the extremities” has been described in patients with chronic pulmonary insufficiency. Tremulousness is most prominent with the fingers outstretched and has the characteristics of an action tremor or the features of asterixis; in some patients, it resembles myoclonus. The headaches are attributed to the increased intracranial pressure. Arterial oxygen saturations in 125 one study ranged from 81 to 94 percent (but may be as low as 40%), and the Paco2 levels ranged from 39 to 68 mmHg (but can be higher). The electroencephalogram shows slowing in the theta or delta range. The etiology of such CO2 narcosis is probably multifactorial, including hypercapnia, hypoxia, and elevated intracranial pressure. 126 The increased intracranial pressure may produce papilledema that can progress to blindness. Ventilatory support and discontinuation of sedative drugs constitute effective treatment. Acute Hypercapnia Nervous system abnormalities from hypercapnia are related in significant measure to the rate of increase of Paco2. The rapid diffusibility of carbon dioxide across the blood–brain barrier produces a prompt fall in CSF pH in respiratory acidosis, a decrease that does not occur in + metabolic acidosis. A potent inhibitory effect of H upon the postsynaptic receptor for glutamate, the brain's major excitatory neurotransmitter, has been described and may be 127 responsible for the acute encephalopathy of hypercapnia.
Hypocapnia Acute Hypocapnia Acute hypocapnia occurs during hyperventilation. The symptom complex of dizziness, lightheadedness, faintness, paresthesias, and impaired consciousness can be reproduced in normal subjects during hyperventilation, supporting a cause-and-effect relationship between acute hypocapnia and the symptoms of the hyperventilation syndrome (Table 1-2), although 128 some have found hyperventilation as a consequence, rather than a cause, of the attacks. 129 Asthma was significantly associated in one series. This syndrome has its maximal incidence during the third decade. Distal paresthesias are notable and may be asymmetric, prompting evaluation for a more sinister cause. Alteration or loss of consciousness is common (31% in the series of Perkin and Joseph; Table 1-2), leading to an inappropriate diagnosis of epilepsy. Symptoms can often be reproduced by voluntary hyperventilation, and the electroencephalographic findings while the patient is symptomatic can help to exclude a diagnosis of seizure disorder. The effects of hypocapnia include cerebral vasoconstriction, alteration in the ionic balance of calcium, and a shift in the oxyhemoglobin dissociation curve with reduced delivery of oxygen to peripheral tissues. A combination of these events is responsible for the clinical symptoms. Click here to view this table.... Chronic Hypocapnia Fixed respiratory alkalosis is a common or even diagnostic finding in a number of metabolic disorders, the most prominent being hepatic encephalopathy; sepsis and salicylate poisoning are additional examples. However, the role of the alkalosis itself in causing CNS dysfunction
2009.01.05. 11:50
Aminoff: Neurology and General Medicine: Breathing and the Nervou...
20 / 20
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
is uncertain. Potential mechanisms by which alkalosis may affect the brain include a shift in the oxyhemoglobin dissociation curve (which decreases oxygen availability to tissues), a decrease in cerebral blood-flow resulting from cerebral vasoconstriction, and alkalosis-induced hypophosphatemia. Posner and Plum also found that control of the alkalosis by mechanical ventilation did not alter the encephalopathic manifestations in 130 patients with hepatic failure. Accordingly, alkalosis per se appears to have a minimal effect on the CNS. HICCUP 131
Persistent or intractable hiccup is an abnormality resulting from many133 systemic, 132 134 pharmacological, and CNS causes, including brainstem neoplasm, multiple sclerosis, 135 136,137 and thoracic herpes zoster. It may also occur with cortical pathology. Cases of 138 intractable hiccup are much more common in men than women. Hiccup results from CNS-induced synchronous contraction of the diaphragm and the external (inspiratory) intercostal muscles, followed rapidly by inhibition of expiratory intercostal muscles and glottal 139 closure. The glottal closure minimizes air exchange. However, with tracheostomy, the induced ventilatory movements of hiccup cause air exchange, and a respiratory alkalosis is 139,140 produced. The frequency, but not amplitude, of hiccuping is modulated by arterial Paco2. Hiccup 139 frequency is reduced with elevated Paco2 levels and increased with a fall in arterial Paco2. This observation is in keeping with the traditional cure for hiccups—breath-holding. Another common lay remedy for hiccup is swallowing or pharyngeal stimulation, maneuvers that may increase vagal tone. Thus, hiccups are most common at maximal inspiration because vagal afferents are inhibited by maximal lung inflation. High-frequency diaphragmatic flutter, 137 responsive to carbamazepine, is responsible for hiccups in some patients. Chlorpromazine remains the most141–143 popular pharmacological treatment, although baclofen and gabapentin are 144 ; a host of other approaches has been suggested. now also popular SNEEZING The coordinated act of sneezing arises from a caudal brainstem center near the nucleus 145 mass lesion or lateral medullary syndrome can prevent sneezing ambiguus. A medullary146–148 despite the urge to do so. Cortical input to sneezing has149 long been recognized. The central mediation of sneezing was noted by Penfield and Jasper in a patient during temporal lobe stimulation when both sneezing and chewing movements were induced. A common reflex that induces sneezing is 150 that which occurs on sudden exposure to bright light. This reflex was found in 80 percent of the families of medical students in whom the phenomenon of light-induced sneezing was reported.151 It has been suggested that this reflex is inherited in an autosomal dominant manner. YAWNING 152
Yawning is coordinated from brainstem sites near the paraventricular nucleus via 153 extrapyramidal pathways using a number of neurotransmitters and neuropeptides. This reflex may occur in patients “locked in” from pontine transection who have nonvolitional 154 mouth opening with spontaneous yawns. Yawning in the setting of a pyramidal lesion (capsular infarction) may be associated155 with arm stretching in the paretic limb, supporting the input also occurs, as reflected by the involvement of extrapyramidal circuitry. Cortical 156 Yawning has been seen to initiate a yawning related to boredom and somnolence. 149 temporal lobe seizure. Previous
Next
Return to Previous Page
2009.01.05. 11:50
Aminoff: Neurology and General Medicine: Neurological Complicatio...
Return to Previous Page
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Print this page
This information has been developed and provided by an independent third party source. Merck & Co., Inc., does not endorse and is not responsible for the accuracy of the content, or for practices or standards of non-Merck sources. This resource may discuss regimens that have not been approved by the FDA. For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences please see the appropriate manufacturer's product circular. View Prescribing Information for Merck products.
Table of Contents This Chapter by Chapters
Keyword Index
Michael J. Aminoff
NEUROLOGY and GENERAL MEDICINE 2 Neurological Complications of Aortic Disease and Surgery DOUGLAS S. GOODIN •
Previous
Next
CLINICAL NEUROLOGICAL SYNDROMES DUE TO AORTIC PATHOLOGY Spinal Cord Ischemia Anatomy Ischemic Cord Syndromes Cerebral Ischemia Anatomy Strokes and Transient Ischemic Attacks Peripheral Neuropathy Mononeuropathies Radiculopathies Polyneuropathies Autonomic Neuropathies AORTIC DISEASES AND SURGERY Aortitis Syphilitic Aortitis Takayasu's Arteritis Giant Cell Arteritis Aortic Aneurysms Nondissecting Aneurysms Dissecting Aortic Aneurysms Traumatic Aortic Aneurysm Coarctation of the Aorta Surgery and Other Procedures Aortic Surgery Aortography and Other Procedures on the Aorta Intraoperative Adjuncts to Avoid Spinal Cord Ischemia
The aorta is the main conduit through which the heart supplies blood to the body, including the brain, brainstem, and spinal cord. In addition, this vessel is situated close to important neural structures. In consequence, both disease of the aorta and operations on it may have profound but variable effects on nervous system function. Often the neurological syndrome produced by aortic disease or surgery depends more on the part of the aorta involved than on the nature of the pathological process itself. For example, either syphilis or atherosclerosis may produce symptoms of cerebral ischemia if the disease affects the aortic arch or of spinal
1 / 22
2009.01.05. 11:52
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
cord ischemia if the pathological process is in the descending thoracic aorta. Even when the nature of the pathological process is important in determining the resultant neurological syndrome, several diseases may result in the same pathological process. Thus, atherosclerosis, infection, inflammation, and trauma may each result in the formation of aortic aneurysms; similarly, coarctation of the aorta may be congenital, a result of Takayasu's arteritis, or a sequela of radiation exposure during childhood. The initial focus of this chapter is on the three major areas of neurological dysfunction resulting from aortic disease and surgery: spinal cord ischemia, cerebral ischemia, and peripheral neuropathy. Specific conditions that merit special consideration are then discussed individually. The normal anatomical relationships are also considered in order to provide insight into the pathogenesis of the resulting neurological syndromes. CLINICAL NEUROLOGICAL SYNDROMES DUE TO AORTIC PATHOLOGY Aortic disease may produce a variety of neurological syndromes. The specific syndrome depends to a large extent on the site of involvement along the aorta.
Spinal Cord Ischemia Anatomy Embryological Development
During embryological development, primitive blood vessels arise along the spinal nerve roots bilaterally and at each segmental level. Each of these segmental vessels then divides into anterior and posterior branches, which ramify extensively on the surfaces of the developing spinal cord. As development proceeds, most of these vessels regress and a few enlarge, so that by birth, the blood supply to the spinal cord depends on a small but highly variable 1–11 (Fig. 2-1). In the thoracic region, where the aorta number of persisting segmental vessels is situated to the left of the midline, the persisting vessels entering the spinal canal are those 5,6,8 from the left in 70 to 80 percent of cases.
2 / 22
2009.01.05. 11:52
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 2-1 Extraspinal contributions to the anterior spinal arteries showing the three arterial territories. In the cervical region, an average of three arteries (derived from the vertebral arteries and the costocervical trunk) supply the anterior spinal artery. The anterior spinal artery is narrowest in the midthoracic region, often being difficult to distinguish from other small arteries on the anterior surface of the cord; occasionally it is discontinuous with the anterior spinal artery above and below. In addition, this region is often supplied by only a single small radiculomedullary vessel. The lumbosacral territory is supplied by a single large artery, the great anterior medullary artery of Adamkiewicz, which turns abruptly caudal after joining the anterior spinal artery. If it gives off an ascending branch, that branch is usually a much smaller vessel. This artery is usually the most caudal of the anterior radiculomedullary arteries, but when it follows a relatively high thoracic root, there is often a small lumbar radiculomedullary artery below. In this and subsequent illustrations, a indicates artery; m, muscle; n, nerve. Anterior Spinal Artery
The anterior spinal artery is formed rostrally from paired branches of the intracranial vertebral arteries that descend from the level of the medulla (Fig. 2-1). These two arteries fuse to form1 a single anterior spinal artery that overlies the anterior longitudinal fissure of the spinal cord. This artery is joined at different levels by anterior radiculomedullary arteries, which are branches of certain segmental vessels (Fig. 2-2). The number of these vessels is variable among5,6individuals, ranging from 2 to 17, although 85 percent of individuals have between 4 and 7.
3 / 22
2009.01.05. 11:52
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 2-2 Anatomy of the spinal cord circulation, showing the relationship of the segmental arteries and their branches to the spinal canal and cord. The left rib and the left pedicle of the vertebra have been cut away to show the underlying vascular and neural structures.
The anterior spinal artery in the region that includes the cervical enlargement (C1 to T3) is particularly well supplied, receiving contributions from an average of three segmental 6 vessels. One constant artery arises from the costocervical trunk and supplies the lower segments; the others arise from the extracranial vertebral arteries and supply the middle 6 cervical segments. In addition, branches of the vertebral arteries have rich anastomotic connections with other neck vessels, including the occipital artery, deep cervical artery, and 6 ascending cervical artery. The anterior spinal artery in the midthoracic portion of the cord (T4 to T8) often receives only 6,8 a single contribution from a small artery located at about T7, most often on the left. The anterior spinal artery has its smallest diameter in this region, and it is sometimes 5,6 discontinuous with the vessel in more rostral or caudal regions. The anterior spinal artery in the region of the lumbar enlargement (T9 to the conus medullaris) is, as at the cervical enlargement, richly supplied, deriving its blood supply predominantly from a single large (1.0 to 1.3 mm in diameter) artery, the great anterior medullary artery of Adamkiewicz. This artery almost always accompanies a nerve root between T9 and L2,5,6usually on the left, although rarely it may accompany a root above or below these levels. Identification of the actual location of this great vessel has become an important part of the planning and execution of operations on the aorta such as repair of thoracoabdominal aortic aneurysms. Although digital subtraction angiography has been used for this purpose, the use of contrast-enhanced magnetic resonance angiography has recently 11 medullaris, the been proposed to offer a noninvasive alternative. Caudally, at the conus 6 anterior spinal artery anastomoses with both posterior spinal arteries. Posterior Spinal Arteries
The paired posterior spinal arteries are formed rostrally from the intracranial portion of the vertebral arteries. They are distinct paired vessels only at their origin,5,6however, and thereafter become intermixed with an anastomotic posterior pial arterial plexus (Fig. 2-3). This plexus is joined at different levels by a variable number (10 to 23) of posterior radiculomedullary 5 vessels that accompany the posterior nerve roots.
4 / 22
2009.01.05. 11:52
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 2-3 Vascular anatomy of the spinal cord. The anterior spinal artery gives off
both peripheral and sulcal branches. The sulcal branches pass posteriorly, penetrating the anterior longitudinal fissure. On reaching the anterior white commissure, they turn alternately to 5the right and to the left to supply the gray matter and deep white matter on each side. Occasionally two adjacent vessels pass to the same side, and on other occasions, a common stem vessel bifurcates to supply both sides. Terminal branches of these vessels overlap those from vessels above and below on the same side of the cord. The peripheral branches of the anterior spinal artery pass radially and form an anastomotic network of vessels, the anterior pial arterial plexus, which supplies the anterior and lateral white matter tracts by penetrating branches. The posterior pial arterial plexus is formed as a rich anastomotic network from the paired posterior spinal arteries. Penetrating branches from this plexus supply the posterior horns and posterior funiculi. Intrinsic Blood Supply of the Spinal Cord
In contrast to the extreme interindividual variability in the extraspinal arteries that supply the spinal cord, the intrinsic blood supply of the cord itself is more consistent. The anterior spinal artery gives off central (sulcal) arteries that pass posteriorly, penetrating the anterior longitudinal fissure and supplying most of the central gray matter and the deep portion of the anterior white matter (Fig. 2-4). The number of these sulcal vessels is variable, with 5 to 8 vessels per centimeter in the cervical region, 2 to 6 vessels per centimeter in the thoracic 5,6 region, and 5 to 12 vessels per centimeter in the lumbosacral region.
5 / 22
2009.01.05. 11:52
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 2-4 Intrinsic blood supply of the spinal cord. The vascular territories are depicted on the right half of the cord. The hatched lines indicate the territory supplied by the posterior spinal arterial system. The remainder is supplied by the anterior circulation, with the dark stippling indicating the area supplied exclusively by the sulcal branches of the anterior spinal artery.
The anterior spinal artery also gives off peripheral arteries that pass radially on the anterior surface of the spinal cord to supply the white matter tracts anteriorly and laterally. These arteries form the anterior pial arterial plexus, which is often poorly anastomotic with its 5 posterior counterpart. The posterior horns and posterior funiculi are supplied by penetrating vessels from the posterior pial arterial plexus. Ischemic Cord Syndromes Ischemia of the spinal cord may be produced either by the interruption of blood flow through critical feeding vessels or by aortic hypotension. The resulting neurological syndrome depends on the location of ischemic lesions along and within the spinal cord, which depends, in turn, on the vascular anatomy discussed previously. A wide variety of pathological disturbances of the aorta result in 12–15 spinal cord ischemia. They include both iatrogenic causes, and intrinsic aortic diseases, such as dissecting and 20 such as surgery and aortography, 16,17 6,18,19 inflammatory aortitis, occlusive atherosclerotic disease, nondissecting aneurysms, 21,22 6,23 infective and noninfective emboli, and congenital coarctation. Spinal cord ischemia is a 24 possibly due to aortic compression, which can occur toward rare complication of pregnancy, 25 the end of gestation. Some authors have suggested that the midthoracic region (T4 to T8) is particularly vulnerable to ischemia because of the sparseness of vessels feeding the anterior spinal artery in this 6 region and its poor anastomotic connections. Others have stressed the vulnerability of the watershed areas between the three anterior spinal arterial territories. Although the concept is theoretically appealing, documentation of the selective vulnerability of these regions is not 16,26–29 with respect to the completely convincing. For example, a review of 61 case reports distribution of ischemic myelopathies resulting from surgery on the aorta does not especially suggest that either of these areas is more vulnerable than other cord segments (Table 2-1). Even when the operation was performed on the thoracic aorta (and thus the proximal clamp was placed above the midthoracic cord feeder), the lumbosacral cord segments were the site of the ischemic damage more often than the supposedly more vulnerable midthoracic segments (Table 2-1). Similarly, the watershed area between these two arterial territories (T8 to T9) does not seem particularly vulnerable. In fact, the most frequently affected cord segment within each vascular territory in these 61 cases was centrally placed—T6 in the midthoracic territory and T12 in the lumbosacral territory—rather than at the borders, as would be anticipated with watershed vulnerability (Fig. 2-5). Click here to view this table....
6 / 22
2009.01.05. 11:52
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 2-5 Upper segmental level of spinal cord involvement in 61 cases of spinal cord ischemia after surgery on the aorta (based on previously published 16,26–29 reports ).
Moreover, of the 25 cases of spinal cord infarction in an unselected autopsy series of 300 6 cases, two thirds were in cervical cord segments ; the most commonly affected segment was C6. Such a distribution would be unexpected if either the midthoracic or the watershed area was particularly vulnerable. Perhaps relating to such observations, it was recently found that, contrary to earlier reports, the anterior 9spinal artery is continuous along its length without interruption in all 51 cadavers studied. If this observation can be generalized, it may be the case that the poorly vascularized thoracic cord, which has much less gray matter than the cervical and lumbar enlargements, actually matches its sparse blood supply with its reduced 3,6,30 metabolic requirements. The site of aortic disease also plays an important role in the location of the lesion along the spinal cord. For example, distal aortic occlusion often presents with lumbosacral 6,20 whereas dissecting6,17,31,32 aneurysm of the thoracic aorta commonly presents with involvement, Similarly, cord ischemia following surgery on the infarction in the midthoracic region. abdominal aorta is essentially confined to the lumbosacral territory, whereas surgery on the thoracic aorta not infrequently involves the midthoracic segments (Table 2-1). Regardless of the pathological process affecting the aorta, however, it generally involves the suprarenal 6,33 because the important radiculomedullary arteries usually portion if there is cord ischemia originate above the origin of the renal arteries. Anterior Spinal Artery Syndrome
Ischemic injury of the spinal cord at a particular segmental level may present with a complete 6 transverse myelopathy. Within the spinal cord, however, there are certain vascular territories that can be affected selectively. In particular, the territory of the anterior spinal artery, 3,6 especially its sulcal branch, is prone to ischemic injury. This increased vulnerability probably relates to two factors. First, the anterior1,3,4,6 circulation receives a much smaller number Second, the posterior circulation is a of feeding vessels than the posterior circulation. 1,3,6 and therefore probably provides better collateral flow network of anastomotic channels than the single anterior artery, which in some6,34,35 patients is discontinuous along its length. The presumably reflects the relative constancy relative constancy of the resulting syndrome of the intrinsic vascular anatomy of the cord. As mentioned earlier, the anterior spinal artery supplies blood to much of the spinal gray matter and to the tracts in the anterior and lateral white matter. Ischemia in this arterial territory therefore gives rise to a syndrome of diminished pain and temperature sensibility with preservation of vibratory and joint position sense. Weakness (either paraparesis or quadriparesis, depending on the segments involved) occurs below the level of the lesion and
7 / 22
2009.01.05. 11:52
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
may be associated with other evidence of upper motor neuron involvement, such as Babinski signs, spasticity, and hyperreflexia. Bowel and bladder functions are affected, owing to interruption of suprasegmental pathways. Segmental gray matter involvement may also lead to lower motor neuron deficits and depressed tendon reflexes at the level of the lesion. Thus, a lesion in the cervical cord may produce flaccid areflexic paralysis with amyotrophy in the upper extremities, spastic paralysis in the lower extremities, and dissociated sensory loss in all limbs. In contrast, a lesion in the thoracic cord typically presents with only spastic paraplegia and dissociated sensory loss in the legs. The syndrome usually comes on 36 abruptly, although occasionally it is more insidious and progressive. Motor Neuron Disease
On occasion, diseases of the aorta (e.g., dissecting aneurysms or atherosclerosis) that interfere with the blood supply to the anterior spinal artery result in more restricted cord ischemia, perhaps because of better anastomotic connections between the anterior and the posterior pial arterial plexuses in some individuals or because of greater vulnerability of the 6,14,36 The ischemic injury in these anterior horn cells with their greater metabolic activity. circumstances is limited to the gray matter supplied by the sulcal branches (Fig. 2-6). Clinical impairment is then confined to the motor system and is associated with amyotrophy. When 6 the ischemic nature of the lesion usually is apparent, but when the onset the onset is abrupt, 6,36 and especially when pyramidal signs are also present, it may mimic other is more gradual, diseases, such as amyotrophic lateral sclerosis or spinal cord tumors.
FIGURE 2-6 Area of infarction within the spinal cord over four adjacent spinal segments in a patient reported by Herrick and Mills (Herrick MK, Mills PE: Infarction of spinal cord. Two cases of selective gray matter involvement secondary to asymptomatic aortic disease. Arch Neurol 24:228, 1971). The infarction was extensive but limited to the gray matter, particularly the anterior horns. Posterior Spinal Artery Syndrome
In contrast to the anterior spinal artery syndrome, selective ischemia of the posterior circulation, characterized by prominent loss of posterior column function with relative sparing 2,14 and only occasionally reported of other functions, is rarely recognized clinically 10,20,37 For example, in a review of 27 cases 10 of nonsurgical spinal cord pathologically. ischemia, only 2 (7%) had posterior spinal artery patterns. The relative infrequency of this syndrome presumably relates to the more abundant feeding vessels and better anastomotic connections in this arterial system compared to the anterior spinal artery. Unilateral Cord Syndromes
8 / 22
2009.01.05. 11:52
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
In some cases, the area of ischemic damage can be confined to only a small portion of the 10 spinal cord. For example, in the review cited previously, eight (29%) of the patients with nonsurgical spinal cord ischemia had unilateral syndromes involving either the anterior or posterior aspects of the spinal cord. Intermittent Claudication
Intermittent claudication (limping) refers to a condition in which a patient experiences difficulty in walking that is brought about by use of the lower extremities. Charcot initially described this syndrome in381858 and related it to occlusive peripheral vascular disease in the lower extremities. In 1906, Dejerine distinguished claudication39caused by ischemia of the leg muscles from that caused by ischemia of the spinal cord. In the latter condition, the arterial pulses in the legs tend to be preserved, pain tends to be dysesthetic or paresthetic in quality and may not occur, and neurological signs are frequently present, especially after exercise. In 1961, Blau and Logue identified another form of neurogenic claudication caused by ischemia or compression of the cauda equina and resulting from a narrowed lumbosacral canal (either 40 congenital or due to degenerative disease). This condition is similar to that produced by ischemia of the spinal cord; however, the sensory complaints tend to have a more radicular distribution, and signs of cord involvement (e.g., Babinski signs) are not present. The clinical distinction between various types of claudication, particularly between the two neurogenic varieties, is sometimes 6,41 difficult. The cauda equina variety, however, is far more Intermittent spinal cord ischemia, when it occurs, is common than the spinal cord form. often associated with intrinsic diseases of the aorta, such as coarctation or atherosclerotic 6 occlusive disease. Bony erosion through vertebral bodies from an abdominal aortic aneurysm with direct compression of the spinal nerve roots has also been reported to produce intermittent 42 neurological symptoms. The clinical details of the single reported case, however, are not sufficient to determine whether the symptoms resemble those of intermittent claudication.
Cerebral Ischemia Anatomy The aortic arch gives rise to all the major vessels that provide blood to the brain, brainstem, and cervical spinal cord (Fig. 2-7). The first major branch is the innominate (brachiocephalic) artery, which subsequently divides into the right common carotid and right subclavian arteries. The latter artery subsequently gives rise to the right vertebral artery, which ascends through the foramina of the transverse processes of the upper six cervical vertebrae to join with its counterpart on the left and form the basilar artery. The basilar artery provides blood to the posterior fossa and posterior regions of the cerebral hemispheres. The second major branch of the aortic arch is the left common carotid artery, and the third is the left subclavian artery, which, in turn, gives rise to the left vertebral artery.
9 / 22
2009.01.05. 11:52
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 2-7 Vascular anatomy of the aortic arch and its branches.
Strokes and Transient Ischemic Attacks Diseases of the aortic arch, such as atherosclerosis, aneurysms, and aortitis as well as surgery on this segment of the aorta, may give rise to symptoms of6,13,18,32,43–47 cerebrovascular A young insufficiency, such as strokes or transient ischemic attacks (TIAs). woman has even been reported with a stroke secondary to an occlusion of the48aorta that was associated with the use of birth control pills and recurrent venous thromboses. Cerebral ischemia is produced either by occlusion of a major vessel or by embolization of atheromatous or other material to more distal arteries. The resulting neurological syndromes are not specific for any disease process but depend on the location and duration of the vascular occlusion. Atherosclerosis
Atherosclerosis of the aortic arch and its branches, compared with atherosclerosis at the origin of the internal carotid artery, is an infrequent cause of stroke or TIAs, probably for two reasons. First, atherosclerosis is much less common in this location than at the carotid 49 Second, the anastomotic connections between the major vessels in bifurcation (Table 2-2). 6,50 and an occlusion at their origin from the aortic arch is therefore the neck are extensive, less likely to be associated with symptoms of ischemia than a more peripheral obstruction. Click here to view this table.... Transient Emboligenic Aortoarteritis
10 / 22
2009.01.05. 11:52
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Transient emboligenic aortoarteritis has51been reported by Wickremasinghe and colleagues to be a cause of stroke in young patients. They described 10 patients (aged 16 to 36 years), all of whom had presented with pathologically verified thromboembolic strokes, and 3 of whom had a history of TIAs preceding the event by as much as 4 years. All these patients had both active and healed inflammatory lesions of the central elastic arteries, such as the aorta, innominate, common carotid, and proximal subclavian arteries. Active lesions were small (200 to 300 μm in diameter) and associated with a mural thrombus on the intimal surface. Healed lesions usually were associated with fibrous plaques but not with a mural thrombus. More peripheral arteries supplying the brain were normal. This condition seems to be distinct from segmental aortitis of the Takayasu type. Clinically it is an acute, intermittent disorder with an approximately equal sex incidence, whereas Takayasu's disease is more chronic and has a strong female predominance. The systemic symptoms of Takayasu's disease are absent, and occlusion of the central arteries does not occur in this condition. Subclavian (Cerebral) Steal
Disease of the aortic arch may result in occlusion of either the innominate artery or the left subclavian artery proximal to the origin of the vertebral artery. This, in turn, may result in the reversal of the usual cephalad direction of blood flow in the ipsilateral vertebral artery (Fig. 2-8), depending on individual variations in the collateral circulation and may result in ischemia 52–56 In some patients, this is particularly evident when the in the posterior cerebral circulation. metabolic52demand (and therefore the blood flow) of the affected arm is increased during exercise. If the innominate artery is blocked proximally, it may also cause a reversal of blood flow in the right common carotid artery, resulting in anterior circulation ischemia (Fig. 2-8).
FIGURE 2-8 Mechanisms producing subclavian steal syndrome in diseases of the aortic arch and its branches. A, Obstruction of the left subclavian artery at its origin, resulting in reversal of blood flow in the left vertebral artery. B, Obstruction of the right subclavian artery distal to the takeoff of the right common carotid artery, resulting in reversal of blood flow in the right vertebral artery. C, Obstruction of the innominate artery at its origin, producing reversal of blood flow in the right common carotid artery.
Killen and colleagues reviewed the clinical features of a series of patients with demonstrated reversals of arterial blood-flow in52a vertebral artery (i.e., with flow from the vertebral artery into the ipsilateral subclavian artery). The left subclavian artery was affected more than twice as often as the right subclavian and innominate arteries combined, probably as a result of the more frequent involvement of this artery by atherosclerosis (Table 2-2). Men were affected three times as often as women, probably reflecting the greater prevalence of atherosclerosis in men. Of the 87 patients in this series with symptoms that were adequately described, 75 (86%) had symptoms referable to the central nervous system (CNS). These symptoms were usually transient, lasting seconds to a few minutes, although the deficits were sometimes permanent. The neurological manifestations of steal were varied but most frequently included motor difficulties, vertigo, visual deficits, or syncope. Ischemic symptoms in the arms occurred in only a few patients, and precipitation of CNS symptoms by exercise of the arm ipsilateral to the occlusion was uncommon. Although reconstructive surgery relieved
11 / 22
2009.01.05. 11:52
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
52
symptoms in most patients in this series, it was the frequent failure of surgery to correct such nonspecific symptoms that led to a more recent reassessment of the importance of 56 cerebral steal. Thus, when noninvasive techniques such as Doppler ultrasonography have been used to define the direction of blood flow in the great vessels in a large spectrum of patients with vascular disease, the majority (50% to 75%) of patients with documented subclavian steal are 53–55 When symptoms do occur, found to be asymptomatic, even when the steal is bilateral. they are suggestive of transient vertebrobasilar insufficiency in only 7 to 37 percent of 54,55 For patients with steal; the occurrence of infarcts in this vascular territory is distinctly rare. this reason, a recent review of this topic concluded that subclavian steal is a actually a marker of generalized atherosclerotic disease and that it is rarely a cause for symptoms of 56 cerebral ischemia.
Peripheral Neuropathy The peripheral nervous system is sometimes affected by aortic disease or surgery. The syndromes produced may be the presenting manifestations of aortic disease and may mimic less life-threatening conditions. Mononeuropathies Left Recurrent Laryngeal Nerve
The left recurrent laryngeal nerve descends in the neck as part of the vagus nerve and wraps around the aortic arch just distal to the ligamentum arteriosum (Fig. 2-7) before reascending in the neck to innervate all the laryngeal muscles on the left side except the cricothyroideus. It may be compressed by disease of the aortic arch, such as dissecting and 56 nondissecting aneurysms or aneurysmal dilatation proximal to a coarctation of the aorta. The resulting hoarse, low-pitched voice may be one of the earliest presenting symptoms of these conditions, although it is often overshadowed by other symptoms or57signs, such as chest pain, shortness of breath, congestive heart failure, or hypertension. Femoral Nerve
The femoral nerve arises from the nerve roots of L2, L3, and L4. It forms within the belly of the psoas muscle and then exits on its lateral aspect to innervate the quadriceps femoris, iliacus, pectineus, and sartorius muscles and the skin of the anterior thigh and medial aspect of the leg. The nerve is located considerably lateral to the aorta (Fig. 2-9) and hence is rarely involved by direct compression. It may, however, be compressed by a hematoma from a ruptured aortic aneurysm into the psoas muscle and thereby signal a life-threatening 6,58–60 condition that requires an urgent operation.
12 / 22
2009.01.05. 11:52
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 2-9 Anatomy of the abdominal aorta showing its relationship to the femoral and obturator nerves, which form within the psoas muscle from branches of the L2, L3, and L4 segmental nerves.
The femoral nerve may also be injured as a consequence of aortic surgery. Boontje and Haaxma reported this complication in 3.4 percent of 1,006 abdominal aortic operations for atherosclerotic or aneurysmal disease, the left femoral nerve being involved unilaterally in two 61 thirds of the cases and jointly with the right femoral nerve in another 6 percent. The mechanism of injury in these cases was presumed to be ischemic and related to poor collateral blood supply to the intrapelvic portions of the femoral nerves, especially on the left. Obturator Nerve
The obturator nerve also forms within the belly of the psoas muscle by the union of fibers from the L2, L3, and L4 segments, but, in contrast to the femoral nerve, exits medially from this muscle (Fig. 2-9). It innervates the adductors of the leg and the skin on the medial aspect of the thigh. It too is lateral to the aorta and not usually involved by direct compression. Like the femoral nerve (and often together with it), the obturator nerve may be compressed by a 6 hematoma in the psoas muscle. Radiculopathies Nerve roots, particularly L4, L5, S1, and S2, which lie almost directly underneath the terminal aorta and iliac arteries (Fig. 2-10), may be directly compressed by an aortic aneurysm in this region. The syndromes produced are typical of radicular disease, with unilateral radiating pain 6 and a radicular pattern to the sensory and motor findings.
13 / 22
2009.01.05. 11:52
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 2-10 Anatomy of the terminal branches of the aorta in relationship to
the nerve roots that subsequently join to form the sciatic nerve. Aneurysmal dilatation of the abdominal aorta often includes dilatation of these branch vessels, which can compress the nerve roots, particularly the L4, L5, S1, and S2 nerve roots, which lie directly underneath. Radiculopathies may also be produced by erosion of one or more vertebral bodies by an aortic aneurysm, with consequent compression of the nerve roots in the cauda equina or at the root exit zones. The syndrome produced is not necessarily associated with back pain; it 62–64 may result in multisegmental involvement on one side or even in paraplegia. Polyneuropathies Ischemic Monomelic Neuropathy
Ischemic monomelic neuropathy was described in detail by Wilbourn and co-workers, who reported 3 patients (and alluded to another 11) who had a distal “polyneuropathy” in one limb 65 after sudden occlusion of a major vessel. One of their patients had a saddle embolus to the distal aorta that occluded the right common iliac artery, another had a superficial femoral artery occlusion after placement of an intra-aortic balloon pump, and the third had upper-extremity involvement. The syndrome consists of a predominantly sensory neuropathy with a distal gradient. It affects all sensory modalities and is associated with a constant, deep, causalgia-like pain. The symptoms persist for months, even after revascularization or without evidence of ongoing ischemia. The results of nerve conduction studies and needle electromyography suggest an axonal neuropathy. There is no evidence of ischemic muscle injury, such as induration, muscle tenderness, or elevated serum creatine kinase levels. This condition is rare, 66 although a similar syndrome has been reported in the setting of an acute aortic dissection, and it may be that it is more prevalent than currently appreciated. Autonomic Neuropathies Anatomy
14 / 22
2009.01.05. 11:52
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
The autonomic nerves, particularly the lower thoracic and lumbar sympathetic fibers that lie close to the aorta and its branches, may be injured by disease of or surgery on the aorta. The preganglionic efferent sympathetic finerve fibers originate in the intermediolateral cell column 67 in the spinal cord (Fig. 2-4) and exit segmentally between T1 and L2 with the ventral roots. The sympathetic fibers part company with the segmental nerves through the white rami communicantes (Fig. 2-2), which enter the paravertebral sympathetic ganglia and trunks to form bilateral sympathetic chains; these chains are situated lateral to and parallel with the vertebral column (Fig. 2-11). Some of these fibers synapse on postganglionic neurons in the ganglia of their segmental origin, whereas others ascend or descend in the trunk to different segmental levels before making such synapses. In the lumbosacral and cervical segments, where there are no white rami (i.e., below L2 or above T1), the segmental ganglia receive preganglionic contributions only from cord segments either above them (lumbosacral ganglia) 67 or below them (cervical ganglia). The postganglionic fibers rejoin the segmental nerves through the gray rami communicantes (Fig. 2-2) to provide vasomotor, sudomotor, and pilomotor innervation throughout the body.
FIGURE 2-11 Anatomy of the terminal aorta and pelvis in the male in
relationship to the sympathetic and parasympathetic nerves in the region. Some of the preganglionic fibers, in contrast, do not synapse in the paravertebral ganglia but pass through them to form splanchnic nerves, which then unite in a series of prevertebral ganglia and plexuses (many of which overlie the thoracic and abdominal aorta). These structures, in turn, provide sympathetic innervation to the viscera. The plexus that overlies the aorta in the region of its bifurcation, the superior hypogastric plexus (Fig. 2-11), is responsible (via the inferior hypogastric and other pelvic plexuses) for sympathetic innervation of the pelvic organs, including the prostate, prostatic urethra, bladder, epididymis, vas deferens, seminal vesicles, and penis in men (Fig. 2-12) and the uterus, bladder, fallopian tubes,
15 / 22
2009.01.05. 11:52
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
vagina, and clitoris in women. This plexus is formed by the union of the third and fourth lumbar splanchnic nerves with fibers from the more rostral inferior mesenteric plexus. Its segmental contribution usually derives from T11 to L2.
FIGURE 2-12 Distribution of sympathetic (left) and parasympathetic (right) nerves to the pelvic viscera and sexual organs in the male.
The visceral afferent fibers accompany the efferent autonomic fibers and pass uninterrupted back through the trunk, ganglia, and white rami to reach their nerve cells of origin in the dorsal root. Postsympathectomy Neuralgia
Operations on the distal aorta to treat symptomatic aortic disease from atherosclerosis or other causes frequently include intentional sympathectomy as part of the effort to improve blood flow to the legs. This is usually done by dividing the sympathetic chain below the last white ramus at L2, thereby depriving the lower lumbar and sacral ganglia of their preganglionic innervation. Such an operation is often followed by a distinctive pain 68 68,69 which Raskin and associates termed postsympathectomy neuralgia. In their syndrome, experience with 96 such operations, this syndrome occurred in 35 percent of the patients. In each case, the sympathetic chain was interrupted at L3 by removal of the segmental ganglion. The pain was characterized as deep, boring, nonrhythmic, and nonradiating; it had an abrupt but delayed onset. The mean delay from sympathectomy to onset of pain was 12 days. The pain was located predominantly in the thigh, either medially or laterally, and was associated with tenderness in the area of pain. The course was always self-limited, with an average duration of 3 weeks.
16 / 22
2009.01.05. 11:52
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Disorders of Sexual Function
Normal male sexual function has two distinct components. The first, erection, is a response mediated predominantly through the parasympathetic nervous system by the pelvic splanchnic nerves (nervi erigentes) arising from segments S2, S3, and S4 (Fig. 2-12). Activation of 6,70 these nerves causes vasodilatation and engorgement of the penile musculature The blood supply to the penis is provided by the internal pudendal artery via and sinuses. have at the internal iliac artery (Fig. 2-10). The sympathetic nervous system, however, must 6,70 The least a modifying influence on erection because sympathectomy may disturb it. second component, ejaculation, can be divided into two phases. The first phase, expulsion of seminal fluid into the prostatic urethra, is a response mediated predominantly by the 6,70 The second phase, sympathetic nervous system through the superior hypogastric plexus. emission, is produced by the clonic contraction of penile musculature (bulbocavernosus and ischiocavernosus) innervated by somatic (pudendal) nerves (Fig. 2-12). 6,71–76
Female sexual Male sexual function may be disturbed by aortic disease or surgery. function has not been as well studied in77these circumstances, although it seems to be affected to a similar degree as in men. Because the superior hypogastric plexus lies close to the aortic bifurcation (Fig. 2-11), most preoperative and postoperative sexual disturbances occur with disease of this portion of the aorta, and most involve ejaculation (Table 2-3). The pelvic splanchnic nerves are not situated near the aorta (Fig. 2-11) and usually are not affected by aortic disease or surgery. Disturbances in erection, however, do occur, possibly because of sympathetic dysfunction, a71–76 reduction in blood flow to the internal pudendal artery To determine whether blood flow or sympathetic and penis, or cavernovenous leakage. function was more important in this regard, Ohshiro and Kosaki examined the outcome of (1) terminal aortic operations either done traditionally or designed to spare the superior 74 hypogastric plexus and (2) operations that did or did not preserve internal iliac blood-flow. Their results indicated that preservation of the hypogastric plexus appeared to be more important for maintenance of normal erection and ejaculation than was preservation of internal iliac artery blood-flow (Table 2-4). Other authors have also found that modification of operative technique to spare the superior hypogastric plexus considerably improves 6,71,73 postoperative sexual function. Click here to view this table.... Click here to view this table.... Despite the importance of operative technique in preserving sexual function, preservation of blood flow is probably also important. Thus, Nevelsteen and colleagues reported a clear relationship between the occurrence of preoperative impotence and the adequacy of blood 75 flow through the internal iliac arteries. In this study, however, no special attempt was made to improve blood flow in the internal iliac artery during surgery, so that it is unclear whether a different operative approach might have been beneficial in restoring postoperative sexual function. AORTIC DISEASES AND SURGERY Certain conditions affecting the aorta merit special consideration because of the variety of nervous system syndromes that each can produce.
Aortitis Injury to the aorta by a variety of infectious, toxic, allergic, or idiopathic causes may produce 18 similar inflammatory pathological changes in the elastic media (Table 2-5). Such aortic damage may lead to neurological syndromes either primarily through direct involvement of important branch arteries by the pathological process or secondarily through the development of aneurysms, aortic stenosis, or atherosclerosis. The neurological syndromes produced either primarily or secondarily by aortitis depend on both the nature and the location of the resulting aortic lesion. Click here to view this table.... Syphilitic Aortitis 18,78
During the prepenicillin era, syphilis was a common cause of aortitis, although by the 78 1950s, its occurrence had markedly declined. A report in 1958 on the relative occurrence of atherosclerotic and syphilitic thoracic aortic aneurysms showed cases of syphilis 79 outnumbering atherosclerosis by a ratio of 1.3:1.0. A similar report published in 1982 gave
17 / 22
2009.01.05. 11:52
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
79
this ratio as 0.13:1.0. The pathological process in syphilitic aortitis is almost always in the 19,78 in contrast to the distribution of atherosclerosis, which is more prevalent in thoracic aorta, the abdominal aorta (Table 2-2). The aortitis78is accompanied by aneurysmal dilatation of the aorta in approximately 40 percent of cases. 6 Rarely, it presents with multiple arterial occlusions and mimics Takayasu's arteritis, although patients are generally older than those with Takayasu's arteritis and are usually men. Takayasu's Arteritis Takayasu's arteritis is an idiopathic inflammatory condition affecting the large arteries, 6,45,80,81 The pathogenesis seems to involve particularly the aorta and its branches. cell-mediated autoimmunity, although the responsible antigen is unknown. The onset of disease is typically between the ages of 15 and 30 years, and the condition seems most 6 prevalent in Asian and Hispanic populations. More than 85 percent of affected individuals are women. In the early (prepulseless) phase, the disease may be characterized by systemic symptoms such as fever, night sweats, weight loss, myalgia, arthralgia, arthritis, and chest pain. In some patients, however, the systemic symptoms are either inconspicuous or absent. The later (pulseless) phase of the disease is characterized by occlusion of the major vessels of the aortic arch, producing symptoms such as Takayasu's retinopathy, hypertension (secondary to renal artery stenosis, coarctation, or both), aortic regurgitation, and aortic aneurysms. Symptoms of cerebral ischemia can occur; however, they are typically reported in 6,45,81 Nevertheless, a report from South Africa on 272 patients who were only a few patients. diagnosed with Takayasu's arteritis, based on the criteria of the American College of Rheumatology, found that 20 percent of the cohort had symptoms of cerebrovascular 81 of this cohort experienced disease, including TIAs and stroke. In addition, 32 percent 81 Seizures and headaches have also intermittent claudication of either upper or lower limbs. 6 been reported but are uncommon. Involvement along the aorta is typically diffuse, although some patients (perhaps as many as 20%) present with symptoms related to more restricted 18,81 The disorder is discussed further in Chapter 29. aortic involvement. Giant Cell Arteritis Giant cell arteritis (GCA) seems to be a particularly important cause of aortitis in the 6,18,19,82 ; although it typically affects medium-sized vessels, as many as one fourth or elderly 83 more of affected individuals have large-artery involvement. For example, in18one series of eight consecutive patients with aortitis, GCA seemed to be its basis in many. Thus, four had definite GCA diagnosed based on their age at onset, the new onset of headaches, and an elevation in erythrocyte sedimentation rate. However, all these patients were older than 57 years, each of the eight had an elevation of some serum inflammatory marker (e.g., increase in Creactive protein levels, erythrocyte6 sedimentation rate, or fibrinogen levels), and three had symptoms of polymyalgia rheumatica. In another series of 45 patients undergoing aortic resection and who had microscopic evidence of active noninfectious aortitis, the majority had either unclassifiable aortitis (47%) or GCA (31%), two entities that were histopathologically 82 indistinguishable. The presenting symptoms in patients with GCA or unclassified aortitis are generally nonspecific and include exhaustion, night sweats, weight loss, chest and back pain, 19,82 Typically, all segments headache, fevers of unknown origin, TIAs, and arm claudication. of the aorta (ascending aorta, arch, and descending aorta) are involved in the inflammatory 6,18,19 Between 10 and 20 percent of process, although involvement can be more restricted. patients with unclassified aortitis or GCA will82,83 subsequently develop either dissecting or, more commonly, nondissecting aortic aneurysms.
Aortic Aneurysms Nondissecting Aneurysms Nondissecting aortic aneurysms can be caused by any pathological process that weakens the 6,15,18,53,60,84,85 In the past, arterial wall, such as inflammation, infection, or atherosclerosis. 86 syphilis was an important cause, but at present, almost all these aneurysms are caused by atherosclerosis. As a result, the distribution of aortic aneurysms essentially parallels the distribution of atherosclerosis within the aorta, with most occurring in the abdominal aorta (Tables 2-2 and 2-6). In a study from Sweden, it was found that the incidence of ruptured abdominal aortic aneurysms in men (but not women) had increased by more than 100 87 percent between 1971 to 1986 and 2000 to 2004. The reason for this increased incidence is unclear, and it is unknown whether a similar increase has occurred in other parts of the world. The prognosis of untreated aneurysms is grave, with 80 percent of patients dying of rupture 84 within 12 months of the onset of symptoms. Disturbances of neurological function in aortic
18 / 22
2009.01.05. 11:52
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
aneurysms are uncommon, but when they occur, they are variable and depend in part on the location and extent of the lesion. Abdominal aneurysms may result in sexual dysfunction, 6,58–62,71–77 or, rarely, spinal cord ischemic syndromes, including compressive neuropathies, 88 ; descending thoracic intermittent claudication, asymmetric paraparesis, and paraplegia 16 arch aneurysms may result in aneurysms may produce spinal cord ischemia, and aortic6,57 Most commonly, neurological cerebral ischemia or recurrent laryngeal nerve dysfunction. symptoms are produced by either rupture or direct compression. Even when aneurysms result in paraplegia, the neurological deficit is often caused by bony erosion through the vertebral bodies and direct compression of the spinal cord or cauda equina rather than by 64,89 ischemia. Click here to view this table.... Dissecting Aortic Aneurysms Dissecting aortic aneurysms, in contrast to nondissecting aortic aneurysms, predominantly involve the thoracic aorta, either at the beginning of the6,17,32,57,66,89,90 ascending segment (type A) or Their etiology has not immediately distal to the left subclavian artery (type B). been established. Atherosclerosis is probably not a major factor because atherosclerosis is seldom found in the region of the intimal tear because the distribution of these aneurysms along the aorta is unlike that of atherosclerosis and because atherosclerosis is only 90–92 Nevertheless, hypertension probably is a factor as it is present in infrequently present. 91,92 Moreover, the large majority of patients with either type A or type B dissections. dissecting aortic aneurysms have been associated with cystic medial necrosis, a degenerative condition focally affecting the arterial media, which may itself be related to hypertension. This condition is increased in patients with Marfan's syndrome, as are dissecting aneurysms. Most aneurysms, however, do not occur in patients with Marfan's syndrome89,91,92 or other identifiable collagen disorders, and the pathophysiology remains Neurological involvement from dissecting aneurysms (due to the cutoff of unknown. important arteries by the dissection or by embolization) is well described but uncommon. It 91,92 and it usually involves either occurs more frequently with type A than type B dissections, spinal or cerebral ischemia. Neurological involvement may also occur during surgery to repair 57 the aneurysm. Thus, in one large series of 527 patients, preoperative stroke occurred in 4 percent, and paraparesis occurred in another 2 percent. Patients with aortic dissection usually present with acute chest or back pain, which generally leads to the proper 57,91,92 On6,66 occasion, however, pain is absent, and the neurological syndrome is the diagnosis. Moreover, the neurological deficit produced by the dissecting presenting feature. aneurysm is sometimes only transient, lasting for several hours, and thereby mimicking other 6 transient disturbances of neurological function. Traumatic Aortic Aneurysm Brutal deceleration injuries to the chest, especially from motor vehicle accidents, may result in traumatic rupture of the thoracic aorta, often just distal to the left subclavian artery. Many of 93–96 Still others these patients die immediately, but some present with an acute paraplegia. have a chronic aortic aneurysm that may present years later with acute spinal cord 93 94 ischemia or other neurological symptoms.
Coarctation of the Aorta 97
Coarctation of the aorta, a relatively common congenital condition, typically results in constriction of the thoracic aorta just distal to the origin of the left subclavian artery. Less commonly, it occurs as part of Takayasu's arteritis, and this condition should be suspected if 6,81 It may also follow radiation exposure during the location of the coarctation is atypical. 6,98 infancy ; in these cases, the pathological process is focal and limited to the segment of aorta that was in the field of irradiation. Coarctation can result in a variety of neurological 6,23,97,98 Cerebral infarcts probably result from embolization of symptoms (Table 2-7). 6 thrombotic material in the dilated aorta proximal to the obstruction. Click here to view this table.... Subarachnoid hemorrhage from ruptured saccular aneurysms can occur with coarctation. In the general population, aneurysmal hemorrhage has an annual incidence of approximately 8 6,99 6,99 and rarely occurs before the age of 20 years. Accordingly, the reported97 per 100,000 occurrence of ruptured aneurysms in 2.5 percent of patients with coarctation of the aorta suggests an association of these two disorders,6 although the coincidental occurrence of the two conditions cannot be completely excluded.
19 / 22
2009.01.05. 11:52
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Headache is a common accompaniment of coarctation, perhaps as a result of secondary hypertension, but, again, the incidental occurrence of two unrelated conditions cannot be excluded. Episodic loss of consciousness may also occur in patients with coarctation of the aorta. It6,97 may result either from syncope due to associated cardiac abnormalities or from seizures. It is unclear, however, whether seizures unrelated to cerebrovascular disease are more 97 prevalent in these patients than in the general population. Neurogenic intermittent claudication can result from aortic coarctation. In patients with coarctation of the aorta, blood flow to the legs is often provided by collateral connections between the spinal arteries and the distal aorta. In these situations, the blood 6,52 flow through the and the radiculomedullary and intercostal arteries distal to the obstruction is reversed, exercise-related spinal ischemia may be related to “steal” by the increased metabolic 6 demands (and thus increased blood flow) of the legs rather than aortic hypotension distal to the coarctation (Fig. 2-13). These collaterals are sometimes so extensive that they cause spinal cord compression and mimic (clinically and radiologically) vascular malformations of 6,14,98 the spinal cord.
FIGURE 2-13 Mechanism of steal in coarctation of the aorta. Obstruction of the
aorta at the isthmus causes dilatation of the anterior spinal artery and reversal of blood flow in anterior radiculomedullary arteries distal to the obstruction. In this circumstance, the blood flow to the lower extremities is provided by these (and other) collaterals, and use of the lower extremities may cause shunting of blood from the spinal circulation to the legs, which, in turn, sometimes results in spinal cord ischemia.
Surgery and Other Procedures Aortic Surgery
20 / 22
2009.01.05. 11:52
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
As with diseases of the aorta, the risks of aortic surgery depend in part on the site of operation. Thus, operations on the aortic arch may produce cerebral ischemia either by intraoperative occlusion of major6,13,46,47 vessels or by embolization of material such as calcified Operations on the suprarenal aorta may result in plaque loosened13during surgery. on the distal aorta may result in sexual dysfunction or spinal ischemia, whereas operations 6,58–62,71–77 ischemia of the femoral nerve. The major complication of all aortic operations, however, is intraoperative spinal cord ischemia with resultant paraplegia or paraparesis. The occurrence of this complication varies with the location of the surgery and the nature of the pathological process affecting the aorta (Table 2-8). Thus, operations on dissecting or nondissecting aortic aneurysms that are entirely abdominal are associated with a lower incidence of this complication than operations 6,26,100–104 Surgery on aneurysms involving 100 the on aneurysms confined to the thoracic aorta. entire abdominal and thoracic aorta carries the highest risk of producing cord ischemia. Operations on the distal aorta for occlusive disease only rarely result in spinal ischemia, 26,33 This variability presumably occurs especially when confined to the infrarenal portion. because important feeding arteries to the spinal circulation are more likely to be ligated during surgery, included within the segment of the aorta that is cross-clamped, or subjected to distal hypotension when the aortic lesion is above the level of origin of the renal arteries. Click here to view this table.... Operations on the thoracic aorta for coarctation are much less frequently complicated by 23 spinal ischemia than thoracic operations done for other reasons. There are probably at least two reasons for this difference. First, the former patients are younger, and the extent of overall arterial disease is therefore less. Second, as mentioned earlier, 6,105 the flow in the so obstruction of radiculomedullary vessels below the coarctation is frequently reversed, blood flow in them (either by ligation or cross-clamping the aorta above and below their origin) may actually result in an increased blood supply to the spinal cord. Aortography and Other Procedures on the Aorta 16
6,106
Aortography may be associated with either spinal or cerebral ischemia, depending on the portion of the aorta visualized. This complication, however, is distinctly rare (Table 2-8). Paraplegia may also occur during intra-aortic balloon assistance after myocardial 6,107 revascularization. Intraoperative Adjuncts to Avoid Spinal Cord Ischemia Several adjuncts are commonly used during surgery in an attempt to avoid spinal cord injury. They include the use of deep hypothermia and circulatory arrest in addition to thiopental anesthesia and intraoperative corticosteroids, all of which are thought 57 to reduce the metabolic requirements of the cord or otherwise enhance tolerance to ischemia. In addition, many authors have reported that minimization of cross-clamp time results in a lower incidence of spinal ischemia. Other adjunctive methods such as the reattachment of intercostal arteries, the use of shunts to maintain distal perfusion pressure, and the use of cerebrospinal fluid drainage have not 7,46,49,108–114 although the more proved consistently effective at preventing cord ischemia, 7,49,113,114 Part of recent experience with such adjunctive techniques has been quite favorable. the difficulty with these procedures may relate to the extreme variability of the blood supply to the spinal cord. For example, if a crucial spinal artery leaves the aorta within the cross-clamped section, the preservation of distal blood-flow is irrelevant. Furthermore, because the important intercostal arteries are few and unpredictably situated, the random reattachment of a few intercostal arteries may be fruitless. There has been considerable interest in the use of somatosensory evoked potentials (SEPs) and motor94,115–125 evoked potentials (MEPs) for assessing spinal cord function during operations on The combined use of SEPs and MEPs may ultimately prove better than the aorta. 124 and, indeed, the most recent reports with both techniques have either technique alone, 7,46,123–125 An approach that seems particularly valuable is the use of been encouraging. intraoperative MEPs or SEPs to identify those vessels that perfuse the spinal cord and therefore need reattachment, should not be sacrificed, or should not be included within the 7,121,124 Another approach that has been reported to be useful is the use of aortic cross-clamp. intraoperative MEPs to monitor patients and to quickly increase both the123 distal aortic pressure and the mean arterial pressure in response to a drop in MEP amplitude. Nevertheless, although these reports are quite encouraging, the best method of monitoring intraoperative
21 / 22
2009.01.05. 11:52
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
spinal cord function and how best to use the information to alter the operative technique so that postoperative spinal cord function is maintained are still being determined. Previous
Next
Return to Previous Page
22 / 22
2009.01.05. 11:52
Aminoff: Neurology and General Medicine: Neurological Complicatio...
Return to Previous Page
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Print this page
This information has been developed and provided by an independent third party source. Merck & Co., Inc., does not endorse and is not responsible for the accuracy of the content, or for practices or standards of non-Merck sources. This resource may discuss regimens that have not been approved by the FDA. For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences please see the appropriate manufacturer's product circular. View Prescribing Information for Merck products.
Table of Contents This Chapter by Chapters
Keyword Index
Michael J. Aminoff
NEUROLOGY and GENERAL MEDICINE 3 Neurological Complications of Cardiac Surgery JOHN R. HOTSON •
Previous
Next
EXTRACORPOREAL CIRCULATION Technique Consequences During “Normal” Convalescence NEUROLOGICAL SEQUELAE OF CARDIAC SURGERY Brain Disorders Peripheral Nerve Disorders Neuro-ophthalmological Disorders NEUROCOGNITIVE DECLINE RISK FACTORS FOR STROKE PREVENTION OF NEUROLOGICAL COMPLICATIONS CARDIAC TRANSPLANTATION
Neurological complications are a potential consequence of cardiac surgery that can nullify or 1–8 limit any benefits of such surgery. The probability of these complications increases as coronary artery bypass graft surgery is used for treating ischemic heart disease in older patients,9 in patients with multiple comorbid conditions, and as heart transplantation programs expand. In spite of the increased use of catheter-based coronary revascularization, more than 400,000 people per year have coronary artery bypass graft surgery in the United 10 adverse cerebral outcome States. A substantial number of patients have a postoperative 6,11 Many more patients may develop such as stroke or hypoxic-ischemic encephalopathy. 8,12 Prevention of perioperative neurological loss of cognitive performance after heart surgery. complications remains an important medical problem. EXTRACORPOREAL CIRCULATION Cardiopulmonary bypass was first used successfully in cardiac surgery in 1953 and was the 13 pivotal development that led to modern cardiac surgery. Its early use in humans resulted in frequent complications, which restricted its employment to seriously ill patients with progressive heart failure. Although the safety of extracorporeal circulation has increased, it remains a potential cause of neurological complications independent of other heart surgery procedures.
Technique
1 / 10
2009.01.05. 11:53
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Open heart surgery with cardiopulmonary bypass begins with exposure of the heart, usually by a median13sternotomy, followed by cannulation of the ascending aorta and vena cava or material in a right atrium. Insertion of the aortic cannula can dislodge atheromatous 14 severely diseased aorta, thereby leading to cerebral embolization. In addition, this procedure can produce rotational torsion or compression of the brachial plexus, with 15,16 subsequent injury. Extracorporeal circulation is used in association with systemic heparinization, hypothermia, 13 and hemodilution. Anticoagulation is used to prevent clot formation when blood is exposed to the nonendothelial surfaces of the bypass pump oxygenator and microaggregation filtration system. Core hypothermia is often used in combination with selective cooling of the heart, or cold cardioplegia, in order to protect the heart, brain, and other vital organs from ischemic damage. Infusion of ice slush solutions into the pericardium is one technique for inducing 17–19 Normothermic cold cardioplegia, but it occasionally produces focal phrenic nerve injuries. cardiopulmonary bypass may also be used in patients with few risk factors for stroke because 20,21 it provides better hemodynamic function and decreases cardiopulmonary bypass time. Normovolemic hemodilution is used in part to conserve blood loss. It also compensates for the progressive hemoconcentration,13decrease in plasma vol ume, and reduced blood flow that is associated with hypothermia. During cardiac surgery with extracorporeal circulation, the ascending aorta is routinely cross-clamped; during valve-replacement surgery, congenital heart disease repair, or left ventricular aneurysm resection, the cardiac chambers are entered. These procedures may disrupt diseased tissue and produce emboli. Arterial systolic, diastolic, and mean pressure, pump pressure and flow rate, and central venous pressure are monitored during cardiopulmonary bypass. Mean arterial pressure13is usually maintained above 40 to 50 mmHg by vasodilators, pressors, or volume expanders.
Consequences During “Normal” Convalescence Extracorporeal circulation has predictable effects that result in a postperfusion syndrome and 13,22 This syndrome includes systemic inflammatory response during “normal” convalescence. the following conditions. Reduced Clotting Factors. Exposure of blood to an abnormal environment during cardiopulmonary bypass leads to consumption of platelets and coagulation factors. Platelets adhere to the unphysiological surface of the oxygenators and filtration system of the bypass pump. This clumping of platelets not only predisposes to platelet emboli but also can reduce the number of circulating platelets. The exposure to foreign surfaces also causes release and depletion of granule-stored aggregating proteins in 13,22 surviving platelets. Therefore, the remaining platelets have decreased adhesiveness. Coagulation factors are also consumed during cardiopulmonary bypass. A variety of carrier proteins and lipoproteins are denatured when blood passes through the bypass pump oxygenator. Even with adequate heparin levels, these damaged proteins can initiate a 22,23 The clinical significance of cascade in several coagulation and inflammatory systems. these hematological changes is usually minor. They may contribute, however, to the 24 intracranial hemorrhages that are occasionally observed after open heart surgery. Cardiovascular Response. During the early postoperative period, the degree of peripheral 13 vasoconstriction provides a clinical estimate of cardiac output. Transient atrial fibrillation, 25,26 A which carries a risk of cardiac emboli, is common during the convalescent period. metabolic acidosis is also common during the 2 hours immediately after operation and reflects a washout of lactic acid from regions of poor perfusion during extracorporeal circulation. Persistence of a metabolic acidosis may indicate inadequate tissue perfusion 13 secondary to low cardiac output. Red Blood Cell Fragmentation. Exposure of blood to nonendothelial surfaces during bypass surgery causes a breakdown of13red blood cells, with subsequent anemia, hemoglobinemia, and hemoglobinuria. Mild Mental Confusion. Transient mild disturbances of orientation, memory, and level of alertness that resolve13within the first few days after open heart surgery with cardiopulmonary bypass are frequent. Whether the changes in mentation are totally reversible events that accompany most major operations or whether they indicate long-term sequelae is an area of 8,11 sustained interest.
2 / 10
2009.01.05. 11:53
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Brain Swelling. Brain swelling is present when magnetic resonance imaging (MRI) is obtained immediately following coronary artery bypass surgery. When brain imaging studies are repeated 2 to 3 weeks after the surgery, the brain swelling has remitted. There are no 27 clinical findings associated with the brain swelling, and its cause is unknown. These expected consequences of cardiopulmonary bypass are functionally reversible and compensated for during convalescence. Firm evidence that extracorporeal circulation itself permanently harms the brain is lacking. Cardiopulmonary bypass, however, does create numerous potential hazards that, if augmented by procedural mishap, may lead to permanent injury of the central nervous system (CNS). Cardiac operations using extracorporeal circulation carry the risks of embolus formation (from platelets, fibrin, tissue or surgical 13,22 For these reasons, debris, air, or fat), cerebral hypoperfusion, and even hemorrhage. there is 28 interest in performing coronary artery surgery without the use of cardiopulmonary bypass. This off-pump technique can produce excellent cardiac outcomes. It is associated with fewer cerebral microemboli and29,30 less short-term neurocognitive decline when compared The short-term difference in cognitive performance, to on-pump coronary artery surgery. however, is limited, has not been consistently found across studies, and is not statistically 28,30,31 The off-pump technique does not lower the overall stroke rate, but significant at 1 year. may decrease stroke in a high-risk subgroup of patients with a severely atheromatous 32 aorta. Comparisons of performing coronary artery bypass grafting off-pump and28with cardiopulmonary bypass have not proven the overall superiority of either method. NEUROLOGICAL SEQUELAE OF CARDIAC SURGERY Diffuse or multifocal anoxic-ischemic damage, focal cerebral infarction, and brachial plexus injuries remain the main causes of permanent, disabling neurological complications after 1,6,15,33 Therefore, the common, obvious postoperative symptoms include cardiac surgery. diffuse impairment of cognition and level of consciousness, focal deficits from stroke, and isolated peripheral weakness and sensory loss in one arm and hand.
Brain Disorders Stroke, encephalopathy, coma, and seizures are the major brain disorders complicating 6,34 Stroke is reported in prospective studies to occur in 1 percent to more cardiac surgery. than 5 percent of patients following coronary artery bypass surgery, and the incidence 6,21,35–37 Stroke after cardiac increases in association with preoperative stroke risk factors. surgery increases hospital mortality approximately five- to sixfold, prolongs intensive care, 38,39 and typically requires inpatient rehabilitation or nursing home placement. 39The majority of stroke patients who survive to hospital discharge are substantially disabled. Most strokes occur in the first 2 to 3 days after coronary artery bypass surgery, but they may continue with 8,39,40 Stroke occurs more increased frequency during the first 2 postoperative weeks. frequently when valvular heart surgery is combined with coronary artery bypass graft 41,42 This increase is due to the additional risk of cerebral macroemboli with operations. operations that require opening a heart chamber and removal or repair of diseased mitral or aortic valves. Imaging and clinical studies, including cerebral arteriograms, suggest that the main cause of cerebral infarction with either coronary artery bypass surgery or valvular heart 40,43 Diffusion-weighted brain MRI is more surgery is embolization and not hypoperfusion. sensitive that computed tomography (CT) for detecting acute stroke after heart surgery and, when combined with measurements of the apparent diffusion coefficient, distinguishes acute 44 from chronic ischemic lesions. Intra-arterial thrombolysis for stroke occurring 1 to 14 days after heart surgery has been reported as a potential treatment option that merits further 45–47 study. Intracranial hemorrhage is an infrequent cause of stroke, but its rapid 40,48,49 identification is Hematomas may important so that surgical evacuation can be undertaken if necessary. be located in the brain parenchyma or in subdural or epidural spaces. Intracranial hemorrhage may be related to reduced platelet adhesion and coagulation factors during cardiopulmonary bypass. The global encephalopathy that can follow heart surgery varies from coma to confusion or delirium with impaired cognition. Stupor or coma after uncomplicated surgery is infrequent, 34 occurring in less than 1 percent of patients. It may be due to global anoxia-ischemia, massive stroke, or multiple brain infarctions. Postoperative hyponatremic encephalopathy is important to recognize and reverse because it can lead to brain damage and death, 50 Additional, rarely reported causes of encephalopathy or particularly in younger women. 51 52 a hypernatremic hyperosmolar state, and acute obstructive coma include hypoglycemia, 53 hydrocephalus.
3 / 10
2009.01.05. 11:53
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
When anoxia-ischemia is the cause of coma, myoclonus, at times accompanied by seizures, may be prominent. Recurrent postanoxic myoclonus and seizures are often poorly responsive to anticonvulsant therapy. The outcome in these comatose patients is usually extremely poor, 54 with only a rare patient making a meaningful recovery. Clinical assessment55,56 identifies confusion or delirium after cardiac surgery in greater than 8 Its prevalence is even greater in patients57older than 65 to 70 years percent of patients. and in patients with known preexisting cerebrovascular disease. Confusion and delirium after cardiac surgery increase postoperative morbidity and prolong postoperative hospitalization. These encephalopathic patients may be slow to emerge from anesthesia, are often agitated, and have fluctuating moderate to severe impairment of cognitive function. Hallucinations may be present, and occasionally there are bilateral Babinski signs. Improvement often occurs during the first postoperative week. In comparison, patients who are matched for age and clinical condition but who have major surgery for peripheral vascular disease without 3 cardiopulmonary bypass rarely develop such transient impairment of intellectual function. Some confused patients have multiple, acute, small44ischemic brain lesions detected with diffusion-weighted MRI, suggesting multiple emboli. However, in many patients, the cause of confusion or delirium cannot be clinically defined. Coronary artery bypass grafting without the use of cardiopulmonary bypass results in less55frequent postoperative delirium, whereas prolonged operating time increases its frequency. Therefore, exposure to cardiopulmonary bypass appears to be a contributing factor to a transient encephalopathic state in otherwise uncomplicated cardiac surgery. Acute psychosis after open heart surgery has been attributed to a situational psychiatric 58 reaction if the level of alertness and memory remain intact. When the latter processes are also impaired, the psychotic behavior has been called an organic delirium. In patients undergoing cardiac surgery, this differentiation may be incorrect. When the psychotic response has cleared and neuropsychological testing is performed, both groups have similar, 59 multiple cognitive impairments compared to patients without neurobehavioral complications. The diagnosis of an intensive care unit psychosis is usually restricted to reactions that begin 2 to 5 days after surgery, are associated with preserved memory and alertness, and rapidly resolve after treatment with neuroleptic agents or discharge from the intensive care unit. Psychotic reactions that occur during the first 48 postoperative hours in a previously stable patient probably represent a behavioral response to an anoxic-ischemic insult associated with 58,60 cardiac surgery and cardiopulmonary bypass. Seizures may accompany coma, encephalopathy, or delirium, or they may occur 6,34 They occur in fewer than 1 percent of patients, usually independently after cardiac surgery. early in the postoperative period and often within the first 24 hours. Tonic-clonic or partial motor seizures are clinically apparent, but partial complex seizures in an encephalopathic patient may be difficult to recognize clinically. Choreoathetosis after heart surgery, a complication that occurs mainly in children, sometimes raises the question of a seizure 61 disorder. Nonconvulsive status epilepticus may occur with stroke complicating cardiac surgery and will then contribute to a prolonged confusional state that is treatable with 62 anticonvulsant drugs. Therefore, the electroencephalographic evaluation of patients with a persistent encephalopathy may be valuable.
Peripheral Nerve Disorders The brachial plexus and phrenic nerves are the most frequent peripheral nerves injured during cardiac surgery. A polyneuropathy may also occur under certain circumstances. A persistent brachial plexopathy after median sternotomy has been reported to occur in more 1,15,16 Transient and minor brachial plexus injuries may be even than 5 percent of patients. 63 more common. Most frequently, the lower trunk of the brachial plexus is injured. Therefore, the intrinsic hand muscles are often most severely impaired, and the triceps reflex may be decreased in the affected arm. Sensory loss is sometimes present in the affected hand. Pain is prominent in some patients, and a minority have Horner's syndrome. Injuries of the upper brachial plexus can also occur but are less frequent. Although not life-threatening and usually reversible in 1 to 3 months, a brachial plexus injury may produce permanent disability, particularly if it affects the dominant hand or produces intractable causalgia. The plexus injuries may be due to torsional traction or compression during the open heart 16,63 Intraoperative electrophysiological monitoring of upper extremity sensory nerve surgery. conduction reveals significant disturbances during sternal retraction in the majority of patients. This intraoperative monitoring technique can detect functional disorders of the
4 / 10
2009.01.05. 11:53
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
brachial plexus during surgery, predict postoperative nerve injury, and identify intraoperative 64,65 Brachial plexus injuries may be reduced factors that predispose to brachial plexus injury. by minimizing the opening of the sternal retractor, placing the retractor in the most caudal 16 location, and avoiding asymmetric traction. Unilateral phrenic nerve injuries with hemidiaphragmatic paralysis occur in at least 10 percent 18,66,67 The location of the phrenic nerve adjacent to the of patients during open heart surgery. pericardium makes it particularly vulnerable to injury from hypothermia associated with topical cold cardioplegia, as well as injury from manipulation and ischemia. Unilateral phrenic nerve injury causes atelectasis and inspiratory muscle weakness, predisposing to postoperative respiratory complications. Phrenic nerve injury in patients with preoperative chronic obstructive pulmonary disease adds particularly to postoperative morbidity. In most patients, however, morbidity is low. Some recovery is usually evident by about 6 months after injury, but there may be a more protracted course consistent with axonal injury and regeneration. Severe, bilateral phrenic nerve injury is a rare complication of heart surgery and leads to 68 prolonged mechanical respiration. Mononeuropathies resulting from compression or trauma during surgery may involve the accessory, facial, lateral femoral15,69–72 cutaneous, peroneal, radial, recurrent laryngeal, saphenous, A recurrent laryngeal nerve injury with vocal cord long thoracic, and ulnar nerves. 15 Ischemia to the paralysis and a persistent peroneal neuropathy can be disabling. 73 cochlea-auditory nerve can result in severe hearing loss. Most compressive mononeuropathies, however, are transient. This reversibility, usually within 4 to 8 weeks, may reflect the focal selective injury to myelin, with relative sparing of nerve axons, which occurs 74 with compression neuropathies. Awareness of possible intraoperative compression sites helps to prevent these complications. Diffuse paralysis as a result of the Guillain–Barré syndrome may follow otherwise 75 uncomplicated cardiac surgery as well as other surgical procedures. Persistent paralysis also occurs after cardiac surgery in critically ill patients 76 who have renal failure and require days of vecuronium to facilitate mechanical respiration. If heart surgery is complicated by sepsis and multiorgan failure lasting for more than a week, a “critical illness” polyneuropathy and myopathy may develop, with difficulty in weaning from a respirator, distal weakness, and 77 reduced tendon reflexes.
Neuro-ophthalmological Disorders Visual disorders from cardiac surgery are frequent but usually asymptomatic and reversible. Retinal disorders include multifocal areas of retinal nonperfusion in almost all patients, cotton wool spots consistent with retinal infarctions in 10 to 25 percent of patients, and visualization of retinal emboli in fewer individuals. These retinal disorders are infrequently associated with 5,78 reduced visual acuity. An anterior ischemic optic neuropathy is an uncommon, disabling complication of heart surgery. It produces infarction of the optic nerve head, optic disc swelling with a painless and usually permanent decrease in visual acuity. An anterior ischemic optic neuropathy may 78 produce a monocular altitudinal, arcuate, or central scotoma. A retrobulbar or posterior 79 ischemic optic neuropathy due to infarct of the intraorbital nerve is even less common. It produces 80 acute blindness without optic disc swelling accompanied by impaired pupillary posterior ischemic optic neuropathies may produce reactions. Both the anterior and 79 unilateral or bilateral blindness. Homonymous visual field defects occur with focal ischemic injury of the visual cortex or retrochiasmal visual pathways. An occasional patient is found to be cortically blind after heart surgery, usually from bilateral ischemia of the occipital cortex. Retinal and pupillary examination are both normal in patients with cortical blindness. Some of these patients deny 5,78 any visual impairment. At least partial recovery from cortical blindness is possible. Horner's syndrome occurs in association with injuries to the lower brachial plexus and may result from concomitant injury to the preganglionic sympathetic fibers that travel through the 5 eighth cervical and first thoracic ventral roots. It also develops in the postoperative period in81 hypertensive and diabetic patients, presumably due to ischemic injury to sympathetic fibers. Gaze deviations, gaze paralysis, and dysconjugate gaze may occur in postoperative patients who have a brainstem or large hemispheric stroke involving eye movement systems. Intermittent gaze deviation with nystagmoid movements raises concerns about postoperative 82 focal seizures.
5 / 10
2009.01.05. 11:53
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Pituitary apoplexy resulting from acute hemorrhage or infarction of a pituitary adenoma is a 83 rare complication of cardiopulmonary bypass. The pituitary tumor is usually not recognized prior to surgery and is particularly susceptible to the ischemic and hemorrhagic risks associated with cardiopulmonary bypass. After heart surgery, patients awake with headache, ptosis, ophthalmoplegia, and visual impairment from compression of the adjacent cranial nerves and the anterior visual pathways. Transsphenoidal surgical decompression has been used safely in some patients. Infarction of a normal pituitary during coronary84artery bypass surgery also occurs, may initially be silent, and leads to panhypopituitarism. Visual hallucinations solely on eye closure have been reported following cardiovascular 85,86 Patients are otherwise fully alert and lucid and can stop the hallucinations simply surgery. by opening their eyes. Atropine or lidocaine toxicity and complex partial seizures have been associated with such hallucinations. NEUROCOGNITIVE DECLINE Neuropsychological studies of cognitive function before and after cardiac surgery have identified both a transient early and a subsequent late decline in cognitive function occurring 7,87–91 The early postoperative changes in cognition have been shown by after heart surgery. comparing repetitive neuropsychological test results in patients undergoing coronary artery surgery with extracorporeal circulation to nonsurgical control subjects. Performance declines on tests of attention, visuospatial ability, and memory 3 days after coronary artery bypass surgery compared to preoperative testing. A similar decline does not occur in age- and gender-matched nonsurgical control subjects. The impaired neurocognitive performance, 87,89–92 Although numerous however, typically returns to the preoperative level within weeks. factors may contribute to this transient postoperative cognitive impairment, direct evidence of 7 a specific etiology in individual patients is often lacking. A late decline in cognitive function occurs in the interval from 1 to 5 years after coronary 88,90,93 The cause of this late92decline is unproven, in part because few artery bypass surgery. of the longitudinal studies included control groups. One postulated etiology is that diffuse brain microemboli associated with extracorporeal circulation injure a neuronal reserve that is 94,95 Transcranial Doppler needed to compensate for brain aging and to prevent dementia. ultrasonography of the middle cerebral artery and carotid artery can detect microemboli during heart surgery. During cardiopulmonary bypass, there is a continuous dissemination of 78,94,96–98 The brain microemboli producing microvascular occlusions followed by reperfusion. washout of brain emboli 99 and reperfusion may be impaired if there is concurrent systemic or localized hypoperfusion. Patients with a high total microemboli count during heart surgery have a significantly higher frequency of neuropsychological test deficits than patients with low microemboli counts. Patients with long cardiopulmonary bypass durations also have a higher total microemboli 100–102 If extracorporeal circulation count and higher frequency of neuropsychological decline. does lead to a late decline in cognitive performance, then patients with off-pump coronary surgery on the beating heart should have less of a late decline. This comparative study is 103 pending. Evidence exists against the belief that disseminated brain microemboli from the extracorporeal circulation account for the late cognitive decline. Cognitive function 5 years after patients are randomly assigned to undergo either coronary surgery or angioplasty is 104 similar. Cognitive performance at 3 years is also similar in patients receiving on-pump coronary103 artery bypass surgery and a nonsurgical control group with coronary artery disease. One study with a small number of patients in which individuals with preexisting neurological or psychiatric diseases or impaired cognition were excluded showed no late decline in cognitive performance after 3 to 5 years. These patients also had very good 105 vascular risk factor control over the interval of neuropsychological testing. A case-control study found a similar incidence of coronary artery bypass surgery in control subjects and patients with dementia, including a subgroup with a diagnosis of Alzheimer's disease. 106 Coronary artery bypass surgery does not appear to be a major risk factor for dementia. A slow accumulation of microvascular brain ischemia due to vascular risk factors is an alternative explanation for the late decline in neurocognitive performance after cardiac surgery. Elderly subjects with asymptomatic ischemic lesions on brain imaging who have not had heart surgery have a greater decline 107–109 in cognitive function over a period of 3 to 4 years Similarly, subjects with symptomatic than individuals without ischemic lesions. cerebrovascular disease have increased progressive cognitive decline compared to control 110,111 Patients undergoing coronary artery bypass grafts typically have vascular risk subjects. factors for asymptomatic and symptomatic brain lesions that are associated with cognitive
6 / 10
2009.01.05. 11:53
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
112
decline. It would be valuable to know whether very good control of vascular 7,105 risk factors eliminates the late decline in cognitive performance that follows heart surgery. RISK FACTORS FOR STROKE Several preoperative factors have been identified as placing a patient at a higher risk of a neurological complication (Table 3-1). Increasing older age is associated with increasing frequency of neurological and cognitive disorders following coronary artery bypass 6,113,114 A multicenter, prospective study of 5,000 patients found that the occurrence surgery. of stroke was 1 percent in patients younger than 50 years of age, almost 2 percent in patients aged 50 to 59 years, approaching 4 percent in patients aged 60 to 69 years, and greater than 115 5 percent in patients older than 70 years. With a growing elderly population, the number of patients older than 80 years who are evaluated for coronary artery bypass grafts may 116 increase. Click here to view this table.... Dislodgment of prothrombotic atheroma during instrumentation of the aorta is a risk factor for 14,32,117–120 Atheromatous aortic disease can be identified with intraoperative stroke. ultrasonographic scanning and transesophageal echocardiography. Approximately 25 to 50 percent of patients receiving a coronary artery bypass graft have atherosclerotic plaques in their ascending aorta identified by these techniques. The frequency of such aortic disease increases with age and is particularly prominent in patients older than 70 years. Identification 118,121 of a moderately to severely atheromatous aorta may alter surgical management. A preoperative history of hypertension, diabetes mellitus, stroke, severe stenosis of the carotid artery (>70%), and other markers 6,8,38,114,115,122 of vascular disease are also risk factors for stroke Cardiac surgery123 within 3 months of a following coronary artery bypass surgery. stroke may carry a risk of worsening preoperative neurological deficits. The greater the number of preoperative risk factors, the higher is the probability of a perioperative stroke. For example, a 65- to 75-year-old patient with a history of a stroke and hypertension has a risk of postoperative stroke that is three times greater than that of a patient of the same age without a history of stroke or hypertension. A patient older than 75 years with a history of stroke and hypertension has a probability for postoperative stroke that is 13 times greater than a patient younger than 65 years with no previous stroke or history of hypertension. Stroke risk indexes may identify patients124,125 prior to coronary artery bypass surgery who are at high risk of a perioperative stroke. Intraoperative factors also influence the frequency of stroke (Table 3-1). As noted previously, individuals who require coronary artery bypass surgery combined with a left-sided 38,126 Patients who require intracardiac procedure have a relatively high rate of stroke. cardiopulmonary bypass lasting more than 2 hours have a higher number of intraoperative cerebral microemboli detected by transcranial Doppler ultrasound monitoring and a higher 38,115,127,128 A large fluctuation in hemodynamic parameters during frequency of stroke. surgery, such as129 mean arterial pressure, has been associated with postoperative stroke and encephalopathy. The risk from sustained intraoperative hypotension with a mean arterial pressure below 40 to 50 mmHg during cardiopulmonary bypass remains unclear. Atrial fibrillation occurs in approximately one third of continuously monitored patients following cardiac surgery and is a risk factor for stroke. Its initial occurrence is most common during the first 3 postoperative days, and 20 percent of patients have more than one episode. Advancing age is a risk factor for atrial fibrillation, and patients older than 70 years are at high risk of arrhythmia. Withdrawal from β-adrenergic receptor–blocking agents or angiotensin-converting enzyme inhibitors is also associated with recurrent atrial fibrillation. Use of β-blocking drugs or angiotensin-converting enzyme inhibitors preoperatively and postoperatively and β-blockers postoperatively is associated with a reduced risk of atrial 25,115,122,130,131 fibrillation. PREVENTION OF NEUROLOGICAL COMPLICATIONS Attempts to prevent neurological sequelae after cardiac surgery have focused on improved 8,132,133 surgical and cardiopulmonary bypass techniques and neuroprotective drugs. Identification of surgical and technical factors that carry particular risks of neurological 8,13,132 An complications after cardiac surgery has led to the adoption of preventive measures. arterial line microfilter system has been incorporated into the extracorporeal circulation with the aim of reducing cerebral embolization. Improved surgical techniques reduce the bypass time and the total number of cerebral microemboli. Maintenance of the mean arterial blood pressure above 50 mmHg provides a safety margin against periods of relative hypoperfusion.
7 / 10
2009.01.05. 11:53
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
The use of a membrane oxygenator decreases the magnitude of air emboli. Preoperative or early postoperative administration of β-blocking agents decreases the incidence of postoperative atrial fibrillation. Early postoperative use of aspirin decreases ischemic 134 complications of multiple organs including132,135 the brain. Perioperative monitoring and control Delaying heart surgery for 4 or more weeks of hyperglycemia may influence outcome. 132 after a recent stroke has been recommended if the cardiac condition allows such a delay. The benefit of combined carotid revascularization and coronary artery bypass surgery in patients with asymptomatic carotid stenosis awaits confirmation in a prospective clinical 114,136–139 Carotid endarterectomy for patients with severe (70% to 99%) internal carotid trial. stenosis that has been neurologically symptomatic in the past 6 months is of established 140 benefit independent of cardiac surgery. Performing a carotid endarterectomy before or simultaneous with coronary artery bypass surgery in such patients is an accepted 132,141,142 Carotid stenting has evolved as an alternative procedure for such practice.8,138,139,143,144 patients. An increased concern that an atheromatous aorta is a primary source of embolic stroke has led to intraoperative identification with transesophageal echocardiography and epiaortic 14 scanning. The presence of prominent aortic atheroma alters surgical techniques including the site of aortic cannulation, the aorta clamping technique, the use of intra-aortic filtration, and using off-pump coronary artery surgery to avoid manipulation of a severely diseased 28,32,118,132,145,146 aorta. The magnitude of cerebral microemboli and the frequent neuropsychological and anoxic-ischemic findings associated with cardiac surgery suggest a need and opportunity to study brain protective agents. Proposed mechanisms of pharmacological neuroprotection include decreasing cerebral oxygen consumption; decreasing cerebral blood-flow and, with it, the total number of microemboli; interrupting the cascade of cerebral ischemic events that are mediated via excitotoxins such as glutamate; and decreasing the inflammatory response 133,147–151 Clinical trials, and coagulation cascade associated with cardiopulmonary bypass. however, have yet to identify an effective pharmacological neuroprotective agent that has wide clinical application during coronary artery bypass surgery. CARDIAC TRANSPLANTATION Cardiac transplantation is an established treatment for selected patients with progressive, preterminal heart failure. Cardiac transplantation centers now report survival rates at 1 year of greater than 80 to 85 percent, at 5 years of 60152,153 to 80 percent, at 10 years of approximately The annual153 number of heart 50 percent, and at 15 years of 30 to 40 percent. transplantations worldwide is estimated to be greater than 4,000. Neurological sequelae occurring either in the perioperative period or as a late complication may negate an otherwise successful heart transplantation. The early identification of treatable complications offers the best opportunity to prevent severe disability. The perioperative neurological sequelae from cardiac transplantation are similar to the complications associated with valvular or bypass graft surgery, dis cussed previously, except 41 that neurological complications occur more frequently in transplant recipients. Postoperative encephalopathy, stroke, headaches, psychosis, seizures, and peripheral nerve disorders are 154–160 the most common problems. Vascular headaches accompanied by nausea and vomiting may occur in the first week after 156 transplantation. The headaches are associated with a rapid shift from low preoperative to high postoperative mean arterial pressures. Similar headaches may rarely precede an intraparenchymal hemorrhage. These vascular headaches respond to β-adrenergic receptor–blocking agents. 157
Seizures have been reported in as many as 15 percent of patients with cardiac transplants. They commonly occur during the perioperative period. They also occur as a side effect of cyclosporine or as a late complication of a brain infection or tumor. Seizures in the perioperative period are usually due to stroke and may not require long-term anticonvulsant therapy. When anticonvulsant drugs are indicated, phenytoin, phenobarbital, and carbamazepine are often avoided because they induce the hepatic metabolism of cyclosporine, tacrolimus, and sirolimus. When these antiepileptic agents are used, immunosuppression may be reduced. Levatiracetam and gabapentin have negligible hepatic 161 enzyme–inducing effects and few drug interactions and may be preferred anticonvulsants. Pregabalin, a newer antiepileptic drug, has similar characteristics. Psychotic behavior with hallucinations, delusional thought processes, and disorganized behavior can occur during the first 2 weeks after transplantation or as a late complication.
8 / 10
2009.01.05. 11:53
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
When it occurs during the postoperative period, multiple causal factors may be present, but with time, the psychotic behavior usually resolves. When psychotic behavior occurs as a late complication, it is often a manifestation of an intracranial infection, most commonly viral. A thorough neurological evaluation is therefore indicated when a cardiac transplant recipient 154,155 develops an acute late psychosis. Immunosuppression remains a cause of late neurological complications after cardiac transplantation. Opportunistic infections can occur as early as 2 weeks after surgery and immunosuppression, but usually there is an interval of at least 1 month. Focal meningoencephalitis or brain abscess, meningitis, and diffuse encephalitis are three common 154,155,162 Aspergillus fumigatus, presentations of infections in cardiac transplant recipients. Toxoplasma gondii, Cryptococcus neoformans, Listeria monocytogenes, and herpesvirus infections are the more common causes of CNS infections in heart transplant 162,163 recipients. Aspergillosis is the most frequent fungal infection that produces a necrotizing 162 meningoencephalitis and single or multiple brain abscesses. Cerebral aspergillosis is almost always disseminated from a preceding pulmonary infection.164 The abscesses may have MRI ring, irregular, or no contrast enhancement on MRI and CT scans. Diffusion-weighted 165 may demonstrate restricted diffusion of water in the center of the abscess. Aspergillosis also causes an invasive necrosis of intracranial vessels that may lead to hemorrhagic infarction. Therefore, focal hemorrhage on brain imaging is suggestive of Aspergillus infection. The diagnosis is confirmed by direct needle aspiration or biopsy; cerebrospinal fluid studies and cultures usually are not helpful. If the diagnosis is made late, the disease is fatal; early diagnosis and treatment in an immunosuppressed patient, however, improve 166,167 survival. T. gondii is the second most common cause of focal162,168 or multifocal meningoencephalitis and abscess formation following cardiac transplantation. It can produce multiple ring-enhancing lesions, seen with contrast CT scans. MRI may demonstrate additional lesions not apparent on CT and may also show a rapid response to antibiotic therapy. Serological evidence of T. gondii is supportive evidence, particularly if there is seroconversion 168 after transplantation or an increase in titer compared to the preoperative baseline serology. While tissue diagnosis with material aspirated from a brain abscess is diagnostic, a presumptive diagnosis based on imaging and serological testing may lead to a therapeutic trial. Consideration of the diagnosis is mandatory because of the excellent therapeutic 169 cause an inflammatory response to antitoxoplasmic antibiotics. Toxoplasmosis may also170,171 myopathy in association with intracranial and multisystem infection. Other less frequent opportunistic infections that produce focal meningoencephalitis or brain abscess include the rhinocerebral phycomycotic organisms, Candida albicans in the setting of disseminated candidiasis, Nocardia infections, Klebsiella (abscess), and Rhodococcus 155,162,172–175 equi. Meningitis after cardiac transplantation is most commonly due to C. neoformans when the symptoms are subacute or chronic and the white blood count in the cerebrospinal fluid is mildly to moderately elevated with predominantly mononuclear cells. L. monocytogenes is the most common organism when the symptoms are acute and there is a prominent cerebrospinal fluid pleocytosis consisting of polymorphonuclear and mononuclear cells. Coccidioides immitis and Pseudoallescheria boydii, as well as previously mentioned fungi, 154,157,176,177 are less frequent causes of meningitis. Cytomegalovirus, herpes simplex, and herpes zoster encephalitis also occur, in association 157,163,178 with a disseminated viremia, in patients who have undergone cardiac transplantation. Immunosuppression, however, transforms the acute necrotizing focal herpes simplex encephalitis into a more diffuse and slowly progressive process. Progressive multifocal leukoencephalopathy after heart transplantation is thought to be due to reactivation of a JC 179 virus infection that is initially acquired during childhood. Pathogens can also be transferred from donor to transplant recipients, typically causing neurological deterioration during the first post-transplantation month. West Nile virus has been transferred from a donor heart to a 180 heart recipient causing an encephalitis shortly after transplantation. Rabies virus, lymphocytic chorimeningitis virus, and Trypanosoma cruzi are also reported donor-derived 181–183 infections. Immunosuppression for cardiac transplantation combined with Epstein–Barr virus infection can cause a post-transplantation lymphoproliferative disorder that leads to systemic 184 malignant lymphoproliferation including involvement of the brain. Post-transplantation lymphoproliferative disorders may regress with reduction of immunosuppressive therapy or
9 / 10
2009.01.05. 11:53
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
185,186
they may require radiotherapy. The CNS can be the only site of malignant lymphoproliferation in association with Epstein–Barr virus in brain tissue. The response of this 184,187 post-transplantation primary CNS lymphoma to multimodal therapies is often poor. Glioma is another isolated brain tumor that can188occur after heart transplantation, although the relationship to immunosuppression is unclear. Immunosuppressive agents can also cause neurological side effects more directly. Prior to the use of cyclosporine, high-dose prednisone in combination with azathioprine was commonly used. The main side effect of the prednisone was weakness of the proximal lower extremities, osteoporosis 176 with lower thoracic and lumbosacral compression fractures, or psychiatric complications. With the use of calcineurin inhibitors, cyclosporine, and 189,190 tacrolimus, the dose of prednisone has been lowered, thereby reducing its side effects. Cyclosporine and tacrolimus themselves, however, may have neurotoxic side effects, including prominent tremor, headache, a lowered seizure threshold, paresthesias, mental confusion, acute mania, weakness, ataxia, dysarthria, visual hallucinations, and cortical blindness. Brain imaging may reveal a posterior leukoencephalopathy. Diffusion-weighted MRI studies suggest that the onset of neurotoxicity is due to vasogenic brain edema. Vasogenic edema is reversible, which is consistent with the typical remission of adverse effects and MRI findings following reduction of the cyclosporine or tacrolimus dose. Prolonged drug exposure at neurotoxic levels, however, may cause residual neurological 191–193 The newer immunosuppressive agent sirolimus has few reported impairment. neurotoxic effects and may be used as an alternative to cyclosporine or tacrolimus when 194 neurotoxicity occurs. 190
Cyclosporine also induces gout and produces chronic nephrotoxicity. When gout is treated with colchicines, the impaired renal function may lead to colchicine toxicity and a peripheral 195 neuromuscular disorder that improves when the colchicine is stopped. The monoclonal anti-CD3 antibody (OKT3) is used to prevent and treat graft rejection following cardiac transplantation. Aseptic meningitis with fever, headache, seizures, and a variable encephalopathy is reported to occur in 5 percent of patients as a reaction to it. This aseptic meningitis may occur during the course of OKT3 therapy or in the weeks immediately subsequent to it. The aseptic meningitis and encephalopathy resolve within days of 176,196,197 onset. As noted previously, most of the neurological complications of cardiac transplantation with immunosuppression may present with a confusional state in which headache and focal neurological findings may be present or absent. It is not uncommon, however, for more than one complication of 155 immunosuppression to cause symptoms in an individual cardiac transplant recipient. Previous
Next
Return to Previous Page
10 / 10
2009.01.05. 11:53
Aminoff: Neurology and General Medicine: Neurological Complicatio...
Return to Previous Page
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Print this page
This information has been developed and provided by an independent third party source. Merck & Co., Inc., does not endorse and is not responsible for the accuracy of the content, or for practices or standards of non-Merck sources. This resource may discuss regimens that have not been approved by the FDA. For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences please see the appropriate manufacturer's product circular. View Prescribing Information for Merck products.
Table of Contents This Chapter by Chapters
Keyword Index
Michael J. Aminoff
NEUROLOGY and GENERAL MEDICINE 4 Neurological Complications of Congenital Heart Disease and Cardiac Surgery in Children CATHERINE LIMPEROPOULOS • ADRÉ J. DU PLESSIS •
Previous
Next
NEUROLOGICAL DYSFUNCTION BEFORE CARDIAC SURGERY Chromosomal Disorders Cerebral Dysgenesis Acquired Preoperative Cerebrovascular Injury MECHANISMS OF NEUROLOGICAL INJURY DURING CARDIAC SURGERY Intraoperative Brain Injury Focal or Multifocal Hypoxic-Ischemic Injury Global Hypoxic-Ischemic Injury Mechanisms of Postoperative Injury MANIFESTATIONS OF NEUROLOGICAL DYSFUNCTION IN THE POSTOPERATIVE PERIOD Delayed Recovery of Consciousness Postoperative Seizures Periventricular White Matter Injury Stroke Movement Disorders Spinal Cord Injury Brachial Plexus and Peripheral Nerve Injury NEUROLOGICAL COMPLICATIONS OF CARDIAC TRANSPLANTATION
Pediatric neurologists have become increasingly challenged by diagnostic and management decisions in children with congenital or acquired heart disease experiencing neurological dysfunction. Of the 30,000 infants born with heart defects in the United States each year, 1,2 approximately half require some form of surgical intervention within the first year of life. Since the late 1960s, there have been major changes in the clinical profile of neurological injury in children with congenital heart disease. In earlier years, the neurological complications of congenital heart disease were mediated for the most part by chronic hypoxia and polycythemia in cyanotic children, uncorrected right-to-left shunts, and the effects of 3,4 repeated palliative heart operations. Advances in surgical technique and intensive care management have allowed the anatomical correction of many heart lesions in early infancy. These early-life corrective procedures have resulted in major decreases in the mortality rate of congenital heart disease. Consequently, neurological sequelae are now increasingly seen
1 / 11
2009.01.05. 11:54
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
in adult survivors of congenital heart disease. Heart defects considered inoperable in the mid-1980s are now successfully repaired with a very low mortality rate. More infants with critical congenital heart disease and profound hemodynamic disturbances in the newborn period are now rescued, only to manifest later the neurological consequences of this early-life morbidity. Furthermore, the same surgical support techniques responsible for advancing survival have, paradoxically, been associated5 with an incidence of neurological complications that approaches 25 percent in some centers. Consequently, mechanisms of brain injury during cardiac surgery have been the focus of intense investigation over the past two decades. Understanding of these intraoperative mechanisms has been advanced through 6,7 7–12 as well as by intraoperative animal experimental models and several large clinical trials, cerebral monitoring and perioperative magnetic resonance imaging (MRI). More recently, there has been increased recognition that both acquired and developmental brain disturbances in infants with congenital heart disease may have their origin prior to 13–22 It is expected that these surgical intervention, in many cases during the fetal period. mechanisms will receive particular attention over the next few years as the role of fetal 23,24 imaging expands and the potential for fetal interventions is explored. NEUROLOGICAL DYSFUNCTION BEFORE CARDIAC SURGERY Recent studies have demonstrated a high prevalence of neurological abnormalities prior to infant cardiac surgery, in some studies exceeding 50 percent. These abnormalities include 8,13,15,25 as well as microcephaly, hypotonia, behavioral dysregulation, and feeding difficulties 14,16 These preoperative neurological and abnormal electrophysiological studies. electrophysiological abnormalities are increasingly recognized as significant predictors of 14,16,25–28 The presence of these preoperative longer term neurodevelopmental sequelae. abnormalities in the early neonatal period strongly suggests a fetal onset of neurological impairment.
Chromosomal Disorders A number of chromosomal disorders have a phenotype that includes both cardiac and neurological malformations, including trisomies 11, 18, and 21. The most common neurological manifestation in children with trisomy 21, or Down syndrome, is cognitive dysfunction. Epilepsy develops in approximately 5 percent of children with trisomy 21. Congenital heart defects, most commonly endocardial cushion defects, are present in 40 percent of children with Down syndrome. Gross structural brain alterations in Down syndrome include a narrow superior temporal gyrus and a disproportionately small cerebellum and 29 brainstem. Trisomy 13 is associated with ventricular septal defects and patent ductus arteriosus; the associated cerebral dysgenesis in this syndrome is often severe, with holoprosencephaly and agenesis of the corpus callosum being the most common lesions. The most common cardiac lesions in infants with trisomy 18 are ventricular septal defects and patent ductus arteriosus, with neuronal migration defects the usual form of brain 30 dysgenesis. The phenotypic spectrum of specific chromosome 22 deletions, particularly in31the 22q11 region, includes a variety of cardiac malformations and neurological features. Recent population-based data suggest that at least 700 infants with chromosome 22 deletion 32 syndromes are born annually in the United States. The acronym CATCH 22 (cardiac defect, abnormal facies, thymic hypoplasia, cleft palate, hypocalcemia, chromosome 22q11 deletions) has been used to designate this group of apparently related syndromes. The two most common syndromes, DiGeorge and velocardiofacial (or Shprintzen) syndromes, have 33 neurological and cognitive manifestations in association with structural cardiac defects. The fundamental problem in DiGeorge syndrome is a developmental defect of the third and fourth pharyngeal pouches, manifesting with thymic and parathyroid hypoplasia and conotruncal cardiac malformations, which include interrupted aortic arch (type B), truncus arteriosus, and tetralogy of Fallot. A common neurological presentation in both DiGeorge and the velocardiofacial syndrome is hypocalcemic seizures due to hypoparathyroidism. In addition to the usual cardiac lesions (i.e., ventricular septal defect or tetralogy of Fallot), the velocardiofacial syndrome is associated with cleft palate or velopharyngeal insufficiency and a typical facial appearance, including a broad, prominent nose and retrognathia, and microcephaly in up to 40 percent. Neuroimaging and autopsy studies may show a small posterior fossa and vermis, small cystic lesions adjacent to the frontal horns of the lateral ventricles, dysgenesis of the corpus 34–42 Delayed opercular development callosum, and abnormal cortical gyrification patterns. and disproportionately enlarged sylvian fissures as well as white43matter abnormalities might underlie some of the developmental problems in these children, including nearly universal
2 / 11
2009.01.05. 11:54
Aminoff: Neurology and General Medicine: Neurological Complicatio... 44
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp 33,44
learning difficulties. The mean intelligence quotient (IQ) in this syndrome is around 70, with mild to moderate mental retardation in up to 50 percent of patients.
In recent years, a high rate of autism spectrum disorders and attention deficit/hyperactivity 45,46 disorder has been described in this group. 34,36Psychiatric disorders occur in up to 22 percent A peculiar and inappropriately blunt affect of patients with 22q11 deletion syndromes. 47 often evolving to frank psychosis during adolescence and may be evident during childhood, 48 adulthood. Altered prefrontal cortex-amygdala circuitry, reduced cerebellar and thalamic volumes, and increased basal ganglia and corpus callosal volumes, as shown by quantitative neuroimaging studies, may underlie the disrupted emotional processing and form the 38,39,44,49–51 neurobiological substrate for the psychiatric disturbances in these children.
Cerebral Dysgenesis The prevalence of brain dysgenesis in children with congenital heart disease approaches 30 29,52,53 The risk of cerebral dysgenesis appears related to percent in some autopsy studies. the underlying cardiac lesion. For example, infants with hypoplastic left heart syndrome may be at particular risk of associated developmental brain lesions, which range in severity from 52 microdysgenesis to gross malformations, including agenesis of the corpus callosum, holoprosencephaly, and immature cortical mantle. With advances in neuroimaging, the relationship between cardiac and brain dysgenesis is becoming more clearly defined. Clinically, these dysgenetic lesions may present in the newborn period with seizures, alterations in level of consciousness, and abnormalities in motor tone. Conversely, these lesions may remain clinically occult until later infancy and childhood, when they present with developmental delay, epilepsy, and cerebral palsy. For these reasons, it is important to consider cerebral dysgenesis in any child with congenital heart disease and neurological manifestations.
Acquired Preoperative Cerebrovascular Injury Infants with congenital heart disease are at increased risk of acquired antenatal or perinatal brain injury. During fetal life, congenital heart lesions may be associated with changes in cerebrovascular blood-flow distribution and resistance. Fetuses with hypoplastic left heart syndrome, whose cerebral perfusion is supplied retrograde through the ductus arteriosus, 19,20 Preoperative MRI studies have demonstrated that brain injury is may be at particular risk. common in infants with critical congenital heart disease and during invasive diagnostic 54,55 Preoperative findings detected by MRI procedures (e.g., balloon-atrial septostomy). include intracranial hemorrhage, cerebral venous thromboses, thromboembolic infarctions, dilation of the ventricles and subarachnoid spaces (suggestive of cerebral atrophy), 17,18,20,56,57 Elevated preoperative brain periventricular leukomalacia, and gray matter injury. lactate levels have been found by magnetic resonance spectroscopy in over half of 17,24,56 newborns. Complex corrective operations are performed in ever smaller and less mature newborn 58 infants. Consequently, the vascular lesions associated with less mature infants are now seen. Intraventricular/periventricular hemorrhage (IVH-PVH) is a common neurological 59 complication in the newborn. The risk of IVH-PVH is related to the severity of the vascular insult and inversely to the infant's gestational age. Prematurity predisposes to IVH-PVH because of the structural and physiological vulnerability of the immature periventricular germinal matrix. The hemodynamic instability commonly seen in more severe forms of congenital heart disease predisposes to the systemic hypotension or fluctuations in blood 59 pressure that trigger IVH-PVH. Compared with the incidence of 3.5 percent for IVH-PVH in term infants overall, the incidence in term infants with congenital heart disease is as high as 22 16 percent in some studies. At autopsy,6025 percent of infants with hypoplastic left heart syndrome have intracranial hemorrhage. Infants with coarctation of the aorta are also at increased risk of intracranial hemorrhage because of the intracranial vascular malformations 59,61 and hypertension associated with this condition. The detection of intraventricular hemorrhage in infants with congenital heart disease in the preoperative period creates a major management dilemma because the risk of extending such hemorrhage is increased by cardiopulmonary bypass and cardiac surgery. Specifically, cardiopulmonary bypass requires anti-coagulation to prevent clot formation in the bypass 62 circuit; in addition, it has been associated with enhanced systemic fibrinolytic activity. The more complex operations require periods of decreased perfusion to approach the cardiac defect. The requirement for anticoagulation and the potentially severe intraoperative perfusion changes increase the risk of extending any preoperative intracranial hemorrhage. The dilemma is further complicated by the fact that intracranial hemorrhage occurs most
3 / 11
2009.01.05. 11:54
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
commonly in infants with the most critical cardiac lesions, that is, those in greatest need of early surgical repair. There are no prospectively tested protocols for managing the dilemma of preoperative intracranial hemorrhage in infants requiring cardiac surgery. At our center, we use the following guidelines. We perform preoperative cranial ultrasonography to exclude IVH-PVH in all premature infants with a birth weight less than 1,500 g and newborn infants with preoperative neurological dysfunction, coagulation disturbances, or hemodynamic instability causing significant metabolic acidosis. In those infants with IVH-PVH, surgical planning is based on the severity of the cardiac illness (which may directly affect the risk of hemorrhage extension), the likely complexity of surgery, and the severity of preoperative IVH-PVH. Minor 63,64 and should not delay cardiac subependymal hemorrhage carries a low risk of extension surgery. In infants with hemorrhage into the ventricles or the parenchyma, we delay cardiopulmonary bypass for at least 7 days if the cardiac condition permits. MECHANISMS OF NEUROLOGICAL INJURY DURING CARDIAC SURGERY Neurological dysfunction presenting during the early postoperative period is likely due in most cases to intraoperative hypoxic-ischemic/reperfusion injury. However, the risk of cerebrovascular injury extends into the postoperative period, when cardiorespiratory instability, together with cerebral autoregulatory dysfunction, predisposes to cerebral hypoxic-ischemic injury. Despite the remarkable advances facilitated by deep hypothermia and pharmacological agents, the persistent neurological morbidity in the postoperative period 65,66 attests to the incomplete neuroprotection offered by these strategies. The precise onset and evolution of hypoxic-ischemic/reperfusion injury may be difficult to establish. First, the mechanisms of both parenchymal and vascular hypoxic-ischemic/reperfusion injury are known to evolve over time. Second, during the early posthypoxic-ischemic period, cells that have sustained an insult may be at particular risk of irreversible injury from subsequent disturbances in oxygen supply. Consequently, it is difficult to ascribe with any certainty hypoxic-ischemic/re-perfusion injury to one of the preoperative, intraoperative, or postoperative periods. Rather, it is likely that in many cases the injury is multifactorial and cumulative.
Intraoperative Brain Injury There are multiple interrelated mechanisms by which brain injury may occur during cardiac surgery. However, hypoxic-ischemic/reperfusion injury is likely60,67 the principal mechanism, a that is, laminar cortical notion supported by the topography of injury seen at autopsy, 68,69 Animal models of deep hypothermic necrosis and periventricular white matter injury. circulatory arrest have also demonstrated selective neuronal necrosis in a distribution that70 corresponds closely to that seen after normothermic hypoxic-ischemic/reperfusion injury. Neuropathological studies of infants after deep hypothermic cardiac surgery suggest that cerebral white matter lesions tend to be the most prevalent and severe, followed by a 67 spectrum of gray matter lesions. The changes in cerebral perfusion and metabolism during cardiac surgery are complex, interrelated, and often extreme. When these changes exceed the brain's ability to maintain a balance between cerebral oxygen/substrate supply and utilization, a hypoxic-ischemic/reperfusion insult is triggered. The multiple factors determining intraoperative cerebral oxygen availability may be categorized as extrinsic, that is, related to the extracorporeal circulation (e.g., loss of pulsatility, low or no pump flow, hypothermia, emboli) or intrinsic (e.g., disturbances in cerebral blood-flow autoregulation). During deep hypothermic cardiac surgery, cerebral oxygen delivery may be impaired by focal or multifocal vaso-occlusive phenomena generated by 65,66 the bypass circuit or global hypoperfusion due to excessive attenuation of bypass flow rate. Focal or Multifocal Hypoxic-Ischemic Injury The relatively small intravascular volume of the young infant compared with the large blood volume required to “prime” the cardiopulmonary bypass circuit results in increased exposure 65,66 71 These may be either 72 embolic or inflammatory due to the to insults related to the bypass. extensive interface between blood and artificial surfaces. The replacement of bubble oxygenators with membrane devices has decreased but not eradicated the embolic “load” of bypass circuits. Both gaseous and particulate emboli may enter the circulation directly from the surgical field. Because the bypass circuit delivers oxygenated blood directly to the aorta, circulating emboli circumvent the normal pulmonary filtration bed and enter the systemic (and
4 / 11
2009.01.05. 11:54
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
cerebral) arterial circulation directly. Earlier autopsy studies described cerebral embolic brain injury after cardiac surgery, and subsequent studies following cardiopulmonary bypass have 71 described a significant prevalence of cerebral capillary-bed aneurysmal dilatations. Cardiopulmonary bypass activates a host of inflammatory cascades that cause diffuse vascular injury, resulting in a postperfusion syndrome that in severe cases is associated with 73 and multiple organ failure. Pathways triggered include the eicosanoid, complement, 74 cause antioxidant kallikrein pathways. These pathways activate free radical generation, 75 depletion, and upregulate adhesion molecules on neutrophils and endothelial cells. These activated neutrophils appear to be potent mediators of reperfusion injury in the brain. Hypothermia delays and modifies the effect of these processes but does not completely 76 prevent them. Global Hypoxic-Ischemic Injury Several techniques used during neonatal cardiac surgery jeopardize cerebral oxygen delivery by altering cerebral perfusion, arterial oxygen content, and tissue oxygen delivery. Under deep hypothermic conditions, cerebral oxygen availability may be limited by cold-induced 77,78 impairment of cerebral pressure-flow increases in cerebral vascular resistance, 79,80 81 and increased oxygen-hemoglobin affinity. Normally, during periods of autoregulation, decreased perfusion pressure, cerebral oxygen delivery is maintained by an initial 82 However, both these vasodilatory response followed by an increase in oxygen extraction. 83 compensatory responses are compromised at deep hypothermia. To approach the often tiny cardiac defects, the bypass flow rate is decreased and often arrested for periods depending on the complexity of the lesion. Although there are general guidelines for “safe periods” of deep hypothermic circulatory arrest at different temperatures, these remain controversial and unpredictable in the individual infant. In addition, the safety of low-flow bypass compared with hypothermic circulatory arrest has been debated. Low-flow bypass prolongs exposure to bypass-related phenomena, as well as increasing the risk of incomplete ischemia. Conversely, deep hypothermic circulatory arrest (DHCA) allows more rapid completion of the intracardiac phases of the repair and reduces the exposure to bypass 65,66 Over the past perfusion; however, it exposes the infant to periods of complete ischemia. 15 years, a number of studies have focused on the relationship between DHCA and84–87 In the neurological outcome; most studies have reported a deleterious effect on outcome. first major clinical trial randomizing infants to a strategy of predominant hypothermic circulatory arrest or low-flow8 bypass, infants exposed to the former were at significantly 9 greater risk of perioperative and 1-year neurological sequelae. At age104 years, the DHCA group had significantly worse behavior, speech, and language function, but no difference in mean intelligence score. Furthermore, at 8-year follow-up, those assigned to DHCA scored worse on motor and speech domains, whereas those assigned to low-flow bypass had worse 11 scores for impulsivity and behavior. Therefore, the long-term follow-up of this large cohort has provided important insights into the evolution of neurodevelopmental outcome in this 88 complex population over time. Although it is now generally accepted that prolonged periods of uninterrupted DHCA may have adverse neurological effects, certain studies have shown 89–91 that shorter durations of DHCA are not consistently associated with adverse outcomes. In fact, available data suggest that the relationship between DHCA duration and neurodevelopmental sequelae is not linear and that the risk of brain injury increases 84,92 These studies have again emphasized that significantly after about 40 minutes of DHCA. the neurological dysfunction in this population is undoubtedly mediated by numerous interrelated preoperative and postoperative risk factors in addition to DHCA. In addition to the bypass flow rate, a number of other factors associated with cardiopulmonary bypass may affect cerebral perfusion and predispose to hypoxic-ischemic/reperfusion injury. Most centers in the United States use nonpulsatile bypass devices as well as hemodilution to reduce the magnitude of blood cell trauma. Deep hypothermia is widely used to suppress oxygen consumption during infant cardiac surgery. In addition to their intended beneficial effects, these techniques all have potential adverse effects on cerebral oxygen delivery. The nonpulsatile perfusion of cardiopulmonary93bypass, particularly at low-flow rates, may fail to maintain perfusion in distal capillary beds. Furthermore, nonpulsatile blood-flow may disrupt pressure-flow and metabolism-flow 77,80,94 Hemodilution is used during bypass to reduce rheologic injury to autoregulation. circulating red cells during deep hypothermia. However, because the concentration of oxygenated hemoglobin is the major determinant of oxygen-carrying capacity, hemodilution may limit cerebral oxygen delivery. In animal studies, extreme hemodilution (to hematocrit levels less than 10%) was associated with neurological injury, whereas hematocrit levels 6 above 30 percent improved cerebral recovery after DHCA. These experimental results were
5 / 11
2009.01.05. 11:54
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
confirmed by a randomized clinical trial in which infants randomized to a hematocrit of 20 percent during cardiac surgery had significantly worse developmental scores at 1 year than 7 those randomized to a hematocrit of around 30 percent. Another important intraoperative factor is the management of acid-base status during cardiopulmonary bypass. In a randomized, single-center trial, infants undergoing cardiac operations were assigned12to the alpha-stat versus pH-stat strategy during deep hypothermic pH-stat management was associated with lower cardiopulmonary bypass. The use of 12 had no effect on overall early postoperative morbidity. Treatment assignment 95 neurodevelopmental outcome at 1, 2, and 4 years of age. Despite these equivocal findings, many centers are currently using pH-stat management during core cooling. After repair of the cardiac defect, bypass flow rates are increased using rewarmed and highly oxygenated blood. Rewarming aims to reactivate cellular enzyme function and oxygen utilization. During this period of reperfusion, a number of factors may predispose to free 65,66 Several studies have suggested a delay in recovery of mitochondrial 97 radical injury. 96 function, possibly by nitric oxide, which is generated in abundance during the bypass. The combination of a highly oxygenated reperfusion and98persistent mitochondrial dysfunction may after deep be a major source of injurious oxygen free radicals. Excessively rapid rewarming 100 99 hypothermia may be deleterious. Hyperthermia is a trigger for glutamate release, predisposing to excitotoxicity as well as further stressing the recovering cerebral metabolism.
Mechanisms of Postoperative Injury During the postoperative period of intensive care, a number of factors may predispose to brain injury. Cerebral perfusion pressure may be compromised by a combination of decreased cardiac output and elevated central venous pressure resulting from postoperative cardiac dysfunction. In addition to these systemic circulatory factors, there may be intrinsic cerebrovascular disturbances in the postoperative period. Specifically, elevated cerebral 3,66,79,101,102 and impaired vasoregulation vascular resistance, decreased cerebral blood-flow, have been described after deep hypothermic circulatory arrest. Together, these factors may render the brain vulnerable to injury in the postoperative period. MANIFESTATIONS OF NEUROLOGICAL DYSFUNCTION IN THE POSTOPERATIVE PERIOD 103
Recent studies suggest a decrease in acute neurological morbidity following surgery. However, intraoperative and postoperative insults may injure the neuraxis at any level. Because a detailed discussion of the entire spectrum of neurological manifestations is not possible in the current context, this review focuses on the more common clinical issues confronting the child neurologist.
Delayed Recovery of Consciousness Prolonged impairment of mental status after cardiac surgery, anesthesia, and postoperative sedation is a common reason for neurological consultation. The evaluation104should follow the well-established clinical guidelines for assessing impaired consciousness. Certain specific etiologies should be excluded, including postoperative hepatic or renal impairment, which may impair the metabolism or excretion of sedating drugs. Prolonged use of neuromuscular blocking agents in the preoperative or postoperative period may delay the recovery of motor 105 function (discussed later) and, if severe, may suggest impaired consciousness. This condition should be excluded at the bedside with a peripheral nerve stimulator or formal nerve conduction studies. Postoperative seizures are a common complication of cardiac surgery (as discussed in the next section), and not infrequently these seizures are clinically 8 silent. Such “occult” seizures or a prolonged postictal state should be considered in the evaluation of a depressed postoperative mental state. In spite of this approach, the precise cause of an impaired postoperative mental status is not established in most cases. Many of these children ultimately demonstrate features suggestive of hypoxic-ischemic/reperfusion injury.
Postoperative Seizures Seizures early in the postoperative period are among the most common neurological complications after open heart surgery. Postoperative clinical seizures have been reported to 106 occur in up to 19 percent of survivors of neonatal cardiac surgery, and in certain subgroups this risk may reach 50 percent. Clinical seizures are reported8,107 less frequently than those since postoperative seizures detected by continuous electroencephalographic monitoring
6 / 11
2009.01.05. 11:54
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
8
may occur without typical motor correlates.
Postoperative seizures may be divided into two broad groups. First are those seizures with a readily identifiable cause, such as hypoglycemia, hypocalcemia, and cerebral dysgenesis. Postoperative seizures may also result from hypoxic-ischemic/reperfusion injury due to either generalized cerebral hypoperfusion (e.g., cardiac arrest) or focal vaso-occlusive insults. The second and more common category of postoperative seizures is that in which the etiology remains unknown. Although these cryptogenic seizures, commonly referred to as postpump seizures, are often assumed to relate to hypoxic-ischemic/reperfusion injury, their etiology is likely multifactorial8,108 with risk factors that include the use and duration of deep hypothermic circulatory arrest, younger age at106 surgery, the type of heart defect (e.g., aortic arch obstruction), and genetic conditions. Furthermore, postpump seizures differ in several respects from other forms of posthypoxic seizures. First, these seizures typically develop later than, for instance, those occurring after perinatal asphyxia. Second, although less 9 benign than previously believed, the prognosis of postpump seizures is significantly better than that 109 of asphyxial seizures, in which up to 50 percent of survivors are neurologically disabled. Both the delayed onset and more favorable outcome of postpump seizures may be due to the partial protective effect110of hypothermia at the time of intraoperative hypoxic-ischemic/reperfusion insult. The clinical course of postpump seizures is fairly typical. These seizures appear confined to a relatively narrow time-window, with onset between 24 and 48 hours after surgery. This is followed by several days during which serial seizures occur, often evolving to status epilepticus; thereafter, the tendency toward further seizures wanes rapidly. The clinical manifestations of these electrographic seizures are often subtle even in the absence of sedating and paralyzing drugs and may be confined to paroxysmal autonomic changes. When evident, convulsive activity is usually focal or multifocal. The therapeutic approach to postpump seizures should be based on their typical clinical course. After excluding reversible etiologies such as hypoglycemia, hypomagnesemia, and 111,112 the tendency toward repeated seizures and status epilepticus should be hypocalcemia, countered by rapid achievement of therapeutic anticonvulsant levels by an intravenous route. Most postpump seizures are controlled by lorazepam, followed by phenobarbital or phenytoin. Potential cardiotoxicity due to these agents in children recovering from cardiac surgery should be monitored carefully, particularly during the initiation of treatment. The apparently circumscribed window of susceptibility to postpump seizures often allows early withdrawal of anticonvulsants. Prospective studies have demonstrated a significant correlation between postoperative 8 9 seizures and9,106,113 risk of perioperative and 1-year neurological sequelae, as well as abnormal The longer term impact of postpump seizures may be less than MRI studies. 11,88,107 The development of subsequent epilepsy is rare; however, West previously thought. 114 syndrome (infantile spasms, mental retardation, and epilepsy) has been described after more intractable postpump seizures. When postoperative seizures have an identified cause, the long-term outcome is related to etiology. For instance, cerebral dysgenesis, which is increased in congenital heart disease, may present with seizures in the early postoperative period, and here the long-term outcome 106 to is usually poor, with epilepsy a common sequela. Infants with seizures due 115 postoperative stroke have a 20 to 30 percent risk of subsequent epilepsy.
Periventricular White Matter Injury Brain MRI of neonates following cardiac surgery has shown a prevalence of periventricular 116 leukomalacia in excess of 50 percent in some studies ; this is a rare finding in older infants. The precise onset of these lesions remains unclear, but the MRI features appear to be 56 transient in many cases. Reported risk factors for these MRI lesions include prolonged exposure to cardiopulmonary bypass (with or without DHCA), possibly related to inflammatory mechanisms activated by cardiopulmonary bypass. In addition, early postoperative hypotension (especially diastolic) and hypoxemia appear to increase the risk of periventricular 116,117 Magnetic resonance spectroscopy studies are leukomalacia in these MRI studies. beginning to provide insights into disturbed brain metabolism in the postoperative 17,118,119 Although significant decreases in brain N-acetyl-aspartate, a neuronal-axonal period. 118,119 marker, have been described, more recent data have shown an apparently improved cerebral oxidative metabolism postoperatively as evidenced by improved lactate/choline 17 ratios. The long-term significance of these acute structural and metabolic disturbances in children who survive cardiac surgery remains to be determined.
7 / 11
2009.01.05. 11:54
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Stroke The incidence of cerebrovascular accidents (strokes) in children ranges from 2.5 to 8 per 120 leading known association of childhood stroke 100,000. Congenital heart disease is the 120–122 In earlier autopsy studies, almost 20 and is present in 25 to 30 percent of cases. percent of children with congenital heart disease demonstrated features of cerebrovascular injury. Stroke associated with heart disease (cardiogenic stroke) may be classified on the basis of the likely embolic or thrombotic source as (1) cardioembolic (i.e., a probable intracardiac embolic source); (2) paradoxical (i.e., a cardiac anatomy that permits an embolus of systemic venous origin access to the cerebral circulation); or (3) venous (i.e., cerebral vein thrombosis due to central venous hypertension and venous stasis). Risk factors for cardiogenic stroke include the elements of Virchow's triad—altered vascular surface, stasis, and hypercoagulability—as well as the presence of “paradoxical” embolic pathways. Risk factors for cardiogenic stroke have changed over the years. In earlier studies, the risk of stroke was related to the effects of long-standing heart defects, such as chronic hypoxia and polycythemia, and uncorrected paradoxical pathways (e.g., right-to-left shunts). 1 The trend in recent decades toward earlier corrective surgery has reduced exposure to such stroke risk factors, shifting the focus to intraoperative and postoperative mechanisms for stroke. A number of intraoperative mechanisms related to cardiopulmonary bypass may predispose 71 to cerebral vascular occlusion. Embolic material (particulate/gaseous) generated during bypass avoids filtration by the pulmonary bed, gaining direct entry to the systemic arterial circulation. Earlier autopsy data demonstrated a substantial incidence of cerebral embolic infarction after surgery for congenital heart disease. Advances in bypass technique, including refinements in membrane oxygenators, in-line arterial filters, and anticoagulation, have 123 reduced the incidence of macroembolization and large-vessel occlusion. The impact of these advances on the incidence of microembolization and small-vessel disease is difficult to evaluate. The extensive interface between circulating blood and the artificial surface of the bypass circuit may trigger an inflammatory response, which in turn activates complex physiological 72 cascades, including endothelium–leukocyte interactions. This process further enhances the risk of ischemic injury during the intra-operative and postoperative periods. In the postoperative period, factors predisposing to stroke include stasis (intracardiac and extracardiac), altered vascular surfaces (native or prosthetic), and, in some situations, a 124 Intracardiac stasis may result potential procoagulant shift in the humoral clotting systems. 125 from localized areas of low flow or global ventricular dysfunction. Transient or sustained elevations of right heart and, hence, central venous pressure in the 126 early postoperative period predispose to local thrombosis in the right atrium and central veins. Prosthetic material in such areas of disturbed flow increases the likelihood of thrombus formation, and the presence of a right-to-left shunt (native or iatrogenic) compounds the risk of paradoxical embolization. Elevated right atrial pressure transmitted to the cerebral venous circulation predisposes to venous thrombosis, particularly in the dural venous sinuses. Elevated 127 impairment, and systemic venous pressure may cause a protein-losing enteropathy, liver124 pleural effusions, factors that may disturb the humoral coagulant systems. A number of the aforementioned stroke risk factors may be present after the Fontan operation, as highlighted 125,128 In one study, a 2.6 percent incidence of stroke was found in a in several reports. retrospective review of 645125patients after the Fontan operation; the risk extended over 3 a 20 percent incidence of years after the procedure. Rosenthal and co-workers found 128 thromboembolic complications after the Fontan procedure. Strokes originating during or immediately after cardiac surgery may escape clinical recognition for several days because of the effects of postoperative sedating and paralyzing 129 agents. In the young infant, stroke often presents with focal seizures or changes in mental status; focal motor deficits may be subtle. In older infancy and childhood, stroke usually presents with acute focal motor deficits, language disturbance, or visual dysfunction. The therapeutic approach to stroke in the child with heart disease includes (1) preventive and (2) “rescue” strategies. Experience with rescue therapies remains confined to adult and experimental stroke. These rescue therapies aim to salvage potentially viable brain using techniques designed to revascularize ischemic brain regions (thrombolytic therapy) or to 130 curtail injurious biochemical cascades. This discussion focuses on the principles of stroke prophylaxis using antithrombotic agents. Preventive stroke therapy may be categorized as
8 / 11
2009.01.05. 11:54
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
131
primary or secondary. Primary stroke prevention aims to identify and treat high-risk patients before a stroke, whereas secondary prevention aims at minimizing the risk of stroke recurrence. Consistent and universally accepted guidelines for both primary and secondary stroke prophylaxis in children are lacking. Current guidelines are largely empirical, anecdotal, and derived from experience in adults. Established indications for primary stroke prophylaxis in children include prosthetic heart valves, dilated cardiomyopathy, or intracardiac thrombus on echocardiogram. The decision regarding whether and when to initiate secondary stroke prophylaxis with antithrombotic agents should aim to balance the risk of (1) recurrent cerebral embolization and (2) potentiating secondary hemorrhage into an area of cerebral infarction. Embolus recurrence risks after cardioembolic stroke are unknown in children. In adults (after myocardial infarction), this risk is highest in the early 132 poststroke period, at approximately 1 percent per day (10% to 20% over the first 2 weeks). Cardioembolic strokes are 133 particularly prone to hemorrhagic transformation, especially in the early poststroke period. Hemorrhagic transformation occurs (often silently) in 20 to 40 percent of adult cardioembolic 133 strokes. The risk of significant clinical deterioration after hemorrhagic transformation is greater in the anticoagulated patient. Although it is difficult to predict which infarcts will undergo hemorrhagic transformation, certain guidelines have been formulated. Among infarcts destined to83undergo hemorrhagic transformation, 75 percent do so within 48 hours after stroke onset. Large infarcts, particularly those larger than 30 percent, or one lobe, of a cerebral hemisphere, are at greater 134 risk of hemorrhagic transformation. Uncontrolled systemic hypertension and stroke due to septic emboli and cerebral venous thrombosis are additional risk factors for hemorrhagic infarction. The details of antithrombotic management are discussed elsewhere. The cerebrovascular disease associated with infective endocarditis warrants brief mention. The protean neurological manifestations of infective endocarditis include meningitis, brain abscess, and seizures. However, cerebrovascular injury, specifically septic embolism and hemorrhage, is the most common complication. Even with advanced antibiotic agents, neurological complications occur in one third of infective endocarditis cases in children; in 135 one half of such cases, the complications are embolic in origin. Cerebrovascular complications carry the highest mortality rate (up to 80% to 90%), primarily due to intracranial hemorrhage. The risk of and mortality rate of cerebral hemorrhage in this population contraindicates anticoagulant therapy. In all cases of cardiogenic stroke, the possibility of septic embolism should be considered before initiating anticoagulant therapy.
Movement Disorders 136
Reports of serious postoperative movement disorders go back to the early 1960s and the 137,138 Choreoathetosis is the most frequent early days of deep hypothermic cardiac surgery. form of dyskinesia complicating cardiac surgery; other rarer postoperative movement disorders include oculogyric crises and parkinsonism. The reported 139 incidence of 88 postoperative choreoathetosis reached 19 percent in earlier years ; fortunately, this complication has become rare in recent years. Despite their relative rarity, these movement disorders are often dramatic, frequently intractable, and, in severe cases, associated with a substantial mortality rate. Postoperative movement disorders have a fairly typical clinical course. The involuntary movements are preceded in most cases by a 2- to 7-day latent period during which postoperative neurological recovery appears to be uncomplicated. Thereafter, a subacute delirium (marked irritability, insomnia, confusion, and disorientation) develops, followed closely by the emergence of involuntary movements. Typically, these movements start in the distal extremities and orofacial muscles, progressing proximally to involve the girdle muscles and trunk. In severe cases, violent ballismic thrashing may develop. The abnormal movements are present during wakefulness, peak with distress, and resolve during brief periods of sleep. Oculomotor and oromotor apraxia are common, with loss of voluntary gaze as well as feeding and expressive language skills. The involuntary movements often intensify over a 1-week period, followed by a 1- to 2-week period during which movements remain relatively constant. The period of recovery is highly variable in duration. The long-term outcome of postoperative movement disorders depends largely on their initial severity. Mild cases tend to resolve within weeks to months, whereas severe cases have a mortality rate approaching 40 percent and a high incidence of associated, significant, long-term neurodevelopmental deficits, including diffuse hypotonia, persistent dyskinesia (47%), and 137,139 pervasive deficits in memory, attention, language, and motor abilities. The diagnosis of postoperative hyperkinetic syndromes is essentially clinical. Currently
9 / 11
2009.01.05. 11:54
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
available neurodiagnostic studies are useful only for excluding other disorders. Cerebral changes by computed tomography (CT), MRI, and single-photon emission CT are137 nonspecific, seldom focal, and most commonly consist of diffuse cerebral atrophy and a high incidence of both cortical and subcortical perfusion defects. The electroencephalogram is usually normal or diffusely slow, with no ictal changes associated with the involuntary 140 movements. Descriptions of the neuropathological findings at autopsy are limited and inconsistent. Findings have ranged from normal to extensive neuronal loss and gliosis, 140 particularly in the external globus pallidus. Typical features of infarction are characteristically absent. Certain risk factors have been suggested, including (1) cyanotic congenital heart disease, particularly with systemic-to-pulmonary collaterals from the head and neck; (2) age at surgery older than 9 months; (3) excessively short cooling periods before attenuation of intraoperative blood-flow; (4) alpha-stat pH management strategy; 141–143 (5) deep hypothermia and extracorporeal Postoperative dyskinesias, usually circulation; and (6) preexisting developmental delay. 144,145 mild and transient, have been reported after prolonged use of fentanyl and midazolam. Once manifest, the involuntary movements are very refractory to treatment and generally respond poorly to a wide variety of conventional antidyskinetic medications, including dopamine receptor blockers (phenothiazines and butyrophenones), dopamine-depleting agents (reserpine, tetrabenazine), dopamine agonists (levodopa), GABAergic agents (benzodiazepines, barbiturates, baclofen), and other agents such as valproic acid, carbamazepine, phenytoin, diphenhydramine, and chloral hydrate. In general, successful movement control has been achieved only at the expense of excessive sedation. Given these limitations, the management of postoperative movement disorders should focus on the often severe agitation and insomnia. General measures, such as a decrease in the level of external (e.g., noise, light) and internal (e.g., pain) stimuli, are useful in decreasing the intensity of involuntary movements. Judicious use of sedation should aim to restore the fragmented sleep-wakefulness cycle. Oromotor dyskinesia is often severe enough to impair feeding and predispose to aspiration. Nasogastric or even gastrostomy tube feedings may be necessary to meet the high caloric demands of the constant involuntary movements.
Spinal Cord Injury 146,147
Spinal cord injury is a relatively rare complication of pediatric cardiac surgery and usually occurs after aortic coarctation repair, in which 0.4 to 1.5 percent of cases may be affected. Intraoperative spinal cord injury is mediated by hypoxic-ischemic/reperfusion injury to watershed territories in the cord, most commonly in the lower thoracic cord, where transverse infarction results in postoperative paraplegia. An additional watershed zone runs between the supply territories of the anterior and posterior spinal arteries; ischemia in this region results in predominant or selective anterior horn cell loss.
Brachial Plexus and Peripheral Nerve Injury Prolonged immobility during and after cardiac catheterization and surgery predisposes peripheral nerves to pressure and traction injury. Pressure palsies may occur at any dependent site, but most commonly involve the peroneal and ulnar nerves. Brachial plexus 148,149 Injury to the lower plexus results injury is not uncommon after cardiac catheterization. from prolonged traction during the extreme and sustained arm abduction required in some procedures. This neuropraxic lesion resolves gradually but usually completely. During cardiac catheterization, the insertion of indwelling central venous catheters through the internal jugular vein may injure the upper brachial plexus by direct physical trauma or extravasation of blood into the plexus. Phrenic nerve injury results from150 hypothermic injury by ice packed around the heart or from phrenic nerve injury has also been direct intraoperative transection. Postoperative 151,152 Intraoperative phrenic nerve injury presents described after malposition of chest tubes. with diaphragmatic palsy and prolonged postoperative ventilator dependence. The lesion may 153 be confirmed at the bedside by nerve conduction studies and electromyography. Most phrenic nerve injuries resolve spontaneously, but154 occasionally diaphragmatic plication or, in Younger infants are more likely than rare instances, diaphragmatic pacing is required. 151,152 older children to require diaphragm plication. Postoperative ventilation is commonly facilitated by the use of neuromuscular blocking agents. Prolonged use of nondepolarizing agents, especially vecuronium and pancuronium, 105,155–157 The concomitant use of has been associated with neuromuscular dysfunction. 157 steroids may increase the risk. The neuropathological spectrum in these conditions is
10 / 11
2009.01.05. 11:54
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
highly variable, ranging from necrotizing myopathy to axonal motor neuropathy with variable 156 sensory involvement. These conditions may be difficult to distinguish from “critical illness polyneuropathy.” NEUROLOGICAL COMPLICATIONS OF CARDIAC TRANSPLANTATION Cardiac transplantation has become a rescue treatment for children with either primary (myocarditis/cardiomyopathy)158 or secondary (to associated congenital heart disease) 10-year survival rates from various pediatric end-stage myocardial failure. Reported 159 institutions range from 42 to 73 percent. More effective immunosuppression has advanced the survival of transplant recipients; however, long-term immunosuppression remains a major challenge and has well-recognized neurological complications. The passage to heart transplantation is itself fraught with risk of neurological injury, particularly hypoxic-ischemic, as is the transplantation procedure, which may be complex and involve long periods of bypass support. Adult autopsy studies have described brain injury in more than 80 percent of transplant recipients, consisting of vascular (up to 60%), infectious (20%), and lymphoproliferative disorders (13%). In a recent pediatric 160 autopsy study, brain injury was described in 87 percent of transplant recipients. In the first 2 weeks after transplantation, the most common complications are stroke, drug neurotoxicity, hypoxic-ischemic encephalopathy, and acute psychosis. In a recent report, 161 seizures occurred in 21 percent of children post-transplantation. Later, the complications of chronic immunosuppression, such as opportunistic 162 infections, lymphoma, drug neurotoxicity, and metabolic encephalopathy, are more common. Further discussion of these complications is provided in Chapters 3 and 46.
Previous
Next
Return to Previous Page
11 / 11
2009.01.05. 11:54
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
Return to Previous Page
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Print this page
This information has been developed and provided by an independent third party source. Merck & Co., Inc., does not endorse and is not responsible for the accuracy of the content, or for practices or standards of non-Merck sources. This resource may discuss regimens that have not been approved by the FDA. For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences please see the appropriate manufacturer's product circular. View Prescribing Information for Merck products.
Table of Contents This Chapter by Chapters
Keyword Index
Michael J. Aminoff
NEUROLOGY and GENERAL MEDICINE 5 Neurological Manifestations of Acquired Cardiac Disease, Arrhythmias, and Interventional Cardiology COLIN D. LAMBERT • DAVID J. GLADSTONE •
Previous
Next
CARDIOGENIC EMBOLISM Clinical Features Investigations Causes Atrial Fibrillation and Flutter Cardioversion in Atrial Fibrillation or Flutter Chronic Sinoatrial Disorder Cardiomyopathies Myocardial Infarction and Left Ventricular Dysfunction Rheumatic Heart Disease Atrial Myxoma Marantic (Nonbacterial Thrombotic) Endocarditis Other Echocardiographic Abnormalities Linked to Stroke Acute Medical Treatment of Cardiogenic Embolism SYNCOPE INTERVENTIONAL PROCEDURES Coronary Catheterization Percutaneous Transluminal Coronary Angioplasty and Stenting Thrombolytic Therapy for Acute Myocardial Infarction
The neurological manifestations of acquired cardiac disease fall into several categories: 1. The sudden onset of a focal neurological deficit due to occlusion of a cerebral or retinal artery by an embolus that has developed within the heart (cardiogenic embolism) 2. Transient, self-limited episodes of generalized cerebral ischemia that occur as a consequence of brief failures of cardiac output, due to either rhythm disturbances or outflow obstruction, resulting in presyncope or syncope 3. The complications of invasive techniques for the investigation or management of cardiac disease
1 / 16
2009.01.05. 11:55
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
The major exceptions to these generalizations occur with atrial fibrillation (AF), which is associated with embolus formation rather than syncope, and with chronic sinoatrial disorder, which predisposes to both syncopal and embolic disturbances. Topics that are the focus of other chapters are not considered here. In this chapter, the term stroke is used to mean the sudden onset of a focal neurological deficit of ischemic origin. Cerebral embolus is used where the deficit is thought to be of embolic origin. The term cardiogenic embolism is reserved for events in which the embolic occlusion is considered to be the result of a cardiac source of emboli. This chapter addresses three major situations: (1) cardiogenic embolism, (2) arrhythmias and their manifestations (syncope), and (3) interventional procedures. CARDIOGENIC EMBOLISM
Clinical Features Ischemic stroke or transient ischemic attack (TIA) may be classified into six major etiological 1 categories, which have implications for treatment and prognosis. This is the TOAST (Trial of ORG 10172 in Acute Stroke Treatment) classification, the standard now for clinical studies. These categories are cardioembolism, large-artery atherosclerosis, small-artery (lacunar) occlusion, stroke of other determined etiology, stroke of undetermined etiology, and events of multiple possible etiologies. The first four categories are also subdivided into probable or possible. Strokes in the undetermined group are classed as either completely or incompletely evaluated. The last category accommodates those in whom more than one established cause is present. Cardiogenic brain embolism accounts for about 20 percent of acute ischemic strokes overall. Coexistent pathology (i.e., arterial and heart disease in the same patient) may be present in 2 up to one third of patients with a potential cardiac source of embolism. The most common 3 cardiac cause of ischemic stroke is AF, which accounts for about one sixth of all strokes. Other cardiac causes of stroke are listed in Table 5-1. Click here to view this table.... In the young stroke population (generally regarded as patients who have their first stroke 4 around the age of 15 to 45 years), 60 or so causes had to be considered in one study. In that study of 329 patients, cardioembolism was thought to be responsible in 64 (just under 20 percent). There were 13 diagnoses in these 64 patients, with the top three being paradoxical embolism and prosthetic or rheumatic valve disease. No patients had AF, a feature also 5 noted in a Swedish study. Strokes attributable to a cardiac source show striking differences in various studies. In a Persian study of 124 patients, 54 percent were thought to be of 6 cardiac origin. Rheumatic heart disease was the major culprit.7 In contrast, a French study of 296 patients attributed less than 9 percent to a cardiac cause. In Italy, the figure was 34 8 percent. This was a hospital-based study of 394 consecutive young adults with ischemic stroke submitted to a comprehensive diagnostic protocol. Of the 133 considered to be of cardiac origin, these were subdivided into two groups according to TOAST criteria. The smaller group (23) had a probable cause including recent myocardial infarction, AF, valvulopathy, patent foramen ovale (PFO) with deep vein thrombosis (DVT) and atrial myxoma. The much larger group (110 patients) had various possible causes: PFO with right to left shunt (60), atrial septal aneurysm (ASA) (22), and PFO plus ASA (16). Looked at another way, 23 of 394 patients (6%) had an established cardiac cause. Attribution was less certain in 28 percent. In Korea and Taiwan, around 18 percent of cases were attributed to a 9,10 Comparison of etiological factors in the occurrence of TIAs in younger, as cardiac cause. opposed to older, patients disclosed that only two cardiac sources were encountered 11 more frequently in the younger age group: valvular heart disease and mitral valve prolapse. Features suggesting cardioembolism are usually derived from analysis of the clinical presentation and neuroimaging features of acute ischemic strokes that occur in12–19 patients with Emboli cardiac abnormalities thought to predispose to thrombus formation (Table 5-2). may lodge in either the anterior (carotid) or the posterior (vertebrobasilar) circulation. The anterior circulation is affected four times more commonly than the posterior. Least likely to be affected are the20entire internal carotid artery, deep branches of the middle cerebral artery, and brainstem. Although the posterior circulation is less commonly affected, studies of the mechanism of infarction in specific territories (e.g., those of the posterior inferior cerebellar artery and superior cerebellar artery) implicate cardiogenic embolism in 50 percent of 21 with isolated cerebellar cases. A cardioembolic mechanism occurred in 67 percent of cases 22 infarcts (i.e., without concomitant brainstem or occipital infarcts). Embolism is also a
2 / 16
2009.01.05. 11:55
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp 23
common mechanism of infarction within the territory of the posterior cerebral artery. Click here to view this table....
Stroke recurrence rate and prognosis have been estimated in several studies. A meta-analysis showed that the 3-month risk of recurrent stroke was 12 percent if the etiology was cardioembolism, compared to 19 percent for large-vessel atherosclerosis, 3 percent for 24 small-vessel disease, and 9 percent for unknown cause. In a population-based study of first stroke in Bavaria, patients with cardioembolic stroke had the lowest 2-year survival rate (55%) and were three times more likely to be dead at 2 years compared to those with 25 small-artery occlusion.
Investigations The first neurological investigation for suspected stroke is usually a computed tomography (CT) scan of the head to exclude intracranial hemorrhage or other nonischemic pathological processes and to identify signs of acute infarction or vessel occlusion. In patients at high-risk of cardioembolism, cranial CT disclosed infarcts that were more likely to involve one half of a 12 lobe or more, or the infarcts involved both superficial and deep structures. Deep small infarcts were underrepresented and were considered to have a predictive value of 90 percent 12 for the absence of a major cardiac source. Similar conclusions were drawn in an earlier study, namely, that the mechanism underlying lacunes is infrequently embolic and that infarctions in26the pial (superficial) artery territory are usually indicative of an embolic mechanism. The potential for embolic infarcts to develop hemorrhagic transformation remains a concern, especially when anticoagulant therapy has to be considered. A hemorrhagic infarct was seen on the initial CT scan of 612percent of patients in a series of 244 cases, none of whom were In a series of scans performed within 48 hours of onset, the figure receiving anticoagulants. 27 rose to2824 percent ; on prospective follow-up scanning, a total of 40 percent was found at 1 month. With the more sophisticated technology of magnetic resonance imaging (MRI), the figure rose to nearly 70 percent at 3 weeks. Both of the latter studies showed that larger infarcts were more liable to demonstrate hemorrhagic3 transformation, with a figure of 90 29 percent for infarcts with a volume greater than 10 cm . Thus, the key factors that determine whether hemorrhagic transformation occurs appear to be the time of the study, size of the infarct, and technology applied. The age of the patient may also be a factor in that patients 28 older than 70 years may be more liable to hemorrhagic transformation. Because of concerns for the complications of acute stroke treatment by thrombolysis or anticoagulation, early pointers to hemorrhagic transformation have been sought. The only independent predictor identified in a study of 150 consecutive patients was focal hypodensity found by CT scanning within the first 5 hours after stroke onset. Mortality was twice as high in the hemorrhagic-transformation group owing to the larger size of infarcts in that group. Evolution29of the transformation process was similar in anticoagulated and nonanticoagulated patients. MRI is the most sensitive test for detecting 30 early infarction. Diffusion-weighted images are superior to T2-weighted images and to CT. The pattern of diffusion-weighted imaging abnormalities can help to determine the most likely etiological diagnosis. For example, a pattern of multiple acute lesions in more than one vascular territory (bilateral lesions or lesions in the anterior and posterior circulations) suggests a shower of cardiogenic emboli. Single cortical-subcortical lesions are also associated with a cardiac source of emboli. Conventional catheter angiography remains the definitive method for assessing structural abnormalities of the extra- and intracranial circulation. Use of this invasive procedure requires recognition of the associated risks. A review of 15 studies (8 prospective) concluded that the mortality rate was very low (less than 0.1%) but that the risk of a neurological complication (TIA or stroke) was approximately 4 percent and that of a permanent neurological deficit was 31 1 percent. The characteristic angiographic appearance of an embolic occlusion is of a proximal, meniscus-like filling defect in an artery that is otherwise normal and lacks evidence of atherosclerotic change. Emboli tend to fragment. In a study of 142 patients who underwent angiography, the initial procedure, performed at a median of 1.5 days after the precipitating event, revealed an occlusion in 82 percent. Follow-up angiography, at a median of 20 days, 28 showed reopening of the vessels in 95 percent. Distal branch occlusions are often also considered to be embolic manifestations. Conventional catheter angiography has now been largely replaced by noninvasive contrast-enhanced CT angiography or magnetic resonance angiography in many countries because of increased availability and lower complication rates.
3 / 16
2009.01.05. 11:55
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Echocardiography has come to occupy a preeminent place in the structural evaluation of the heart. Transthoracic echocardiography (TTE) is noninvasive but has limitations that can be overcome by using the transesophageal (transesophageal echocardiography [TEE]) route. For the latter procedure, the patient is usually mildly sedated and topical anesthetic is applied to the posterior pharynx. In experienced hands, the procedure was successfully 32 accomplished in 98 percent of instances. The complication rate was less than 1 percent. The technique employed (TEE or TTE) depends on the area to be visualized. The two procedures can be considered complementary; TTE images the left ventricle well, but TEE is required for adequate assessment of the left atrium and its appendage. TEE is also better for visualizing a PFO. TEE is the most sensitive and specific test for detecting a cardiac source of embolism. For patients with AF, TEE may assist in risk stratification and guide 3 cardioversion. A review of papers published between 1966 and 1998 evaluated the yield of TTE or TEE, or both, in various subgroups of patients with stroke. The figures reached were, for TTE, an overall yield of less than 1 percent in patients without clinical evidence of cardiac disease, rising to 13 percent in those with cardiac disease. The corresponding figures for TEE were 33 less than 2 percent and 19 percent. The recommendations reached highlight some uncertainties. It was concluded that there was fair evidence to recommend echocardiography in patients with stroke and clinical evidence of heart disease (grade B recommendation). Because the yield from TEE is higher than that for TTE, controversy arises as to whether this should be the first intervention. Some have preferred a sequential approach with TTE 34 but others have suggested that it is more cost-effective to followed by TEE, if indicated, 35 proceed directly to TEE. Clearly, the area to be visualized is a major consideration. Cardiac MRI is emerging as a new technology for noninvasive structural imaging of the heart. MRI is more sensitive than TTE and comparable to TEE for the detection of cardiac thrombi. Transcranial Doppler ultrasonography is a noninvasive tool that can be of value in the acute stroke setting for detecting acute intracranial vascular obstruction (e.g., due to an occlusive embolus in the middle cerebral artery) and can monitor recanalization following treatment with thrombolysis. It can also be used to detect right-to-left cardiac shunts due to PFO. By identifying microbubbles reaching the middle cerebral arteries, especially following the Valsalva maneuver, contrast-enhanced transcranial Doppler ultrasonography has shown near-perfect 36,37 correlation with contrast-enhanced TEE for the detection and quantification of such shunts. It remains necessary for the clinician to balance extensive investigation against its impact on patient management, usually the justification for lifelong anticoagulant therapy and its consequent risks. In several situations, there are no established guidelines for management. The onus remains on the clinician to determine the significance of potential sources of emboli and their implications for management.
Causes Atrial Fibrillation and Flutter Atrial fibrillation, the most common arrhythmia in medical practice, is a major risk factor for stroke and death. This arrhythmia accounts3 for nearly half of all cardiac causes of stroke and about one quarter of strokes in the38elderly. Strokes associated with AF are generally severe, and 1-year39,40 mortality is 50 percent. AF is also a risk factor for silent strokes and vascular dementia. The prevalence of AF is strongly age dependent, ranging from 0.1 percent among adults 38 older than 55 years to 9 percent in those 80 years38or older. Over 2 million individuals have AF in the United States, and prevalence is rising. AF typically occurs in patients with underlying cardiac disease (i.e., valvular heart disease, heart failure, coronary disease, hypertension, cardiomyopathy, mitral valve prolapse, mitral annular calcification, and cardiac tumors), but may also occur as “lone AF” in young patients who have no cardiac disease. It may be paroxysmal (self-terminating episode, lasting less than 7 days), recurrent (2 or more episodes), persistent (more than 7 days), or permanent (cardioversion failed or not attempted). Reversible or temporary causes include alcohol, surgery, hyperthyroidism, acute 3 myocardial infarction, pulmonary embolism, and pericarditis, among others. The average annual risk of stroke in individuals with AF is 5 percent and is heavily dependent on age and the presence of additional risk factors (Table 5-3). In the Framingham Study, stroke risk41was 1.5 percent in the age group 50 to 59 years and 23.5 percent in those 80 to 89 years.
4 / 16
2009.01.05. 11:55
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Click here to view this table.... It is well established that the risk of stroke in AF is related to the presence or absence of associated structural cardiac disease and other risk factors. For example, in the absence of rheumatic heart disease, there is a fivefold increase in stroke42incidence, but this increases to 17-fold when associated with rheumatic mitral valve disease. Only in lone AF (i.e., fibrillation in the absence of overt cardiovascular disease or precipitating illness) developing in middle age is the prognosis relatively benign. Follow-up at 1543years disclosed a rate of thromboembolic events of 0.55 per 100 person-years. This was equivalent to 1.3 percent of the patients experiencing a stroke on a cumulative actuarial basis. The most important predictor of stroke risk in patients with AF is a history of thromboembolism (i.e., previous TIA, stroke, or systemic arterial embolism). Other independent risk factors for stroke in AF are hypertension, heart failure, increasing age, and diabetes mellitus. Other factors that have been associated with increased stroke risk in some 3 studies include female sex, systolic hypertension, and left ventricular dysfunction. Echocardiographic features that have been used for risk stratification in patients with AF include left ventricular systolic dysfunction, atrial thrombus, dense spontaneous echo contrast or reduced blood flow velocity within the left atrium or left atrial appendage on 44 TEE, and aortic atheroma. Left atrial size does not appear to predict risk of thromboembolism. TEE is the method of choice for evaluating the left atrial appendage, the site at which most thrombi form, and the left atrium. In a prospective study of patients with AF considered on clinical grounds to be at high risk of stroke, risk was 18 percent per year in those with dense spontaneous echo contrast who were treated with low-dose warfarin (international normalized ratio [INR] 1.2 to 1.5) plus aspirin compared to 4.5 percent for those on dose-adjusted warfarin. Prevalence of thrombus in the left atrial appendage was similar initially in the two treatment groups (10% to 12%) when TEE was performed more than 2 weeks after study entry, but atrial thrombus was present in 6 percent of those on warfarin compared to 18 percent of those on combination therapy, and stroke rate was 13 percent per year in the latter group. Absence of thrombus predicted a low rate of ischemic events (2.3% per year); the presence 45 of thrombus predicted a high rate (18% per year). That the risk of stroke in AF can be significantly reduced by anticoagulation was clearly 46–49 A fifth, Canadian, study was terminated prior to established by four independent studies. 50 completion because the other studies51had shown clear evidence of benefit. A meta-analysis published in 1999 evaluated 16 trials. Six were of dose-adjusted warfarin versus placebo. The conclusions drawn from the original four studies were upheld. Warfarin reduced stroke risk by 62 percent overall. Absolute risk reductions were higher for secondary prevention (8.4% per year) than primary prevention (2.7%). These percentages translate into the numbers needed to treat (NNT) of 12 and 37, respectively. Although more intracranial hemorrhages (ICHs) occurred in the warfarin group (0.3% per year) compared to those on placebo (0.1%), this was not statistically significant. Major extracranial hemorrhage occurred in 0.6 percent per year of patients on placebo, with a relative risk of those on warfarin of 2.4 (absolute risk increase, 0.3% per year). The total number of patients in the six trials was 2,900, with an average follow-up of 1.7 years. The aforementioned risk reduction with warfarin was based on intention-to-treat analysis; the on-treatment analysis reveals more than 80 percent relative risk reduction in stroke. This meta-analysis also evaluated adjusted-dose warfarin compared to aspirin. There were five trials, all unblinded, totaling 2,837 individuals. Excluding one study because the range of the INR was wide (2.0 to 4.5), the relative risk reduction for warfarin compared to aspirin was 46 percent. 51
The issue of aspirin as an alternative to warfarin has also been addressed in several trials. Aspirin dose ranged from 25 to 1,200 mg daily. More than 3,000 patients were studied, with an average follow-up of 1.5 years. In patients receiving placebo, the stroke rate was 5.2 percent per year for primary prevention and 12.9 percent for secondary prevention. Aspirin reduced stroke risk by 22 percent, resulting in numbers needed to treat of 67 and 40, respectively. The trials showed only a trend toward reduced stroke in aspirin-treated patients. All-cause mortality was not reduced. The authors suggested that the benefit of aspirin is to prevent nondisabling stroke that is not of cardioembolic origin. Therefore, published guidelines strongly recommend warfarin52rather than aspirin for stroke prevention in individuals with AF who are at high risk. In practice, despite the clear benefit of warfarin in stroke prevention in patients with AF, this therapeutic intervention is frequently underused. Many studies from different countries have 53–55 demonstrated suboptimal rates of appropriate antithrombotic therapy for patients with AF.
5 / 16
2009.01.05. 11:55
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Several potential reasons account for underuse of warfarin, including physician factors, patient factors, and geographic practice variations. Warfarin is a difficult medication for patients because of the inconvenience of INR monitoring, drug and food interactions, and bleeding risks. However, physicians frequently overestimate the bleeding risks 56 but underestimate the benefits of warfarin and overestimate the benefits of aspirin. Although major adverse bleeding events associated with warfarin occur with a relatively low 57 58 incidence, they may profoundly bias physician prescribing behavior. There is often a bias against prescribing warfarin to patients of advanced age, especially elderly women, despite 59 the fact that safety in patients 80 years and older has been established. Individual patient preferences, knowledge, and attitudes affect compliance with long-term anticoagulation therapy. Among AF patients taking warfarin in one study, about one half did not know that AF was a risk factor for stroke and could not state why they were taking warfarin; ethnic differences in knowledge about their diagnosis and treatment were also 60 identified. Methods to encourage compliance with appropriate antithrombotic prophylaxis include use of a patient decision aid. One such tool is available for download at www.canadianstrokenetwork.ca/research.clinicians.php and is highly recommended for use by primary care physicians and specialists who are counseling AF patients about the benefits and risks of warfarin compared to those of aspirin for stroke prevention. A home INR finger-stick device for self-monitoring may increase the duration patients spend in the 61 therapeutic INR range. Bleeding is the major concern with anticoagulant therapy. The average risk of major bleeding in the clinical trials was 1.3 percent per year with warfarin compared to 1 percent with aspirin 62 rate of major or placebo. The Stroke Prevention in Atrial Fibrillation study had a higher 62 bleeding at 2.3 percent on warfarin and 1.1 percent per year on aspirin. Rates of ICH were 0.9 percent per year and 0.3 percent per year, respectively. Age older than 75 years increased the risk of major hemorrhage to 4.2 percent per year (relative risk = 2.6) compared to 1.7 percent per year in the younger population. Of patients on warfarin, 16 were in the therapeutic range, 4 were below, and 13 were above at the time of their bleed. All had had therapeutic levels on their last routine prothrombin time ratios. Intensity of anticoagulation was a risk factor for bleeding only in those older than 75 years. The other identified risk factor 62 was the use of more than three prescription drugs. Interestingly, in another study, patients with cerebral ischemia of presumed arterial origin had a substantially higher risk of ICH than 63 those anticoagulated for AF. Leukoariosis is a newly identified risk factor. Analysis of a cohort of patients attending five anticoagulation clinics documented the cumulative risk of bleeding over an 8-year period. Serious bleeds occurred at a rate of 7.5 events per 100 patient-years. Points that emerged were that the incidence of bleeding and thromboembolic complications remained approximately constant, with a prothrombin time ratio of 1.3 to 2.0, but it increased sharply above or below those limits (i.e., thromboembolism was much more likely with a prothrombin time ratio of less than 1.3). No increase in bleeding complication was found related to any specific indication for therapy, including cerebrovascular disease. Older patients did not have a greater risk of bleeding. The highest risk of bleeding was seen during the first 3 months of therapy, and then it tended to plateau somewhat. Of particular note was the high risk of recurrence (32%) in patients who experienced one serious bleed. It was also noted that patients who had more than four dose 64 adjustments per year bled 25 percent more often than those who had fewer adjustments. With the exception of some patients with lone AF, all patients with AF (regardless of whether this is paroxysmal, persistent, or permanent) require some form of antithrombotic therapy unless contraindicated. It remains necessary to individualize management strategies for specific patients, taking into account compliance, risk of bleeding complications, and other medical conditions. Risk stratification is essential to determine the optimal treatment, i.e., warfarin or aspirin. Many different schemes have been devised for identifying patients with AF unassociated with valvular heart disease that are at high, moderate, or low risk of stroke. According to the 2006 American Heart Association guidelines, high risk factors 3are previous stroke, TIA, or systemic embolism, mitral stenosis, and prosthetic heart valves. Moderate risk factors include age 75 years or older; hypertension; heart failure; left ventricular ejection fraction 35 percent or lower; and diabetes. Warfarin is recommended for patients with any high risk factor or more than one moderate risk factor. This means that all patients with a previous ischemic stroke or TIA are considered at high risk and require warfarin anticoagulation for secondary stroke prevention, unless contraindicated. Warfarin or aspirin (81 to 325 mg) is recommended for those with only one moderate risk factor. Aspirin alone (81 to 325 mg) is considered sufficient for patients without any of these risk factors. For patients receiving warfarin, the target INR should be 2.5 (range 2.0 to 3.0). The INR should be monitored closely: usually weekly initially and then monthly once stable. A
6 / 16
2009.01.05. 11:55
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
minimum INR of 2.0 is recommended for stroke prevention; stroke risk increases 65 exponentially as the intensity of anticoagulation declines. In addition to protecting against stroke, antithrombotics attenuate stroke severity: patients taking warfarin at the time of stroke have less-disabling strokes compared to individuals taking aspirin or no antithrombotic therapy, and stroke severity is negatively correlated with 66,67 Table 5-4 gives a summary of the indications for warfarin in INR at stroke onset. secondary stroke prevention for patients with selected cardiac conditions. Click here to view this table.... For patients with a mechanical heart valve, the INR should be maintained above 2.5, and for 52 secondary stroke prevention, the target INR should be 3.0 (range 2.5 to 3.5) Dual antiplatelet therapy (aspirin plus clopidogrel) was investigated in a randomized trial and found to be inferior to warfarin for stroke prevention in AF and associated with a higher rate of 68 adverse bleeding events than warfarin. If warfarin therapy needs to be interrupted for surgical procedures, temporary discontinuation for up to 1 week is usually considered reasonable for patients without mechanical heart valves. However, this practice can be associated with increased stroke risk. Heparin may be substituted in high-risk patients. In addition to medical therapy for stroke prevention in AF, interventional techniques are being investigated. These include percutaneously implanted left atrial appendage occlusive devices and surgical resection of the left atrial appendage, given that 91 percent of thrombi are 69 localized at that site. Carotid artery endovascular devices to filter emboli are also under investigation. Cardioversion of AF to sinus rhythm (either pharmacological or electrical) does not reduce the risk of stroke and therefore does not obviate the need for continued anticoagulation 70,71 therapy for stroke prevention. AF occurring in the postoperative setting following cardiac surgery is fairly common and usually self-limited. Anticoagulation is reasonable if AF persists for more than 48 hours, but it may not need to be continued long-term if sinus rhythm is restored. Similarly, other conditions associated with transient AF (e.g., alcohol, thyrotoxicosis) usually do not need long-term 3 antithrombotic prophylaxis. In patients with atrial flutter, the risk of thromboembolism is thought to be less than that for AF but higher than for patients in sinus rhythm. These patients frequently go on to develop AF. For practical purposes, the antithrombotic treatment recommendations are similar to 3 those for AF. Cardioversion in Atrial Fibrillation or Flutter Cardioversion (electrical or pharmacological) undertaken to convert AF back to sinus rhythm is associated with an increased risk of thromboembolism. Review of7222 series published over a 30-year period showed an overall risk of embolism of 1.5 percent. Figures have changed 73 It appears that up to 3 weeks may be little in recent years, with an incidence of 1.3 percent. 74 required for atrial mechanical activity to recover. It is therefore recommended that warfarin (INR 2.0 to 3.0) be given for at least 3 weeks before elective cardioversion of patients who have been in AF for 2 days or more or when the duration of AF is unknown and that it be 3 continued until normal sinus rhythm has been maintained for 4 weeks. For patients requiring immediate cardioversion, intravenous heparin is recommended 3 concurrently followed by warfarin for at least 4 weeks. Alternatively, TEE prior to cardioversion can be performed; if no thrombus is detected, then cardioversion can occur as soon as the patient is anticoagulated and continue for at least 4 weeks. If a thrombus is detected on TEE, warfarin is recommended for at least 3 weeks before and may need to be continued for a longer duration afterward. 3
The recommendations for cardioversion in atrial flutter are the same as for AF. Atrial flutter has been studied less extensively than AF, but embolism can occur in relation to cardioversion or during subsequent months. The total incidence of acute and chronic events was found to be 7 percent over a period of 26 75 ± 18 months in a consecutive series of 191 unselected patients undergoing cardioversion. The same percentage was found in a smaller study of 86 patients who were followed for a longer period (mean,764.5 years). Annual risk was estimated at 1.6 percent, one third of the rate for those with AF. Prior
7 / 16
2009.01.05. 11:55
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
transesophageal echocardiography is not an adequate predictor of those at risk. A total of 3 of 41 patients who had no left atrial77clot developed ischemic neurological syndromes within echo contrast was a more 48 hours of elective cardioversion. In another study, spontaneous 78 common finding than atrial thrombosis (34% versus 11%). Chronic Sinoatrial Disorder As with atrioventricular block, chronic sinoatrial disease (sick sinus syndrome) presents usually with syncope and dizziness but differs in predisposing to systemic embolism. In a study comparing age- and sex-matched control subjects with atrioventricular heart block to those having chronic sinoatrial disorder, prevalence of systemic embolism was found in 16 percent of those with 79 sick-sinus syndrome compared to 1.3 percent of those with patients with the atrioventricular block. Other studies have disclosed similar figures; 80,81 Insertion of a “brady-tachy” form of the disorder appear to be particularly at risk. pacemaker does not protect against embolic phenomena. In one series, 6 of 10 strokes developed after pacemaker insertion. Only one of these patients was anticoagulated at the 82 time. Concern was raised that, although ventricular pacing provides symptomatic relief, this modality may worsen the underlying disease process by increasing the rate at which AF, 83 congestive heart failure, and thromboembolism occur. Many studies relating to various pacemaker types have followed. A Cochrane review noted poor quality of reporting but concluded that physiological (primarily dual-chamber) pacing had a statistically significant 84 benefit in preventing the development of AF compared to ventricular pacing. A nonsignificant preference for stroke prevention was found. A large subsequent study, also comparing ventricular with dual-chamber pacing, concluded that clinical features were the 85 key predictors of stroke. In the same year, a Danish study showed single-chamber atrial pacing to be superior to dual-chamber pacing in the prevention of AF and 86 thromboembolism. Patients in the brady-tachy group were noted to be more at risk of developing AF and stroke. It was concluded that warfarin treatment should be considered for these patients. Cardiomyopathies This continues to be a rapidly changing field. A new definition and classification were 87 proposed in 2006. Cardiomyopathies are defined as “a heterogeneous group of diseases of the myocardium associated with mechanical and/or electrical dysfunction that usually ‘but not invariably’ exhibit inappropriate ventricular hypertrophy or dilatation and are due to a variety of 87 causes that frequently are genetic.” Specifically excluded are those diseases of the myocardium secondary to congenital or valvular heart disease, systemic hypertension, or atherosclerotic coronary disease. The cardiomyopathies are then divided into two major groups based on predominant organ involvement. The primary cardiomyopathies are those solely or predominantly confined to heart muscle. Genetic, mixed, and acquired forms are recognized. Both hypertrophic and dilated cardiomyopathies are considered primary diseases. Also now included are the ion channel disorders, in which there is a primary electrical disturbance without structural cardiac pathology. These are further considered in the section devoted to syncope. The list of secondary cardiomyopathies is extensive. Neuromuscular or neurological causes listed are Friedreich's ataxia, Duchenne or Becker muscular dystrophy, Emery–Dreifuss muscular dystrophy, neurofibromatosis, and tuberous sclerosis. Surprisingly, the mitochondrial cytopathies, quintessentially multisystem disorders, are listed as primary cardiomyopathies. The secondary cardiomyopathy table classification does not include infective processes, such as Chagas' disease or infection with human immunodeficiency virus, although these are briefly mentioned in the text. In North America, the most common cardiomyopathy is hypertrophic cardiomyopathy, which 88 is an autosomal-dominant disease affecting 1:500 of the general population. The disorder is notorious as 89 a major cause of sudden cardiac death in athletes but is compatible with survival until old age. Mortality rates overall have been estimated at 1.0 to 1.5 percent for ages 16 to 65, 3.9 percent over the next decade, and 4.7 percent for ages older than 75 years. Risk was 90 risk in hypertrophic generally similar in Western and Asian populations. Stroke 91 cardiomyopathy has been studied in a group of 900 patients. Stroke occurred in 44 patients over a period of 7 ± 7 years. A small number (7) of other vascular events were noted. Age at first event ranged from 29 to 86 years, with a mean of 61 ± 14 years. Stroke was particularly associated with advanced age, congestive symptoms, and AF. The cumulative incidence of events was significantly higher in nonanticoagulated patients with AF compared to those receiving warfarin. Other studies confirm increased risk of stroke when AF develops in
8 / 16
2009.01.05. 11:55
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
hypertrophic cardiomyopathy, but surprisingly also identified a subgroup in which the course 92 92,93 also increased the risk of stroke. The odds was largely benign. Outflow tract obstruction 92 ratio for stroke in patients with AF was 17.7. There are considerable geographic variations in the causes of cardiomyopathy. In Latin America, American trypanosomiasis (Chagas' disease) is a major cause. Stroke has been increasingly well documented as a complication. A study of 94 consecutive stroke patients with the cardiomyopathy of Chagas' disease compared these with 150 consecutive stroke 94 patients without Chagas' disease. A cardioembolic basis for stroke was considered present in 56 percent of the former compared to 9 percent of the controls. Most strokes in the group with Chagas' disease were in the anterior circulation (85%); the posterior circulation was rarely affected (5%) and less than 10 percent of the patients presented with lacunar syndromes. In Chagasic cardiomyopathy, the apical region of the left ventricle is the typical site for formation of thrombosis or aneurysm. Echocardiography in this study revealed an apical aneurysm in 37 percent and mural thrombosis in 12 percent, but the most common finding was left ventricular diastolic dysfunction (49%). The ECG was abnormal in 67 percent. The most common abnormality was a right bundle branch block pattern (35%), followed by left His fascicular block (17%), and AF (15%). A pacemaker had been inserted in 10. Oral anticoagulation has been recommended for all94individuals with Chagasic stroke who demonstrated risk factors for cardioembolism. In Africa, the major cardiomyopathy is the dilated type, but peripartum cardiomyopathy is 95 ubiquitous with an incidence ranging from 1:100 to 1:1,000. There are regional variations: endomyocardial fibrosis is restricted to the tropical regions of East, Central, and West 95 Africa. The incidence of human immunodeficiency virus (HIV)–associated cardiac disease, including cardiomyopathy, is increasing in contrast to developing countries where the availability of96highly active antiretroviral therapy has significantly reduced the incidence of myocarditis. In Japan, hypertrophic cardiomyopathy is the most97common cause of cardiomyopathy, followed closely by dilated cardiomyopathy (DCM). Cardiomyopathy associated with the prolonged QT interval syndrome came in a distant third, followed by mitochondrial disease, 97 arrhythmogenic right ventricular dysplasia, and Fabry's disease of the heart. In young adults arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is 98 another rare hereditary disorder causing sudden death. In a natural history study of 130 patients, 100 male, age at onset of symptoms was 32 ± 14 years. The annual 99 mortality rate Diagnosis was 2.3 percent; all patients who died had a history of ventricular tachycardia. 87 requires a high index of suspicion. In the dilated cardiomyopathies, a necropsy study showed a high incidence of embolic events (systemic or pulmonary) at 60 percent of 152 cases. In the living, once52a TIA or stroke has occurred, either warfarin or antiplatelet therapy should be considered. There is insufficient evidence to recommend warfarin or antiplatelet therapy for primary prevention, in the 100 absence of other indications. Myocardial Infarction and Left Ventricular Dysfunction 101
Patients with a history of coronary artery disease have a threefold increase in stroke risk. 102 This risk is particularly high within the first month after myocardial infarction (MI). Mechanisms include embolism from left ventricular 103 mural thrombosis and the development of AF (which occurs in up to 20% of patients after MI). A community-based study of 2,160 patients hospitalized between 1979 and 1998 found stroke risk during the 30 days after a first MI to be increased 44-fold, and it remained two to 102 three times higher than expected during the subsequent 3 years. Of note, the 20-year duration of the study enabled the conclusion to be drawn that acute MI treatment by 102 following MI is approximately 1 thrombolysis did not reduce stroke risk. Overall, stroke risk104,105 For a non-ST elevation percent during the first month and about 2 percent at 1 year. 106 acute coronary syndrome, the early stroke risk was found to be 0.7 percent at 3 months. In large randomized trials of aspirin versus the combination of aspirin and clopidogrel in patients 103 with MI or acute coronary syndrome, the stroke rate ranged between 0.9 and 1.7 percent. In a meta-analysis, predictors of stroke following MI included advanced age, diabetes,104 hypertension, previous stroke or MI, anterior MI, AF, heart failure, and nonwhite race. 107 Anterior wall MI has been a predictor of stroke in some, but not all, studies. Left ventricular
9 / 16
2009.01.05. 11:55
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
thrombus develops in about one third of individuals in the first 2 weeks following an anterior 108 MI. A meta-analysis of 11 studies concluded that mural thrombus formation after an MI109 poses a significantly increased risk of embolization, which is reduced by anticoagulation. The current recommendation, in the absence of thrombolytic therapy, is that, after acute MI, heparin should be initiated and followed by warfarin for 3 months in patients considered to be at increased risk of embolism, either pulmonary or systemic. High-risk patients are those with severe left ventricular dysfunction, congestive heart failure, a history of pulmonary or systemic embolism, echocardiographic evidence of mural thrombosis, or the presence of AF. Because of the increased frequency of mural thrombosis in anterior as opposed to inferior myocardial infarcts, it is also recommended that patients with an anterior Q-wave infarction 110 receive heparin followed by warfarin. In patients with TIA/ischemic stroke related to an acute MI in which LV mural thrombus is identified, oral anticoagulation is recommended for at least 3 months and52up to 1 year (INR 2 to 3) in addition to aspirin for coronary artery disease (up to 162 mg/day). Stroke risk is inversely proportional to left ventricular ejection fraction (LVEF). In a study of 2,231 patients with LV dysfunction after an acute MI, those with LVEF less than 29 percent had a stroke risk nearly double that of patients with LVEF exceeding 35 percent: the annual stroke rate was 1.5111 percent overall. Thus, reduced LVEF is an independent risk factor for in risk of embolic events for subsequent stroke. Another study found a 58 percent increase 112 every 10 percent decrease in LVEF in women, but not men. Congestive heart failure carries a two- to threefold increase in the relative risk of stroke. Among patients enrolled into heart failure trials, the overall annual stroke 113 risk has ranged between 1.3 to 3.5 percent; most patients were taking aspirin or warfarin. In the absence of clinically overt heart failure or MI, the presence of asymptomatic left ventricular systolic 114 dysfunction, even of mild degree, is an independent risk factor for stroke. The optimal antithrombotic prophylaxis for patients with poor LV function remains uncertain; 115 the efficacy of warfarin versus aspirin is the subject of ongoing trials. Rheumatic Heart Disease Extensive experience has accumulated over several decades concerning the association of systemic embolism with rheumatic heart disease. A 1973 review concisely summarized 116 relevant features. A minimum of 20 percent of patients with rheumatic heart disease experience a thromboembolic complication at some time, and 40 percent of these arterial emboli involve the brain. Embolic events are the cause of death in 16 to 35 percent of adults dying of rheumatic heart disease, and subgroups of patients having a much greater frequency of embolic complication can be identified. The risk of embolism is substantially increased when atrial thrombus is present (risk increases from 16% to 41%) or AF develops (risk increases from 7% to 30%). The proportion of patients developing left atrial thrombus increases from 9 to 41 percent when AF is present; conversely, 80 percent of patients with atrial thrombus are in AF. Embolism is most likely to occur when the dominant valvular lesion is that of mitral stenosis, either alone or in combination with aortic valve disease or mitral insufficiency. Isolated aortic valve disease is rarely associated with embolic events. Older patients more frequently have AF, atrial thrombus, and embolic events. Studies of atrial thrombosis initially involved TTE, an insensitive method. Of 293 patients in one study who were to undergo open heart surgery, TTE disclosed thrombi in the left atrium in 33. At surgery, this was confirmed in 30 of the cases, but the study had missed 21 additional patients, including all 11 in whom thrombus was located in the left atrial 117 appendage. 118
Once embolization has occurred, recurrence rate is high, approaching 60 percent. Current recommendations are therefore strongly in favor of the use of long-term warfarin (to prolong the INR to 2.0 to 3.0) in patients with rheumatic mitral valve disease who have a history of systemic embolism or who develop AF, either chronic or paroxysmal. It is also recommended that the same treatment be given to patients in normal sinus rhythm if the left atrial diameter is in excess of 5.5 cm. Furthermore, if recurrent systemic embolism occurs despite adequate 119 warfarin therapy, addition of aspirin should be considered. The beneficial effect of adding aspirin,120 100 mg daily, to warfarin has been demonstrated in the context of prosthetic heart valves.
10 / 16
2009.01.05. 11:55
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Atrial Myxoma Atrial myxomas have long been recognized as a cause of cerebral embolism. They are uncommon. A French hospital reviewed experience with 112 cases collected over 40 121 years. Women outnumbered men 72 to 40; ages ranged from 5 to 84 years. The presenting symptoms were cardiac, constitutional, and embolic in 67, 34, and 29 percent, respectively. Younger and male patients were more liable to have embolic events.122 Neurological manifestations, in 113 patients, were evaluated in a literature review. Ischemic stroke was the most common at 83 percent, often at multiple sites. Syncope (28%), psychiatric presentations (23%), headache (15%), and seizures (12%) were all encountered. In a Spanish study of 28 patients, it was noted that in the 9 with stroke, TIA had preceded the 123 A rare delayed complication is that of distal multiple stroke in 7. Treatment is surgical. 124 cerebral aneurysm formation. Transient ischemic attacks led to this diagnosis 5 years after successful surgery in one person. Symptoms were controlled with clopidogrel. Marantic (Nonbacterial Thrombotic) Endocarditis Although there are several causes of nonbacterial thrombotic endocarditis, a review of 14 series, predating the era of echocardiography, found an underlying malignancy in half. The most common tumor was lung cancer. Cancers of gastrointestinal origin accounted for a similar number of cases. Breast cancer appeared underrepresented. The mitral valve was most commonly affected (43%), followed by the aortic valve (36%). Overall, embolism 125 cancers of the occurred in 42 percent of patients. An autopsy series (171 cases) found126 ovaries, biliary system, pancreas, stomach, and lung to be most common. The widespread availability of echocardiography has facilitated recognition of vegetations. A prospective study of 200 unselected ambulatory patients with solid tumors found vegetations in 19 percent compared to 2 percent in controls. Vegetations were seen in 50 percent of pancreatic cancers, 28 percent of lung cancers, and 19 percent of lymphomas. Only two 127 patients had cerebral events. On MRI, numerous lesions of various sizes may be found in multiple arterial territories. At one cancer center, 96 stroke patients were assessed. Echocardiography (TTE) was performed in 61; none had TEE. An embolic mechanism was thought to be causative in 52. The heart was implicated in 14, but nonbacterial thrombotic endocarditis in only 3. Stroke of embolic origin carried a dismal prognosis. Life expectancy was just over 2 months, and 128 treatment had no apparent influence. Other Echocardiographic Abnormalities Linked to Stroke Patent Foramen Ovale and Atrial Septal Aneurysm
A PFO is present in about one quarter of adults and represents a potential mechanism for 129 cardiogenic embolism. Case-control studies of young adults (younger than 55 years) with cryptogenic stroke found130a fivefold increase in prevalence of PFO compared to control subjects without stroke. In a French prospective study of individuals with stroke and an isolated PFO, the 4-year stroke recurrence risk was 2.3 percent. For those with both PFO and ASA, the rate was 15.2 percent compared to 0 percent for those with ASA alone. In the “control group” with neither 131 PFO nor ASA, the rate was 4.2 percent. All patients in this study were taking aspirin. In another study, the presence of a PFO (with or without ASA) did not confer a significant increase in stroke recurrence rate over a 2-year follow-up; furthermore, recurrence rate did 132 not differ between patients on aspirin or warfarin or in those with large or small PFO. 133
ASA was found in 2 percent of persons in a population-based study. In elderly patients undergoing cardiac surgery, the incidence was nearly 5 percent. No patient had a cerebrovascular event over a follow-up period of 70 months; most were receiving aspirin. It 134 was concluded that the risk of embolic stroke was low. The optimal management of patients with PFO is not currently known. Treatment options include (1) antiplatelet therapy, (2) anticoagulation, (3) percutaneous device closure, and (4) surgical closure. Opinions differ between specialists: neurologists are more likely to recommend medical management, whereas cardiologists are more likely to suggest device 135 closure. Randomized trials are currently under way to compare the efficacy and safety of medical therapy with percutaneous closure. For patients with cryptogenic stroke and isolated 136 PFO, antiplatelet therapy is usually recommended. For patients with PFO and ASA,
11 / 16
2009.01.05. 11:55
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
anticoagulation or device closure may be considered, although evidence to support these treatments is lacking. Left Atrial Spontaneous Echo Contrast
Left atrial spontaneous echo contrast (smoke) may be detected by TEE and is thought to represent stasis of blood within the atrium. The finding may thus indicate a predisposition to thrombus formation. It is most commonly encountered in patients with either AF or mitral stenosis and has been found to be highly associated with previous stroke or peripheral 137 embolism in this context. Mitral Annular Calcification
Mitral annular calcification (MAC) has been suggested as a potential source of calcific or thrombotic emboli to the cerebral and retinal circulations, but the evidence has been conflicting on whether it is an independent risk factor for stroke. A Framingham study documented a doubled stroke risk in those with MAC compared to those without, but it was unclear whether this relationship is causal or a marker for other risk factors; for example, in 138,139 Although one study found MAC to MAC, the risk of developing AF is increased 12-fold. 140 141,142 did not. One of these involved be an independent predictor of stroke, two others 142 nearly 6,000 patients followed over 6 to 7 years. MAC appears to be a marker of generalized atherosclerotic disease including carotid stenosis, calcified aortic plaque, and 143,144 coronary disease. Mitral Valve Prolapse
Mitral valve prolapse (MVP) is the most frequent valve disease in adults, with146a prevalence of 145 a cause of stroke/TIA in the young, this has not about 2 percent. Initially postulated as 147,148 Stroke risk is increased with older age and the been confirmed in more recent studies. development of cardiac conditions: AF, mitral valve thickening, left atrial enlargement, and 149 diagnosis of MVP alone, confirmed by mitral regurgitation. In those with an auscultatory 150 significant echocardiography, no increase in risk was found. In the Framingham cohort, no151 difference was found in the prevalence of stroke/TIA in those with or without MVP. Treatment guidelines are therefore (1) no antithrombotic therapy151for primary prevention in individuals with MVP who have not experienced embolic events and (2) long-term antiplatelet therapy for secondary prevention in MVP patients who have had ischemic stroke 52 or TIA. If other cardiac abnormalities develop, these are treated according to their own merits. Aortic Valve Sclerosis and Stenosis
Systemic embolism in patients with aortic valve disease is uncommon in the absence of AF or other risk factors. Aortic sclerosis (valve thickening without outflow obstruction) is a common finding in the elderly and is associated 152 with generalized atherosclerotic vascular disease and increased cardiovascular mortality. A prospective study of patients with echocardiographically documented aortic valve calcification showed no statistically significant difference in stroke risk in patients with calcification without stenosis (8%) compared to those with stenosis (5%) or control subjects 153 (5%). Additionally, aortic valve disease was not associated with the presence of silent brain infarcts in this study. A larger study compared stroke risk in those with stenosis to those with sclerosis. Over a mean follow-up of 5 years, stroke risk was 12 percent in those with stenosis and 8 percent in those with sclerosis compared to 6 percent in those with a normal aortic valve. After adjusting for other variables,152 there was no statistically significant increase in stroke153 risk in those with aortic sclerosis. A similar conclusion was found in another cohort only if severe was it an independent predictor of study. With regard to aortic stenosis, 154 stroke in addition to age and AF.
Acute Medical Treatment of Cardiogenic Embolism The landmark study comparing thrombolysis of acute ischemic stroke with intravenous tissue plasminogen activator 155 (t-PA) against placebo showed improved clinical outcome at 3 months for all stroke subtypes. Cardioembolism accounted for 28 percent of the patients. Therefore, this acute intervention should be considered for stroke of cardioembolic origin. The two fundamental eligibility criteria are (1) treatment initiated within 3 hours of stroke
12 / 16
2009.01.05. 11:55
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
onset (therefore the time of stroke onset must be clearly defined) and (2) absence of hemorrhage on CT brain scan. Prompt assessment and treatment are required because the odds of a favorable outcome with t-PA decline rapidly the longer the interval to t-PA injection time. 156
A series of inclusion and exclusion criteria exist. The purpose is to minimize the risk of intracerebral hemorrhage, the major complication of intravenous t-PA, and to avoid treating minor or rapidly resolving processes such as TIAs, or nonischemic events. The dose of t-PA for stroke thrombolysis (0.9 mg/kg) is lower than that for acute MI. The risk of intracerebral hemorrhage in the treated group (6.4%) was 10 times higher than that of the placebo group in 155 one report. This risk appears increased if the treatment window is extended beyond 3 hours. Patients treated with t-PA cannot receive heparin, warfarin, or aspirin for the first 24 hours after infusion. Subsequently, long-term anticoagulation for secondary stroke prevention must be considered. Other interventional approaches to achieve recanalization include direct intraclot lysis via a microcatheter and mechanical clot disruption, but availability of such procedures is limited. Mechanical clot removal devices may especially have a role in the acute treatment of patients 157 with severe stroke in whom thrombolysis is contraindicated (e.g., recent cardiac surgery). Some embolic infarcts undergo secondary hemorrhagic transformation, which may lead to clinical deterioration. Factors found to increase this possibility in one study were large infarct 158 size and initiation of early anticoagulation (less than 12 hours from presentation). The optimal timing of initiation of anticoagulation after cardioembolic stroke is not known. One recommendation is that nonhypertensive patients without evidence of hemorrhage on CT scan performed 24 to 48 hours after stroke can start anticoagulation. Anticoagulation is usually delayed for about 7 days in those with large infarcts. The American Stroke Association states that initiation of warfarin is generally recommended within 2 weeks after a stroke, but longer delays may be appropriate in patients with large infarcts or uncontrolled 52 hypertension. Decisions must be individualized. SYNCOPE Transient self-limited interruptions of cardiac output result in generalized cerebral ischemia, a 159 condition that is termed syncope when it results in a loss of consciousness. Syncope is discussed in Chapter 8 but is considered further here with particular regard to its occurrence in patients with acquired cardiac disease and arrhythmias. A study of syncope induced in 14 patients with pacemakers noted that consciousness was lost 9 or more160seconds after induction of a ventricular arrhythmia (fibrillation or tachycardia). Patients felt distant, dazed, or as if they were “fading out” before loss of consciousness. Motor activity was noted in 10 of 15 episodes, with generalized tonic contraction of axial muscles followed or accompanied by irregular jerking of the extremities, generalized rigidity without clonic activity, or irregular facial movement or eyelid flutter without tonic activity. None of the patients bit their tongue or was incontinent. During the recovery phase, tonic flexion of the trunk was seen in three patients. Patients remained dazed or confused for up to 30 seconds or more after restoration of the circulation. This study confirmed that motor phenomena occur in association with syncope without corresponding electroencephalographic (EEG) evidence of epileptic discharges. The authors noted 160 variability in EEG findings and poor correlation of these changes with the clinical ones. Videometric analysis of syncope lasting on average 12 seconds induced in 42 healthy volunteers showed that myoclonic activity occurred in 90 percent. Head turns, oral automatisms, and writhing movements were common. Upward eye deviation was also common, and eyes remained open in three quarters of the subjects. Visual hallucinations occurred in 60 percent and were associated with auditory hallucinations in 36 percent, 161 although never with intelligible speech. Focal neurological symptoms are rare with cardiac arrhythmia. Evaluation of 290 patients who required pacemaker insertion disclosed that only 4 had focal neurological symptoms or signs; among these,162 only 2 had focal symptoms that could be related to a specific episode of cardiac dysfunction. Rarely, features suggestive of complex partial seizures are seen. The clinical spectrum of abnormalities that occur with generalized cerebral hypoperfusion is thus an extended one, ranging from nonspecific “dizziness” through a variety of sensory disturbances, including paresthesias and alterations of vision to loss of consciousness, sometimes with convulsive features. This has long been recognized in the context of blood donation, where 12 percent of syncopal reactions were shown to have some convulsive
13 / 16
2009.01.05. 11:55
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
163
features. Confusion may occur upon recovery. These observations highlight potential difficulties in distinguishing syncope from seizure. A collaborative study between cardiologists and neurologists identified historical criteria to identify seizure patients among those presenting with presumed syncope: waking with a lacerated tongue, loss of consciousness with emotional stress, head turning 164 to one side during loss of consciousness, and postictal confusion or abnormal behavior. Of note, syncopal events indistinguishable from seizures have been observed in the context of cardiac arrhythmias. Additionally, seizures may cause arrhythmias. 165
Syncope is common, especially in the elderly, who show a high recurrence rate. Of the many causes, it is important to identify those of cardiac origin because mortality is significantly increased in this group of patients. A cardiac basis, in different studies, ranged 159 from 1 to 8 percent for organic heart disease and 4 to 38 percent for arrhythmias. In addition to common structural causes, aortic tract outflow stenosis or intermittent obstruction to outflow may occur, for example, by a mobile thrombus or tumor in the left atrium. Echocardiography is the test of choice. In the case of arrhythmias, the prime objective is to document a relevant abnormality during an episode. In the past, no cause for syncope was found in about one third of patients, but diagnostic yields as high as 76 percent have been achieved,166 for example, in a Swiss study of 788 patients presenting to an emergency department. Evaluations were completed in 650 of those patients. History and clinical examination led to a diagnosis in 38 percent. In 10 percent, a possible cause for syncope was identified, and in about 3 percent this was refuted. In 21 percent, the cause of syncope was not initially determined, and the majority of this group underwent an extensive work-up. A probable cause of syncope was found in only 30 of the 122 patients in this group. Among the 650 patients, 69 (11%) were considered to have a cardiac cause, and arrhythmias were most prominent (44 patients). A sinus bradycardia or pause was seen in 15, as was atrial ventricular block, whereas 4 showed a supraventricular tachycardia and 1 had a pacemaker malfunction. Acute coronary syndromes were found in 9, aortic stenosis in 8, and pulmonary embolism in 8. The 18-month mortality in the cardiac group, noncardiac group, and group with unidentified cause was 26, 6, and 7 percent, respectively. A relatively common disorder predisposing to paroxysmal supraventricular tachycardia is the Wolff–Parkinson–White syndrome, usually a sporadic disorder, with a prevalence of up to 1 167 in 1,000 persons. AF may develop. Dizziness, syncope, and, rarely, sudden death may occur. The characteristic electrocardiographic (ECG) hallmarks are a short PR interval and a slowly rising prolonged QRS complex. It is those patients with an apparently normal heart that present a special challenge and raise 168 the possibility of disorders of the conducting tissues. The long QT syndrome is seen throughout the world. A recessive form is associated with deafness, whereas the more common form, without deafness, has autosomal-dominant inheritance. Acquired forms, often drug related, are more common. Exertion or emotion may trigger events. The characteristic feature, as the name implies, is a prolonged QT interval (corrected for heart rate) on a standard ECG. The disorder predisposes to87polymorphic ventricular tachycardia, which in turn predisposes to syncope and sudden death. 169
Recently, a short QT interval syndrome has been identified. Especially affected are the young, including infants. It is rare and predisposes to paroxysmal AF and episodes of ventricular fibrillation, which may lead to syncope and sudden death. It has been suggested 170 that the disorder may be responsible for some cases of sudden infant death. Sudden death in males from Southeastern Asia attributable to ventricular fibrillation has been recognized for more than 20 years. Episodes indistinguishable from generalized seizures 171 may occur in sleep, and the sudden death is presumed due to ventricular fibrillation. It is now known as SUNDS (sudden unexplained nocturnal death syndrome) and has been linked to the 172 Brugada syndrome, which is said to be phenotypically, genetically, and functionally the same. However, the Brugada syndrome has been described in Europe and in females. The Brugada syndrome is also characterized by sudden death due to malignant arrhythmias. The baseline ECG may be abnormal in showing ST elevation in leads V1, 2, and 3, together with the presence of a right bundle branch block pattern. However, this pattern may be concealed and require unmasking by the use of sodium channel blockers. Another disorder, but one in which the resting ECG is unremarkable, although it may show a sinus bradycardia and prominent U waves in some patients, is catecholamine-induced 173 polymorphic ventricular tachycardia. This is a disorder of childhood with an average age at symptom onset of 8 years. Syncope or events indistinguishable from seizures are triggered
14 / 16
2009.01.05. 11:55
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
by exercise or emotional stress. Evaluation of syncope therefore requires attention to family history, age at onset, unexplained sudden deaths, note of apparent epileptic disorders, relation of events to exertion and distress, and effects of postural change. In the presence of an apparently normal heart, evaluation of the standard ECG may suggest a cause, as indicated previously. In the context of a normal ECG or with intermittent events, prolonged recordings may be required in order to capture an episode. With daily events, a Holter monitor may suffice. More prolonged recording techniques are available, as are sophisticated electrophysiological studies. Details are beyond the scope of this chapter;174 a useful modern overview of an approach to the investigation of syncope is available. Cardiac arrhythmias may also result from175 epileptic events. Tachycardia is the most atrioventricular commonly observed rhythm disturbance. Sinus bradycardia, complete176–178 Asystole block, and cardiac arrest all have been documented as epileptic effects. secondary to179 an epileptic event, often a partial seizure, has been documented to last for up to It should be noted that carbamazepine can cause heart block, especially in 60 seconds. 180 elderly women. INTERVENTIONAL PROCEDURES
Coronary Catheterization Coronary angiography carries a small (0.2%) risk of central nervous system (CNS) complications. An unexplained observation is the preponderance of embolic events within the 181 posterior circulation, regardless of the route of catheterization. The corresponding clinical features are visual disturbances that may be migrainous, transient, or persistent; confusion 182,183 For patients experiencing an iatrogenic ischemic stroke in the context may also occur. of coronary 184 catheterization, thrombolytic therapy is a potential treatment option that should be considered.
Percutaneous Transluminal Coronary Angioplasty and Stenting Percutaneous transluminal coronary angioplasty had an overall mortality of 0.1 percent in a large series of more than 12,000 patients. Of the 121 who died, low-output failure was the 185 most common cause (66% of deaths); stroke was responsible for 4 percent. Another study showed that in the presence of peripheral vascular186 disease the risk of any major complication (stroke included) was higher: 12 versus 8 percent. Angioplasty has187 also been compared to coronary stenting. Stroke rate (0.2%) was equal in the two groups. To prevent stent thrombosis, an antithrombotic regimen is required. The addition of clopidogrel188 to aspirin reduces stroke incidence both before and after percutaneous coronary intervention. In a study of more than 18,000 patients with a non–ST-segment elevation acute coronary syndrome, the 6-month stroke risk was 1.3 percent (1.1% for those not undergoing coronary189 artery bypass graft surgery) and the 6-month mortality in these patients was 27 percent. Independent predictors of stroke risk were coronary bypass surgery (especially when performed early), previous stroke, diabetes, and older age, among others. Percutaneous coronary intervention was not associated with an increased risk of stroke in this group. In a study of 12,407 percutaneous coronary interventions (1990190to 1999), the periprocedural risk of stroke and TIA was 0.38 and 0.12 percent, respectively. More than 90 percent of patients in this study underwent balloon angioplasty, and nearly half also underwent coronary stenting. Independent predictors of stroke were advanced age, use of an intra-aortic balloon 190 pump, and need for saphenous vein graft intervention. Primary angioplasty, compared to thrombolysis, has been noted to decrease significantly the 191 192 risk of stroke, but when used as a rescue therapy, stroke risk was marginally increased. In a review of 23 randomized trials involving more than 7,000 patients with acute MI and ST-segment elevation who were randomly assigned to either primary percutaneous transluminal coronary angioplasty or thrombolysis, the overall stroke rate was 1 percent with angioplasty compared to 2 percent with thrombolysis (a statistically significant reduction in 193 favor of angioplasty).
Thrombolytic Therapy for Acute Myocardial Infarction Concern that the introduction of thrombolytic therapy for MI would result in an increase in
15 / 16
2009.01.05. 11:55
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
stroke was not substantiated by the results of the initial large Italian trial of nearly 12,000 patients. Stroke rate was 0.77 percent in the streptokinase group compared to 0.92 percent in the control group. An excess of stroke was evident only during the first day after randomization to streptokinase. After this time, patients in194 the control group had more stroke or TIA events. The study did not include CT scan results. Extended experience from this group, specifically stressing stroke risk, found that stroke occurred in 236 (1.14%) of 20,768 patients. Autopsy or CT scanning enabled the cause of stroke to be identified in 74 percent. Perhaps surprisingly, infarction was more common (42%) than hemorrhage 195 (31%). Patients receiving recombinant t-PA showed a small but significant excess of stroke. Comparison of four thrombolytic strategies confirmed a slight excess of hemorrhagic stroke in those receiving t-PA and in those receiving196 combined thrombolytic agents. This excess risk was on the order of 2 to 3 per 1,000 treated. In the four groups, stroke risk rate ranged from a low of 1.22 percent in those treated with streptokinase and subcutaneous heparin to 1.64 percent in those treated with intravenous heparin and both t-PA and streptokinase. These percentages are equal to or less than those documented in recent large prethrombolytic studies of acute MI. The risk of ICH following thrombolytic therapy has been linked to the intensity of heparin anticoagulation and timing of partial thromboplastin time (PTT) monitoring. Recent trials that have used reduced-dose heparin regimens and 3-hour PTT monitoring have reduced ICH 197 rates. When ICH does occur, it is likely to be large in size, supratentorial in site, and more often lobar than deep. Mass effect is common, and blood may extend into the ventricles or subarachnoid space. Of the 244 cases in the study referred to earlier, symptoms emerged within 8 hours of treatment in 55, after 30 hours in 58, and between these times in the 194 remainder. A small percentage (3%) of hemorrhages were subdural. Syncope within 48 hours of treatment, or facial or head trauma within 2 weeks of treatment were 198 disproportionately noted, but numbers were small (7). Review of risk factors in 150 patients with documented ICH identified four factors as independent predictors: age older than 65 years, body weight less than 70 kg, hypertension on hospital admission, and administration of alteplase. The same risk factors for ICH were identified in the GUSTO-I trial; additional predictors included a history of cerebrovascular 199 disease or hypertension, and elevated systolic and diastolic blood pressure on admission. If ICH is suspected, immediate brain CT scan and discontinuation or reversal of thrombolytic or antithrombotic therapy are recommended. Neurosurgical consultation should be 200 considered.
Previous
Next
Return to Previous Page
16 / 16
2009.01.05. 11:55
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
Return to Previous Page
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Print this page
This information has been developed and provided by an independent third party source. Merck & Co., Inc., does not endorse and is not responsible for the accuracy of the content, or for practices or standards of non-Merck sources. This resource may discuss regimens that have not been approved by the FDA. For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences please see the appropriate manufacturer's product circular. View Prescribing Information for Merck products.
Table of Contents This Chapter by Chapters
Keyword Index
Michael J. Aminoff
NEUROLOGY and GENERAL MEDICINE 6 Neurological Manifestations of Infective Endocarditis LINDA S. WILLIAMS • BRADLEY L. ALLEN •
Previous
Next
HISTORICAL OVERVIEW EPIDEMIOLOGY OF NEUROLOGICAL COMPLICATIONS PATHOPHYSIOLOGY OF NEUROLOGICAL COMPLICATIONS RISK FACTORS FOR NEUROLOGICAL COMPLICATIONS Site of Infection Infecting Organism Acuteness of Infection Valvular Vegetations Hematological Risk Factors ISCHEMIC STROKE Clinical Presentation Seizures Evaluation of Patients Treatment of Ischemic Stroke Anticoagulation in Native Valve Endocarditis Anticoagulation in Prosthetic Valve Endocarditis Surgical Treatment HEMORRHAGIC STROKE Clinical Presentation Evaluation Treatment of Hemorrhagic Stroke Intraparenchymal Hemorrhage Mycotic Aneurysms CEREBRAL INFECTION Clinical Presentation Evaluation Treatment of Cerebral Infection OTHER NEUROLOGICAL COMPLICATIONS SUGGESTED MANAGEMENT ALGORITHM PROGNOSIS CONCLUDING COMMENTS
HISTORICAL OVERVIEW
1 / 16
2009.01.05. 11:56
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
The relationship between infection of the heart valves and arterial embolization was first 1 recognized by Rudolf Virchow in the mid-1800s and the classic clinical triad of fever, heart murmur, and hemiplegia was described 30 years later by Osler in his Gulstonian Lectures of 2 1885. The understanding of infective endocarditis has evolved since these early descriptions to a concept of the disease having different predisposing conditions, different propensity for sites of valve infection, different infecting organisms, and different treatments, but the proportion of patients with neurological manifestations has remained relatively constant. It is important to recognize any neurological complications not only because they are frequent but also because they may require alterations in treatment and are often associated with increased morbidity and mortality in infective endocarditis. Although the key to treating neurological complications is appropriate antibiotic therapy, the presence of neurological manifestations often alters concomitant medical or surgical treatment of infective endocarditis. This chapter reviews the most common neurological manifestations of infective endocarditis, detailing their epidemiology and clinical presentations, suggesting appropriate diagnostic evaluations, and discussing treatment options. EPIDEMIOLOGY OF NEUROLOGICAL COMPLICATIONS Neurological events have long been recognized as frequent and severe complications of infective endocarditis. In series of patients from the 1950s onward, the overall frequency of neurological complications has remained relatively constant at approximately 20 to 40 3–15 One reason for the similarity of these reports is that cerebral emboli percent (Table 6-1). are almost always symptomatic; the only study to date that has systematically performed cerebral and abdominal imaging in patients with infective endocarditis regardless of symptoms showed that the overall proportion of cases with cerebral embolization was 34 9 percent and that more than 90 percent of these cerebral emboli were symptomatic. Nevertheless, because of the high overall incidence of stroke in the general population, infective endocarditis is an unusual cause of stroke. Neurological complications of infective endocarditis can be divided into three major types: ischemic stroke, hemorrhagic stroke, and cerebral infection (Table 6-1). Ischemic stroke is by far the most common, occurring in 20 to 30 percent of patients and accounting for 50 to 75 percent of all neurological complications. Primary cerebral hemorrhage, usually intraparenchymal or subarachnoid, is less common, reported in 2 to 17 percent of patients. Secondary hemorrhagic transformation of an ischemic stroke, however, is not uncommon and is estimated to occur in 20 to 40 percent of ischemic strokes. Cerebral infections may manifest without previous clinical evidence of ischemic or hemorrhagic stroke in less than 10 percent of cases; typical infections include cerebritis, meningitis, and microabscesses or macroabscesses. Other neurological symptoms, including seizures, headache, mental status changes, and neuropsychological abnormalities, sometimes occur but are usually secondary to one of the three major complications. Rarely, endocarditis has been associated with spinal cord infarction or abscess, discitis, retinal ischemia, and ischemic cranial and peripheral neuropathies. Click here to view this table.... PATHOPHYSIOLOGY OF NEUROLOGICAL COMPLICATIONS Almost all the neurological complications of infective endocarditis have embolization as their primary9cause. Although cerebral emboli are probably not more common than extracerebral emboli, they are more often symptomatic and thus more frequently reported, and they are associated with an increased morbidity and mortality compared to other systemic emboli. Cerebral emboli most often affect the middle cerebral artery (MCA) territory and may be septic or nonseptic; either type can cause ischemic stroke. Septic emboli may also lead to hemorrhagic stroke through the development of arteritis or mycotic aneurysm, to cerebral microabscess or macroabscess, usually by seeding of ischemic tissue, and to cerebritis or the term bacterial intracranial meningitis by seeding of the meninges (Fig. 6-1). Although 16 aneurysm has been suggested as more appropriate, the term mycotic aneurysm continues to be widely used and is therefore used here.
2 / 16
2009.01.05. 11:56
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 6-1 Embolization to various cerebral structures is responsible for most of the neurological complications of infective endocarditis. Emboli that lodge in the lumen of cerebral vessels may lead to ischemic stroke and can lead to arteritis or mycotic aneurysm formation with resultant vessel rupture and cerebral hemorrhage. Emboli to the meninges may produce meningitis, and emboli to the brain parenchyma, especially when associated with cerebral ischemia, may result in meningoencephalitis or abscess. (Reprinted with permission from Solenski NJ, Haley EC Jr: Neurological complications of infective endocarditis. p. 331. In Roos KL [ed]: Central Nervous System Infectious Diseases and Therapy. Marcel Dekker, New York, 1997.)
Most primary intracerebral hemorrhages in infective endocarditis result from septic embolism, followed by septic necrosis and5,17,18,19 rupture of the vessel wall; less commonly, they result from Masuda and colleagues found that 10 of 16 patients rupture of mycotic aneurysms. with infective endocarditis and intracerebral bleeding had pyogenic arteritis, in 5 of whom rupture occurred without evidence of concomitant mycotic aneurysm; 13 of the 16 had either 18 septic emboli or arteritis, or both. Intracerebral hemorrhage may also occur owing to a secondary hemorrhage into an ischemic infarct. In one histopathological series of 17 patients, it was due to secondary transformation of ischemic infarction in 24 percent of cases, necrotic arteritis in 24 percent, mycotic aneurysm in 12 percent, and other causes in 11 percent; in 29 17 percent it was of unknown etiology. Mycotic aneurysm formation has been related to (1) septic embolization20to the arterial lumen, producing intraluminal wall necrosis and outward extension of infection, and (2) septic embolization to the adventitial layer of the artery, resulting in destruction of the adventitia and 21,22 Mycotic aneurysms are usually muscularis layers and subsequent aneurysmal dilation. small, located at distal arterial bifurcations, rather than on the circle of Willis, and can be single or multiple. Branches of the MCA are the most common location for mycotic aneurysms; in one series, almost 40 percent of all mycotic aneurysms involved distal MCA 23 vessels. Rarely, mycotic aneurysms involve extracranial vessels, including the internal carotid artery (Fig. 6-2).
3 / 16
2009.01.05. 11:56
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 6-2 This patient with fungal endocarditis developed headache, confusion, and decreased level of consciousness without focal deficits. A, Head computed tomography (CT) showed subarachnoid hemorrhage (increased density) in the perimesencephalic cistern, left more than right, and dilatation of the temporal horns of the lateral ventricles. B, Digital subtraction angiography showed a large aneurysm of the cavernous portion of the left internal carotid artery. The aneurysm was treated with endovascular coils to occlude the carotid artery.
Brain macroabscesses account for less than 1 percent of all neurological complications of infective endocarditis and may occur secondary to ischemic infarction from a septic embolus or to extension of infection from adjacent arteritis or mycotic aneurysm. Brain microabscesses are more common than macroabscesses and usually occur in cases with multiple ischemic infarctions as a result of distal migration of septic embolic fragments. Microabscesses have been associated most commonly with Staphylococcus aureus infections. Meningoencephalitis is usually a result of embolization to meningeal vessels, with subsequent parenchymal or cerebrospinal fluid (CSF) invasion of the infecting organism. Aseptic meningitis may also occur with subarachnoid hemorrhage due to a necrotic arteritis or ruptured mycotic aneurysm. RISK FACTORS FOR NEUROLOGICAL COMPLICATIONS A variety of clinical and laboratory variables have been associated with an increased risk of neurological complications (Table 6-2), including site and type of valve infection, virulence of the infecting organism, acuteness of infection, presence of valvular vegetations, increased size and mobility of vegetations, and certain hematological factors. Click here to view this table....
Site of Infection Neurological 11,24,25 complications are more common with left-sided than with right-sided valve although some series have found increased embolism in patients with involvement, 26,27 Cerebral embolization in right-sided endocarditis may right-sided infective endocarditis. occur via embolization through a patent foramen ovale or a pulmonary arteriovenous 28,29 Mitral valve infection has been associated most commonly with neurological fistula. complications; in one series, mitral valve infection was found in 76 percent of cases with 30 < 0.005), and this neurological complications compared to 37 percent of other cases (P 3,10,31–33 association has also been reported by others. However, Wong and colleagues reported associations between aortic valve infection and stroke, with 44 percent of those with stroke having large aortic valve vegetations compared with a 9 percent prevalence in those 34 relationship between the site of infection and without stroke. Some authors have found no4,13,26,35 36,37 Although disagreement exists, most the occurrence of neurological complications. reports comparing native valve and prosthetic valve endocarditis indicate no significant difference in the proportion of patients with neurological complications. Among patients with prosthetic valve endocarditis, however, mechanical 38 valves may be associated with complications more often than bioprosthetic valves.
4 / 16
2009.01.05. 11:56
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Infecting Organism Several important changes in the type and characteristics of the infecting organism in infective endocarditis have become evident in the past few years. Although streptococci, staphylococci, and enterococci remain the three most prevalent infecting organisms, some recent studies report that staphylococcal is now more common than viridans group 12,39 More problematic than a shift in type of infecting streptococcal infective endocardi tis. organism is the growing prevalence of antibiotic resistance among these organisms, especially resistant viridans group streptococci and methacillin- and van-comycin-resistant S. 40,41 aureus. This changing resistance pattern is reflected in updated guidelines from the American Heart Association on diagnosis, antimicrobial treatment, and management of 42 complications in patients with infective endocarditis. It is unclear whether antibiotic susceptibility changes have an impact on the risk of embolic complications, although an infection with a resistant organism that takes longer to control might well be associated with an increased risk of embolization. Previous studies have linked 3,4,30,33,35,43 S. aureus, an increased3 risk of cerebral embolization to endocarditis due to 3 44 3 enterococci, Escherichia coli, Streptococcus bovis, various fungi, enterobacteriaceae, 3,45 and anaerobic bacteria. Several14studies have shown that, even after adjusting for other 14,15 and S. bovis were independently associated with embolism. In factors, S. aureus prosthetic valve endocarditis, specifically, Staphylococcus epidermidis has been associated 46 with more neurological complications than S. aureus. Endocarditis due to Streptococcus pneumoniae has been associated with an increased risk of meningitis (50% to 90% of 47,48 49 cases), and S. aureus endocarditis has been associated with brain abscess. The current summation of these varied reports is that the virulence of the organism, the availability of effective antimicrobial therapy, and the potential development of large, friable vegetations all contribute to the propensity for embolization.
Acuteness of Infection There is a higher risk of neurological complications with acute endocarditis than with subacute endocarditis. This probably relates to the typical etiological agents noted in acute disease (S. aureus and beta-hemolytic streptococci), the potential for large vegetations or valve damage, and the subsequent increased risk of cerebral embolization. Many authors have observed that the risk of cerebral embolization is highest in the first 1 to 2 weeks of infection, with most patients either presenting with a neurological3,5,10,13,14,33,50 complication or Similarly, the experiencing an acute event in the first 48 hours after diagnosis. risk of embolization decreases as the duration of effective antibiotic treatment increases, with 14,33,50 most events occurring in the first 2 weeks of therapy.
Valvular Vegetations Valvular vegetations are detected by two-dimensional echocardiography in 50 to 80 percent of patients with infective endocarditis and by transesophageal echocardiography (TEE) in 32,36,51–53 Because of its increased sensitivity and ability to more than 90 percent of cases. evaluate the more posteriorly located aortic valve, transesophageal echocardiography appears to be cost-effective as the initial study if clinical suspicion of infective endocarditis is 54,55 Although some older clinical series revealed no significant difference in the high. development4,8,50,56–58 of neurological complications between patients with and without most recent studies have linked either the presence of vegetations, vegetations, increased vegetation size, or vegetation mobility to an increased risk of 13,26,27,32,59–63 The emergence of this relationship may be related to greater embolization. access and improved technical capabilities of echocardiography in the more recent series. A prospective study of 384 patients with infective endocarditis, all of whom had transesophageal echocardiography, found that vegetation length greater than 10 mm and vegetation mobility increased the risk of embolism and that vegetation length greater than 15 14 mm independently increased 1-year mortality. The significance of changes in vegetations on serial echocardiography remains unclear: some investigators report that morphological 64 changes in vegetation size or consistency are not associated with complications, whereas others find that an increase in vegetation size during antibiotic treatment is associated with 33,65,66 A final echocardiographic variable that may be related to increased complications. complications is the presence of spontaneous echo contrast imaging. In a multivariate analysis, Rohmann and colleagues found that spontaneous echo contrast on transesophageal echocardiography was an independent predictor for embolization and 67 hypothesized that this finding signified increased spontaneous platelet aggregation. Current recommendations suggest that repeat echocardiography may be useful if clinical changes
5 / 16
2009.01.05. 11:56
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
that suggest treatment failure occur during antibiotic therapy and that it should be performed urgently for unexplained42progression of heart failure, new heart murmurs, or the development of atrioventricular block.
Hematological Risk Factors In addition to spontaneous echo contrast, some reports also present evidence of an 13,68–71 In a series of association between coagulation system activation and embolic events. 91 patients with infective endocarditis, antiphospholipid antibodies were present in 62 percent of patients with embolic events compared to 23 percent of those without such events (P = 0.008) and were also positively correlated with69other markers of endothelial cell activation, have also been thrombin generation, and impaired fibrinolysis. Antiphospholipid antibodies 70 reported to decrease after successful treatment of infective endocarditis. Whether antiphospholipid antibodies independently increase the risk of embolism or this risk results from the association of these antibodies with increased numbers and size of vegetations remains to be determined. Similarly, soluble adhesion molecules have also been reported to 13,71 At present, however, these hematological independently increase the risk of embolism. studies do not clearly aid in risk prediction for patients with infective endocarditis. ISCHEMIC STROKE Ischemic stroke secondary to embolization of friable valvular material is the most common neurological complication of infective endocarditis. Most cerebral emboli are symptomatic, 9 stroke is the but they can be asymptomatic in as many as 35 percent of patients. Ischemic 3,30 and is most presenting symptom of infective endocarditis in up to 20 percent of cases common in the acute stage of the infection, that is, before antibiotic treatment is begun or 4,5,10 Because of this during the first several days of treatment (median time, 4 to 10 days). clustering of symptoms in the acute phase, transient focal neurological symptoms in a febrile patient, especially in the presence of a regurgitant murmur, should always raise suspicion for infective endocarditis.
Clinical Presentation In accordance with their embolic etiology, the majority of ischemic strokes involve the cortex, rather than being confined to subcortical brain tissue. One series found that 62 percent of strokes affected the cerebral or cerebellar cortex (with or without additional subcortical 5 Brainstem strokes account involvement), and only 16 percent were exclusively subcortical. 3 for 10 percent or less of all strokes in infective endocarditis. Because of their cortical involvement, ischemic strokes often present with aphasia, if the dominant hemisphere is involved, or visual or spatial neglect, if the nondominant hemisphere is affected. If the embolus lodges in the posterior cerebral artery, homonymous hemianopia can result. In addition to the more typical focal cerebral hemispheric or brainstem syndromes, 3 in more multiple microemboli are clinically manifest in as many as 11 percent of cases and 72 than 50 percent of cases systematically evaluated with neuroradiological studies. Patients with microemboli can present with nonlocalizing symptoms, including diminished level of consciousness, encephalopathy, or psychosis. Clinical worsening of ischemic stroke may result from a variety of mechanisms, including development of cerebral edema, recurrent embolization and stroke, secondary hemorrhage into the ischemic area, and development of cerebral abscess. Cerebral edema may occur regardless of ischemic stroke mechanism, is more likely to be symptomatic in larger strokes and younger patients, and is typically maximal between 72 to 96 hours after stroke. Recurrent embolization should be suspected if new focal deficits develop; this complication is most likely to occur early in the course of treatment or if infection is uncontrolled. Hemorrhagic transformation of an ischemic stroke occurs in 18 to 42 percent of all patients73with ischemic stroke and has been reported to be more common in cardioembolic strokes. An autopsy series of patients with neurological complications of infective endocarditis found hemorrhagic 18 transformation of an ischemic infarct in 9 of 16 patients. Hemorrhagic transformation of an ischemic stroke is often asymptomatic, although development of intrainfarct hematoma is 73 more likely to be symptomatic than is the development of petechial hemorrhage. The term septic infarction has been used when, several days to72weeks after an ischemic stroke, a cerebral abscess develops within the infarcted tissue (Fig. 6-3). The frequency with which this occurs is not known.
6 / 16
2009.01.05. 11:56
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 6-3 This patient presented with left hemiparesis and mitral valve endocarditis. A, Noncontrast head CT showed a focal low-density lesion in the right internal capsule and lentiform nucleus with a central area of hemorrhage (increased density) and cortical hemorrhage in the insula. B, With contrast, large confluent areas of enhancement representing leaky blood–brain barrier can be seen in the right caudate and lentiform nuclei, the insula, and the temporal cortex. C, Fluid-attenuated inversion recovery (FLAIR) magnetic resonance imaging (MRI). MRI 2 days after the head CT showed diffuse increased signal in the regions of CT enhancement and the right thalamus. D, After gadolinium, ring-like enhancement in the area of a previous infarct can be seen, representing possible secondary infection. This pattern is sometimes referred to as a “septic infarction.” This enhancement pattern resolved with antibiotic treatment and without development of a macroabscess.
Seizures Although seizures can occur in patients with infective endocarditis as a result of toxic or metabolic disturbances (e.g., hypoxia, antibiotic toxicity), most often seizures are secondary to ischemic or hemorrhagic stroke. The proportion of patients with seizure as the presenting symptom of infective endocarditis was 2 percent in one large series; 11 percent of patients 3 had seizures during the course of their illness. Seizures that are secondary to focal brain injury are usually focal in nature, with or without secondary generalization, whereas seizures due to metabolic or toxic factors are more often primarily generalized. The development of seizures during antibiotic treatment often signifies clinical worsening from either recurrent stroke, hemorrhagic transformation, or abscess formation. Thus, new onset of seizures
7 / 16
2009.01.05. 11:56
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
should always prompt an urgent neuroimaging study. Rarely, seizures are secondary to antibiotic therapy, with imipenem the antibiotic having the greatest seizure proclivity.
Evaluation of Patients All patients with acute focal neurological deficits should have a noncontrast head computed tomography (CT) scan or brain magnetic resonance imaging (MRI). Noncontrast CT allows for the most accurate distinction between hemorrhagic and ischemic events and can be done more quickly than MRI in most settings. If infective endocarditis is known or suspected, head CT with and without contrast may be useful; areas of increased contrast enhancement, representing possible cerebral abscess may then be distinguished from areas of ischemia (Fig. 6-3). Although published radiological series are few, brain MRI appears to be more sensitive than CT in detecting the multiplicity of neurological lesions seen in infective endocarditis. In one series, multiple lesions were found in 10 of the 12 patients studied, with embolic branch infarction (8), multiple emboli and microabscesses (7), and hemorrhagic 72 stroke (4) being the most common findings. MRI findings have been categorized into four patterns: (1) embolic infarction, (2) multiple patchy infarctions (nonenhancing), (3) small nodular or ring-enhancing white matter lesions (probably microabscesses), and (4) 74 hemorrhagic infarctions (intraparenchymal or subarachnoid). Microabscesses usually develop several days75after the ischemic stroke and can be asymptomatic or associated with clinical deterioration. Multiple microabscesses are often responsible for nonfocal encephalopathy. MRI is superior to CT for symptoms referable to the brainstem or cerebellar regions. Once cerebral embolism has occurred, serial neuroimaging studies or subsequent angiography can be performed to assess the presence of secondary complications such as microabscess or macroabscess formation, hemorrhagic transformation of ischemic stroke, or development of a mycotic aneurysm. Most authors agree that patients without neurological symptoms do not require cerebral angiography and that those with intracerebral hemorrhage 76 do require angiography, but whether to perform cerebral angiography after ischemic stroke in patients with infective endocarditis is especially controversial. The 2005 AHA statement on diagnosis and treatment of infective endocarditis suggests that diagnostic pursuit of mycotic aneurysms should be considered in patients with severe headache, erythrocytes or 42 xanthochromia in CSF, or focal neurological signs. Based on the evidence that subarachnoid hemorrhage can occur without previous symptoms in more than 50 percent of patients with mycotic aneurysm, some authors recommend that all patients with cerebral embolism have arterial imaging performed at some time beyond 48 77 hours after the initial event. The basis for the timing of this recommendation is that mycotic aneurysm formation after septic embolization takes at least 48 hours to develop, and angiography immediately after embolization may therefore be negative. Although some studies suggest a more rapid angiographic evaluation based on78early mycotic aneurysmal rupture within 24 hours of the onset of neurological symptoms, others argue that a mycotic aneurysm develops in so few patients that angiographic complications present a greater risk. Using the published literature, van der Meulen and colleagues estimated the probability of 12-week survival in patients with infective endocarditis and ischemic stroke and found no added survival benefit for patients who had angiography, largely owing to the low prevalence of mycotic aneurysms and the low risk of their rupture in patients with adequate antibiotic 76 therapy. Since so few patients with infective endocarditis harbor mycotic aneurysms, the need to perform initial or serial angiography depends on the clinical presentation and proposed treatment. Patients with hemorrhagic stroke or hemorrhagic transformation of an ischemic stroke should have angiography to delineate mycotic aneurysm from arteritis because this distinction often influences subsequent evaluation and treatment. Patients with ischemic or hemorrhagic stroke who require long-term anticoagulation for mechanical valves or treatment of systemic thromboembolism, for example, may also benefit from angiography to exclude a mycotic aneurysm. Patients with ischemic stroke without hemorrhagic transformation or any indication for long-term anticoagulation probably do not benefit from repeated neuroimaging studies or conventional angiography. The diagnosis of infective endocarditis depends on the documentation of an infecting organism on serial42blood cultures and, in part, on the presence of valve abnormalities on echocardiography. Echocardiography is also important in assessing valve function and excluding conditions such as valve thrombosis or abscess formation that would change clinical management. Transesophageal echocardiography is more sensitive to mitral and aortic valve pathology and has been reported to change patient management in as many as 79 one third of cases. Whether serial echocardiography provides data that reliably predict risk of subsequent thromboembolism or otherwise influence management is not known.
8 / 16
2009.01.05. 11:56
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
CSF examination is regarded by some authors as part of the standard evaluation of patients with infective endocarditis and neurological symptoms. The manner in which the CSF results will influence therapy, however, is not clear. The interpretation of CSF findings as a diagnostic tool for infective endocarditis in patients with acute stroke is complicated by the tendency for patients with cerebral embolism unrelated to endocarditis also to have mild to moderate increases in either white blood cells, red blood cells, or protein concentration in the 80,81 In one large series,3 CSF was abnormal in 48 of 69 patients with CSF shortly after stroke. infective endocarditis in whom it was examined. Of these, 28 percent had a purulent profile, 25 percent were aseptic, 13 percent were hemorrhagic, and 30 percent were normal. With the exception of purulent CSF in patients with meningismus, the type of neurological event in these patients did not correlate with the CSF pattern. For these reasons, CSF examination does not usually aid in the diagnosis or management of patients with neurological symptoms and infective endocarditis.
Treatment of Ischemic Stroke The cornerstone of treatment of infective endocarditis is appropriate antibiotic therapy directed at the infecting organism. Numerous studies have shown that the risk of either initial or recurrent thromboembolism decreases sharply after the first few days of adequate 4–7,33,51 Although this association may result in part from an ascertainment antibiotic therapy. bias, it is critical to ensure that antibiotics are begun empirically, immediately after drawing initial blood for cultures (preferably three sets from separate sites) in febrile patients with stroke in whom infective endocarditis is among the differential diagnoses. Since effective long-term antimicrobial therapy will be required to treat infective endocarditis, the isolation and susceptibility testing of the pathogen are of critical importance. Involvement of an infectious diseases consultant is recommended. Thorough discussion of a current approach to diagnosis and antimicrobial treatment in various clinical scenarios can be found in the 2005 42 AHA guideline statement. Recent studies have addressed the question of whether acute antiplatelet therapy is beneficial in reducing the risk of thromboembolism in infective endocarditis. In animal models of the disease, aspirin or aspirin plus ticlopidine has been found to reduce vegetation weight, echocardiographic evidence of vegetation growth, bacterial85titer of vegetations, or systemic 82–84 Although one pilot study confirmed this finding, a larger randomized controlled emboli. trial found no reduction of embolic events in patients treated with 325 mg aspirin compared to those given placebo, and there was a nonsignificant trend toward increased bleeding in the 86 aspirin-treated group. Based on this study, routine use of antiplatelet therapy for the purpose of decreasing embolic risk in patients with acute infective endocarditis is not 42 recommended. Anticoagulation in patients with infective endocarditis remains a controversial and complicated topic. Hemorrhagic complications are clearly more common in anticoagulated patients, with one retrospective study finding that 50 87 percent of the hemorrhages occurred in the 13 percent of subjects receiving anticoagulation. However, patients with mechanical prosthetic valves may be receiving long-term anticoagulation, and the decision as to whether and for how long to withhold anticoagulants in this setting is especially difficult. Given the divergent management strategies required, it is useful to consider anticoagulation in native and prosthetic valve endocarditis separately. Anticoagulation in Native Valve Endocarditis Many authors have documented an increased risk of hemorrhagic complications in anticoagulated patients with native valve endocarditis and ischemic stroke, and the risk of recurrent embolism is low in patients receiving appropriate antibiotic therapy. Accordingly, there appears to be little benefit to anticoagulating patients with native valve endocarditis. Whether lower-level anticoagulation (e.g., for prevention of deep venous thrombosis) is safe in patients with stroke and infective endocarditis is unknown. Because other strategies, such as using sequential compression devices, have been shown to be equally efficacious, a conservative approach is to use these nonpharmacological methods of prevention of venous thrombosis. Anticoagulation in Prosthetic Valve Endocarditis Patients with bioprosthetic valves are typically not on long-term anticoagulation and have a 38,46 ; thus, lower risk of stroke in infective endocarditis than patients with mechanical valves the same rationale applies to them as for patients with native valve endocarditis. Patients with
9 / 16
2009.01.05. 11:56
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
mechanical prostheses who have endocarditis and stroke, however, present especially difficult management dilemmas. Most studies indicate that the proportions of patients with 4,5 native and prosthetic valves having endocarditis and cerebral embolism are similar ; initiating anticoagulation in a previously nonanticoagulated patient with infective endocarditis and a mechanical valve thus appears unwarranted. If a patient with a mechanical valve is receiving long-term anticoagulation and develops a cerebral embolus as a complication of infective endocarditis, the decision as to whether to continue anticoagulation or temporarily withhold it depends on several factors, including the size of the stroke and type of mechanical valve. Some authors have suggested that anticoagulation decreases the risk of cerebral embolism and87,88 should be instituted in all Because larger strokes, patients with newly diagnosed prosthetic valve endocarditis. especially those secondary to emboli, may be more likely to develop secondary hemorrhagic 76 complications, other authors favor withholding anticoagulation for several days in patients with acute cerebral embolism and mechanical valve endocarditis, especially when S. aureus 89,90 is the infecting organism. Regardless of the timing of anticoagulation, it is safer to convert the patient from oral anticoagulation to the more controlled intravenous route of therapy during the acute phase of infective endocarditis. Some authors have not found a decrease in cerebral emboli in patients 46 a with acute prosthetic valve endocarditis anticoagulated with warfarin or have documented 88 rate of hemorrhagic complications as high as 36 percent in this subgroup of patients, thus leading to the position that anticoagulants should not be initiated and perhaps should be temporarily discontinued in previously anticoagulated patients with prosthetic valve 5,91 If temporary discontinuation of anticoagulation is considered, determination endocarditis. of the patient's type of mechanical valve and consultation with a cardiologist or a cardiothoracic surgeon concerning the risk of valve thrombosis with that valve type will help guide the decision about how long the patient can safely remain off anticoagulation. Although the use of anticoagulants remains controversial, converting to the most controllable (i.e., intravenous) form of therapy and frequent monitoring of anticoagulation parameters (activated partial thromboplastin time or international normalized ratio [INR]) are recommended. Solenski and Haley recommend that large cerebral infarctions, hemorrhage on CT scan, presence of mycotic aneurysm, uncontrolled infection or infection with S. aureus, history of bleeding diathesis, and possibly advanced patient age are factors arguing against the use of anticoagulation in patients with neurological complications of mechanical valve 92 endocarditis.
Surgical Treatment Valve replacement is not usually recommended as a therapy for preventing initial or recurrent stroke, although multiple emboli, infection with a “virulent”26,61 organism, and the presence of Typically, surgery is reserved for large vegetations may be relative indications for surgery. patients with acute or refractory congestive heart failure, perivalvular abscess, unstable valve prosthesis, continued embolism, infection with a pathogen resistant to effective antimicrobial agents, or inability to clear the infection. If surgery is required, the timing of the procedure in a patient with ischemic or hemorrhagic stroke is controversial. If surgery is contemplated to prevent embolization, early surgery is associated with greatest benefit since the risk of embolization is greatest in the first 2 weeks of the infection. If stroke has occurred, the first 72 to 120 hours after stroke are the period of maximal risk of cerebral edema and disruption of cerebral autoregulation; thus, most authors recommend delaying cardiac surgery for at least 1 week after stroke if possible. One retrospective assessment of 247 patients operated on for left-sided native valve endocarditis found that operation at approximately 3 weeks after the neurological deficit appeared was as safe for patients with previous neurological 93 complications as for those without neurological manifestations of endocarditis. HEMORRHAGIC STROKE Intracerebral hemorrhage in infective endocarditis may be primary or secondary to ischemic stroke or other pharmacological or hematological conditions (Table 6-3; Fig. 6-4). Of the primary hemorrhages, intraparenchymal and subarachnoid hemorrhage are most common. Secondary transformation of an ischemic stroke is the most common form of intracerebral hemorrhage in17,18 infectious endocarditis, accounting for 24 to 56 percent of all hemorrhages in Intracerebral hemorrhage is a much less common complication than this condition. ischemic stroke, accounting for 2 to 17 percent of all neurological complications. In one recent series, only 8 cases of subarachnoid hemorrhage occurred among 489 patients with infective endocarditis; in 6 of these, no cause for the hemorrhage was identified by autopsy or 94 aneurysms in patients with infective angiography. The prevalence of asymptomatic mycotic 17 endocarditis is not known, but seems to be small.
10 / 16
2009.01.05. 11:56
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Click here to view this table....
FIGURE 6-4 This patient had tricuspid valve endocarditis secondary to intravenous drug abuse. Initially, the patient had no neurological symptoms but left the hospital against medical advice after completing 6 days of antibiotic therapy. He returned 2 days later with a decreased level of consciousness and a right gaze preference. A toxicology screen was positive for cocaine. Noncontrast axial head CT at that time showed an approximately 3 × 4-cm hemorrhage in the right frontal lobe with intraventricular extension and subfalcial herniation. Cerebral angiography did not show a mycotic aneurysm. Echocardiography showed a large patent foramen ovale with right-to-left shunting and vegetations on the tricuspid valve. This case underscores several clinical points: (1) neurological complications of endocarditis are more common during uncontrolled infection; (2) neurologically asymptomatic patients may have silent cerebral emboli, particularly in the nondominant hemisphere; and (3) patients with right-sided endocarditis may develop cerebral embolization via a right-to-left shunt.
As described previously, in at least 40 percent of patients, septic embolization is the first 3,17,77 Depending on the location of the embolus, event leading to intracerebral hemorrhage. arteritis with secondary vessel rupture or development of a mycotic aneurysm may occur. Several series have documented that hemorrhagic complications are more common in anticoagulated patients, with one third of patients with endocarditis and subsequent 17 intracerebral hemorrhage either anticoagulated or having an underlying bleeding diathesis. In one series, 23 percent of all intracerebral hemorrhages occurred in the 3 percent of 3 50 percent of all such bleeds occurred in the 13 percent anticoagulated patients ; in another, 87 of patients who were anticoagulated. These observations have led to the consensus to avoid anticoagulation in native valve endocarditis and to a judicious approach to its use in
11 / 16
2009.01.05. 11:56
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
prosthetic valve endocarditis. Other conditions that sometimes accompany infective endocarditis may also predispose to bleeding complications, including disseminated intravascular coagulation, thrombocytopenia, and vitamin K deficiency. Although mycotic aneurysms are most commonly found in the intracranial vessels, rarely these aneurysms may involve the extracranial carotid (Fig. 6-1), thoracic, or abdominal 95–97 Management in these cases should be individualized but may include surgical or vessels. endovascular interventions or vessel ligation.
Clinical Presentation Intracerebral hemorrhage usually presents with focal neurological symptoms as in ischemic stroke, but nonlocalizing symptoms, such as headache and decreased level of consciousness, may also predominate. Seizures may occur at the onset of the hemorrhage or later in its course. If subarachnoid hemorrhage occurs, either from rupture of an arteritic vessel or from a mycotic aneurysm, meningismus may be a prominent feature. Headaches 94 may be more diffuse and subacute than is typical with saccular aneurysm rupture. A transient ischemic attack (TIA) may precede intracerebral hemorrhage in as many as 25 98 percent of patients or may be the presenting symptom.
Evaluation As in ischemic stroke, noncontrast head CT is the best initial neuroimaging procedure. The hematoma appears as an increased-density signal on CT (Fig. 6-4) and can be localized to the intraparenchymal, subarachnoid, subdural, or intraventricular space. Hemorrhagic transformation of an ischemic infarct is most often patchy and may follow the contour of the gyri (Fig. 6-3A), but may appear as a homogeneous hematoma within an infarct. MRI is also useful and can better delineate stroke in the posterior fossa, although the signal change of blood products over time may make MRI more difficult to interpret in hemorrhagic stroke. A clue to the presence of an underlying mycotic aneurysm may be a focal area of cortical 99 enhancement adjacent to an area of hemorrhage. All patients with intracerebral hemorrhage complicating infective endocarditis should have imaging of the cerebral vasculature to visualize any underlying mycotic aneurysm. Since mycotic aneurysms tend to be small and to occur distally, rather than at the more proximal arterial branch-points as do saccular aneurysms, conventional cerebral angiography is preferred over magnetic resonance angiography (MRA) or CT angiography (CTA) for aneurysm detection. Although the resolution of these techniques continues to improve, at present they are adequate for screening in patients with infective endocarditis and ischemic stroke but should not be the primary diagnostic tool for evaluating patients with infective endocarditis and hemorrhagic stroke. They may be useful, however, for serial monitoring of aneurysm size following conventional angiography. One study reported the utility of monitoring mycotic aneurysms with serial thin-slice CT or MRI and found that all of six aneurysms identified with conventional angiography could be successfully followed for 6 to 8 100 weeks. Repeat angiography at the end of antibiotic treatment confirmed the resolution (in 2) or persistence (3 enlarged, 1 unchanged) of the aneurysms.
Treatment of Hemorrhagic Stroke Intraparenchymal Hemorrhage The mainstay of treatment for either primary or secondary intracerebral hemorrhage in patients with infective endocarditis is the same as that for cerebral emboli: effective treatment of the underlying infectious organism. This is especially true for patients with pyogenic arteritis but is also critical for the treatment of mycotic aneurysms. Some patients with intracerebral hemorrhage and progressive neurological deterioration, either from expanding hematoma or edema, may benefit from surgical evacuation of the clot, but no firm guidelines exist for assisting with management in these cases. Similarly, although recombinant factor VIIa has been used successfully to reduce hematoma growth and improve outcomes in 101 patients with intracerebral hemorrhage, no data are available for its use in patients with infective endocarditis and cerebral hemorrhage. The increased risk of thrombosis and stroke associated with its use would be of concern in this population. As discussed previously, patients with mechanical valves and receiving anticoagulation therapy may have their anticoagulant discontinued temporarily or converted to an intravenous form. All patients should have close neurological monitoring in an intensive care setting because deterioration from recurrent hemorrhage or edema is not uncommon.
12 / 16
2009.01.05. 11:56
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Mycotic Aneurysms The natural history of mycotic aneurysms is that approximately one third resolve with 6 to 8 weeks of antibiotic treatment, one third remain unchanged in size, and the remaining one third 17,78,100,102,103 are equally divided among those that increase and those that decrease in Because of their propensity to resolve with antibiotic therapy, the evaluation size. and treatment of mycotic aneurysms are controversial. Aspects of care that remain unclear are whether serial angiography is needed in patients with mycotic aneurysms and the indications for surgical therapy. Because more than one third of mycotic aneurysms either are unchanged in size or enlarge during antibiotic therapy, some authors recommend serial angiography every 2 weeks during 77,104,105 antibiotic treatment.104–106 If an aneurysm enlarges, surgical treatment to prevent rupture Late hemorrhage from a ruptured mycotic aneurysm in patients who may be advocated. have completed adequate 77 antibiotic therapy is rare, occurring in none of 122 patients with a 17,107 As discussed previously, the need mean 40-month follow-up, but it has been reported. for ongoing or subsequent long-term anticoagulation is another factor that may favor angiographic surveillance and surgical treatment, especially in patients with known cerebral embolization. Once an aneurysm is discovered, controversy also exists about its treatment. Asymptomatic aneurysms are often treated medically, with surgical intervention reserved for those that 105,106 Although either enlarge or do not resolve after antibiotic therapy is completed. symptomatic aneurysms may also resolve with antibiotic treatment and the risk of rebleeding is low, some authors105,106 favor surgical treatment of symptomatic mycotic aneurysms in addition This recommendation is usually based on the fear of recurrent to antibiotic therapy. bleeding, the associated increased morbidity and mortality, and the potential development of new aneurysms. Aneurysm accessibility and number are other features that influence the decision for surgical treatment; single aneurysms in a peripheral location are more likely to be treated surgically. Inaccessible aneurysms may be successfully treated endovascularly, 108–111 although the management and outcomes in these cases are highly individualized. Whether to undertake surgery at presentation or to wait until the completion of antibiotic therapy is debatable. For unruptured mycotic aneurysms, some authors have suggested 77,104,105 although the proportion of serial angiography every 2 weeks during antibiotic therapy, aneurysms that enlarge and thus may require urgent surgery is small. Since at least half of mycotic aneurysms persist after adequate antibiotic treatment and since new aneurysms can appear, it seems reasonable to repeat angiography, either conventional or MRA, at the conclusion of antibiotic therapy (usually 4 to 6 weeks) or to undertake serial imaging with a noninvasive procedure, such as MRA. Accessible aneurysms that persist after adequate antibiotic therapy or that enlarge during therapy are usually treated surgically. Because mycotic aneurysms often lack a defined neck amenable to clipping, other surgical techniques, including wrapping, excision, or endovascular obliteration, may be necessary. Because mycotic aneurysms are often difficult to locate at the time of surgery, new techniques, including stereoscopic brain-surface imaging 112 113 with MRA and stereotactic angiographic localization, are sometimes used to aid in aneurysm localization. CEREBRAL INFECTION Cerebral infection, most commonly abscess or meningitis, has been reported as a primary complication in 6 to 31 percent of cases, although these cases typically represent less than 10 percent of the entire population of patients with endocarditis and neurological complications (Table 6-1). These infections most typically occur after cerebral embolism; infection arising without clinical evidence of prior cerebral embolization is unusual. Encephalitis has also been reported, although the usual pathology in these cases is multiple emboli with microabscess formation. Meningitis accounts for 4 to 7 percent of all neurological manifestations of infective endocarditis and is reported to be more common with either S. aureus or S. pneumoniae 3,114,115 infections. When meningitis is associated with involvement of the cerebral cortex, evidenced by gyral enhancement on MRI, the terms cerebritis and meningoencephalitis are used. Rarely, cerebritis can lead to the development of a parameningeal abscess in the cortex. Meningitis typically results from septic emboli to the meningeal vessels with subsequent CSF colonization. Less commonly, meningitis is nonseptic, resulting from sterile inflammation of the meninges due to blood products or circulating immune complexes in the CSF.
13 / 16
2009.01.05. 11:56
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Cerebral abscesses are rare, accounting for approximately 2 percent of all neurological 116 Small “microabscesses,” often defined as complications in infective endocarditis. 3 abscesses smaller than 1 cm , are more common than “macroabscesses” but still account for less than 4 percent of all neurological complications. Cerebral abscess usually develops as the result of septic embolus and is not necessarily preceded by clinical symptoms. Radiographically, infarction-related abscesses are usually small and multiple and 72,74 demonstrate areas of nodular or ringlike enhancement in an area of prior ischemic stroke (Fig. 6-3D). Abscess has also been reported as a consequence of mycotic aneurysm or 117 septic arteritis.
Clinical Presentation Although the clinical diagnosis of meningitis is infrequent in infective endocarditis, symptoms of meningitis are not. In one series, meningeal symptoms or signs occurred in more than 40 31 percent of 84 patients with endocarditis. In addition to meningismus, headache, encephalopathy, cranial neuropathies, seizures, and increased intracranial pressure may occur. These symptoms may be subtle, especially in the elderly, and, when associated with fever, elevated white blood cell count, and regurgitant murmur should prompt an urgent evaluation for infective endocarditis.
Evaluation All patients with known or suspected infective endocarditis and neurological symptoms, whether focal or nonfocal, should have imaging with noncontrast head CT prior to lumbar puncture. This is critical because multiple embolic strokes, intracerebral hemorrhage, and abscess may all present with nonfocal symptoms and can also cause significant compartmental increases in intracranial pressure, thus increasing the risk of cerebral herniation. Lumbar puncture should not be done in any patient with a focal lesion and evidence of mass effect on neuroimaging studies. Because patients with endocarditis have a propensity toward hematological abnormalities, coagulation tests, including a platelet count and INR, are especially important before one performs a spinal tap.
Treatment of Cerebral Infection As for any type of meningitis, the goal of treatment is adequate antibiotic therapy to which the infecting organism is sensitive and that has good CSF penetration and activity in brain abscesses. Both microabscesses and macroabscesses usually respond to antibiotic treatment, although macroabscesses may occasionally produce significant mass effect and thus require stereotactic aspiration or surgical drainage. OTHER NEUROLOGICAL COMPLICATIONS Other extracerebral neurological complications may rarely occur. Although cerebral and 9 systemic emboli appear to occur with similar frequency, cerebral neurological complications predominate over extracerebral complications, probably because the brain receives more blood flow than peripheral neurological tissues and because cerebral complications are more likely to be symptomatic. Mononeuropathy simplex or multiplex has been reported in as many as 1 percent of patients 118 with infective endocarditis. Both peripheral and cranial nerves may be involved, and viridans streptococci appear to be an especially prominent infectious organism in these cases. Discitis, occasionally with associated abscess or osteomyelitis, has also been reported and is more common with S. aureus infection. Other rare sites of embolization include the spinal cord and the retina. SUGGESTED MANAGEMENT ALGORITHM The management of neurological complications of infective endocarditis is not standardized and substantial variations in care may be necessary based on the individual patient's characteristics. Nonetheless, it is helpful to consider a treatment algorithm that includes pathways for the major neurological manifestations of the disease (Fig. 6-5). This algorithm differs from some proposed previously in that cerebral angiography is not suggested for all patients with ischemic stroke, lumbar puncture is not recommended for all patients with 92,105 As many neurological complications, and serial angiography every 2 weeks is optional. other authors have suggested, the two keys to managing patients, regardless of any neurological complications, are (1) a high level of suspicion for the possibility of infective endocarditis and (2) prompt initiation of appropriate antibiotic therapy after obtaining multiple
14 / 16
2009.01.05. 11:56
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
sets of blood cultures.
FIGURE 6-5 Suggested management algorithm for patients with focal neurological deficits and known or suspected infective endocarditis. Factors favoring either surgical or medical treatment of mycotic aneurysms are presented; management of these cases is highly individualized. Repeat angiography at the conclusion of medical therapy is suggested for all patients with known mycotic aneurysms and may be considered either for patients with intracerebral hemorrhage and a negative initial angiogram or for patients with ischemic stroke who require long-term anticoagulation. LP, lumbar puncture, MRA, magnetic resonance angiography.
PROGNOSIS Among patients with infective endocarditis, mortality is increased in those with neurological 3,4,9,10 Estimates of in-hospital mortality in various complications compared to those without. clinical series range from 16 to 58 percent compared with 14 to 20 percent for patients with and without neurological complications, respectively, although a population-based study from 12 France reported 16 percent in-hospital mortality in 1999. Mortality is higher in infections with more virulent organisms,14,15,39,119 with several large cohort studies showing an association between S. aureus and mortality. Intracerebral hemorrhage appears to confer added risk, as 17,30,119 mortality in these patients is reported to be 40 to 90 percent. Although rare, mycotic 106 aneurysm rupture is associated with even higher mortality. Mortality in patients with unruptured mycotic aneurysms appears no different from16the aggregate mortality rate in all patients with neurological manifestations of endocarditis. A multicenter, prospective study of 384 patients with infective endocarditis found that increasing age, female gender, serum creatinine greater than 2.0 mg/L, moderate to severe congestive heart failure, infection with S. aureus, increased medical comorbidity, and 14 vegetation length greater than 15 mm were all independently associated with 1-year mortality. Another study of factors related to in-hospital death also found an association with S. aureus infection and comorbidity as well 119 as embolic events and diabetes.
15 / 16
2009.01.05. 11:56
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp 3,5,6,77
The risk of recurrent neurological events, either embolic or hemorrhagic, is quite low.5 Recurrent ischemia has been documented in less than 0.5 percent of cases per day and 77 recurrent hemorrhage in less than 1 percent of all cases. Elimination of recurrent events 33,46,50 appears to depend more on effective antibiotic treatment than on other specific therapy. CONCLUDING COMMENTS Although infective endocarditis has evolved over the past several decades with regard to frequency of involvement of different valves and prevalence and susceptibility of infecting organisms, the proportion of patients with neurological manifestations and the type of neurological complications remain remarkably consistent. Most neurological complications are caused by embolization of friable valvular material resulting in either ischemic or hemorrhagic stroke. A high index of suspicion for infective endocarditis as the cause of stroke is critical because common treatments for acute stroke, such as thrombolysis or anticoagulation, are contraindicated in patients with native valve endocarditis and ischemic stroke. Management of patients with endocarditis and mechanical prosthetic valves is complicated, and decisions about continued anticoagulation in these patients must be individualized. Similarly, decisions about medical or medical plus surgical treatment of mycotic aneurysms must also be individualized because a number of clinical factors may influence treatment. Although many clinical decisions in patients with neurological manifestations of infective endocarditis must be individualized, it is clear that the cornerstone of prevention and treatment of all neurological complications is rapid delivery of appropriate antibiotic therapy. ACKNOWLEDGMENTS Dr. Williams is supported by grants from the Department of Veterans Affairs and the National Institutes of Health. Previous
Next
Return to Previous Page
16 / 16
2009.01.05. 11:56
Aminoff: Neurology and General Medicine: Neurological Complicatio...
Return to Previous Page
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Print this page
This information has been developed and provided by an independent third party source. Merck & Co., Inc., does not endorse and is not responsible for the accuracy of the content, or for practices or standards of non-Merck sources. This resource may discuss regimens that have not been approved by the FDA. For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences please see the appropriate manufacturer's product circular. View Prescribing Information for Merck products.
Table of Contents This Chapter by Chapters
Keyword Index
Michael J. Aminoff
NEUROLOGY and GENERAL MEDICINE 7 Neurological Complications of Hypertension S. CLAIBORNE JOHNSTON • JACOB S. ELKINS •
Previous
Next
EPIDEMIOLOGY PATHOPHYSIOLOGY EVALUATION AND TREATMENT STROKE CEREBRAL ANEURYSMS Unruptured Cerebral Aneurysms Subarachnoid Hemorrhage INTRACEREBRAL HEMORRHAGE LACUNAR INFARCT PERIVENTRICULAR WHITE MATTER DISEASE BINSWANGER'S DISEASE CADASIL CAROTID ARTERY STENOSIS INTRACRANIAL ATHEROSCLEROSIS AORTIC ARCH ATHEROSCLEROSIS CARDIAC EMBOLUS DEMENTIA PERIPHERAL NEUROPATHY HYPERTENSIVE ENCEPHALOPATHY ECLAMPSIA IMMUNOSUPPRESSION
Blood pressure was first measured in 1707 by an English divinity student, Stephan Hales, 1 using a glass tube attached directly into the arteries of animals. Methods of measurement improved slowly over the next 200 years, with Nikolai Korotkoff describing the modern cuff-and-stethoscope technique in 1905. Hypertension was recognized as an indicator of poor prognosis by Theodore Janeway, who published a case series of 7,872 hypertensive patients gathered from 1903 to 1912, in which hypertension was defined as a systolic blood pressure greater than 160 mmHg. He found a mean survival of 4 to 5 years after the development of symptoms of hypertension, with stroke being an important cause of death. Hypertension was initially considered a compensatory phenomenon rather than a disease in itself. Even into the 1940s, physicians were concerned that lowering blood pressure would exacerbate end-organ damage, particularly in the kidneys. Treatment options were not
1 / 24
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
available until 1925, when surgical sympathectomy was shown to reduce blood pressure without impairment in renal function. The first antihypertensive medication, tetraethylammonium, was used in a patient in 1946, but the agent was poorly tolerated because of severe anticholinergic side effects. A tolerable oral agent was not available until 1957, when chlorothiazide was shown to reduce blood pressure in patients with essential hypertension and rapidly became the most commonly prescribed medication. Both acute hypertension and chronic hypertension produce neurological disease. Acute hypertension is associated with hypertensive encephalopathy, an uncommon presentation since the widespread identification and treatment of hypertension. Chronic hypertension is associated with stroke, which is its most important neurological complication. All stroke subtypes are linked to hypertension, including ischemic infarction, intraparenchymal hemorrhage, and aneurysmal subarachnoid hemorrhage. Chronic hypertension is also associated with dementia and with peripheral neuropathy in those with diabetes. EPIDEMIOLOGY Both systolic and diastolic blood pressures are distributed approximately normally in the population. For convenience, physicians have defined pathological states such as hypertension based on specific blood pressure thresholds, typically a systolic blood pressure of 140 mmHg or greater or a diastolic blood pressure of 90 mmHg or greater, or both. Thus defined, hypertension is common, affecting2 approximately 50 million individuals in the United States and as many as 1 billion worldwide. In the Framingham study, individuals who were normotensive3at age 55 had an approximately 90 percent lifetime risk of developing hypertension. Despite the frequent division of blood pressure into diagnostic categories such as hypertension and normotension, there is no obvious threshold at which higher blood pressure begins affecting the risk of complications, and even patients with diastolic blood pressures of 80 to 90 mmHg are at increased risk of stroke compared with those with blood 4 pressures of 70 to 80 mmHg (Fig. 7-1). Reflecting a growing awareness of the continuous risk associated with blood pressure, blood pressures in the range of 120–140/80–90 mmHg, 2 once considered to be “normal,” are now labeled as “prehypertensive.” Throughout much of the twentieth century, blood pressure risk was assessed according to the diastolic blood pressure, and it was not until 1993 that systolic blood pressure was formally incorporated into 5 the definition of hypertension in U.S. guidelines. Since that time, however, it has been increasingly recognized that systolic blood pressure is somewhat more informative than 6 diastolic blood pressure at predicting future cardiovascular events.
2 / 24
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 7-1 Relative risks of stroke. Estimates of the usual diastolic blood pressure (DBP) in each baseline DBP category are taken from mean DBP values 4 years after baseline in the Framingham study. Solid squares represent disease risks in each category relative to risk in the whole study population; sizes of squares are proportional to the number of events in each DBP category; and 95 percent confidence intervals for estimates of relative risk are denoted by vertical lines. (From MacMahon S, Peto R, Cutler J, et al: Blood pressure, stroke, and coronary heart disease. Lancet 335:764, 1990, with permission.)
PATHOPHYSIOLOGY In the brain, the primary pathophysiologic process of hypertension is related to increases in vasomotor tone and peripheral arterial resistance. Acute elevation in blood pressure results in constriction of small arteries in the brain in a compensatory response termed autoregulation. Brain blood-flow is maintained at a relatively constant level over a range of pressures. At high pressures, vasoconstriction is thought to be protective by reducing pressure at smaller, more distal vessels. Acute severe hypertension overwhelms normal autoregulation at a mean arterial pressure of approximately 150 mmHg, with increased cerebral blood-flow occurring above this pressure threshold. Vasoconstriction in acute hypertension is patchy, and some small vessels are exposed to high pressures, which may lead to endothelial injury and focal 7 breakdown of the blood–brain barrier. Acute hypertensive encephalopathy is a fulminant presentation of this process. Fibrinoid necrosis of small vessels may also occur, lowering the threshold for future ischemic and hemorrhagic events. Chronic hypertension results in8 cerebral vascular remodeling. The media hypertrophies, and the lumen becomes narrowed. These changes are protective, with reduction in wall tension 9 and shifting of the autoregulation curve to allow compensation at higher blood pressures. However, vascular remodeling is accompanied by endothelial dysfunction, with impaired relaxation and poor compensation for hypoperfusion. The result is greater susceptibility to 7 ischemic injury due to reduced collateral flow. Hypertension also predisposes to atherosclerosis. Hypertension is proinflammatory and is 10 accompanied by increased plasma oxygen free radicals. Free radicals induce vascular
3 / 24
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
smooth muscle cell proliferation and may oxidize low-density lipoproteins, which in turn promotes macrophage activation and monocyte extravasation. Angiotensin II is elevated in many hypertensives and may play a direct role in atherogenesis independent of its effects on 11 blood pressure. It directly stimulates smooth muscle cell growth, hypertrophy, and 10 lipoxygenase activity, with resultant inflammation and low-density lipoprotein oxidation, thus accelerating atherosclerosis. Angiotensin II also stimulates the production of transforming growth factor β (TGF-β), a cytokine that is linked to fibrosis in a number of disease states. In animal models, transforming growth factor β appears12to play a causal role in the development of hypertension and pathological vessel remodeling. EVALUATION AND TREATMENT The gold standard of blood pressure measurement is auscultation using a mercury sphygmomanometer. Newer devices can provide accurate readings but require calibration. Blood pressure should be measured in the seated position after a 5-minute rest with the patient's feet resting on the floor and the arm supported at heart level during the measurement. Accurate readings depend on the use of an appropriate-sized cuff with the bladder covering at least 80 percent of the arm. The classification of blood pressure into specific diagnostic categories is based on the average of two or more readings on each of 13 two or more office visits. A complete history and physical examination with basic laboratory measurements are essential to evaluate for identifiable causes of hypertension and assess risk. Several patient characteristics may suggest an identifiable cause of hypertension including young age, severe hypertension, hypertension that is refractory to multiple interventions, and physical or laboratory findings suggestive of endocrinological disorders, such as truncal obesity or hypokalemia. Abdominal bruits or decreased 14 femoral pulses may also be an indicator of renovascular disease or coarctation of the aorta. Lifestyle modification is recommended as an initial therapy for patients with blood pressure of 2 120/80 mmHg or higher. Effective lifestyle interventions include weight loss, limited alcohol intake, aerobic physical activity, adequate potassium intake (approximately 90 mmol/day), reduction in sodium intake, and dietary regimens such as the Dietary Approaches to Stop 15 Hypertension (DASH) eating plan. Antihypertensive medications are recommended in addition to lifestyle measures for patients with blood pressure of 140/90 mmHg or higher, and when the blood pressure is 130/80 mmHg or higher in those with diabetes and chronic kidney disease. For subjects without a history of cardiovascular disease or other compelling indication, initiating therapy with a thiazide diuretic such as chlorthalidone, is generally recommended. In the Antihypertensive and Lipid Lowering to Prevent Heart Attack Trial (ALLHAT), involving more than 33,000 participants, therapy with chlorthalidone was either equivalent or superior to lisinopril and amlodipine for the primary prevention of cardiovascular endpoints, with a 16 particular benefit for African American subjects both in terms of safety and efficacy. When the blood pressure is 160/100 mmHg or higher, initiating therapy with two-drug combinations 2 is generally recommended. There are many benefits to treating hypertension, especially reductions in myocardial infarctions, congestive heart failure, retinopathy, renal failure, and overall mortality. The focus of the remainder of this chapter is on specific neurological complications of hypertension and the unique aspects of treatment that they necessitate. STROKE Of all the identified modifiable risk factors for stroke, hypertension appears to be the most important, owing to its high prevalence and its associated three- to fivefold increase in stroke 17 percent of strokes could be risk. Based on epidemiological data, approximately 50 18 prevented if hypertension were eliminated (Table 7-1). Even small reductions in blood pressure result in large reductions in stroke risk. For example, in a meta-analysis of 37,000 hypertensive subjects from 14 studies, a reduction of 5 to 6 mmHg in diastolic blood pressure 19 with active treatment was associated with a 42 percent reduction in stroke risk. The benefits of blood pressure reduction on stroke risk extend similarly to the elderly with isolated elevations in systolic blood pressure. In the Systolic Hypertension in the Elderly Program (SHEP) trial of 4,736 subjects 60 years and older, a 36 percent reduction in stroke was seen with a20,21 12-mmHg decline in systolic pressure, a finding confirmed in other large randomized Although there is still some uncertainty surrounding the treatment of blood pressure trials. in the oldest old (>85 years), the best available data suggest that benefits will be comparable 22 with those seen in younger individuals. Stroke rates have generally declined worldwide, especially throughout the 1970s and 1980s, although more recently they appear to have 23 plateaued (Figs. 7-2 and 7-3). Although these historic trends are not entirely explained by
4 / 24
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
better control of blood pressure, the rates of decline have roughly paralleled increased use of antihypertensive medications, suggesting that benefits of blood pressure therapy observed in 24 randomized trials have been at least partially realized in community practice.
FIGURE 7-2 Percent change in stroke mortality, men aged 35 to 74, 1972 to 1982. (From Thom TJ: Stroke mortality trends: an international perspective. Ann Epidemiol 3:509, 1993. Copyright 1993, with permission from Elsevier Science.)
5 / 24
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 7-3 Age-adjusted death rates for stroke among men and women in the United States, 1900 through 1990. (From Higgins M, Thom T: Trends in stroke risk factors in the United States. Ann Epidemiol 3:550, 1993. Copyright 1993, with permission from Elsevier Science.)
Click here to view this table.... Hypertension contributes to each of the major intermediate causes of both ischemic and hemorrhagic stroke including carotid stenosis, intracranial atherosclerosis, small-vessel arteriosclerosis, and both macroscopic and microscopic aneurysms. Each of these conditions is considered separately in this chapter. In part because of the heterogeneity of its manifestations in the brain, there continues to be some uncertainty about the optimal management of blood pressure in both the acute and chronic phases after stroke. In the acute phase of cerebral ischemia, hypertension may play a compensatory role in 25 maintaining cerebral perfusion to viable but threatened areas of the brain. Loss of normal cerebral autoregulation has been demonstrated in areas of ischemic brain. When autoregulation is lost, blood flow to the brain becomes directly proportional to mean arterial pressure, and therefore, in theory, pharmacological increases in blood pressure could have 26 salutatory effects in preserving hypoperfused regions of the brain. In some small studies, rapid pharmacological reductions in blood pressure have predicted worse outcomes, and there are numerous anecdotal reports of the recrudescence of stroke symptoms after a 27,28 Therefore, most stroke guidelines recommend withholding decrease in blood pressure. pharmacological treatments of blood pressure in acute stroke in the absence of acute end-organ injury29or administration of thrombolytics, unless the blood pressure exceeds 220/120 mmHg. It is also possible, however, to make physiological arguments that would be supportive of acute blood pressure reduction, such as stabilization of an intra-arterial 30 thrombus or to reduce edema formation. Ongoing trials in this area will provide key data to help resolve this debate. Although historically there has been concern about lowering blood pressure even in the chronic phases after stroke, there is now overwhelming evidence to support the use of pharmacological interventions to lower blood pressure for secondary stroke prevention. In 6,105 subjects with a history of stroke, the Perindopril Protection Against Recurrent Stroke Study (PROGRESS) demonstrated a 43 percent relative risk reduction for secondary stroke prevention when subjects were randomized to the combination of the angiotensin-converting 31 enzyme (ACE) inhibitor perindopril and the thiazide diuretic indapamide. Combination therapy with the ACE inhibitor and thiazide, which resulted in a mean blood pressure reduction of 12.3/5 mmHg, demonstrated a substantially more robust benefit for stroke prevention than monotherapy with ramipril (relative risk reduction 5%), which produced only a 4.9/2.8-mmHg average reduction in blood pressure (P for heterogeneity between treatments <0.001). Combination therapy with an ACE inhibitor and a thiazide is now commonly recommended for secondary stroke prevention, with benefits appearing to be similar
6 / 24
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
regardless of whether measured blood pressure is above or below the traditional cut points 32 for hypertension. Although other studies have supported the finding that therapy with renin-angiotensin system antagonists and diuretics provides especially strong benefits for 33 stroke prevention, particularly when compared with β-blockers, the degree of hypertension control that is achieved is usually the best predictor of protection against recurrent stroke. Therefore, response to therapy and other comorbidities, such as heart failure, diabetes, asthma, and arrhythmia, should2 be considered when deciding on an appropriate antihypertensive drug regimen. There is still debate about how soon after stroke to initiate therapy, as the majority of patients in trials of blood pressure therapy after stroke have been randomized months after their qualifying event. Early initiation of therapy is increasingly practiced to improve patient compliance, and current guidelines recommend consideration of 32,34 treatment once the “hyperacute” period has ended. CEREBRAL ANEURYSMS Cerebral aneurysms are focal dilations of blood vessels. Subarachnoid hemorrhage, an important form of hemorrhagic stroke, occurs when a cerebral aneurysm ruptures (Fig. 7-4). Hypertension is associated with cerebral aneurysm formation and with subarachnoid hemorrhage. In a large sample of Medicare patients, hypertension was listed as a secondary diagnosis in 43 percent of patients admitted with unruptured aneurysms and in 34 percent of 35 of subarachnoid hemorrhage was hospitalized control subjects. In a meta-analysis, the risk 36 2.8 times greater in those with a history of hypertension.
FIGURE 7-4 A ruptured anterior communicating artery aneurysm producing
acute subarachnoid hemorrhage. A, Head computed tomography (CT) shows a large amount of blood at the base of the brain and a small amount of intraventricular blood. B, Angiogram reveals a complex saccular aneurysm. The cause of the development and rupture of cerebral aneurysms is probably multifactorial. Epidemiological studies have found several environmental risk factors for subarachnoid hemorrhage other than hypertension.36Cigarette smoking increases the risk of subarachnoid by increasing the release of proteolytic hemorrhage by 100 percent or more, perhaps 37 enzymes that affect blood vessel integrity. Heavy alcohol consumption increases subarachnoid hemorrhage risk with 36 a pooled odds ratio of 1.5 in case control studies and relative risk of 4.7 in cohort studies. Alcohol-induced37hypertension, relative anticoagulation, or increased cerebral blood-flow may be responsible. Oral contraceptives are associated with a small but significant38excess risk of subarachnoid hemorrhage, with a relative risk of 1.4 in current and past users. The source of the association is unknown. Genetic factors are also important to aneurysm formation and subarachnoid hemorrhage. The risk of subarachnoid hemorrhage is three to seven times greater in patients with an 39 of unruptured aneurysms is probably at affected first-degree relative, and the prevalence 40 least twice as high as without a family history. Females are twice as likely to have an aneurysm or present with subarachnoid41 hemorrhage. African Americans have twice the rate of subarachnoid hemorrhage as whites. Polycystic kidney disease, Ehlers–Danlos syndrome type 4, and α1-antitrypsin deficiency are also associated with increased risk. Marfan's syndrome has been considered a42risk factor for aneurysm formation, but this association has recently been questioned. The pathology of aneurysms reveals little about the underlying etiology. Two major morphological subtypes are recognized: fusiform and saccular or berry aneurysms. Fusiform aneurysms more commonly occur in children and in the elderly. The childhood form is 43 thought to represent a genetic or early developmental abnormality in vessel wall structure. 44 Fusiform aneurysms in the elderly are often associated with intracranial atherosclerosis.
7 / 24
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Saccular aneurysms commonly occur at vessel branch points at the base of the brain, with the middle cerebral artery bifurcation and origins of the anterior communicating artery and 45 posterior communicating artery representing the most frequent locations. Turbulent flow may be responsible for this tropism.
Unruptured Cerebral Aneurysms Estimates of the prevalence of unruptured aneurysms vary widely. A recent meta-analysis of prospective studies in adults reported463.6 percent prevalence in four autopsy series and 6.0 percent in nine angiographic studies. Prevalence was 2.3 percent in those without a known risk factor. Approximately 90 percent of these aneurysms were less than 10 mm in diameter, and 70 percent were less than 6 mm. Based on the prevalence from angiographic studies, an estimated 11 million American adults have an unruptured aneurysm, and these are being detected more frequently with advances in imaging studies. Annual cost for47unruptured aneurysms in the United States was estimated at $522 million in the 1980s and is probably significantly greater now. Unruptured aneurysms are often asymptomatic, discovered incidentally in a work-up for an unrelated problem. Some aneurysms produce symptoms by compressing neighboring structures. Presentation with a new cranial neuropathy is considered a worrisome sign for imminent rupture and often prompts urgent treatment. New headaches are also a presenting sign of unruptured aneurysm. Although migraine may simply represent an unrelated occurrence prompting head imaging, some headaches may be due to the aneurysm itself. A sudden, severe “thunderclap” headache may herald rapid aneurysm growth or a small leak 48 without evidence of subarachnoid hemorrhage. Catheter angiography is the gold standard for detection of aneurysms. Magnetic resonance (MR) angiography is approximately 85 percent sensitive for detecting aneurysms larger than 49 3 mm, with 85 percent specificity. Head computed tomography (CT) does not reliably detect unruptured aneurysms. Prognosis of unruptured aneurysms, as reflected in the rate of rupture, is a subject of controversy. In the largest prospective cohort study, the International Study of Unruptured Intracranial Aneurysms, 1,692 subjects with unruptured aneurysms who did not undergo surgery or endovascular treatment, were followed prospectively for an average of 4.1 years. The size of the aneurysm (≥7 mm in maximal diameter) and location at the basilar tip or posterior communicating artery were independent predictors of hemorrhage. Among 1,077 subjects with no history of subarachnoid hemorrhage, the annual risk of hemorrhage for an aneurysm less than 7 mm in diameter in the anterior circulation was500 percent; it was 0.5 percent when the aneurysm was located in the posterior circulation. The standard of care for treatment of aneurysms has historically been surgical clipping, in which a metal clip is placed over the neck of the aneurysm, isolating it from the circulation. Coil embolization is an alternative therapy and involves packing platinum coils into an aneurysm through a microcatheter in an angiographic endovascular procedure. The relative merits of the two procedures have been argued. Coil embolization appears to provide a safer 51 approach but may not reduce subsequent rupture rates as effectively as surgical clipping. Whether a given aneurysm requires treatment depends on the anticipated rupture rate. For asymptomatic aneurysms smaller than 7 mm with no history of subarachnoid hemorrhage, treatment may not be justified, particularly when in the anterior circulation, given the risks of 52 surgery and endovascular therapy. Treatment of unruptured aneurysms appears to be cost-effective when they are larger or symptomatic or when there is a history of subarachnoid hemorrhage from a different aneurysm. Controlling or eliminating risk factors, such as hypertension, smoking, and alcohol abuse, may reduce rupture rates, but this has not been systematically studied.
Subarachnoid Hemorrhage Subarachnoid hemorrhage accounts for approximately 5 percent of all strokes, but it tends to occur at a younger age than other stroke subtypes, with median age at death being 59 years for subarachnoid53hemorrhage, 73 years for intracerebral hemorrhage, and 81 years for ischemic stroke. Subarachnoid hemorrhage accounts for nearly one third of the years of potential life lost before age 65 due to stroke. Case fatality rates approach 50 percent, and 54 another 10 to 20 percent remain disabled and dependent at follow-up. Approximately 25,000 Americans present with subarachnoid hemorrhage each year, with total costs 55 estimated at $5.6 billion.
8 / 24
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Presentation with subarachnoid hemorrhage generally involves sudden onset of severe headache, sometimes accompanied by neck pain. Alteration of consciousness occurs in a minority of patients, but it may be severe enough to produce coma or sudden death outside the hospital. Head CT often shows blood surrounding the base of the brain. Intraventricular and intraparenchymal hemorrhage may be present and can provide clues as to the location of the ruptured aneurysm. Lumbar puncture may rarely show signs of hemorrhage when there is no evidence of it on head CT. Blood in the spinal fluid that does not clear is suggestive of subarachnoid hemorrhage. Xanthochromia is present in nearly all cases and may persist for more than 3 weeks, but its appearance is delayed by more than 12 hours in 10 percent of cases. Angiography is required for the characterization of the aneurysm and to plan treatment. Prognosis depends on the ability to treat the underlying aneurysm and on the patient's condition at presentation. Recurrent hemorrhage occurs in more than 4 percent of untreated patients during the first day and then in 1 to 2 percent per day for the next 2 weeks and is 45 associated with even greater fatality and morbidity than primary rupture. Regardless of treatment and recurrent hemorrhage, the level of consciousness is the major predictor of 56 mortality (Table 7-2). The World Federation of Neurological Surgeons developed a Universal Subarachnoid Hemorrhage Grading Scale, similar to the older Hunt and Hess scale, which has been widely adopted but offers little advantage over determinations of level 57 of consciousness alone. Click here to view this table.... To reduce the risk of recurrent hemorrhage, aneurysms are generally rapidly identified and repaired with surgical clipping or endovascular coil embolization. Controversy continues about optimal timing of treatment in high-risk patients. Early surgery may be technically more challenging when a large amount of subarachnoid clot is present, but early surgical treatment reduces the risk of recurrent rupture more quickly than45does later surgery. Most neurosurgeons therefore recommend early treatment. Hydrocephalus from obstruction of the cerebral aqueduct or the meninges by blood clot may require external drainage. Vasospasm is a common complication that produces cerebral ischemia due to blood vessel constriction in areas with aneurysmal subarachnoid clot. It becomes symptomatic in one third of cases, usually 3 to 58 14 days after hemorrhage, and results in cerebral infarction or death in 15 to 20 percent. Transcranial Doppler ultrasonography can59detect vasospasm before it becomes symptomatic and is helpful in monitoring patients. Oral nimodipine, a calcium-channel antagonist, reduces poor outcomes from vasospasm and should be given as soon as possible after the initial bleed in all cases. Hypertension induced with pressors and hydration with intravenous fluids may reduce the risk of infarction, but these measures have never been studied in trials. They should not be used in patients with untreated ruptured aneurysms because of the risk of precipitating further episodes of bleeding. Vasodilatation through angioplasty or intra-arterial verapamil (or other vasodilators) immediately reverses angiographic vasospasm in many cases, but it requires further study before clinical benefits are proven. INTRACEREBRAL HEMORRHAGE Bleeding directly into the substance of the brain is termed intraparenchymal or intracerebral hemorrhage (Fig. 7-5). It may occur as a complication of ischemic stroke, termed hemorrhagic conversion, or as the primary injury without preceding ischemia. Hypertension is the most important identified risk factor for intracerebral hemorrhage. More than 70 percent of patients with intracerebral hemorrhage have a history of hypertension, and the risk of hemorrhagic stroke is elevated 9.5-fold in the highest compared with the lowest quintile of 60 systolic blood pressure.
9 / 24
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 7-5 Head CT of an acute basal ganglia intracerebral hemorrhage with mass effect compressing the ventricles.
Intracranial hemorrhage is responsible for 10 to 15 percent of all stroke deaths but for more than one third of the years53of life lost before age 65 due to the younger age distribution of 50 percent dead at 1 intracerebral hemorrhage. Case fatality rates are high, with 35 to 61 month and only 20 percent returning to independence at 6 months. In the United States, an estimated 37,000 cases of intracerebral hemorrhage55occur each year, with the total estimated cost of care exceeding $6 billion annually. Other risk factors for intracerebral hemorrhage include age, race, substance abuse, anticoagulation, platelet dysfunction, and vascular and structural anomalies. Rates of intracerebral hemorrhage increase with age. African Americans have 40 percent higher rates 41 than those of whites, with larger differences at younger ages. Cocaine and amphetamines are associated with increased risk, particularly acutely, possibly because of transient severe 60 hypertension. Abnormalities in clotting may account for an increased incidence of intracerebral hemorrhage with heavy alcohol use. Excessive warfarin anticoagulation and 62,63 Thrombolytic antiplatelet therapy also increase the risk of intracerebral hemorrhage. agents used for ischemic stroke and myocardial infarction cause intracerebral hemorrhage in some cases. It may also occur with severe thrombocytopenia and platelet dysfunction. Intracerebral hemorrhage may result from and occur in brain tumors, such as glioblastoma multiforme and metastatic melanoma, choriocarcinoma, renal cell carcinoma, and bronchogenic carcinoma. Congophilic amyloid angiopathy, a vasculopathy common in the elderly, is associated with lobar hemorrhages, often centered at the gray-white junction. Other punctate hemorrhages may be apparent on gradient-echo MR images (Fig. 7-6), supporting the diagnosis. Arteriovenous malformations, abnormal complexes of arteries and veins in 60 brain parenchyma, account for 5 percent of intracerebral hemorrhage. Cavernous malformations are dense collections of thin-walled vascular channels and appear to be the 63 cause of intracerebral hemorrhage in 5 percent of autopsies ; they are not apparent on
10 / 24
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
angiography but have a “popcorn” appearance in T2-weighted MR images, with a hyperintense core surrounded by hypointense hemosiderin from previous small hemorrhages (Fig. 7-7). Aneurysms may produce intracerebral hemorrhages when blood is directed into the brain, and these rarely are mistaken for primary hypertensive hemorrhages.
FIGURE 7-6 Imaging findings of amyloid angiopathy, with no evidence of hemorrhage on CT (A) but multiple punctate hypointensities at the gray-white junction on T2-weighted multiplanar gradient-recalled (MPGR) magnetic resonance imaging (MRI) (B), suggesting old hemorrhage (two lesions are apparent on this image in the parieto-occipital region).
11 / 24
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 7-7 A cavernous malformation with a small amount of acute, intracerebral hemorrhage surrounding it on CT (A). T2-weighted MRI (B) shows a lesion with a focal area of high signal intensity surrounded by a thick rim of hypointense siderin. T1-weighted MRI (C) showing the typical “popcorn” appearance. The high signal intensity represents methemoglobin.
Primary hypertensive intracerebral hemorrhage was thought to be caused by chronic vascular injury, resulting in formation of microscopic aneurysms, first characterized by Charcot and Bouchard in 1868. Advances in pathological tissue preparation have raised doubts about the frequency and64importance of microscopic aneurysms, attributing the appearance to complex vascular coils. More recently, fibrinoid65necrosis of small arteries has been proposed as the initial step in intracerebral hemorrhage. When acute hypertension or clotting abnormality precipitates rupture, blood dissects into the brain parenchyma, sometimes producing a hematoma. Brain injury occurs because of compression of surrounding tissue and from the direct toxic effects of blood. Mass effect from the hematoma may lead to uncal, subfalcine, tonsillar, or transtentorial herniation, depending on location, and death may ensue. Clinical presentation depends on the location and size of the hemorrhage (Table 7-3). Nearly all intracerebral hemorrhage is characterized by sudden onset of neurological deficits, progressing over minutes and accompanied by headache, often with alteration of consciousness. Deterioration due to surrounding edema, hydrocephalus, or continuing or recurrent hemorrhage often occurs within the first 24 hours but may be delayed by days. Click here to view this table.... Prognosis is multifactorial. Hemorrhage volume, most easily measured by halving the product of the length, width, and depth on axial head CT images, is a powerful predictor of mortality, with 80 percent 30-day mortality in those with volumes greater than 60 ml and 22 percent 66 mortality in hemorrhages less than6730 ml. Mortality is much greater in those with intraventricular extension of blood. Hydrocephalus due to intraventricular extension or cerebrospinal fluid (CSF) outflow obstruction predicts in-hospital mortality: 51 percent of 68 those with and 2 percent of those without hydrocephalus died in one series. Lower Glasgow Coma Scale scores, greater age, location, and blood pressure or pulse pressure are other independent predictors of69,70 mortality. Simple multivariable prediction models have been developed and validated. Urgent head CT is required in patients with suspected intracerebral hemorrhage. MR imaging (MRI) is probably as sensitive as CT for detecting hemorrhage and is more sensitive for detecting an underlying structural etiology, but the rapidity, availability, and ease of interpretation of CT favor its initial use. Contrast-enhanced head CT scan may show evidence of71persistent hemorrhage at the time of presentation, a sign associated with poor prognosis. Urgent catheter angiography is required whenever aneurysmal subarachnoid hemorrhage is possible, such as in cases with a large amount of subarachnoid blood, and should be considered for all patients without a clear etiology who would be surgical candidates. Early MRI may be indicated if a structural etiology is suspected, but findings are often obscured by the hemorrhage, and a scan delayed by 4 to 8 weeks may provide more useful information if urgent diagnosis is unnecessary. MRI is useful in diagnosing cavernous malformations and may suggest congophilic amyloid angiopathy. Treatment is generally supportive, although surgical intervention is indicated in some cases. Severe hypertension is common after intracerebral hemorrhage, in part because it is a response to elevated intracranial pressure and brain injury. No clinical studies are available for determining optimal blood pressure control after intracerebral hemorrhage. Theoretically, persistent hypertension could increase the risk of ongoing hemorrhage, but antihypertensive treatment may reduce blood72flow to ischemic brain surrounding a hematoma or reduce cerebral perfusion pressure. Consensus guidelines have recommended antihypertensive medications for systolic blood pressure greater than 180 mmHg or diastolic blood pressure greater than 105 mmHg, and fluids or pressors for systolic blood pressure less than 90 61 mmHg, but these thresholds for treatment are frequently debated. Increased intracranial pressure may lead to coma and is treated with extraventricular drainage, osmotherapy, or hyperventilation. Surgical evacuation of primary intracerebral hemorrhages is commonly performed when there is posterior fossa hemorrhage with a risk of brainstem compression or when there is evolving neurological deterioration in patients with lobar hemorrhages and other prognostic signs are favorable. A large, international trial randomized 1,033 subjects with supratentorial hemorrhage to receive early surgical evacuation of the hematoma or initial conservative treatment followed by surgical evacuation only if it was necessitated by neurological
12 / 24
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
deterioration. There was a favorable outcome at 6 months in 26 percent of those allocated to early surgery as compared with 24 percent in those allocated to initial conservative treatment (P = 0.89). In subgroup analysis, it appeared that early surgery was more effective than conservative therapy when the hematoma was 1 cm or less from the cortical surface. Additional trials will be needed to resolve the issue of early surgical benefit for superficial 73 hematomas. After the acute period, aggressive treatment of hypertension is indicated. In addition to reducing cardiovascular disease and ischemic stroke, one study has shown that treating 74 hypertension reduces the risk of intracerebral hemorrhage by more than 50 percent. LACUNAR INFARCT The term lacune was first introduced in 1843 by M. Durand-Fardel to describe small, subcortical areas lacking gray and white matter. These lesions were attributed to infarct and associated with particular clinical presentations by P. Marie and J. Ferrand more than 50 75 years later. In the 1950s C. Miller Fisher reintroduced the term into modern neurology. In a rapid succession of articles, he described the clinical and pathological presentation, recognized the importance of hypertension as an etiology, and developed a theory of pathogenesis that survives today. Less than 2 cm in diameter, lacunes are small infarcts that result from occlusion of small penetrating branches arising from large arteries (Fig. 7-8). There is general agreement about the definition of lacune, but much argument about the interrelationship between lacunar infarcts, lacunar strokes (symptomatic lacunes), lacunar syndromes (symptom complexes often associated with lacunar strokes), and lacunar disease (lacunes due to intrinsic small-vessel changes). Arguments arise from imperfect correlations between these entities. First, not all lacunes produce lacunar strokes because some are silent. Second, lacunar syndromes are sometimes associated with large-vessel strokes. Third, lacunes are produced by intrinsic small-vessel disease and by other etiologies. These issues are discussed in greater detail later.
13 / 24
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 7-8 An acute right thalamocapsular lacunar stroke producing left sensorimotor syndrome. The lesion was hypodense in noncontrast head CT (A). With MRI, it was hyperintense on T2-weighted images (B), inconspicuous on T1-weighted images (C), and hyperintense on diffusion-weighted images (D).
More than 50 percent of lacunes are located in the basal ganglia and thalamus, with the remainder in the internal capsule, pons, cerebellum, and subcortical white matter. Approximately 20 to 30 percent of ischemic strokes are due to lacunes. In a recent study, 23 percent of randomly selected subjects 65 years or older had a lacune on MR scanning, and 76 89 percent of those with a lacune denied a history of stroke or transient ischemic attack. These “silent” lacunes were associated with impairment in cognitive and functional tasks, suggesting that the overall clinical burden of lacunes may be greater than previously suspected. Hypertension is an important risk factor for development of lacunes, ranking as the most 76,77 However, the strength of78the important identified risk factor in multivariable models. association may be no greater for lacunes than for other forms of ischemic stroke, and 79 hypertension is not always present. Nonetheless, since other risk factors are less important for lacunes, eliminating hypertension would be expected to have a greater impact on the occurrence of lacunar infarction than other forms of ischemic stroke. Elevation in the level of serum creatinine is independently associated with lacunar76infarction, perhaps because it is a marker for chronic end-organ damage from hypertension. Diabetes mellitus is a risk factor for symptomatic lacunes, approximately doubling the risk. However, the influence of diabetes 78 on lacunar stroke does not appear to differ from its effect on other ischemic stroke subtypes. This is also true for cigarette smoking, which doubles the risk of all ischemic strokes, including lacunes. Carotid artery stenosis is associated with an increased risk of lacunar stroke, with76more than twice the risk of a symptomatic lacune above a 50 percent or greater stenosis. Cardiac disease is less common in patients with
14 / 24
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Neurological Complicatio...
lacunes (20%) than in those with other ischemic stroke types (47%).
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp 78
The etiology of lacunes has been argued bitterly. Some have suggested that the vast majority of lacunes is due to changes within small penetrating vessels, primarily because of chronic 80 hypertension, but others have argued that emboli to small vessels79and intracranial atherosclerosis are responsible for a significant number of lesions. Fisher produced much of the data supporting intrinsic small-vessel disease. He found degenerative changes in small vessels he termed lipohyalinosis and fibrinoid degeneration, characterized by layers of 81 connective tissue within the vascular media, obstructing the lumen. These changes were proximal to infarcts in some cases. Atherosclerosis at the origin appeared responsible for 81 other infarcts. Fisher recognized that emboli may be responsible for some lacunes. Animal models have shown that particles may embolize to small penetrating arteries, producing 82 lacunes. Risk factor profiles have been used to argue against hypertension and intrinsic small-vessel 79 disease as the sole etiology of lacunes. As discussed previously, the risks imparted by hypertension, diabetes, and cigarette smoking are similar for lacunes and for other forms of ischemic stroke, and carotid and cardiac disease appear to be independent risk factors for lacunes. However, carotid and cardiac disease are much more commonly associated with 83 large-vessel infarctions than with lacunes. The etiology of lacunes is almost certainly multifactorial. Intrinsic small-vessel disease may predominate, but emboli and intracranial atherosclerosis almost certainly account for a significant minority of cases. Several classic presentations of lacunar strokes have been described, termed the lacunar syndromes. Pure motor hemiparesis is the most common, accounting for 45 percent of cases. Motor functions involving face, arm, and leg are impaired, but other neurological functions are spared. The appearance is different from that with cortical strokes, in which deficits in sensation or cognition often accompany motor changes. Pure motor hemiparesis is not always due to a lacune, with 10 to 20 percent of cases attributed to a cortical stroke. When a lacune is responsible, it is most often located in the posterior limb of the internal capsule or in the basis pontis, but any other site along the path of corticospinal fibers can produce the syndrome. Sensorimotor syndrome is the second most common lacunar syndrome, accounting for 20 78 percent of cases. Weakness and numbness are present in varying degrees, usually involving the face, arm, and leg. Other neurological deficits are absent. The syndrome is most commonly produced by a lacune involving the lateral thalamus and internal capsule, but 78 13 percent of cases are not due to lacunes. 78,84
Ataxic hemiparesis accounts for 10 to 18 percent of lacunar syndromes. In the affected limbs, pyramidal weakness is combined with elements normally attributed to cerebellar ataxia. Intention tremor, exaggerated rebound, and irregular rapid alternating movements are superimposed on ipsilateral weakness.78The findings are highly suggestive of a lacunar stroke, with 95 percent attributable to lacunes. Infarct locations are identical to those that cause pure motor hemiparesis. 78,84
Among patients with lacunar syndromes, 7 percent have a pure sensory stroke, characterized by impaired sensation without other accompanying neurological deficits. When the face, arm, and leg are involved, the lesion is nearly always a lacune in the contralateral thalamus. A lesion in the medial lemnicus in the midbrain or rostral pons may occasionally produce an identical syndrome. Pain and dysesthesia in the affected region may accompany the lesion acutely or may be delayed by weeks to months. Many other lacunar syndromes have been described, including clumsy-hand dysarthria, hemiballism, and pure motor hemiparesis combined with various eye movement 81 abnormalities. Although lacunes occur more commonly in certain regions79of the brain, they can occur anywhere, producing an infinite number of potential syndromes. Even signs generally attributed to cortical lesions may be produced by lacunes, including aphasia, abulia, confusion, and neglect. Prognosis for recovery after a lacunar stroke is generally more favorable than for ischemic 85 Recurrent stroke and mortality rates are also strokes due to occlusion of major vessels. 86 lower than for other stroke subtypes. Lacunar syndromes may be produced by cortical strokes or even by small hemorrhages. Also, some lacunes may be associated with carotid disease or intracranial atherosclerosis, and knowledge of this could alter treatment decisions. Therefore, diagnostic imaging has been recommended for all those presenting with lacunar syndromes. An immediate head CT scan will rule out hemorrhage as an etiology but may not distinguish lacunes from
15 / 24
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
large-vessel infarctions. The absence of changes on a head CT scan delayed by more than 6 hours has been used as confirmatory evidence of lacunar infarction. MRI provides more definitive confirmation, and MR angiography may suggest intracranial atherosclerosis. For lacunar strokes in the internal carotid distribution, duplex ultrasonography or neck MR angiography should be performed because a stenosis proximal to the lacune would generally be considered symptomatic. Acute therapy for lacunes has not been well studied. Most studies of ischemic stroke have not examined this subtype separately, except in post hoc analyses with numbers too small to find significant treatment effects. There has been much debate about whether lacunar strokes should be treated with tissue plasminogen activator (t-PA). Some have argued that the predominant etiology of lacunar syndromes is intrinsic small-vessel disease, which would not be expected to respond to thrombolytics, so that patients would be exposed to an increased risk of hemorrhage without a good chance for benefit. In the National Institute of Neurological Disorders and Stroke t-PA trial, t-PA was effective in the85subgroup of patients judged to have small-vessel occlusive strokes prior to randomization. In fact, absolute differences in favorable outcomes were greater for small-vessel strokes than for large-vessel occlusive and cardioembolic strokes, and differences in two indices reached statistical significance despite small numbers. Some have argued that the final stroke occurs suddenly, implying that acute thrombosis in a diseased small vessel may account for a lacunar infarction and that this explains the efficacy of thrombolysis. Others have argued that the correlation between lacunar stroke and lacunar syndrome is so poor that a diagnosis of nonthrombotic small-vessel occlusion cannot be made with accuracy and that all patients with stroke should receive t-PA because of its overall benefit in ischemic stroke. The American 87 Heart Association guidelines do not recommend avoiding t-PA in lacunar syndromes. Although treatment is not recommended for patients with mild neurological deficits, including isolated hemisensory deficits, a patient with a pure motor hemiparesis is considered an appropriate candidate for thrombolysis. Other acute treatment for lacunar strokes is supportive. Aspirin appears to reduce the risk of subsequent ischemic strokes, regardless of etiology. Although differences in effectiveness in stroke subgroups have not been carefully studied, the Chinese Acute Stroke Trial found that aspirin's effect on stroke recurrence was similar in 88 patients with lacunar strokes and those with other ischemic stroke subtypes. Clopidogrel and the combination of dipyridamole/aspirin are alternatives for secondary prevention in those who cannot tolerate aspirin or who have recurrent strokes despite aspirin. Control of hypertension reduces subsequent ischemic stroke risk, and risk reduction may be even greater for lacunes. Treatment of isolated systolic hypertension in elderly patients halved the 74 risk of lacunar stroke, a more dramatic effect than that seen for other ischemic strokes. A lacune89was considered evidence that a carotid stenosis was symptomatic in previous studies. Whether the risk–benefit ratio for endarterectomy in patients with lacunes is different from that in those with large-vessel strokes is not known. PERIVENTRICULAR WHITE MATTER DISEASE With improvements in head imaging, changes in the white matter surrounding the lateral ventricles were recognized frequently in the elderly, prompting Vladimir Hachinski to coin the term leukoaraiosis for the finding. Head CT shows a periventricular mantle of hypodensity, often most profound at the frontal and occipital horns, which is hyperintense on T2-weighted 96 percent of those older than 65 MRI (Fig. 7-9). Age is the most important risk factor, with 90 years showing at least some evidence of such change. Clinically, the changes are most frequently associated with insidious declines in cognitive and motor performance, particularly 90,91 on tests that depend on reaction time and speed.
16 / 24
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 7-9 Imaging findings of periventricular white matter disease, with
hypodensity on head CT (A) and T2-weighted hyperintensities on MRI (B). The etiology of white matter lesions is believed to be related to several distinct pathological processes, including hypoperfusion injury, cerebral amyloid angiopathy, dilated perivascular spaces, axonal loss, astrocytic gliosis, and loss of ependymal integrity with resulting cerebrospinal fluid extravasation. Lesions contiguous with the ventricles show fewer histological and molecular markers of ischemia than lesions in the deep subcortical92areas, where they resemble areas of “incomplete” infarction on pathological examination. Loss of vasomotor reactivity and autoregulation due to93small-vessel vasculopathy is hypothesized to be a frequent cause of the ischemic changes. Leukoaraiosis may be an important clinical indicator of end-organ injury from hypertension, integrating information about cumulative exposure to high blood pressure as well as susceptibility to injury. Individuals with white matter lesions in the brain are at high risk of incident stroke and other clinical cardiovascular 94 is also one of strongest predictors of incident brain infarction events. White matter burden 95 defined by serial cranial MRI. BINSWANGER'S DISEASE In 1894, Otto Binswanger described a form of early dementia distinguishable from 96 syphilitic general paresis and large-vessel vascular dementia by its subcortical involvement. Hypertension is an important risk factor for the disease, existing in 94 percent of cases in one 97 series. Diabetes also appears to be a risk factor. Multiple lacunar infarctions are combined with diffuse and focal myelin loss, particularly in periventricular areas, producing a pathological picture consistent with a combination of multiple lacunes and periventricular white matter disease. Patients present with a stepwise and gradual progression of motor, cognitive, and behavioral deficits, generally over 5 to 10 years. Periods of symptom stabilization or improvement may occur. Imaging studies show patchy periventricular white matter hypodensity or hyperintensity on T2-weighted MRI, with superimposed focal, subcortical lesions consistent with lacunes. Aspirin and control of hypertension are expected to slow progression, but this has not been shown systematically. CADASIL Cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a recently recognized dementing illness caused by mutations in the NOTCH3 98 gene, which encodes a transmembrane receptor protein of unclear function. Clinical presentation is similar to that of Binswanger's disease, with stepwise decline in cognitive and motor functions. However, onset is earlier, beginning at 30 to 50 years of age, and it is often preceded by migraines with aura. Hypertension and diabetes are not associated. Head 99 imaging shows multiple lacunes superimposed on periventricular white matter disease. Degeneration of vascular smooth muscle cells and granular deposits characterize vessels in the brain and in other regions. Involvement of the dermis allows confirmation by skin biopsy. No treatment is available. CAROTID ARTERY STENOSIS The first comprehensive description of carotid occlusion and stroke is attributed to J. R. Hunt, who in 1914 described a patient with decreased carotid pulsation contralateral to a 100 hemiparesis. Autopsy confirmed a hemispheric infarct and showed patent intracranial vessels. With the advent of angiography and surgical exploration, internal carotid artery
17 / 24
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
occlusion with recent thrombus was confirmed in the 1940s. The importance of internal carotid artery stenosis as a cause of stroke is unclear because it is difficult to definitively attribute a stroke to the stenosis. The Stroke Data Bank of the National Institute of Neurological Disorders and Stroke classified 69 of 1,273 ischemic stroke cases as 101,102 Based atherothrombotic and 41 as embolic due to severe carotid stenosis or occlusion. on these numbers, approximately 9 percent of ischemic strokes are due to internal carotid stenosis or occlusion. In the Atherosclerosis Risk in Communities Study, 34 percent of randomly selected subjects aged 45 to 64 years had evidence of carotid plaque on 103 60 percent is found in ultrasonography. An asymptomatic carotid stenosis of more than 104 approximately 5 percent of 65-year-olds and increases with age. Hypertension is an important risk factor for carotid stenosis. In the Framingham study, systolic hypertension was a powerful predictor of subsequent105 carotid stenosis, with twice the pressure is also a odds for each 20-mmHg increase in systolic blood pressure. Systolic 106 predictor of progression in patients with asymptomatic stenoses. Cigarette smoking, high serum cholesterol level, and increased homocysteine are other risk factors for carotid 105 stenosis. Internal carotid artery stenosis is produced by atherosclerosis just distal to the common carotid bifurcation. The pathophysiology of carotid artery stenosis is complex. Hypertension induces vascular remodeling, resulting in medial thickening, luminal narrowing, and impaired 8 smooth muscle relaxation. These changes are concentrated in areas of nonlaminar flow, such as the common carotid bifurcation. Atherosclerotic plaques are thought to develop in these areas as a response to10injury produced by hypertension, blood-flow abnormalities, lipids, and possibly infection. This initiating injury induces endothelial cell expression of cell adhesion molecules that mediate local extravasation of mononuclear cells. Vessel wall inflammation results, with foamy, lipid-laden macrophages and T lymphocytes. Chronic injury leads to intimal hyperplasia and formation of complex plaques that may include a lipid core. When a plaque ruptures into the vessel lumen, thrombosis is induced, which may produce local occlusion, distal embolus, or, after organization, progressive luminal stenosis. Shear forces associated with a severe stenosis may induce platelet activation and thrombus formation without plaque rupture. Clinically, symptomatic patients present with large-vessel ischemic strokes or transient ischemic attacks in the distribution of the ophthalmic, middle, or anterior cerebral artery. Transient monocular blindness (amaurosis fugax), weakness, numbness, aphasia, or neglect may occur, depending on the affected region of the anterior circulation. Border-zone ischemia due to distal hypoperfusion in the anterior and middle cerebral artery territories presents with proximal upper and lower extremity weakness and numbness (“man-in-the-barrel” syndrome) and may indicate a critical stenosis or occlusion with inadequate collateral blood-flow. Artery-to-artery emboli classically appear as cortical wedge-shaped infarcts, indistinguishable from emboli from other sources. Lacunar infarcts, often attributed to intrinsic small-vessel disease, probably represent embolic events from carotid artery stenoses107 in some instances because endarterectomy appears to reduce the risk of ipsilateral lacune. A cervical bruit may be a sign of carotid stenosis, but it is absent in 25 to 40 percent of cases later confirmed to have a greater than 70 percent stenosis and is present in 25 to 40 percent 108 of those without a severe stenosis. Therefore, carotid imaging studies are generally indicated for patients with anterior circulation ischemic strokes or transient ischemic attacks. Carotid Doppler ultrasonography, neck MR angiography, or catheter angiography is required for the determination of whether an internal carotid stenosis is present. All three tests are 109 good predictors of the degree of stenosis determined at surgery. Catheter angiography is considered the gold standard but is limited to producing two-dimensional projections and carries a 1 percent risk of stroke. Therefore, it is generally preferable to perform carotid Doppler ultrasonography or neck MR angiography first. Carotid Doppler ultrasonography is more widely available and usually less expensive. MR angiography provides three-dimensional views and can incorporate the intracranial vasculature. When the findings on either Doppler ultrasonography or MR angiography are positive, performing the other study provides confirmation of degree of stenosis and may obviate the need for catheter angiography. From the perspective of society,104 it does not appear cost-effective to screen patients for asymptomatic carotid stenoses. Because of the limited benefit of surgery and the costs of carotid ultrasonography, the pretest probability of finding a stenosis must be greater than 40 percent before it is cost-effective to screen those without symptoms. Carotid ultrasonography probably is not cost-effective even in asymptomatic elderly patients with bruits because the pretest probability of finding a high-grade stenosis is only approximately 15 percent, given the
18 / 24
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
5 percent prevalence of a high-grade stenosis in those older than 65 years and a threefold 108 increased likelihood of stenosis in those with a bruit. Aspirin has been shown to reduce risk of stroke and myocardial infarction in patients with 110 ischemic stroke or transient ischemic attacks, with a risk reduction of about 20 percent. Some clinicians use anticoagulation with heparin or warfarin to treat symptomatic carotid stenosis, but there are no reliable data supporting this approach. Based on results in coronary artery disease, a process with similar pathophysiology, and on overall risk reduction of ischemic stroke, treatment with cholesterol-lowering agents may be of benefit even in those without hypercholesterolemia. Surgical removal of the obstructing plaque by endarterectomy is the established standard of therapy for symptomatic patients with carotid artery stenosis of at least 70 percent (Table 89,111 7-4). Endarterectomy also reduces recurrent stroke rates in patients with symptomatic carotid stenoses of 50 to 69 percent, but the number needed to treat (NNT) to prevent one recurrent stroke is considerably higher in this group when compared with those with stenoses exceeding 70 percent (∼15.4 to prevent one stroke over 5 years in those with 50% to 69% ∼5.8 to prevent one stroke over 2 years in those with 70% to 99% stenosis versus 107 stenosis). Endarterectomy is not beneficial in patients with stenosis less than 50 percent and is generally impractical in those with carotid artery occlusion. The risk of stroke with medical therapy is greater in those with cerebral events compared with ocular events, with plaque surface irregularity consistent with ulceration, with a symptomatic event within 2 112 weeks of presentation, and with greater degrees of stenosis. The risk of surgery is greater in females, in those with severe hypertension, and in those with peripheral vascular disease. These prognostic factors may be useful in fine-tuning patient selection for endarterectomy. Click here to view this table.... For patients with asymptomatic carotid artery stenosis, endarterectomy also prevents stroke when there is stenosis of at least 60 percent as assessed by carotid ultrasonography, but again the number needed to treat to prevent one stroke over 5 years remains large (∼20), and, therefore, current guidelines recommend consideration of endarterectomy for asymptomatic stenosis for patients with a surgical risk less than 3 percent and life expectancy 32,113 of at least 5 years. Endovascular angioplasty and stenting are an evolving approach to treatment of carotid stenosis, and stenting has been shown to be not inferior to endarterectomy in patients with both symptomatic and asymptomatic stenoses who have comorbidities associated with high surgical risk during endarterectomy. Large-scale trials comparing endarterectomy and stenting in more representative patient populations are ongoing. High-grade stenoses of the carotid arteries could impair distal cerebral blood-flow in some patients without adequate collateral supply. When endarterectomy is planned for the near future, physicians will routinely allow higher than normal blood pressures to reduce the risk of symptomatic hypoperfusion. Whether such a practice is truly justified when compared to the risk of plaque rupture associated with hypertension has not been addressed in clinical trials. INTRACRANIAL ATHEROSCLEROSIS Atherosclerosis involving the large intracranial vessels causes about 8 percent of ischemic 114 strokes. African Americans, Hispanics, and Asians have a higher prevalence of intracranial atherosclerosis, and relatively low prevalence of extracranial carotid artery stenosis 114,115 Extracranial carotid atherosclerosis is associated with a higher compared with whites. prevalence of peripheral vascular and coronary artery disease, but intracranial 114 atherosclerosis is not. Given racial and risk factor distribution differences, it seems appropriate to consider intracranial atherosclerosis an entity distinct from carotid artery disease rather than as an additional manifestation of widespread atherosclerotic changes. Hypertension is an important risk factor for intracranial atherosclerosis,116with a two- to threefold higher risk of disease in those with a history of hypertension. Smoking may be the most important risk factor, with a 50 percent increase in odds of disease for every 10 years of smoking. Diabetics have about three times the risk of developing intracranial atherosclerosis. Hypercholesterolemia also increases risk, but probably to a lesser degree. The relative contribution of these factors to intracranial atherosclerosis as opposed to other stroke subtypes is unclear. Distribution of known risk factors probably accounts for some of 114 the racial differences. There are intriguing differences in the pathophysiology of intracranial atherosclerosis and other forms of vascular disease. Intracranial arteries are less susceptible to
19 / 24
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
117
hypercholesterolemia than are extracranial arteries, and atherosclerotic plaque rupture 118 appears to be less common. Release of endothelial adhesion molecules is greater with intracranial atherosclerosis than in other ischemic stroke 119 subtypes, suggesting that inflammation is particularly important in its pathogenesis. There is no accepted unifying theory on the etiology of intracranial atherosclerosis. Clinical presentation is characterized by large-vessel or penetrating artery ischemia. The middle cerebral artery is most commonly involved, followed in order by the basilar, 114 intracranial internal carotid, anterior cerebral, and posterior cerebral arteries. Thrombosis at the site of the stenosis may lead to hypoperfusion in the entire distal territory or artery-to-artery embolus indistinguishable from events caused by extracranial carotid artery stenosis or cardiac embolus. Basilar thrombosis may result from underlying atherosclerosis in the basilar or vertebral arteries or after cardiac embolus. It is a life-threatening, often delayed diagnosis characterized by coma, quadriplegia, and cranial nerve findings. Involvement of the origin of penetrating small vessels may produce lacunar infarctions. Presentation with transient ischemic attack prior to infarction is more common with intracranial atherosclerosis than with other stroke subtypes. Intracranial MR angiography may reveal narrowing or occlusion of large vessels. However, artifacts may suggest a stenosis where none is present, and sensitivity is low for medium-sized and smaller vessels. Transcranial Doppler ultrasonography shows increased blood flow velocities in large stenotic vessels. Its sensitivity and specificity are also low, so it may be most useful as an adjunct to MR angiography. Catheter angiography is the gold standard for establishing the diagnosis, but it is associated with a 1 percent stroke risk that is probably even higher in the population being evaluated for intracranial atherosclerosis. Given the risk of angiography, it is only justified if results will alter treatment decisions. Prognosis in symptomatic patients is poor. Stenosis generally becomes more severe with time, but regression in some segments may occur. In the largest randomized trial of treatment for symptomatic intracranial atherosclerosis, the Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) trial, 569 subjects were randomized to aspirin (1,300 mg/day) 120 and warfarin (target international normalized ratio, or INR, of 2.0 to 3.0). The trial was stopped early because of safety concerns among subjects randomized to warfarin, and there was no significant difference in the primary endpoint of stroke, brain hemorrhage, or vascular death (P = 0.83). The 2-year rates of ischemic stroke were 19.7 percent in the aspirin group and 17.2 percent in the warfarin group (P = 0.29), indicating that intracranial atherosclerosis is a high-risk condition for recurrent stroke. For comparison, the 2-year risk of ischemic stroke was 26 percent among individuals with symptomatic carotid stenosis between 70 and 99 percent assigned to medical therapy in the North American Symptomatic Carotid Endarterectomy Trial and approximately 11 percent among those assigned to aspirin in the Warfarin-Asprin Recurrent Stroke Study (WARSS), in which more than 75 percent of 121 subjects had a lacunar or cryptogenic etiology for stroke. In part because of the high recurrent stroke risk, intracranial angioplasty and stenting are sometimes considered for patients who have failed medical therapy because of recurrent ischemic symptoms. Given the current lack of efficacy data, such an approach remains investigational, but historical case-series data are encouraging, and122 as techniques and devices improve, the indications for endovascular treatment may broaden. Patients with intracranial atherosclerosis also have a theoretical risk of hypoperfusion distal to the stenosis when blood pressure is lowered. Since these lesions are less commonly corrected compared with those in the carotid artery, some physicians may be less aggressive about treating hypertension in these patients. Newer imaging modalities provide a way to assess whether there is sufficient vascular dilatory capacity distal to a stenosis to preserve blood flow in response to systemic changes in arterial resistance, but the integration of this 123 information into clinical practice has not been fully resolved. There is currently no evidence to justify higher long-term blood pressure thresholds in patients with intracranial atherosclerosis or to support the belief that lower blood pressures could in fact increase the 124 risk of infarction distal to a stenosis. It would be prudent, however, to consider lower initial doses, slower titration schedules, and more frequent monitoring for orthostasis and other adverse effects of antihypertensive therapy in such patients. AORTIC ARCH ATHEROSCLEROSIS The aortic arch has only recently come to be appreciated as a source of emboli to the 125 brain. An autopsy study found a 28 percent prevalence of ulcerated plaque in the aortic arch of patients with ischemic stroke compared with a 5 percent prevalence in a control 125 of a thickened aortic arch population. Transesophageal echocardiograms show evidence126 in 14 percent of stroke patients and 2 percent of control subjects. In those with no other
20 / 24
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
identified etiology, a thickened aortic arch is present in 28 percent. Aortic arch atherosclerosis 127 is more strongly associated with peripheral vascular disease than with carotid stenosis. Epidemiological studies have been small, and only cigarette smoking has been identified as an important risk factor. Hypertension, diabetes, and hypercholesterolemia may be risk factors, but this has not been confirmed. Strokes and transient ischemic attacks produced by aortic atherosclerosis are identical to those produced by cardiac sources of emboli. Large-vessel territories are generally affected, producing weakness and numbness in similar distributions or cortical signs, such as aphasia and neglect. Stroke patients with atherosclerotic plaque 4 mm thick or larger in the aortic arch have a 127 fourfold increase in the risk of recurrence after correcting for other risk factors. Optimal treatment is not known but should include an antiplatelet agent or anticoagulation. Aortic endarterectomy has been performed in some patients who have failed medical therapy, but it has not been systematically studied. CARDIAC EMBOLUS Hypertension increases the risk of myocardial infarction and atrial fibrillation. These diseases are associated with increased stroke risk from cardiac embolus, as discussed in Chapter 5. DEMENTIA There is evidence from multiple cohort studies that cardiovascular risk factors, including hypertension, are risk factors for the development of dementia and cognitive 128–130 The biological basis for these associations remains unresolved. Although impairment. there are some data to support a direct association between hypertension and Alzheimer 131 individuals with dementia have a pathology, there is increasing recognition that most 132 mixture of neurodegenerative and vascular pathology. The association between hypertension and dementia is likely to be mediated in part by the accumulation of subclinical vascular injury in the brain, including infarct and leukoaraiosis, that results in the interruption of cognitive networks. Whether this process is simply additive to the cognitive effects of Alzheimer's pathology or whether there is synergism between the two processes remains unresolved. There is currently no convincing evidence that treatment of hypertension will make a large impact on the occurrence of dementia outside of its established benefits for stroke prevention. Although one large primary prevention trial using the calcium blocker nitrendipine found that the risk of dementia was reduced by 50133–135 percent in those receiving active therapy, In the PROGRESS trial, which the finding has not been confirmed in other trials. included subjects exclusively with a history of stroke, active therapy with perindopril and indapamide reduced the risk of dementia overall, but the benefit was not statistically 136 significant when the analysis was restricted to those without recurrent stroke. Although it hardly seems necessary to define additional benefits of treating hypertension, the recognition that cognitive decline may be an important manifestation of end-organ injury from hypertension has important implications for testing new treatments for cerebrovascular 137 disease, assessing risk of stroke, and encouraging adherence to treatment. If hypertension therapy is proven to prevent dementia among those without stroke, the cost–benefit ratio for more aggressive screening and therapy could also be substantially improved, an important issue, given that the elderly, who are at highest risk of dementia, are also the least likely to have their hypertension adequately treated. Some have suggested that aggressive blood pressure reduction could worsen cognition, particularly among those with loss of cerebral 138 autoregulation due to small-vessel arteriopathy. Therefore, the benefits of blood pressure therapy for cognition will need better definition in order to optimize treatment regimens. PERIPHERAL NEUROPATHY In diabetics, hypertension appears to be a risk factor for the development of peripheral neuropathy. One recent prospective study found a fourfold increased risk of distal symmetrical sensorimotor polyneuropathy with hypertension among insulin-dependent 139 diabetics. Hypertension probably increases the risk of peripheral neuropathy in non–insulin-dependent diabetics as well, but not all studies have found an effect. Hypertension is thought to accelerate small-vessel changes in diabetics, producing microvascular ischemic injury to peripheral nerves. In the absence of diabetes, hypertension has not been demonstrated as a risk factor for peripheral neuropathy. HYPERTENSIVE ENCEPHALOPATHY
21 / 24
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Hypertensive encephalopathy is one of several forms of reversible posterior leukoencephalopathy, a syndrome also encompassing other etiologies, including renal failure, 140 immunosuppressive therapy, and eclampsia. Hypertensive encephalopathy is an uncommon disease. There are no recent measurements of its incidence, but it is thought to have declined with greater use of antihypertensives. It tends to occur with a sudden elevation in blood pressure rather than with chronic hypertension. A number of medical conditions are known precipitants. Hyperadrenergic states may be responsible, including pheochromocytoma, tyramine ingestion with monoamine oxidase inhibitors, abrupt antihypertensive discontinuation, lower gastrointestinal 141 irritation in paraplegic patients, and stimulant medications. Structural precipitants include aortic coarctation and renal artery stenosis. Acute or chronic renal failure is another cause, probably through volume overload in addition to hypertension, and human recombinant 142 erythropoietin may be a precipitant. In patients in the postoperative period after endarterectomy, changes ipsilateral to the surgery may be identical to those seen with hypertensive encephalopathy, even in the absence of blood pressure elevation, probably because vessels compensate for chronic hypoperfusion above a severe stenosis and sudden return of blood flow produces relative hypertension. Hypertensive encephalopathy is associated with vasogenic cerebral edema, particularly severe in the posterior regions of the cerebral hemispheres, which is sometimes sufficient to result in herniation. The pathophysiology linking hypertension and cerebral edema has been argued. At mean arterial pressures greater than 120 to 170 mmHg, cerebral blood-flow increases linearly with blood pressure, and some have argued that this is the threshold for 140,143 hypertensive encephalopathy, when a “breakthrough of autoregulation” occurs. Angiotensin II may contribute to the formation of edema by increasing cerebrovascular 144 permeability through oxygen free radicals. A predilection toward involvement of the posterior hemispheres may be due to differential vascular innervation by the sympathetic 143 nervous system. Hypertensive encephalopathy is a neurological emergency that can lead to death if untreated. Diagnosis may be delayed when the connection between acute neurological dysfunction and hypertension is not obvious. High blood pressure may be attributed to an underlying neurological condition or agitation rather than identified as the causative agent. Headache is a common early complaint, sometimes accompanied by nausea and vomiting. Confusion with either agitation or lethargy may proceed to obtundation and coma if the process is untreated. Visual disturbance is frequent due to involvement of the retina and occipital lobes, with 140 papilledema and subjective blurred vision, hemianopia, or cortical blindness. Other cortical deficits may occur, including neglect, aphasia, and weakness. Focal or generalized seizures may complicate the course. Head imaging should be performed to exclude hemorrhage or a structural etiology for both the encephalopathy and the hypertension. Since increased intracranial pressure can result in severe hypertension, which may be required to maintain cerebral perfusion, an urgent study is necessary. Head CT may show hypodensity in subcortical white matter, often most obvious in the occipital lobes (Fig. 7-10). MRI can be dramatic, with multifocal T2-weighted hyperintensities particularly apparent in fluid-attenuated inversion recovery images. These changes are distinguished from infarcts by sparing of the cortex and absence of reduced 145 diffusion, as expected with vasogenic edema. Because cerebral edema may be severe, lumbar puncture should be avoided.
22 / 24
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 7-10 A patient with eclampsia. Typical findings in hypertensive
encephalopathy are identical and include normal or subtle hypodensity on CT (A), subcortical hyperintensities on MRI fluid-attenuated inversion recovery (FLAIR) (B), enhancement with gadolinium on T1-weighted images (C), and no abnormality on diffusion-weighted MRI (D). Once a structural etiology has been excluded, treatment of hypertension must be initiated. Target blood pressures are tailored to individual patients, with the goal of returning patients to their recent baseline. For patients without a history of hypertension, normal blood pressure parameters are appropriate, but for those with chronic hypertension, an abrupt return to 140/90 mmHg may result in hypoperfusion owing to chronic vascular compensatory changes. Close observation and intravenous antihypertensives are generally indicated. Nitroprusside is a good choice because of its effectiveness, rapid onset, and ease of adjustment. It produces some cerebral vasodilation, but there is no clinical evidence that this elevates the risk of herniation. Intravenous ACE inhibitors are also effective and easy to titrate and may have less-profound effects on cerebral vessels. Further, animal studies suggest that these agents may have more dramatic effects144 on cerebral edema by blocking increased vessel permeability from angiotensin II. Anticonvulsant therapy may also be indicated. The underlying cause of the hypertensive episode should be sought. Prognosis in treated patients is generally excellent. Neurological deficits usually recover completely within 2 weeks. ECLAMPSIA Eclampsia is a form of reversible posterior leukoencephalopathy. Occurring during the second half of pregnancy or the puerperium, eclampsia presents with proteinuria and clinical
23 / 24
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
and imaging manifestations identical to hypertensive encephalopathy. Hypertension may not be severe, so additional effects on brain endothelial cell permeability are probably important. There is evidence of generalized endothelial cell dysfunction with abnormal vascular 146 reactivity. An underlying inflammatory response may be causative, but other potential etiologies have also been hypothesized. Cerebral venous sinus thrombosis is another complication of pregnancy and delivery and can present with findings similar to those seen with eclampsia. MRI and venography are usually adequate to distinguish the two diseases, showing obstructed venous sinuses or ischemia with cytotoxic edema on diffusion-weighted images in cerebral venous sinus thrombosis. 147
Treatment includes delivery of the fetus and intravenous magnesium. Other antihypertensive medications and anticonvulsants can also be used. Prognosis is good if treatment is initiated quickly. IMMUNOSUPPRESSION Several immunosuppressive agents produce a reversible posterior leukoencephalopathy identical to hypertensive encephalopathy. Cyclosporine is the most commonly identified, and it may produce neurological symptoms at therapeutic levels and without evident hypertension. Tacrolimus,140 FK-506, interferon-alpha, cytarabine, and fludarabine have also been associated. An alteration in the permeability of cerebral endothelial cells has been postulated. Lowering blood pressure and discontinuing immunosuppression generally reverses the process. Previous
Next
Return to Previous Page
24 / 24
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Postural Hypotension: N...
Return to Previous Page
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Print this page
This information has been developed and provided by an independent third party source. Merck & Co., Inc., does not endorse and is not responsible for the accuracy of the content, or for practices or standards of non-Merck sources. This resource may discuss regimens that have not been approved by the FDA. For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences please see the appropriate manufacturer's product circular. View Prescribing Information for Merck products.
Table of Contents This Chapter by Chapters
Keyword Index
Michael J. Aminoff
NEUROLOGY and GENERAL MEDICINE 8 Postural Hypotension MICHAEL J. AMINOFF •
Previous
Next
NON-NEUROLOGICAL CAUSES OF POSTURAL HYPOTENSION Cardiovascular Disorders Alterations of Effective Blood Volume Drugs Endocrine and Metabolic Disorders Inadequate Postural Adjustments Age AUTONOMIC REGULATION OF THE HEART AND BLOOD VESSELS NEUROLOGICAL CAUSES OF POSTURAL HYPOTENSION Central Lesions and Spinal Injury Root and Peripheral Nerve Lesions Toxic Exposure Primary Degeneration of the Autonomic Nervous System Miscellaneous Disorders SYMPTOMS OF DYSAUTONOMIA Syncope Postural Hypotension Vasovagal Syncope Deglutition Syncope Micturition Syncope Carotid Sinus Syncope Syncope With Valsalva Maneuver Cardiac Syncope Hyperventilation EVALUATION OF AUTONOMIC FUNCTION Postural Change in Blood Pressure Postural Change in Heart Rate Valsalva Maneuver Other Cardiovascular Responses Digital Blood-Flow Cold Pressor Test Norepinephrine Infusion Response to Tyramine Norepinephrine Response to Edrophonium
1 / 21
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Postural Hypotension: N...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Sweat Tests Other Studies Pupillary Responses Radiological Studies PATIENT MANAGEMENT Treatment General Precautions in Management of Dysautonomic Patients
When a normal person stands up after being recumbent, approximately 500 ml of blood (or more) pools in the vessels of the legs and abdomen, causing a reduction in filling pressure of the right atrium and thus a decrease in cardiac output and systemic blood pressure. This leads to changes in baroreceptor activity and thus to changes in impulse traffic in the ninth and tenth cranial nerves. These changes affect the activity of the brainstem vasomotor center, which, in turn, influences the autonomic neurons in the intermediolateral cell columns of the thoracolumbar spinal cord, producing reflex peripheral vasoconstriction and an increase in force and rate of myocardial contraction (Figs. 8-1 and 8-2). Cardiopulmonary reflexes, subserved by vagal afferent fibers from mechanoreceptors in the heart and stretch receptors in the lungs, contribute to maintenance of the blood pressure, acting synergistically with the baroreceptor reflexes. The venoarteriolar axonal reflexes may also be important in limiting blood flow to the skin, muscle, and adipose tissues. Standing up also leads to release of norepinephrine. Venous return is aided during maintenance of the upright posture by mechanical factors, such as the tone in the leg muscles and the pumping action of these muscles during walking, and by maneuvers that1 increase intra-abdominal pressure. This has important therapeutic implications (see p. 155). In addition, there is secretion of antidiuretic hormone (arginine vasopressin) and activation of the renin-angiotensin-aldosterone system, so that salt and water are conserved and blood volume increases. These, however, are typically longer term rather than immediate control mechanisms.
2 / 21
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Postural Hypotension: N...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 8-1 Anatomy of the autonomic pathways involved in maintaining the blood pressure on standing.
FIGURE 8-2 Sequence of events that ensure maintenance of the blood
pressure after adoption of the upright posture. Only the immediate cardiovascular changes are shown. As indicated in the text, a variety of other humoral mechanisms are also activated. Postural hypotension is defined as a decrease of at least 20 mmHg in systolic pressure or 10 mmHg in diastolic pressure on standing. It occurs when there is a failure of the autoregulatory mechanisms that maintain the blood pressure on standing. It may therefore occur with any neurological disorder that impairs baroreceptor function, disturbs the afferent input from these receptors, directly involves the brainstem vasomotor center or its central connections, or interrupts the sympathetic outflow pathway either centrally or peripherally. It may also occur with a number of non-neurological disorders, and it is important to consider these disorders if patients are to be managed correctly. NON-NEUROLOGICAL CAUSES OF POSTURAL HYPOTENSION
Cardiovascular Disorders A variety of cardiac disorders may lead to postural hypotension or even syncope. Pathological processes such as mitral valve prolapse, aortic stenosis, or hypertrophic cardiomyopathy may limit cardiac output. Cardiac outflow may also be blocked in rare instances by a thrombus or myxoma when the patient is in the upright position. Certain paroxysmal cardiac dysrhythmias (bradycardias or tachycardias) may occur with activity or on standing and produce episodic hypotension or syncope; however, disturbances of cardiac rhythm are common in
3 / 21
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Postural Hypotension: N...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
asymptomatic elderly persons, and their presence must be interpreted with caution. In patients with congestive heart failure, the heart rate and level of sympathetic tone may be such that compensatory adjustments cannot be made when the patient stands, and postural hypotension therefore results.
Alterations of Effective Blood Volume Postural hypotension can occur because of loss of effective blood volume. Normal adults can withstand the loss of 500 ml of blood or bodily fluids with few if any symptoms, but greater volume depletion may occur acutely for a variety of reasons (e.g., hemorrhage or burns) and cause a postural drop in blood pressure. Hyponatremia and Addison's disease may also lead to an absolute reduction in blood volume. Postural hypotension may occur owing to venous pooling in patients with severe varicose veins or congenital absence of venous valves or because of poor peripheral resistance and reduced muscle tone in patients with paralyzed limbs. Similarly, it may occur during the late stages of pregnancy owing to obstructed venous return by the gravid uterus. Marked vasodilatation, such as occurs in the heat or with the use of certain drugs or alcohol, sometimes causes postural hypotension.
Drugs Numerous drugs may produce postural hypotension, including those given to treat neurological disorders (e.g., dopamine agonists and levodopa) and2 psychiatric disturbances (e.g., tranquilizing, sedative, hypnotic, and antidepressant agents). Antihypertensive drugs, diuretics, and vasodilators commonly lead to postural hypotension as a side effect. Insulin may cause nonhypoglycemic postural hypotension in diabetic patients with autonomic neuropathy, possibly because of vasodilatation and reduced venous return in the absence of functioning compensatory mechanisms or because of impaired baroreceptor responses to changes in arterial pressure. Iatrogenic and toxic autonomic neuropathy is considered later.
Endocrine and Metabolic Disorders Autonomic neuropathy, with consequent postural hypotension, is a major and common complication of diabetes. Postural hypotension may be a feature of Addison's disease, hypopituitarism, myxedema, thyrotoxicosis, pheochromocytoma, carcinoid syndrome, and hypokalemia. It may also occur with anorexia nervosa. Anemia may exacerbate or cause postural hypotension. A patient who had marked postural hypotension and extreme lability of 3 the blood pressure in association with severe hypophosphatemia has been described.
Inadequate Postural Adjustments Prolonged bed rest may result in postural hypotension when patients first begin standing again, but this problem is self-limited. Its cause is poorly understood, but it may be multifactorial. Carotid baroreceptor function is impaired, cardiac vagal activity is reduced, blood pooling is increased in the legs because of greater venous compliance, the total circulating blood volume and central venous pressure are reduced, and the red cell mass 4–6 may decline. Prolonged bed rest also leads to an increased incidence of cardiac dysrhythmias. In otherwise healthy subjects, vigorous exercise to the point of exhaustion may also cause a postural decline in blood pressure, possibly because of marked peripheral vasodilatation and venous pooling.
Age Many patients older than 70 years have a decline in systolic pressure of 20 mmHg or more on standing. 7Several causes for reduced orthostatic tolerance with advancing age have been identified. Baroreflex sensitivity declines with age and certain adrenoreceptors exhibit reduced sensitivity. Loss of preganglionic neurons also occurs with age and becomes symptomatic when approximately 50 percent of the cells are lost. Diuretics (which are commonly taken by the elderly) reduce blood volume and may lead to postural8 hypotension. Finally, structural, mechanical, and functional changes in the vascular system, such as loss of vascular elasticity and the occurrence of varicose veins, may be contributory, as may a reduction in the skeletal muscle mass. Prolonged bed rest, intercurrent illness, and adverse reactions to medication may also be important. Postural hypotension appears not to have an 9 impact on mortality, at least among patients discharged from an acute geriatric ward. Syncope is a common problem in the elderly. Often no precise explanation for it can be found, but postural hypotension is probably responsible in many instances. Nevertheless, it is
4 / 21
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Postural Hypotension: N...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
best not to ascribe patients' symptoms to postural hypotension unless they can be reproduced by a demonstrable fall in blood pressure on standing. Many of the homeostatic mechanisms that maintain intravascular volume and blood pressure may be impaired with advancing age, as discussed earlier, so that syncope is more likely to occur. Indeed, in many elderly patients a number of factors can be found to account for syncope, and it is then difficult to determine which of these factors is responsible in any individual instance. AUTONOMIC REGULATION OF THE HEART AND BLOOD VESSELS The central nervous system (CNS) is important in regulating cardiovascular function. Various lower brainstem centers receive inputs from both the periphery and other central structures such as the cerebral cortex, temporal lobe, amygdala, hypothalamus, cerebellum, 10,11 The nucleus tractus solitarius is the site of periaqueductal gray matter, and pontine nuclei. termination of baroreceptor, chemoreceptor, and cardiopulmonary afferent fibers; it connects with the nucleus ambiguus and dorsal nucleus of the vagus and with neurons in the lateral reticular formation that 12,13 project to the cord in the bulbospinal pathway, thereby influencing the cardiovascular system. The vagus nerve has a major role in regulating the heart rate responses to various maneuvers. The sympathetic nervous system is important in influencing vasomotor tone and peripheral vascular resistance, but the sympathetic outflow to different regions and structures is regulated separately. The sympathetic nervous system causes a vasoconstriction in response to the release of norepinephrine. The occurrence of vasodilatation in the limbs probably depends on reduced sympathetic activity, and, to a lesser extent, on axon reflexes and antidromic conduction, but some of the vessels in limb muscles are probably also supplied by sympathetic vasodilator cholinergic fibers. Microneurographic studies in humans have shown that bursts of impulses occur rhythmically in sympathetic efferent vasomotor fibers to the skin and muscles and are time-locked to the pulse. This rhythmic activity depends on supraspinal mechanisms and is not seen below the level of a complete cord transection. Such sympathetic impulse traffic to vessels in the limb 14 muscles is markedly affected by baroreceptor activity, but not by brief mental stress, whereas the traffic in human cutaneous nerves is markedly increased by mental stress. High-pressure arterial baroreceptors are located primarily in the carotid sinus and aortic arch, from which afferent fibers pass to the brainstem in the glossopharyngeal and vagus nerves, respectively. Sympathetic efferent activity is inhibited by an increase in the pressure in the carotid sinus and aortic arch, whereas a reduced pressure causes increased sympathetic activity and a peripheral vasoconstriction. The heart rate is also influenced by the baroreceptors and cardiopulmonary stretch receptors, so that a bradycardia occurs when the pressure is increased and a tachycardia when the blood pressure declines. Change from recumbency to an erect posture causes blood to pool in the legs and lower abdomen. There is a slight fall in systolic blood pressure; this leads to baroreceptor activation, a peripheral vasoconstriction, and an increase in heart rate and contractile force. Compensatory changes in the splanchnic vasculature, constriction of venous beds, and activation of the renin-angiotensin system also occur. The carotid baroreceptor reflexes seem to be more important in responding to the immediate changes in blood pressure that occur on standing, whereas the aortic baroreceptors assume a greater role with maintenance of the upright posture. The cardiopulmonary stretch receptors act synergistically with the baroreceptor reflexes. The venoarteriolar axon reflex, which is activated by venous distention in the legs and an associated increase in transmural venous pressure, is also important in ensuring an increase in limb vascular resistance with change to an erect posture. During activity, the baroreceptors are reset by an uncertain, probably neural, mechanism to allow the blood pressure to increase with exercise. 15 Unmyelinated chemoreceptor afferent fibers from skeletal muscles are also activated, thereby increasing blood pressure and correcting any deficiency in muscle perfusion pressure during moderate to heavy exercise. In addition, activation of mechanically sensitive muscle receptors (muscle mechanoreflex) occurs, and these exercise pressor reflexes (peripheral neural reflexes originating 16 in skeletal muscle) contribute significantly to cardiovascular regulation during exercise. At the initiation of exercise, “central command” from higher brain centers leads to17,18 an immediate increase in heart rate and output as well as in blood pressure and respiration. NEUROLOGICAL CAUSES OF POSTURAL HYPOTENSION
5 / 21
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Postural Hypotension: N...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Central Lesions and Spinal Injury The autonomic consequences of spinal cord injuries depend on the level and severity of the lesion. In quadriplegic patients, the period of spinal shock that follows injury is associated with a dysautonomia in which the resting blood pressure and heart rate are typically low and postural hypotension is marked. This mandates that the patient be kept flat, without elevation of the head of the bed, and that any loss of blood volume be avoided or treated vigorously. A few weeks after transection of the cervical cord, activity returns to the isolated spinal segment, but the brain is no longer able to control the sympathetic nervous system. Loss of regulation during postural change leads to orthostatic hypotension, whereas overactivity occurs if spinal sympathetic reflexes are activated and leads to the syndrome of autonomic hyperreflexia, which occurs in patients with cervical or high thoracic lesions. It is characterized by episodic hypertension, bradycardia, headache, and hyperhidrosis above the level of the lesion, with pallor and piloerection distal to it. Anxiety, confusion, nasal congestion, and facial flushing may also occur. Treatment of this syndrome thus requires avoidance of stimuli that activate spinal sympathetic reflexes (e.g., a distended bladder), elevation of the head of the bed, and, if necessary, use of short-acting antihypertensive agents such as calcium-channel blockers. In general, spinal cord transection produces postural hypotension if the lesion is above about the T6 level. Intramedullary and extramedullary tumors, transverse myelitis, and syringomyelia involving the cord above T6 may also produce dysautonomia. A variety of brainstem lesions can19,20 impair autonomic function and 21 affect control of the blood and posterior22fossa tumors. Chiari malformation with pressure, including syringobulbia tonsillar herniation may lead to syncopal episodes. Impairment in Wernicke's encephalopathy may relate to central or peripheral involvement. The extent to which autonomic reflex function, and particularly cardiovascular regulation, is impaired in Parkinson's disease is disputed. Several recent studies have indicated that many patients 23 with Parkinson's disease have postural hypotension from cardiac sympathetic denervation. 24 In such patients, responses to the Valsalva maneuver are also abnormal. Other dysautonomic symptoms, such as disturbances of bladder or gastrointestinal function, and excessive salivation, are relatively common. The findings in certain other disorders with parkinsonian features (e.g., Shy–Drager syndrome, olivopontocerebellar atrophy, and striatonigral degeneration) are discussed on p. 147. Mild postural hypotension occurs occasionally in progressive supranuclear palsy, but cardiovascular reflexes are preserved or show only minor abnormalities of dubious 24–26 27 A variety of dysautonomic symptoms may occur in Huntington's disease, significance. 28 but any abnormalities of blood pressure regulation are usually mild and subclinical, except when related to neuroleptic medication taken for chorea or behavioral disturbances. Postural hypotension or other disturbances of cardiovascular autonomic function occur occasionally in 29,30 but disturbances of bladder and bowel function are much patients with multiple sclerosis, more common dysautonomic features of that disorder. Wallenberg's syndrome or bilateral brainstem strokes may lead to bradycardia and hypotension that may exacerbate the 31 underlying neurological problem.
Root and Peripheral Nerve Lesions Postural hypotension may occur in patients with tabes dorsalis because of interruption of circulatory reflexes. In patients with polyneuropathies, autonomic involvement is not uncommon. It is particularly frequent in diabetic neuropathy, although usually relatively mild in 32 is the most common cause of autonomic neuropathy in the more severity ; indeed, diabetes 33 developed countries. Postural hypotension occurs in approximately 25 percent of patients with diabetic neuropathy. In addition to postural lightheadedness, the dysautonomia of diabetes may be manifest by impotence, postprandial bloating, early satiety, gastrointestinal motility disturbances, abnormalities of bladder control, and alterations of sweating. Cardiac vagal control is usually impaired early, before the development of postural hypotension; the quantitative sudomotor axon reflex test is commonly abnormal and indicates involvement of 34 distal postganglionic sympathetic fibers. Other polyneuropathies associated with postural hypotension include those of alcoholism, Guillain–Barré syndrome, malignant disease, idiopathic small-fiber neuropathies, and acute porphyria. In many patients with chronic alcoholism, however, there is no excessive decline in blood pressure on standing, although the cardiovascular responses to various maneuvers are 35 often abnormal and indicate chronic vagal damage. Primary amyloidosis and familial amyloid polyneuropathy of Portuguese type (FAP type 1) are
6 / 21
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Postural Hypotension: N...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
often accompanied by dysautonomia consequent to the loss of predominantly unmyelinated and small myelinated peripheral fibers and of cells in the intermediolateral columns of the cord. Postural hypotension and impotence are early manifestations; episodic constipation and diarrhea, distal anhidrosis, impotence, urinary retention, and cardiac arrhythmias may36also be conjoined. Tests of sympathetic and parasympathetic function are typically abnormal. Autonomic dysfunction with abnormal cardiovascular responses occurs in some patients with chronic renal failure on intermittent hemodialysis, but the site of autonomic involvement is unclear. Vitamin B12 deficiency may lead to autonomic neuropathy and postural hypotension 37,38 Autonomic that improves or resolves completely after vitamin supplementation. involvement, with impairment of sweating and cardiovascular responses, may occur in 39,40 leprosy, sometimes without conspicuous features of peripheral nerve involvement. Symptoms of autonomic impairment, including postural hypotension, may be a presenting 41 feature of systemic autoimmune disorders. In Fabry's disease, disturbed sweating, reduced saliva and tear production, impaired pupillary responses, and gastrointestinal symptoms are common, but postural hypotension does not 42 usually occur, and postural cardiovascular reflexes are normal. Autonomic involvement in Guillain–Barré syndrome is usually mild, but paroxysmal cardiac arrhythmias or asystole or episodic hypertension may lead to a fatal outcome. Postural 43 hypotension is common. It has a number of possible causes including inactivity and bed rest, baroreceptor deafferentation, efferent sympathetic denervation, hypovolemia, cardiac abnormalities, or some combination of these and other factors. The severity of autonomic involvement in Guillain–Barré syndrome is not related to the degree of sensory or motor disturbance, and a wide variety of autonomic abnormalities is found if patients are studied in detail. The hypertensive episodes may relate to catecholamine supersensitivity or denervation of baroreceptors. Treatment of Guillain–Barré syndrome is by supportive measures or with plasmapheresis or intravenous immunoglobulin therapy depending on disease severity. Patients with autonomic instability require close observation and management in an intensive care unit. Further aspects of treatment are given on page 155. Curiously, postural hypotension is uncommon in chronic inflammatory demyelinating polyneuropathy, although 44,45 mild impairment may be found in many patients on tests of autonomic function. Autonomic neuropathy of acute or subacute onset, possibly on an autoimmune basis, sometimes occurs as a monophasic disorder in isolation or with associated sensory or motor involvement. It has occurred in the context of antecedent viral infections, malignancy, 46,47 and Hodgkin's disease, infectious mononucleosis, certain connective tissue diseases, 48 ulcerative colitis. In approximately 50 percent of patients, high titers of ganglionic acetylcholine receptor (AChR) antibody are found. In patients with a paraneoplastic etiology, other autoantibodies may be present, including antineuronal nuclear antibody 1 (ANNA-1 or anti-Hu) or 2 (ANNA-2), Purkinje cell antibody 2 (PCA-2), and collapsin response-mediator 49 protein 5 antibody (CRMP-5). The presence of such antibodies may suggest the likely site of an underlying primary tumor. Both sympathetic and parasympathetic fibers are usually involved, leading to marked postural hypotension accompanied by a fixed heart rate, anhidrosis or hypohidrosis, heat intolerance, sphincter disturbances, gastroparesis, ileus, and dryness of the eyes and mouth, but occasionally abnormalities are confined to postganglionic cholinergic neurons (acute cholinergic neuropathy), in which case postural hypotension does not occur. Pure adrenergic neuropathy has also been described. Autonomic function tests reflect the clinical findings. Nerve conduction study results are typically normal, but sensory abnormalities are sometimes found. Treatment is supportive; immunomodulating therapy may have a role in those with severe disease. Paraneoplastic dysautonomia may remit if the underlying malignancy is treated. The prognosis of patients with acute or subacute autonomic neuropathies is guarded: approximately one third of patients do well, but the remainder either fail to improve or are left with a major residual deficit, including marked postural hypotension. Autonomic involvement may occur in a variety of hereditary polyneuropathies. In familial dysautonomia, or Riley–Day syndrome, many parts of the nervous system are affected. Presentation during infancy may be with inability to suck, but episodic vomiting, recurrent pulmonary infections, hypertension, tachycardia, and diaphoresis occur, especially after 3 years of age. There may also be emotional outbursts, difficulty in swallowing, hypothermia or hyperthermia, poor flow of tears, postural hypotension, and syncope. Sensory abnormalities include impaired pain and temperature appreciation, and the tendon reflexes are depressed. The tongue is smooth and lacks fungiform papillae. Cardiac arrest may occur on tracheal 50,51 Postural hypotension usually is not a intubation. Treatment is essentially supportive. feature of the other hereditary sensory and autonomic neuropathies, whereas sudomotor function is often markedly impaired.
7 / 21
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Postural Hypotension: N...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Autonomic symptoms or signs may occur in patients with hereditary motor and sensory 52 neuropathy type 1, and abnormal vascular reflex responses may be present. Postural hypotension is usually not a conspicuous feature of the disorder. A familial disorder characterized by progressive distal weakness and muscle atrophy, distal53 sensory loss, pyramidal and visual pathway lesions, and dysautonomia has been reported. Patients had a sensorimotor polyneuropathy. The dysautonomia consisted of postural hypotension, lack of normal sinus arrhythmia, an abnormal response to the sweat test, abnormal pupillary responses with denervation supersensitivity, and low serum norepinephrine levels in both the recumbent and upright positions. 54
Iatrogenic postural hypotension is common in the elderly and relates most often to the use of antihypertensive agents or diuretics. Iatrogenic polyneuropathies may be responsible in 55 other instances, as reviewed elsewhere ; postural hypotension may be conspicuous in patients with the neuropathy caused by perhexiline maleate, cisplatin, paclitaxel (Taxol), vinca 55 alkaloids, or amiodarone.
Toxic Exposure Autonomic dysfunction may result from occupational or other exposure to certain neurotoxins but does not usually lead to postural hypotension. One study suggested that long-term occupational exposure to a mixture of organic solvents causes subtle disturbances of peripheral parasympathetic nerves as well56as sensorimotor peripheral neuropathies, as reflected by cardiovascular reflex studies, but other reports of autonomic involvement in this context are few. Intentional inhalation of n-hexane or methyl-n-butyl-ketone for recreational purposes may lead to a rapidly progressive neuropathy with associated postural 55 hypotension. Acrylamide neuropathy is usually accompanied by hyperhidrosis and cold, cyanotic extremities; in intoxicated rats, but not in humans, there is evidence that acrylamide 57 alters common measures of cardiovascular function. A variety of autonomic symptoms (in-cluding tachycardia, hypertension, and disturbances of sweating) may occur with thallium, arsenic, or mercury poisoning, but postural hypotension is not usually a feature. McFarlane and associates described a patient with severe postural hypotension and 58 neurological signs that were attributed to styrene intoxication. The rodenticide N-3-pyridylmethyl-N'-p-nitrophenyl urea (Vacor) has caused severe dysautonomia with 59 disabling postural hypotension, as well as sensorimotor peripheral neuropathy and encephalopathic states. Iatrogenic postural hypotension was considered earlier.
Primary Degeneration of the Autonomic Nervous System Postural hypotension resulting from primary degeneration of the autonomic nervous system is well described. The postural hypotension is often exacerbated postprandially, and the normal circadian rhythm is reversed so that the blood pressure is highest at night and lowest in the morning. In addition, blood pressure typically declines with activity rather than increasing as in normal subjects. Other symptoms of dysautonomia in these patients include impotence, disturbances of bladder and bowel function, impaired thermoregulatory sweating, and xerostomia. Two distinct groups of patients are now recognized. In one, primary or pure autonomic failure leads to idiopathic orthostatic hypotension and other evidence of dysautonomia without peripheral neuropathy or CNS involvement. In the other, autonomic failure is associated with more widespread neurological degeneration (i.e., with evidence of multisystem atrophy) such that there may be clinical features of parkinsonism (or striatonigral degeneration), and often of pyramidal, cerebellar, and lower motor neuron lesions as well (Shy–Drager syndrome). A disorder similar to olivopontocerebellar atrophy may also occur. The autonomic deficit may precede the somatic neurological one, or vice versa, but within a 60 short period there is clinical evidence of both. Occasionally there is a family history of dysautonomia. The time course and pattern of the dysautonomia reportedly differ between these two disorders. In pure autonomic failure, syncope and sudomotor dysfunction may precede the onset of constipation, bladder dysfunction, or respiratory disturbances whereas in multisystem atrophy, urinary complaints occur early and are then followed by abnormalities of 61 sweating or by postural hypotension. Patients61with pure autonomic failure had a slower functional deterioration and a better prognosis. The ingestion of water temporarily increases the seated blood pressure by uncertain mechanisms in patients with chronic autonomic 62 failure. This occurs earlier in pure autonomic failure than multisystem atrophy, perhaps reflecting differing lesion sites in these two disorders. In patients of both groups, plasma renin activity is usually subnormal. There are, however, a
8 / 21
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Postural Hypotension: N...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
number of reported pharmacological differences between them. Patients with pure autonomic failure have low plasma norepinephrine levels when lying down, and these levels fail to increase appropriately on standing; they also have a lower threshold for the pressor response 63 to infused norepinephrine. The increase in plasma norepinephrine level in response to tyramine64(see p. 154) is significantly less than in normal subjects or patients with multisystem atrophy. Extensive cell loss occurs in the intermediolateral cell columns of the thoracic cord, and the autonomic dysfunction has been attributed primarily to loss of these preganglionic sympathetic neurons. However, the pharmacological studies described previously indicate that loss of postganglionic noradrenergic neurons also occurs, and norepinephrine may be depleted from sympathetic nerve endings. By contrast, in multisystem atrophy, in which lesions are situated at multiple sites in the CNS, circulating norepinephrine levels are normal, suggesting that peripheral sympathetic neurons are intact, but plasma norepinephrine fails to63,64 increase appropriately with standing, implying There is also an exaggerated pressor that these neurons have not been activated. response to infused norepinephrine, but only patients with idiopathic orthostatic hypotension show a shift to the left in their dose–response curve, reflecting true adrenergic receptor 64 supersensitivity. Some investigators have not found any clear pattern in the resting level of plasma norepinephrine that distinguishes between these two types of autonomic failure. They have emphasized that low levels probably indicate the severity of sympathetic dysfunction rather 65 than the site of lesions. Endogenous arginine vasopressin is a powerful vasoconstrictor; it also acts on the kidney to control urinary concentrating mechanisms. The cardiovascular responses usually associated with arginine vasopressin are reduced cardiac output, heart rate, and plasma renin activity 66,67 Arginine vasopressin helps and increased vascular resistance and blood pressure. maintain arterial pressure in certain hypotensive situations such as hemorrhage or volume depletion, but increased levels of arginine vasopressin do not normally affect the blood pressure significantly because the acute vasoconstrictor effects are buffered by the baroreceptor reflex. The chronic effects of vasopressin on renal function do not produce sustained retention of sodium and water, and so produce only minimal changes in mean arterial pressure. Vasopressin release is influenced by the plasma's osmotic pressure and by the activity of vascular stretch receptors. In normal people, plasma arginine vasopressin increases in response to standing, presumably because a decrease in venous return influences afferent activity from these stretch receptors. In patients with progressive autonomic failure or with multisystem atrophy, plasma levels similar to control values are found in 68 the horizontal position, but the postural rise is only 10 percent of that in normal people. If hypertonic saline is infused intravenously into such patients, plasma arginine vasopressin increases in a 69 manner comparable with that in normal control subjects. This suggests normal function of the efferent connections from the osmoreceptors within the hypothalamus and implies that in this clinical context, the loss of vasopressin response with head-up tilt is due to lesions in 69 ascending pathways from cardiovascular receptors. A vulnerability has been suggested of the noradrenergic neurons of the caudal ventrolateral medulla that are involved in activating 70 hypothalamic neurons involved in vasopressin secretion. However, in multisystem atrophy, loss of vasopressin neurons occurs in the posterior region of the hypothalamic paraventricular nucleus and may contribute to sympathetic failure, whereas loss of catecholaminergic input from the brainstem to the magnocellular vasopressin neurons may 71 contribute to impaired vasopressin secretion following orthostatic stress.
Miscellaneous Disorders Patients with Holmes–Adie syndrome may present with or develop postural hypotension or abnormalities of thermoregulatory sweating. Postural hypotension may occur in botulism; however, blurred vision, dry mouth, and constipation are much more common autonomic manifestations. In rare instances, it relates to excessive amounts of endogenous bradykinin (a vasodilator) or a congenital defect of norepinephrine release. In patients with dopamine β-hydroxylase deficiency, norepinephrine and epinephrine cannot be synthesized, and 72,73 dopamine is released from central and peripheral adrenergic nerve terminals. Severe postural hypotension is accompanied by other autonomic disturbances in association with absent norepinephrine and excessive dopamine levels in the plasma. Orthostatic symptoms may develop in association with a significant tachycardia (an increase of 30 beats per minute 74,75 or more), but in the absence of consistent postural hypotension or an The designation postural tachycardia syndrome (POTS) is applied autonomic neuropathy.
9 / 21
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Postural Hypotension: N...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
to this disorder, which is more common in women than men and tends to occur in patients between 20 and 60 years of age. Symptoms on standing include tremulousness, lightheadedness, palpitations, visual disturbances, weakness, fatigue, anxiety, hyperventilation, nausea, postprandial bloating, and sweating, and may occur cyclically. Thus, orthostatic symptoms are accompanied by symptoms of sympathetic activation. A preceding viral infection can sometimes be recognized, and the syndrome may also occur in association with mitral valve prolapse or a more specific dysautonomia. Its etiology remains uncertain. A reduced or redistributed blood volume of uncertain cause has been proposed. Partial sympathetic denervation in the legs may be responsible, as suggested by studies of norepinephrine spill-over into the venous circulation of the limbs in response to various 76 vasoconstriction on the Valsalva maneuver, but stimuli. There is impaired peripheral 77 cardiovagal responses are normal. The optimal therapy for the disorder is not clear, but treatment may include volume repletion, fludrocortisone, β-blocking agents, midodrine, and phenobarbital. SYMPTOMS OF DYSAUTONOMIA Postural hypotension is usually the most disabling feature of autonomic failure. Symptoms induced by postural hypotension reflect cerebral hypoperfusion and include faintness, lightheadedness, blurred vision, and syncope. They may be particularly troublesome after exercise or a heavy meal or in the morning when the blood pressure tends to be at its lowest (in contrast to healthy subjects). However, in some patients, marked postural hypotension may be clinically asymptomatic or may be accompanied by symptoms not usually regarded as suggestive of postural hypotension, such as nausea, breathlessness, heaviness or weakness of the limbs, episodic confusion, falling, staggering, and generalized weakness. Constipation may precipitate syncopal attacks during straining. Symptoms may also worsen in the heat because of vasodilatation and volume loss due to sweating. The symptoms of idiopathic postural tachycardia syndromes (discussed earlier) may be mistakenly attributed to postural hypotension, but occur without a significant decrease in blood pressure. Impotence is a common initial symptom of autonomic dysfunction in men, often preceding other symptoms by several months or years. Bladder involvement may manifest by urinary frequency, urgency, incontinence, retention, and increased residual urine; urinary infections and renal calculi may occur in some patients with urinary stasis. Bowel dysfunction may lead to constipation, fecal incontinence, and diarrhea. Thermoregulatory sweating may be impaired. Pupillary abnormalities include Horner's syndrome and anisocoria. Lacrimal dysfunction may lead to inadequate or excessive production of tears. Other symptoms of dysautonomia include night blindness, nasal congestion, and, sometimes, supine hypertension. Vocal abnormalities and respiratory disturbances (especially involuntary inspiratory gasps, cluster breathing, airway obstruction, and sleep apnea) sometimes occur, especially in patients with multisystem atrophy.
Syncope Syncope refers to a sudden, transient loss of consciousness due to diffuse cerebral ischemia or hypoxia. It is usually associated with flaccidity, but a generalized increase in muscle tone sometimes occurs with continuing cerebral ischemia/hypoxia, and there may be arrhythmic transient motor activity as well. Postictal confusion is usually brief (less than 30 seconds) when it occurs at all, unlike the marked postictal confusion that often follows a convulsion. Several causes of syncope have been recognized. Postural Hypotension In patients with orthostatic hypotension due to autonomic dysfunction, there is a fall in blood pressure on standing, without adequate compensatory change in total peripheral resistance or heart rate, and syncope may result. When postural hypotension occurs because of one of the non-neurological causes discussed earlier, it may also lead to syncope if autonomically mediated compensatory mechanisms fail to limit the decline in blood pressure. Vasovagal Syncope During vasovagal syncope, there is an initial increase in heart rate, blood pressure, total peripheral resistance, and cardiac output, followed by peripheral vasodilatation, increased blood flow to the muscles, decreased heart rate, and a decrease in venous return to the heart. Blood pressure falls owing to failure to increase the heart rate and cardiac output sufficiently, a decrease in systemic vascular resistance, or both. The vasodilatation and decline in systemic vascular resistance have been related to depressor Bezold–Jarisch
10 / 21
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Postural Hypotension: N...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
reflexes arising from cardiac sensory receptors and subserved by vagal unmyelinated afferent fibers, perhaps in consequence of a decrease of central blood volume and 78,79 Recordings from nerve fibers reveal that impulse traffic decreased ventricular filling. ceases in the sympathetic outflow to skeletal muscle during syncope and gradually builds up 80 again over the following 5 minutes or so. Syncope of this sort may be precipitated by pain, fear, emotional reactions, injury, and surgical manipulation. It may occur in association with missed meals, heat, or crowds; it usually occurs while subjects are standing. Warning symptoms include weakness, sweating, pallor, nausea, yawning, sighing, hyperventilation, blurred vision, impaired external awareness, and dilatation of pupils. Lying down or squatting at this time may abort actual loss of consciousness. Deglutition Syncope Swallowing precipitates syncope in some subjects (deglutition syncope). In such instances, 81 there may be associated esophageal disorders. The syncope has usually been attributed to atrioventricular heart block or cardiac arrhythmia. It is presumed that the prime factor is clinical or subclinical disease of the conducting system of the heart and that disturbances of cardiac rhythm are then triggered by reflexes originating in the esophagus. A pacemaker may 81,82 prevent further episodes. Micturition Syncope Micturition syncope occurs after urination, particularly when the patient has arisen from bed at night. It may relate to sudden release of the reflex vasoconstriction elicited by a full bladder. Assumption of the upright posture, the peripheral vasodilatation resulting from the warmth of the bed, and, particularly in elderly men, straining to micturate may also contribute to the drop in blood pressure. Occasionally, syncope occurs in response to cardiac dysrhythmia induced by a full bladder before micturition. Carotid Sinus Syncope Carotid sinus syncope may be provoked by neck-turning or a tight collar in susceptible 83 subjects. Certain drugs have also been shown to predispose toward it, especially propranolol, digitalis, and α-methyldopa. A hypersensitive carotid sinus reflex is defined by a slowing in heart rate of more than 50 percent or a decline in systolic pressure by more than 83 40 mmHg during carotid sinus massage. However, less than 50 percent of patients with carotid hypersensitivity have syncope as a result. Conversely, in many patients with syncope of unidentifiable cause, the carotid sinus syndrome may have been overlooked. Syncope With Valsalva Maneuver Vigorous coughing or straining at stool may lead to syncope because of the reduced cardiac output and the peripheral vasodilatation caused by a high intrathoracic pressure. Cerebral perfusion may also be reduced by an increase in intracranial pressure. Cardiac Syncope As discussed earlier, postural hypotension may have a cardiac basis. In addition, atrioventricular conduction block may lead to sudden loss of consciousness, regardless of the position of the body (Adams–Stokes attacks). Further discussion of this topic is provided in Chapter 5. Exertional syncope suggests obstructive valvular disease or a right-to-left shunt. Coronary artery disease may lead to arrhythmias that cause syncope. Hyperventilation Hyperventilation, with consequent hypocapnia and reduced cerebral perfusion, is a common cause of presyncopal symptoms, but actual loss of consciousness is uncommon. EVALUATION OF AUTONOMIC FUNCTION After neurological, cardiological, and metabolic causes of syncope have been excluded, a number of patients remain in whom the diagnosis is unclear. The utility of autonomic studies 84 in these circumstances was examined by Mathias and colleagues. They found that screening autonomic function tests revealed postural hypotension and confirmed chronic
11 / 21
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Postural Hypotension: N...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
autonomic failure in 5 percent, and neurally mediated syncope was diagnosed in 43.5 percent based on clinical features and autonomic studies. Thus, in recurrent syncope or presyncope, autonomic studies are worthwhile as they may clarify the diagnosis. In patients with unexplained syncope, the implantable 85 loop recorder is an important diagnostic tool that may clarify the underlying pathophysiology.
Postural Change in Blood Pressure In investigating patients with suspected autonomic dysfunction or postural hypotension, the blood pressure should be measured with the patient supine for at least 10 (preferably 20) minutes. The patient then stands up, and the blood pressure is measured again after 5 to 10 seconds, and again after 1, 2, and 5 minutes. There is normally an increase in pulse rate on standing, but the pulse rate may not change if there is already a high resting pulse or in patients with dysautonomia; furthermore, the change in heart rate may be blunted in the elderly. As for the blood pressure, there is normally a slight decline in systolic pressure, whereas diastolic pressure increases slightly. The response of the blood pressure is regarded as abnormal if systolic pressure decreases by at least 20 mmHg or diastolic pressure by 10 mmHg on standing. In some instances, postural hypotension develops only after exercise; it is therefore worthwhile to record the postactivity blood pressure if clinically feasible. It may be necessary to record the blood pressure on a number of occasions before the diagnosis of postural hypotension can be confirmed. In other instances, prolonged tilt (for up to 60 minutes) may be required to detect abnormalities. The effect of postural change on blood pressure can be evaluated more accurately if the blood pressure is measured using an intra-arterial cannula or a noninvasive plethysmographic device with the patient resting quietly on a tilt-table; measurements are made continuously while the patient is supine and then at a 60-degree head-up tilt. The response to head-up tilt may differ from that obtained by standing because less enhancement occurs of the venous return to the heart by contraction of leg and abdominal muscles, and thus there is greater peripheral pooling of blood. Mann and co-workers monitored ambulant intra-arterial blood pressure in six patients with 86 autonomic failure and postural hypotension. They found a consistent circadian trend in blood pressure that was the inverse of the pattern in normal subjects, with the highest pressures found at night and the lowest in the morning. Such temporal variation in blood pressure implies that physiological testing should be carried out at a standard time of day, especially if comparative studies are to be performed, and potentially harmful hypertension in response to treatment should be looked for especially during the early part of the night.
Postural Change in Heart Rate A simple, noninvasive test of autonomic function consists of evaluating the response in heart rate to change from a recumbent to a standing position. There is typically a rapid increase in heart rate that is maximal at approximately the fifteenth beat after standing, with a subsequent slowing from the initial tachycardia (i.e., a relative bradycardia) that is maximal at approximately the thirtieth beat (Fig. 8-3). This response is mediated by the vagus nerve. For testing purposes, the R-R interval at beats 15 and 30 after standing can be measured to give 87 the 30/15 ratio. Values greater than 1.03 occur in normal subjects, whereas in diabetic patients with autonomic neuropathy (who typically show only a gradual increase in heart rate), values are 1.00 or less. Some prefer to measure the ratio of the absolute maximum to absolute minimum heart rate after standing, which may not coincide with the heart rates at 88 beats 15 and 30. This test does not depend on the resting heart rate and correlates well with the Valsalva ratio and the beat-to-beat variation in heart rate, described later. Studies 88,89 suggest that the value for the 30/15 ratio declines with age in normal subjects.
12 / 21
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Postural Hypotension: N...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 8-3 Heart rate responses to standing in a normal subject. Immediately on standing, there is a rapid increase in heart rate that is maximal at approximately the fifteenth beat after standing.
In some patients, an excessive and sustained tachycardia develops in response to standing or head-up tilt, without significant drop in blood pressure. A prolonged tilt (for up to 60 minutes) may be necessary to elicit the abnormality. The mechanisms underlying this postural tachycardia have not been clearly established.
Valsalva Maneuver The Valsalva maneuver consists of a forced expiration maintained for at least 10 seconds (preferably 15 seconds) against a closed glottis after a full inspiration. Intrathoracic pressure should be increased by 30 to 40 mmHg. Clinically, this can be ensured by requiring the patient to blow into a mouthpiece connected to a manometer. The response can be recorded with an intra-arterial needle (Fig. 8-4), a noninvasive photoplethysmographic recording device (Finapres), or an electrocardiograph (ECG) (Fig. 8-5).
13 / 21
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Postural Hypotension: N...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 8-4 Cardiovascular responses to the Valsalva maneuver, as recorded with an intra-arterial needle. A, Normal response. B, Abnormal response in a patient with Shy–Drager syndrome. (From Aminoff MJ: Electromyography in Clinical Practice. 3rd Ed. Churchill Livingstone, New York, 1998, p. 206, with permission.)
FIGURE 8-5 Valsalva maneuver as recorded using an electrocardiograph (ECG) or heart rate monitor in a normal subject. The tachycardia that occurs during the forced expiratory maneuver is clearly evident, as is the compensatory bradycardia that occurs when the maneuver is released.
The cardiovascular response is usually divided into four stages. Stage 1 is characterized by a transient increase in blood pressure at the onset of the forced expiration, reflecting the increased intrathoracic pressure. In stage 2, there is normally a gradual decrease in systolic and diastolic pressures, pulse pressure, and stroke volume for several seconds because of a reduction in venous return to the heart, with an associated reflex tachycardia. Reflex vasoconstriction arrests the decline in blood pressure after about 5 to 7 seconds. Stage 3
14 / 21
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Postural Hypotension: N...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
occurs when the patient releases the expiratory maneuver and is characterized by a transient fall in the blood pressure because of pooling of blood and expansion of the pulmonary vascular bed with the abrupt decline in intrathoracic pressure. In stage 4, there is an overshoot of the blood pressure above baseline value as a result of the peripheral vasoconstriction, with a compensatory bradycardia. The Valsalva maneuver is an accurate indicator of baroreceptor reflex sensitivity. Abnormalities are found in patients with dysautonomia (Fig. 8-4) and may consist of loss of the overshoot in systolic blood pressure and compensatory bradycardia in stage 4, a fall in mean blood pressure in stage 2 to less than 50 percent of the previous resting mean pressure, and loss of the tachycardia in stage 2 or a lower heart rate in stage 2 than stage 4. However, abnormalities may also be found in patients with severe congestive heart failure and in those with cardiac lesions other than primary myocardial dysfunction. If the response is recorded noninvasively using an electrocardiograph, the ratio of the shortest R-R interval (the tachycardia) during the maneuver to the longest R-R interval (bradycardia) after it is determined and expressed as the Valsalva ratio. A value of 1.1 or less was arbitrarily defined by Ewing and associates as 90 an abnormal response, 1.21 or greater as a normal response, and 1.11 to 1.20 as borderline. Using such criteria, these authors found that the Valsalva maneuver was abnormal in 62 percent of diabetic patients with symptoms and signs suggestive of autonomic neuropathy. When more generous criteria for abnormality were used, with a lower limit for normal of 1.50, the value was abnormal in 86 percent of these patients, and such an abnormality correlated well with the presence of a significant postural drop in blood pressure.91,92 Subsequent studies have shown that age- and gender-based normal values should be used.
Other Cardiovascular Responses Other cardiovascular responses can also be measured noninvasively (e.g., the beat-to-beat variation in heart rate and the heart rate responses to deep breathing and sustained hand grip). Such tests of parasympathetic function appear to give abnormal results more often and earlier than tests of sympathetic function, at least with the dysautonomia that occurs in 87 diabetes. A particularly useful test is to measure the heart rate variation during deep breathing (Fig. 8-6). In normal subjects, there is considerable heart rate variation, which is accentuated during deep breathing. This variation is reduced or absent in diabetic patients with autonomic neuropathy. The optimal breathing rate for this test is six breaths per minute (i.e., inspiration = expiration = 5 seconds). Heart rate variation scores can be calculated by measuring the difference between the maximal and minimal heart rates in inspiration and expiration, taking the average from 10 breaths in and 10 breaths out. Normal subjects usually have a score greater than 9, and autonomic neuropathy is probably absent if scores greater than 12 are 93 89,91,94,95 Thus, Freeman indicated obtained ; the normal range, however, is age dependent. that heart92rate variability may decline by 3 to 5 beats per minute per decade in normal subjects. The use of a single normal value regardless of age may therefore limit the utility of the test. Physical fitness, body weight and position, time of testing, and concomitant medication may affect the test results.
FIGURE 8-6 Normal variation in heart rate that occurs in response to deep
breathing.
15 / 21
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Postural Hypotension: N...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
An increase in heart rate and blood pressure should also occur in response to startle, such as occurs with a sudden loud noise, and to mental stress, as is produced when the patient attempts to subtract 7 serially from 100 while constantly being distracted.
Digital Blood-Flow Blood flow to a finger can be measured by conventional plethysmography or photoplethysmography. A sudden inspiratory gasp causes reflex digital vasoconstriction as a spinal reflex, and this is easily measured plethysmographically (Fig. 8-7). The response is impaired or absent in patients with a lesion of the cord or sympathetic efferent pathway, as in peripheral neuropathy. In entrapment neuropathy, such as carpal tunnel syndrome, the vasoconstrictor response may be 96 abolished in fingers supplied by the affected nerve but not in those supplied by other nerves.
FIGURE 8-7 Variation in blood volume after a deep inspiration in a normal subject, measured photoplethysmographically by means of an infrared emitter and detector placed on the pad of the index finger. The bottom trace represents the sensor output after it has been amplified by the photoplethysmographic module of a computerized autonomic testing system; it is a function of the absolute blood volume in the finger. Each peak represents a heartbeat, and the amplitude of each wave reflects blood volume in the area about the sensor. The apparent shift of the direct-current signal component is due to the long time constant that is necessary so that signal information is not lost. The relative voltage, representing the amplitude of each pulse, is shown in the upper trace. It is evident in both traces that after the deep inspiration there is a reduction in digital blood flow (i.e., reduced amplitude of the waveforms in the lower trace and a corresponding decline in the upper trace).
Cold Pressor Test In the cold pressor test, one hand is immersed in ice water at 4°C, and this normally produces an increase in systolic pressure of 15 mmHg or more within 1 minute. The afferent pathway involves the spinothalamic tract, and if this tract is intact, the lack of a pressor response suggests a lesion centrally or in the sympathetic efferent pathway. A normal response in a patient with an abnormal Valsalva response and intact pain and temperature sensation suggests an afferent baroreceptor lesion.
Norepinephrine Infusion The plasma norepinephrine level can be used as an index of sympathetic activity. Perhaps of greater value, the blood pressure can be measured in64response to intravenous infusion of norepinephrine at several dose rates up to 20 μg/min. In this way, a dose–response curve can be constructed. In normal subjects, it is usually necessary to administer 15 to 20 μg/min
16 / 21
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Postural Hypotension: N...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
to increase systolic blood pressure to 40 mmHg above baseline. A similar increase in blood pressure results from doses of 5 to 10 μg/min in Shy–Drager syndrome and less than 2.5 64 μg/min in patients with idiopathic orthostatic hypotension.
Response to Tyramine Tyramine, an indirectly acting sympathomimetic drug, can be used to test neuronal uptake and release of norepinephrine. Bolus injections ranging from 250 to 6,000 μg are administered and blood pressure measured at 1-minute intervals. The amount of norepinephrine released into plasma by tyramine can be quantified by obtaining a blood 64 sample shortly after the rise in blood pressure.
Norepinephrine Response to Edrophonium Intravenously administered edrophonium (10 mg) normally leads within 8 minutes to the postganglionic release of norepinephrine and thus to an increase in plasma norepinephrine levels. In patients with central dysautonomias (and intact postganglionic function), a normal response is obtained, whereas patients with more peripheral disease have absent or 97 attenuated responses. The sensitivity and specificity of the test remain to be established.
Sweat Tests Cutaneous blood vessels and sweat glands are supplied by sympathetic fibers intermingled in 14 the same fascicles but of different size and conduction velocity. Commonly used tests of sweating are messy and require application of heat, which is time-consuming. A heat cradle placed over the trunk is used to produce an increase of 1°C (from a resting level of 36.5° to 37.0°C) in the oral temperature over the course of 30 to 60 minutes, and the presence of sweat over selected regions of the trunk and limbs is detected by the change in color of quinizarine powder or a starch-iodide mixture that it produces. Changes in hand blood flow can also be measured with a plethysmograph. The pattern of any impairment of sweating may be helpful in suggesting the underlying cause. For example, impairment is usually distal in the limbs in patients with polyneuropathies. The volume of sweat produced by axon-reflex stimulation either electrically (faradic sweat response) or with parasympathomimetic drugs under specified conditions indicates the state of sudomotor innervation in the tested limb. After a short latent period, sweating occurs in an area that is approximately 4 to 5 cm in diameter about the site of stimulation. The reflex is subserved by sympathetic postganglionic fibers; impulses pass centripetally along these fibers until they reach a branch point and then pass distally again. The receptor involved in 98 the reflex has not been defined. Rather than detecting a sweat response by a color change, as described previously, it may be necessary to quantify the volume of sweat. Recordings can then be made of the humidity 98 change of an air stream of defined flow. Using such an approach, the group at the Mayo Clinic have quantified the sudomotor response to axon reflex stimulation using electrophoresed acetylcholine to stimulate the receptors involved in the axon reflex. Another simple technique for evaluating sudomotor function is to measure changes in skin resistance. With sweating, there is a reduction in skin resistance. This is the so-called galvanic skin response, which can be elicited by painful or emotional stimuli or by deep inspiration. Sudomotor function has also been evaluated in patients with polyneuropathies by recording the change in voltage measured from the skin surface after deep inspiration or startle or after electrical stimuli applied to the skin of the wrist or ankle (sympathetic skin response). Responses are recorded from a pair of electrodes placed on the palm and dorsum of the 99 hand or the sole and dorsum of the foot. The sympathetic skin response is simple to record, but responses tend to habituate and are affected by the recording technique and a number of other factors. The absence of a response, and not the absolute values of latency or amplitude, is regarded as significant for determining abnormality. The normal latency in the upper limb is in the order of 1.5 seconds and in the lower limb is about 2 seconds, reflecting the slow conduction velocity of postganglionic C fibers (approximately 1 m/sec) Abnormalities of the sympathetic skin response reportedly correlate well with the quantitative sudomotor 100 axon reflex test.
Other Studies
17 / 21
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Postural Hypotension: N...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Pupillary Responses Pupillary constriction with 2.5 percent methacholine applied locally indicates denervation supersensitivity due to interruption of postganglionic parasympathetic fibers, as in the Holmes–Adie syndrome. Local instillation of 1:1,000 epinephrine hydrochloride (one or two drops) produces little or no response unless there is postganglionic sympathetic denervation, in which case marked pupillary dilatation occurs. A 4 percent solution of cocaine hydrochloride applied to the conjunctival sac dilates the normal pupil, but fails to do so if sympathetic innervation has been interrupted outside the CNS. Radiological Studies Radiological studies may be helpful in characterizing gastrointestinal and bladder function but are beyond the scope of this chapter. PATIENT MANAGEMENT The initial investigative approach to patients presenting with syncope or other symptoms suggestive of postural hypotension or autonomic dysfunction is to exclude reversible causes such as hypovolemia or certain medications (see pp. 142 to 143). The history must include a detailed account of illnesses and drug intake. Simple laboratory investigations should include a full blood count and erythrocyte sedimentation rate as well as determination of plasma urea, electrolytes, glucose, morning and evening cortisol levels, and lying and standing catecholamine concentrations. Urinary screen for porphyrins; serum protein electrophoresis and immunophoresis; hepatic, renal, and thyroid function tests; chest radiograph; and electrocardiogram (to exclude recent cardiac infarction or cardiac ischemia, heart block, or persisting cardiac dysrhythmia) are also performed, as are serological tests for syphilis and nerve conduction studies. Neuroimaging studies may be helpful if a structural intracranial lesion is suspected. An echocardiogram may help when evaluating patients with suspected structural lesions of the heart predisposing to syncope. Prolonged tilt-table evaluations and invasive cardiac electrophysiological studies may be necessary when an arrhythmia is likely. In patients with symptoms of uncertain etiology in whom general medical causes have been excluded, more detailed evaluation of autonomic function in the manner suggested earlier may be helpful.
Treatment If a specific reversible cause, such as a metabolic or endocrinological disturbance, can be recognized, it must be treated appropriately. The need for continuing with drugs likely to be responsible should be reviewed and, if feasible, treatment discontinued. Patients should be advised against using alcohol. Treatment with antiarrhythmic agents, cardiac pacemaker, or surgery may be indicated in patients with a cardiac cause of syncope or postural hypotension. Pacemaker therapy may also help patients with syncope due to carotid sinus 83 hypersensitivity. If no specific cause can be identified, treatment should be directed to the minimization of symptoms (Table 8-1). The actual extent to which the blood pressure falls on standing, for example, is of less significance than the occurrence of symptoms. Patients with dysautonomia should avoid extreme heat, alcohol, large meals, rapid postural changes, prolonged periods of recumbency, and excessive straining (e.g., during micturition or defecation), each of which may exacerbate symptoms. Diuretics should be stopped, if possible, and salt intake liberalized. Click here to view this table.... When standing, patients often find it helpful to work the leg muscles because this aids the venous return to the heart. Symptoms may also be reduced if patients stand up gradually (e.g., by first adopting the seated position and, after a short pause, getting up from this position). Other physical maneuvers that may be helpful include standing with legs crossed, bending forward, squatting, or placing a foot on a chair, thereby slightly increasing the mean arterial pressure so that cerebral blood flow remains adequate. The underlying common mechanism is held to be1 an increase of thoracic blood volume by transfer from below the diaphragm to the chest. Resistance exercise may increase orthostatic tolerance, plasma volume, and baroreflex gain. Waist-high elastic stockings may be helpful in alleviating postural symptoms but are often difficult to put on (especially for elderly patients) and may be uncomfortable in hot weather.
18 / 21
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Postural Hypotension: N...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
To be effective, the stockings must extend at least as high as the waist. Antigravity suits have been used in the past but are awkward, restrictive, impractical, and not generally available. Many dysautonomic patients have a disturbance in the regulation of body fluids. In particular, there is defective sodium conservation, especially during recumbency at night, associated 101 with, but not entirely due to, low aldosterone levels ; there are also abnormal posture-dependent changes in urine volume (Fig. 8-8) accompanied by an alteration in the 102 secretion of antidiuretic hormone. This leads to relative hypovolemia and postural hypotension that are worse in the morning and improve during the day. The disturbed regulation of body fluids could be due, at least in part, to diminished adrenergic activity in the renal nerves, which affects tubular reabsorption and renin release (and thus angiotensin formation). The effect of recumbency can be minimized by elevating the head of the bed by 5 to 20 degrees, which leads to reduced renal artery pressure, thereby stimulating the renin-angiotensin system and promoting sodium retention. Head-up tilt at night reduces nocturnal shifts of interstitial fluid from the legs into the circulation; furthermore, such interstitial fluid may exert hydrostatic force, opposing the tendency of blood to pool in the legs 103 on standing. Head-up tilt at night also reduces supine hypertension.
FIGURE 8-8 Renal responses of five dysautonomic patients and four parkinsonian
(control) subjects to fluid deprivation for 36 hours, commencing at 6 p.m. Average results are presented for urine osmolality and volume as well as potassium and sodium excretion for each successive 4-hour period. Subjects were lying down (white bars) during the night (10 p.m. to 10 a.m.) and were up and about (black bars) during the day (10 a.m. to 10 p.m.). (From Wilcox CS, Aminoff MJ, Penn W: Basis of nocturnal polyuria in patients with autonomic failure. J Neurol Neurosurg Psychiatry 37:677, 1974, with permission.) If these measures are unsuccessful, the mineralocorticoid fludrocortisone can be tried. This agent seems to exert its effect in part by temporarily increasing plasma volume and also by increasing vascular sensitivity to norepinephrine and improving the vasoconstrictor response to sympathetic stimulation. Treatment is usually commenced with a daily dose of 0.1 mg, which can then be increased by 0.1 mg every 2 weeks or so until benefit occurs or there are intolerable side effects. Some patients may require as much as 1.0 or 2.0 mg daily, but usually a dose of 0.5 mg or less is sufficient. During treatment with fludrocortisone, a positive sodium balance should be ensured, with a sodium intake of at least 150 mEq/day. Side effects include pedal edema, weight gain, recumbent hypertension, cardiomegaly, hypokalemia, and retinopathy; coexisting diabetes mellitus may also be exacerbated. Prostaglandin synthetase inhibitors should expand plasma volume and inhibit vasodilator prostaglandin synthesis. Indomethacin (25 to 75 mg three times daily with meals) increases peripheral vascular resistance, promotes fluid retention, and may increase the sensitivity of 104 It is said to be helpful in the peripheral vasculature to norepinephrine and angiotensin II. 105 some patients with postural hypotension, especially if they are also on fludrocortisone, but, in general, the results with it have been disappointing despite the theoretical advantages of its use. Ibuprofen (200 to 600 mg four times daily before meals) can also be tried and is sometimes helpful. Side effects include gastric irritation, nausea, constipation, and skin rashes.
19 / 21
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Postural Hypotension: N...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Dihydroergotamine is a relatively selective constrictor of peripheral veins. Its action may be mediated partially through α-adrenoreceptors, and enhanced synthesis of a vasoconstrictor prostaglandin may also be important. It is sometimes helpful for treating postural hypotension, but may cause recumbent hypertension. Although it is effective when administered intravenously, its efficacy when taken orally (5 to 10106 mg three times daily) is Cafergot (caffeine and more limited and variable. Inhaled preparations may be effective. 107 ergotamine) suppositories have sometimes been effective. Sympathomimetic drugs that either act directly to constrict blood vessels (e.g., phenylephrine) or that have an indirect action, preventing the destruction of norepinephrine at sympathetic nerve terminals (e.g., ephedrine and amphetamines), have been used to treat postural hypotension. These drugs can sometimes be helpful, but any benefit is often mild and temporary, and they may cause severe recumbent hypertension. Other side effects include nervousness, anxiety, restlessness, tachycardia, and tachyphylaxis. Midodrine is a direct α-adrenergic agonist that causes constriction of arterioles and venous vessels. It is started in a low daily dose (2.5 mg three times daily) that is built up gradually to 10 mg three times daily) depending on response and tolerance. Side effects include supine hypertension, 108,109 Pyridostigmine bromide may reduce postural hypotension by piloerection, and pruritus. enhancing ganglionic transmission without aggravating or precipitating supine hypertension. A recent clinical trial showed that its greatest effect was on diastolic blood pressure, 110 suggesting that improvement is due to increased total peripheral resistance. Its role merits further study. Propranolol may help the postural hypotension associated with postural tachycardia syndrome and also reduces sodium excretion, leading to an increase in blood volume. Furthermore, it has been said to help the hypotension of both idiopathic orthostatic hypotension and the Shy–Drager syndrome; this action has been attributed to the β-blockade correcting an imbalance of α- and β-adrenoreceptor activity in the peripheral nervous 111 system. It can be initiated at a dose of 10 mg four times daily and built up to 40 mg four times daily. Pindolol, a β-blocker with intrinsic sympathomimetic activity, has also been helpful 112 in some instances, but more often it produces no benefit and may lead to cardiac failure. Clinical benefit and an increase in blood pressure on standing in patients with sympathetic 113–115 However, in a patient with more severe efferent failure may occur with cardiac pacing. sympathetic 115 involvement, Goldberg and colleagues failed to show any benefit with atrial tachypacing. Bannister and associates reported a patient with selective impairment of sympathetic cardiovascular reflexes but relative sparing of cardiac parasympathetic 48 function. Because of accentuation of bradycardia and the risk of dysrhythmia with any elevation in blood pressure, it was thought that the use of pressor agents would be especially hazardous. A demand pacemaker was therefore introduced, and, although it did not improve postural hypotension, it enabled blood pressure to be readily and safely controlled by drugs. Atrial tachypacing may thus prove helpful in patients with selective sympathetic autonomic neuropathy by protecting against vagal overactivity. Vasopressin responses to upright posture are often defective in autonomic failure, and patients are hypersensitive to exogenous vasopressin. The long-term therapeutic utility of vasopressin is unclear. Kochar studied the effect of lysine vasopressin nasal spray in 10 patients with chronic orthostatic hypotension and found no significant alteration in the effect of tilt on heart rate, stroke volume, or cardiac output; there was, however, an increase in blood 116 pressure and total peripheral resistance. In five patients with chronic autonomic failure who were not receiving treatment with drugs, Mathias and associates found that the vasopressin analogue desmopressin (given intramuscularly) reduced nocturnal polyuria, raised supine 117 blood pressure, and reduced postural drops in blood pressure. Intranasal desmopressin administered once at night in patients with multisystem atrophy118 and nocturnal polyuria has led to an improvement in nocturia without serious adverse effects. If this approach is to be used, serum sodium should be monitored, especially during the first 4 to 5 days of treatment and then at monthly intervals. Recombinant erythropoietin helps the mild anemia that is common in dysautonomic patients and also reduces postural hypotension. It is expensive, may require concomitant iron supplementation, and sometimes leads to supine hypertension, but can be tried in cases that are otherwise difficult to manage. It is given subcutaneously, with the dose and frequency of administration individualized. There have been a variety of other experimental therapeutic approaches. Yohimbine, a centrally acting α2-antagonist, increases mean arterial pressure and plasma norepinephrine 119 120 levels in normal subjects and dysautonomic patients, but its clinical utility is not clear.
20 / 21
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Postural Hypotension: N...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
The use of a dopamine receptor antagonist, metoclopramide, was suggested because 121 dopaminergic drugs (e.g., bromocriptine) may depress the blood pressure. It is probably most helpful in patients with a diabetic dysautonomia, particularly if gastroparesis is also conspicuous. It is given in a dose of 5 to 10 mg three or four times daily, before meals, but long-term use may lead to tardive dyskinesia. In a few patients with pure autonomic failure, 122 the selective partial α-agonist clonidine may be helpful, but it has caused profound hypotension in a patient with baroreceptor dysfunction123 due to irradiation of the neck; it may reduce supine hypertension and nocturnal natriuresis. It is probably most likely to help in patients with an efferent sympathetic lesion. It is started in a dose of 0.1 mg taken in the morning, and the dose is then built up gradually to 0.2 to 1 mg twice daily. Side effects include xerostomia, constipation, drowsiness, and supine hypertension; hypotension may be exacerbated in patients with non-neurological causes of postural hypotension. Administration of caffeine with meals may markedly reduce postprandial hypotension and is worthy of trial 115 brain when symptoms are particularly troubling after meals. A possible role for deep 124 stimulation of the periventricular/periaqueductal gray region has been suggested. Patients with vasovagal syncope require reassurance coupled with advice about ensuring adequate fluid and salt intake and about sympathetic activation techniques (such as isometric 125 hand exercises) to increase the blood pressure ; sitting or lying down or sitting with head between the knees may help to abort attacks.
General Precautions in Management of Dysautonomic Patients Patients may show postprandial falls in blood pressure because blood is diverted to the hepatic and splanchnic beds. Vasoactive substances may also contribute to the hypotensive response. To avoid or minimize this postprandial hypotension, it is helpful to eat smaller meals and to avoid excessive activity during the immediate postprandial period. Dysautonomic patients often have low circulating catecholamine levels and denervation supersensitivity to sympathomimetic amines. Medications containing such substances should therefore be avoided, even though they are often available without prescription in over-the-counter preparations. Patients with dysautonomia pose special problems during anesthesia. They are unable to tolerate hemodynamic stresses normally because of impaired cardiovascular reflexes. Maintenance of fluid balance is more difficult because of the abnormal manner in which they handle salt and water, and their enhanced sensitivity to volume changes influences blood pressure control. Previous
Next
Return to Previous Page
21 / 21
2009.01.05. 11:57
Aminoff: Neurology and General Medicine: Neurological Complicatio...
Return to Previous Page
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Print this page
This information has been developed and provided by an independent third party source. Merck & Co., Inc., does not endorse and is not responsible for the accuracy of the content, or for practices or standards of non-Merck sources. This resource may discuss regimens that have not been approved by the FDA. For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences please see the appropriate manufacturer's product circular. View Prescribing Information for Merck products.
Table of Contents This Chapter by Chapters
Keyword Index
Michael J. Aminoff
NEUROLOGY and GENERAL MEDICINE 9 Neurological Complications of Cardiac Arrest W.T. LONGSTRETH JR •
Previous
Next
VIEW OF THE PAST OUTCOMES OF CARDIAC ARREST Insults Consequences Complications PREDICTING OUTCOMES OF CARDIAC ARREST General Issues and Physical Examination Ancillary Tests Application of Prognostic Information ALTERATION OF OUTCOMES Minimizing Insult Brain Resuscitation Hypothermia VIEW TO THE FUTURE
VIEW OF THE PAST Not long ago, cardiac arrest was an irreversible event that meant certain death. 1 Mouth-to-mouth resuscitation, described since biblical times, or other types of artificial ventilation alone may save a victim of respiratory arrest but not cardiac arrest. The understanding of the causes and treatment of cardiac arrest is intriguingly intertwined with the study of electricity. By the middle of the nineteenth century, investigators knew that electrical currents caused the ventricles of animals to be thrown into a state of Herzdelirium or fibrillation. A series of experiments by Prevost and Battelli in dogs in 1899 established that 2 electrical current could not only induce ventricular fibrillation but also reverse it, leading Jex-Blake to conclude in the 1913 Goulstonian lectures: “It is more than probable that the same treatment—a hair of the dog that bit them—could be applied with success to human 3 beings apparently killed by electric currents.” Progress was interrupted by World War I, and interest was not rekindled until the 1920s in 4 the United States. Concern about accidental death among linemen led Consolidated Edison Company of New York City to request help from the Rockefeller Institute. Several investigations were initiated, including in 1928 work at Johns Hopkins5University by Kouwenhoven, an electrical engineer, and Langworthy, a neurologist. They confirmed earlier
1 / 18
2009.01.05. 11:58
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
works indicating that lower voltage shocks induced ventricular fibrillation and higher voltage shocks caused respiratory arrest. However, they were unable to reverse the ventricular fibrillation with various treatments. In 1930, a colleague pointed out to them the 1899 works by Provost and Battelli, which they subsequently confirmed. The Johns Hopkins investigators returned to Edison Electric Institute to have them create a portable defibrillator. One of the defibrillators subsequently developed had paddles that had to be pushed against the chest before the current could be discharged. Investigators noted that forceful application of the paddles to the chest wall of dogs led to a rise in blood pressure while the heart was still fibrillating. This serendipitous observation led to closed chest compressions. Now the stage was set to treat effectively a common cause of sudden cardiac death—ventricular fibrillation. Closed chest compression and mouth-to-mouth respiration would keep the patient viable long enough for the portable defibrillator to be brought to the patient and applied. Progress was again interrupted by World War II, and it was not until 1956 that Zoll and colleagues reported 6 the first successful external defibrillation in humans. In 1960, Kouwenhoven and co-workers reported a series of successful resuscitations in hospital with closed chest cardiac massage 7 and external defibrillation. Several epidemiological aspects of8sudden cardiac death led to the application of these same techniques outside the hospital. First, the importance of heart disease as a cause of death was increasingly recognized. Second, sudden cardiac death was the presenting feature in up to one third of people with heart disease. Finally, many people dying of heart disease, especially in the setting of myocardial infarction, were doing so outside the hospital. 9–11
One of the first prehospital emergency medical systems was developed in Belfast, Ireland. In their 1967 report, Pantridge and Geddes describe the out-of-hospital resuscitation of a 55-year-old man who had collapsed while dancing. A bystander performed chest compressions, and personnel from the mobile unit applied cardioversion to restore 10 brain damage. A spontaneous circulation. Unfortunately, the patient died a week later with12,13 and systems similar emergency medical system began in Seattle, Washington, in 1970, rapidly proliferated throughout the United States and elsewhere. Meanwhile, selective application of cardiopulmonary resuscitation in hospital had become common as patients, families, and clinicians tried to decide who was likely to benefit from this technique. Over these decades, the realization has grown that the outcome among those in whom spontaneous circulation can be restored is often dominated by brain damage suffered during 14–16 the arrest.
Between 400,000 and 450,000 people are estimated to experience sudden17cardiac death out of hospital or in the emergency department each year in the United States. The numbers treated by emergency medical systems is lower and estimated to be 155,000 people for all rhythms based on an incidence of 55 per 100,000 person-years and 60,000 for ventricular 18 fibrillation based on an incidence of 21 per 100,000 person-years. In this review including studies from 1980 to 2004, survival was 8.4 percent for all rhythms and 17.7 percent for ventricular fibrillation. In many regions of the United States, cardiac arrest has become a leading cause of coma, along with head trauma and drug overdose. The goal of this chapter is to review the neurological sequelae of cardiac arrest (outcomes) and address linked issues of predicting outcomes (prognostication) and improving outcomes (treatment). The focus is on adults, and extreme caution should be used in extrapolating to 19 children. OUTCOMES OF CARDIAC ARREST
Insults To understand the outcomes of cardiac arrest, the insults must be understood. Interruption of cardiac function, as evidenced by an absent pulse, causes insufficient blood flow to the brain leading to global brain ischemia and global brain dysfunction, as evidenced by an absence of consciousness. The dysfunction can be transient or permanent, depending in large part on the duration and severity of the ischemia. At the extreme, the ischemia may be complete where the initial electrocardiogram (ECG) reveals ventricular fibrillation or asystole. With other pulseless conditions, such as rapid ventricular tachycardia or pulseless electrical activity, the ischemia may be incomplete or unknown. During the resuscitation of individuals with cardiac arrest, the inability of medical personnel to detect a pulse or blood pressure does not preclude the possibility of severe hypotension, which could be detected if more sensitive means of measuring blood pressure were available. In most cardiac arrests, both incomplete (low flow) and complete global brain ischemia (no flow) contribute to the brain dysfunction and possible injury. For example, a patient with myocardial ischemia may have hypotension (low flow) preceding deterioration to ventricular fibrillation (no flow). During cardiopulmonary
2 / 18
2009.01.05. 11:58
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
resuscitation and basic life support, severe hypotension can exist (low flow). Finally, with restoration of spontaneous circulation, hypotension and cardiogenic shock (low flow) can complicate the hospital course. The duration and severity of these components of global brain ischemia probably determine the degree of brain damage and outcome. Unfortunately, duration and severity are usually unknown. Cardiac arrest most commonly results from a primary problem with the heart. Although the list of potential cardiac problems is long, coronary artery disease and myocardial ischemia 20 are the most likely culprits. Cardiac arrest can also occur secondary to other toxic and metabolic problems. With the possible exception of hypothermia and overdoses of sedative drugs, these other problems can augment the insult to the brain, especially when a respiratory arrest precedes a cardiac arrest. The respiratory arrest may occur in many settings and is often not a simple event in itself, as with drowning, decompensation of chronic lung disease, drug overdoses, hanging, strangulation, trauma, asphyxia, and carbon monoxide poisoning. In the absence of a cytotoxic agent, such as carbon monoxide, the 21 hypoxia of respiratory insufficiency can be surprisingly well tolerated by the brain. However, if a cardiac arrest ensues, the resulting brain damage can be devastating. Primary neurological problems, such as focal brain ischemia, hemorrhage, and trauma, can lead to a cardiac arrest, which most commonly results from an initial respiratory arrest. Rarely will the first rhythm be ventricular fibrillation. Some neurological events can result in cardiac arrest without intervening respiratory arrest. Brain–heart interactions are detailed in Chapter 22 10. Their importance is supported by experiments in pigs. When pigs were placed under psychological stress, occlusion of the left anterior descending coronary artery resulted in ventricular fibrillation. Functional blockage with cryoprobes of pathways from the frontal cortex through the posterior hypothalamus to the brainstem prevented or delayed the development of ventricular fibrillation. Such pathways may play a role in the sudden death experienced by some patients with epilepsy in whom a fatal arrhythmia may be the terminal 23 event. Thomas mused on the possibility that mechanisms have evolved to ensure sudden death 24 when the end of an animal's life is near. If such mechanisms exist and are triggered inappropriately, premature sudden death could result. Psychological factors may be important in triggering these responses. Richter presented an experimental model in rats of the influence of psychological factors on sudden death and proposed that deaths in humans due 25 to hexing could represent the same phenomena. All such theories assume a strong interaction among cardiac, psychological, and neurological factors.
Consequences The consequences of global brain ischemia have intrigued investigators since well before resuscitation from cardiac arrest was a reality. In 1836, Cooper, an English physician, carried 26 out experiments on rabbits. After surgically occluding both common carotid arteries, he noted that pinching of the vertebral arteries led to sudden unconsciousness. If the blood flow to the brain was not interrupted for too long, the rabbit regained consciousness rapidly upon release of the vertebral arteries. These seminal observations were extended by Brown-Séquard, who27introduced the concept of a rostral-caudal deterioration of brain function with global ischemia. Simply put, cerebral cortical function was lost before brainstem function. In turn, upper brainstem function, such as the pupillary light reflex, was lost before lower brainstem function, such as spontaneous respiratory efforts. The clinical stimulus for these early investigations is uncertain, given that the only examples of global brain ischemia recognized in humans at the time were conditions like beheading and hanging. Confirmation that cerebral cortical function was lost before brainstem function with global ischemia came from additional studies in the 1940s. These studies entailed rapid inflation of a cuff about the neck of human volunteers, with interruption of blood flow to the brain. 28,29 In a 1957 study in which they recorded Subjects were rendered rapidly unconscious. electroencephalograms (EEGs) on 100 patients with syncope, Gastaut and Fischer-Williams attempted to induce transient cardiac arrest with vagal stimulation induced by ocular 30 compression. “When cardiac arrest lasted more than about 14 sec., one or two generalized clonic jerks appeared without affecting the E.E.G., followed by generalized tonic contraction resembling decerebrate rigidity and accompanied by complete ‘flattening’ of the E.E.G.” More recent examples include observations made during induction of ventricular arrhythmias to test 31,32 33 and head-up tilt testing for syncope. Although the automatic implantable defibrillators electrocerebral accompaniments of global ischemia may be more complex than suggested in the earlier studies, all studies agree that motor activity early in the course of global brain ischemia is common and not related to cerebral cortical hyperactivity. Careful video observations have also been made in patients rendered unconscious following
3 / 18
2009.01.05. 11:58
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp 34,35
hyperventilation, orthostasis, and the Valsalva maneuver to induce global brain ischemia. In addition to the motor activity, various eye movement abnormalities, including downbeat nystagmus, were documented. The cerebellum, in addition to the cerebral cortex, was held to be sensitive to brief global ischemia. Given the observations that the cerebral cortex is more sensitive than the brainstem to global 36,37 Based on experiments of global ischemia, the major clinical outcomes can be anticipated. ischemia in primates, Nemoto and colleagues proposed S-shaped curves relating the 38 duration of ischemia with the degree of brain damage and thus with neurological deficits. Assuming that similarly shaped curves exist for the human brain and that for any duration of ischemia, except at extremes, damage to the cerebral cortex is greater than damage to the The outcomes predicted are similar to those brainstem, Figure 9-1 can be constructed. 39 defined in the Glasgow Outcome Scale. At extreme durations of cardiac arrest, both the cerebrum and brainstem will be totally destroyed and brain death will result. Such an outcome after a primary cardiac arrest, as with ventricular fibrillation or asystole, is uncommon and probably reflects the inability to resuscitate individuals whose arrest has such a long duration. In a study of 459 consecutive patients admitted to one hospital in Seattle after out-of-hospital cardiac16arrest and resuscitation, only about 1 percent had an outcome consistent with brain death. With shorter durations of arrest, the cerebral cortex may still be entirely destroyed, but without as complete a devastation of the brainstem. Such individuals will not be brain dead in that they retain some brainstem function, but 40 they may have evidence of forebrain failure, such as electrocerebral inactivity on the EEG. Various terms have been applied to this type of brain damage, including cortex death, neocortical death, partial brain death, death of the forebrain, and acute failure of forebrain with sparing of brainstem function. Although this condition is well described after cardiac arrest, it also is unusual.
FIGURE 9-1 Hypothetical relationship between duration of ischemia and brain damage, assuming that cerebral cortex is more vulnerable to global ischemia than 36–38 brainstem. For example, in a study of 459 patients admitted to a single hospital in Seattle after out-of-hospital cardiac arrest, 279 (61%) awakened, of whom about two 16 thirds regained independence.
More commonly, the cerebral cortex is severely damaged but not completely destroyed. The damage is extensive enough to preclude the patient ever regaining consciousness even though evidence of cerebral cortical activity may exist on the EEG. Evaluation of brainstem function may reveal some deficits or no abnormality. Spontaneous eye opening is common, 41,42 In one survey of four nursing 43 and such patients are said to be in a vegetative state. homes in Milwaukee, Wisconsin, about 3 percent of patients were in a vegetative state. In about 20 percent, the vegetative state resulted from a respiratory or cardiac arrest. A 44 vegetative state that has lasted at least 1 month can be termed persistent. The time at which it can be considered permanent is a topic of debate, as detailed in a subsequent section. Some aspects of conscious behavior may be difficult to judge, but at a minimum, vegetative patients should not follow commands or have comprehensible speech.
4 / 18
2009.01.05. 11:58
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
With a shorter duration of ischemia, the damage to the cerebral cortex is less and recovery of consciousness or awakening can occur, as evidenced by the patient following commands or 45 having comprehensible speech and entering a minimally conscious state. Typically, brainstem function is normal. These patients can be severely disabled because of their neurological impairments, which can include spastic quadriparesis, cortical blindness, severe ataxia, bowel and bladder incontinence, and severe memory deficits. For these survivors, independence in activities of daily living is not possible. In the series of 459 consecutive patients with out-of-hospital cardiac arrest in Seattle, 18 (4%) had such an outcome, including 16 cortical blindness in 4 patients. With still shorter duration of ischemia, less cerebral cortex is damaged and impairments are thought to relate to the parts of the brain most sensitive to ischemia. Nonetheless, in one study of 17 survivors of out-of-hospital cardiac arrest, memory impairments were related more to global cerebral atrophy on magnetic resonance imaging 46 Memory problems can be seen with subtle (MRI) than to selective hippocampal injury. 47 48–50 The memory problems can range from severe motor findings or can occur in isolation. dementia to mild forgetfulness, and some of these patients may be independent in many of their activities of daily living. Finally, if the duration of ischemia is brief and the resuscitation swift and effective, the brain may escape serious injury. Upon awakening, such patients commonly have severe memory impairments, which clear over days. Those patients who have a complete cardiac51arrest remain amnestic for the event and typically do not report near-death experiences. In a prospective study of 509 successful resuscitations, 12 percent of patients reported at least some recollection of the event and 8 percent described core experiences, including most commonly positive emotions, awareness of being dead, meeting with deceased persons, and 52 moving through a tunnel. Depending on the cardiac status and other comorbidities, patients may be able to return to their previous level of neurological function and are typically independent in their activities of daily living. Neuropsychological testing was performed on 68 long-term survivors of cardiac arrest as part of53a clinical trial and showed no deficits or only was in delayed mild ones in approximately one half at 1 year. The most common deficit 54 memory. Improvement in scores on the Mini-Mental State Examination, a simple cognitive measure familiar to most clinicians, occurs mostly in the first 3 months after the arrest, with results at 1 year being comparable to those at 3 months (Fig. 9-2). Quality of life and the level of function have also been assessed and, for many, are comparable to those of similar 55 patients who have suffered a myocardial infarction without a cardiac arrest.
5 / 18
2009.01.05. 11:58
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
54
FIGURE 9-2 Scores on the Mini-Mental State Examination
at certain times after out-of-hospital cardiac arrest in patients enrolled in a randomized trial of nimodipine versus placebo. Because results did not differ by treatment status, combined results are presented. Patients whose scores were zero are included. (Data from Roine RO, Kajaste S, Kaste M: Neuropsychological sequelae of cardiac arrest. JAMA 269:237, 1993.)
After cardiac arrest, any individual patient may pass through all of the stages illustrated in Figure 9-1. At the initiation of the resuscitation, these patients may lack all evidence of brain function and, with time, move toward complete recovery. As with other forms of ischemic brain injury, most of the recovery occurs in the first 3 to 6 months, for example, as shown in Figure 9-2 for the Mini-Mental State Examination score. In the study from Seattle of 459 patients, 61 percent awakened after out-of-hospital cardiac arrest and about two thirds of 16 those awakening were left without gross neurological deficits. Unfortunately, recovery can become stalled at any stage short of complete recovery, with the best recovery for many 42 being a vegetative state or minimally conscious state. Assessment of 39 outcomes after cardiac arrest has most commonly involved the Glasgow Outcome Scale or a variation on it such as56the Cerebral Performance Category (CPC) developed by investigators from Pittsburgh. Certain dichotomous outcomes, as in the top part of Figure 9-1, are important but vary in the ease with which they can be determined and timed. Death is clear-cut. Awakening is defined by the ability to produce comprehensible speech or follow commands, or both. The reliability of its components has been studied in 57 detail as part of the Glasgow Coma Scale. In addition, the timing of its occurrence can be determined with relative ease, like that of death. Many legal and judicial guidelines concerning limitation of medical support address the probability of awakening. Regaining independence is of great importance to patients, families, and clinicians but lacks a uniform
6 / 18
2009.01.05. 11:58
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
definition. It takes longer to achieve, it is more susceptible to the effects of comorbidity than awakening, and the timing of its occurrence can be problematic. 21
The pathology of global brain ischemia has been well described. It confirms what is seen clinically, namely, that some cell types and some regions of the brain are more vulnerable than others. The explanation for selective vulnerability remains incompletely understood. Rather than destroying multiple cell types, as may occur with focal brain ischemia or infarct, damage after cardiac arrest may be limited to the neurons. Ischemic neurons are seen most prominently in certain layers of the cerebral cortex, parts of the hippocampus, and the Purkinje cells of the cerebellar cortex. In the neocortex, layer 3 is the most sensitive, followed by layers 5 and 6. Layers 2 and 4 are the most resistant. In the allocortex, the parts of the hippocampus most sensitive are the Sommer sector (CA1) and the end folium (CA3 to CA4). The region between these two areas (CA2) is the most resistant. At least in rats, the initial loss of hippocampal CA1 neurons after global ischemia 58 can be followed by their reappearance and by recovery of learning and memory. Whether this capacity to form new neurons occurs in humans and explains delayed recovery of memory after cardiac arrest remains to be established. The gross appearance of the brain of a person autopsied following a brief comatose survival after cardiopulmonary resuscitation can look surprisingly unremarkable. Microscopic examination reveals ischemic changes as described, but quantification of these changes is not readily available. The number of neurons that need to survive to result in the clinical outcomes described Figure 9-1, except at the extremes of all or none, remains poorly defined.
Complications Seizures and myoclonus complicate the clinical course in 30 percent or more of patients 59–61 They tend to occur in the immediate following cardiac arrest and resuscitation. postresuscitation period, and long-term epilepsy is rare. Myoclonus is common and can be diffuse and multifocal, as with myoclonus status epilepticus. Alternatively, the patient may have little clinical manifestation of seizure activity beyond some subtle abnormalities of eye 62,63 movements, yet the EEG can show evidence of ongoing electrical seizure activity. Regardless of the manifestations, seizures and myoclonus can be difficult to control in this setting, and treatment does not seem to affect the outcome. Brain swelling is common, as evidenced by the results of imaging and lumbar puncture, but it rarely leads to herniation and deterioration. Exceptions are patients in whom a respiratory arrest precedes the cardiac arrest. These patients sometimes develop brain swelling severe enough to result in herniation, neurological deterioration, and brain death. In such circumstances, the swelling probably reflects a severely damaged brain, and treatments aimed at controlling increased pressures do not seem to affect outcomes. After cardiac arrest, patients are also at risk of numerous cardiac and general medical complications, which are beyond the scope of this discussion. All these, especially recurrent cardiac arrest and hypotension, tend to worsen the initial injury and thus the outcome. A number of other rare complications can occur in the setting of a mixture of brain insults, sometimes including cardiac arrest. The greater the proportion of incomplete compared with complete global ischemia, the greater is the risk of preferential damage to border-zone regions of the brain and spinal cord. In the brain, this can result in injury between the anterior and middle cerebral artery distributions and a clinical picture of a brachial diplegia. With the upper extremities being more involved than the lower 64 extremities, this clinical picture has been referred to as the “man-in-the-barrel” syndrome. A similar border-zone phenomenon in the spinal cord has been proposed as an explanation for the paraplegia that can complicate cardiac arrest, although a retrospective pathological study of patients dying after global65ischemia found the lumbosacral spinal cord more commonly affected than the thoracic and less commonly from bone marrow secondary to cord. Emboli may arise from the heart 66 the trauma of chest compressions. Interestingly, patients with focal ischemia of the cerebral cortex may have symmetric neurological examinations upon presentation after cardiac arrest. Their examination reflects a level of function below their focal insult. If the level rises, focal abnormalities may become evident. Given the masking capability of global brain ischemia and the elevated risk of cardiac emboli in many of these patients, cardioembolic infarcts may be missed in this setting. Two well-described but rare complications seem to be more a function of respiratory failure mixed with cardiovascular insufficiency than simply of68cardiac arrest: delayed postanoxic 67 encephalopathy and posthypoxic action myoclonus. Many of the cases of delayed encephalopathy have occurred in the setting of carbon monoxide exposure. A period of
7 / 18
2009.01.05. 11:58
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
improvement69and sometimes return to seemingly normal function is followed by marked deterioration. Diffuse demyelination is the apparent cause of the deterioration in those who have died. An70association with a partial deficiency of arylsulfatase A has been described in some cases. Those with posthypoxic action myoclonus awaken soon after their respiratory arrest, often 71 with normal cognitive function but with severe action myoclonus. Attempts at movement are interrupted by myoclonic jerks. These can also be triggered by loud noises and other sensory stimuli. The pathological substrate for the condition is uncertain. Treatment with valproic acid or benzodiazepines is sometimes successful. Clinicians not familiar with posthypoxic action myoclonus may confuse it with myoclonus status epilepticus. Early after the insult, the two conditions can look similar but carry very different prognoses. The confusion usually arises when soon after the inciting insult the action myoclonus is treated aggressively with benzodiazepines. If the benzodiazepines are reduced, the patient lightens but the myoclonus returns. Consequently, the benzodiazepines are reinstituted. What may not be appreciated is that the unresponsive state is more a result of the medications than the original insult. Table 9-1 contrasts the two conditions with the goal of minimizing the risk of a clinician confusing the two. Click here to view this table.... Other movement disorders, including akinetic, dystonic, and hyperkinetic syndromes, have also been described, but not always clearly following sole cardiac arrest with complete global 71 brain ischemia. Imaging and neuropathological examination can reveal injury in the basal ganglia. This topic is discussed further in Chapter 59. PREDICTING OUTCOMES OF CARDIAC ARREST
General Issues and Physical Examination Key to making clinical decisions is information on prognosis. In patients with a poor prognosis, the decisions may range from initiation of potentially dangerous treatments aimed at brain resuscitation to limitations in the intensity of medical support. The outcomes to be predicted include death, awakening, and independence. For the reasons discussed earlier, independence can be difficult to determine and time. Death is easily determined and timed but may relate to cardiac problems and need not reflect the degree of neurological recovery. Consequently, awakening is often used as a simple, easily determined, and timed outcome for identifying important predictors. The accurate delineation of prognosis after cardiac arrest 72,73 and has been the topic of many reports and comprehensive presents74,75 several challenges Some of the major findings of these studies are summarized in this section. reviews. The severity and duration of global brain ischemia are probably the most important predictors of outcome but are usually unknown or, at best, crudely estimated. The cardiac rhythm identified at the start of the resuscitation is a predictor of outcome. The probability of restoring a spontaneous rhythm is higher when the initial rhythm is ventricular fibrillation rather than 76,77 A similar finding holds for survival and awakening. asystole or pulseless electrical activity. Demographic factors such as age and gender are not important predictors of restoration of 78,79 African Americans are more spontaneous circulation or survival to hospital discharge. 80,81 Comorbidity may be an important factor with respect to likely to have poor outcomes. outcome and probably explains why resuscitation rates for out-of-hospital cardiac arrest in 82,83 some regions of the country are better than those for in-hospital cardiac arrest. The amount of brain dysfunction as indicated by the physical examination reflects the severity of the insult. In general, the greater the function at any particular time after the arrest, the better is the eventual outcome. Nonetheless, complete loss of neurological function at the time that the resuscitation is initiated is still compatible with awakening and good recovery. The duration of arrest that is incompatible with recovery is uncertain and, as a practical matter, is often difficult to estimate. The human brain can probably not fully recover from more than 5 to 10 minutes of complete global brain ischemia, as with ventricular fibrillation or 84 asystole. Patients with some degree of neurological function at the start of the resuscitation, such as the presence of pupillary light reflex or spontaneous respiratory efforts, have a better 85–87 As discussed earlier, neurological function is outcome than those without that capacity. lost in a rostral-caudal manner when blood ceases flowing to the brain, with spontaneous respiratory efforts being the last to go. Thus, the presence of neurological function at the start of the resuscitation indicates that the cardiac arrest is likely less than a few minutes old. The physical examination performed once the patient has been stabilized with respect to
8 / 18
2009.01.05. 11:58
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
cardiovascular status gives the clinician the next chance to assess prognosis. Evaluation 39 but should be augmented by further evaluation of includes the Glasgow Coma Scale 56 brainstem function to include pupillary light reflex, corneal reflex, cough, gag, spontaneous respiratory efforts, and eye movements elicited by vestibulo-ocular and cervico-ocular 88 reflexes (Table 9-2). Click here to view this table.... Agreement across clinical studies is remarkable, given the diversity of populations studied and the statistical methods applied. For instance, two studies examined prognostication after cardiac arrest. One study included 389 consecutive unconscious patients admitted to a single 89 hospital in Seattle after out-of-hospital cardiac arrest with ventricular fibrillation or asystole. The other was a multicenter study of 21090patients with a mixture of hypoxic-ischemic insults occurring both in and out of the hospital. The studies used different multivariable techniques to identify independent early predictors of outcome, but both found that pupillary light reflex, motor response, and eye movements were the most important predictors. The other independent predictor of outcome in the study from Seattle was the admission blood glucose, which is discussed later. Figure 9-3 shows a simplification of the multivariable rule from the Seattle study and its performance in predicting outcome based on information collected at the time of admission. By using this rule, the clinician can rapidly form an initial prognostic impression.
FIGURE 9-3 Performance of a simple rule applied at admission to predict awakening after out-of-hospital cardiac arrest due to ventricular fibrillation or asystole. (Data from Longstreth WT Jr, Diehr P, Inui TS: Prediction of awakening after out-of-hospital cardiac arrest. N Engl J Med 308:1378, 1983.)
As would be surmised from Figure 9-1, the finding of persistent brainstem dysfunction suggests a poor prognosis, given that the cerebral cortex, being more sensitive, has suffered an even worse injury. In a detailed review, the clinical signs most strongly related to a poor outcome, which could include patients who regained consciousness but not independence, were absent corneal response at 24 hours, absent pupillary response at 24 hours, absent withdrawal response to pain at 24 hours, no motor response at 24 hours, and no motor 91 response at 72 hours. Unfortunately, preservation of brainstem function does not ensure a good outcome in that the cerebral cortex may still have been damaged to a degree that
9 / 18
2009.01.05. 11:58
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
precludes ever awakening. The pupillary light reflex and the motor function, as assessed in 57 the Glasgow Coma Scale shown in Table 9-2, have emerged as important prognostic factors in a number of studies. In a systematic review of factors that predict a poor outcome after cardiac arrest, which was defined as death or survival in a vegetative state (i.e., never awakening), the absence of a 74 pupillary light reflex on admission had a specificity that ranged from 69 to 100 percent. Specificity is the percentage of all patients with a good outcome who lack the finding. Only when patients were tested on day 3 after the arrest did absence of a pupillary light reflex have 100 percent specificity in all studies. A specificity of 100 percent means that the positive predictive value must be 100 percent and that the false-positive rate must be 0 percent, namely, that all those with the finding (absence of a pupillary light reflex on day 3) have a poor outcome and never awaken. Unfortunately, the sensitivity of this finding was low, ranging from 22 to 55 percent. Sensitivity is the percentage of all patients with a poor outcome who demonstrate the finding. The Glasgow Coma Scale has been used by itself as a predictor of outcome but is dominated by the motor findings. Most of these patients are intubated as part of their resuscitation, so that the verbal response cannot be assessed. Eye opening is an uncertain predictor, with some patients having spontaneous eye opening soon after resuscitation and never regaining consciousness. In a systematic review, the worse the motor response, the worse was the 74 outcome, with the accuracy of predictions improving over time. Thus, a score of 1 on the motor scale (absent motor response to pain) on day 3 after the arrest had a specificity of 100 percent for a poor outcome, but the sensitivity ranged from 11 to 58 percent. In a subsequent large prospective study of 407 patients, specificity92was 95 percent and the false-positive rate was 5 percent for no motor response at 72 hours. 93
As J⊘rgensen and Malchow-M⊘ller first demonstrated and others have confirmed, the longer the delay in the return of neurological function, the worse is the prognosis. For example, recovery of pupillary light reflex within 12 minutes was compatible with a good 93,94 outcome, whereas its absence for more than 28 minutes predicted a poor outcome. Ultimately, duration of unconsciousness itself becomes a predictor of the likelihood of consciousness ever returning. For example, in the study from Seattle, although overall 61 percent of the 459 patients awakened, the probability of ever awakening fell precipitously 16 during the first 3 days after admission from out-of-hospital cardiac arrest. More than 90 percent of those destined to ever awaken did so by 3 days. All those awakening after 4 days had some persistent neurological deficits, and all those awakening after 14 days had persistent severe neurological deficits. Interestingly, in that study as well as a subsequent 95 one, about one in five of those still unconscious 1 week after the arrest eventually awakened. 72
a basic, unavoidable one is the Although these studies are replete with potential problems, 96 where reliability of the information on which prognosis is based. Even in research settings 91 the question of agreement between examiners has been evaluated systematically, it is not 100 percent and is likely lower in a practice setting. In addition, many of the medications administered to these patients may alter the findings on the neurological examination and adversely affect the accuracy of predictions based on them. Consequently, a certain degree of random error or noise will always exist in predictive models based on the neurological examination. In the large prospective study 92 of 407 patients, physical examination findings were inferior to other tests to be discussed. Perhaps the best that can be expected from the neurological examination is to provide an early indication of prognosis, such as with the awakening score provided in Figure 9-3, and to monitor neurological recovery.
Ancillary Tests Laboratory tests typically have greater reliability or precision than that of findings from the physical examination, and several tests have been evaluated for their potential to predict outcome after cardiac arrest. To be clinically useful, such a test must improve on the good, but not perfect, prediction of outcome already available from the physical examination. Several ancillary tests have been used for prognostication after cardiac arrest. Results of most routine laboratory tests are not related to outcome after cardiac arrest, the possible exceptions being thyroid function tests and admission blood glucose levels. For 89 example, admission values for arterial blood gas or hematocrit are not related to outcome. By contrast, in one study, lower total thyroxine, total triiodothyronine, and thyrotropin from 97 In addition, blood collected at the end of resuscitation were associated with a poor outcome. 98 after as predicted from animal experiments, elevated admission blood glucose levels 89,99,100 In cardiac arrest have been shown to be associated with poor neurological outcome.
10 / 18
2009.01.05. 11:58
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
one study that attempted to explain this association, analyses were done of blood glucose levels determined during cardiopulmonary resuscitation in patients with out-of-hospital cardiac arrest and suggested that the admission blood glucose level simply reflected the 101 duration of resuscitation. Because a small detrimental effect of glucose could not be excluded in these observational studies and because of102data from experimental studies in animals, a randomized trial in humans was performed. During resuscitation of patients with out-of-hospital cardiopulmonary arrests, emergency medical services personnel randomized patients to receive either the fluid that had been routinely used, 5 percent dextrose in water, or a glucose-free alternative, 0.5 normal saline. Results indicated that awakening was not related to the glucose content of the fluids that were given (Fig. 9-4), although the amount of fluid administered by emergency medical services personnel was small. An unexpected and not easily explained finding in the clinical trial was that the relationship between blood glucose level and awakening was reversed in patients whose cardiac arrest was not due to ventricular fibrillation or asystole on a presumed cardiac basis. For these other patients, most of whom had pulseless electrical activity, a high blood glucose level on admission was associated with a favorable outcome. Overall, these studies suggest that the admission blood glucose level after cardiac arrest depends on the duration of certain aspects of the arrest and resuscitation. level is not as Although it is an independent predictor of outcome (Fig. 9-3), the blood glucose 89 powerful as certain aspects of the physical examination already discussed.
FIGURE 9-4 Presentation of results on survival and awakening after cardiac arrest from clinical trial of brain-cardiopulmonary resuscitation. This randomized trial examined whether the type of fluids (5% dextrose in water versus 0.5 normal saline) administered in the field by emergency medical services personnel affected outcome. Shown in the graph is the proportion of 291 admitted patients, all of whom were initially comatose after out-of-hospital cardiopulmonary arrest, who went on to awaken or to die without awakening. Solid lines represent the experience among those who received 5 percent dextrose in water (n = 141); dashed lines represent those who received 0.5 normal saline (n = 150). A vertical line from the horizontal axis at any particular time indicates the proportion who had awakened (from the 0.0 horizontal line to the lower pair of curves), who were still comatose (from lower to upper pair of curves), and who had died without awakening (from the upper pair of curves to the 1.0 horizontal line). For example, a vertical line at 3 days indicates for the entire cohort that about 34 percent had awakened regardless of treatment group (34% minus 0%), that about 37 percent were still comatose (71% minus 34%), and that the remaining 29 percent (100% minus 71%) had died without awakening. Of the 117 patients who awakened, 15 subsequently died during hospitalization and are classified in this figure as having awakened. (From Longstreth WT Jr, Copass MK, Dennis LK, et al: Intravenous glucose after out-of-hospital cardiopulmonary arrest: a community-based randomized trial. Neurology 43:2534, 1993, with permission.)
Another study that is typically available in these patients is the EEG. In addition to electrocerebral inactivity and a burst-suppression pattern, other specific patterns have been described, such as spindle coma, theta-pattern coma, and alpha-pattern coma, although no 75 universally accepted EEG classification scheme exists. Both electrocerebral inactivity and a
11 / 18
2009.01.05. 11:58
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp 74,75
burst-suppression pattern are associated with a poor prognosis. In a systematic review, electrocerebral inactivity and a burst-suppression pattern had a specificity for a poor outcome 74 of never awakening of 100 percent in all but one study. Interestingly, the only study not to 103 show a specificity of 100 percent was also the only study in which blinding was employed. Of note, alpha-pattern coma was not necessarily associated with a poor prognosis. Part of the difficulty in assessing the prognostic utility of the EEG relates to its typically being obtained early in the hospital course on patients who are having uncontrolled seizures or myoclonus or later in those who remain unconscious. Thus, confounding by indication may be present, with the seizures and prolonged unconsciousness being markers of a poor prognosis. Whether the EEG provides additional independent prognostic information is uncertain. The prognosis with myoclonus status epilepticus in the first 24 hours following the arrest is especially poor, leading some to equate myoclonus status61,75,92,104 epilepticus with an agonal brain In one review, myoclonus phenomenon indicating severe cerebral cortical damage. status was defined as spontaneous, repetitive, unrelenting, generalized multifocal myoclonus involving the face, limbs, and axial musculature in comatose patients after primary circulatory 75 104 arrest, and it can be associated with abnormal but variable EEG findings. A meta-analysis yielded a specificity of 100 percent and a false-positive rate of 0 percent with 95 percent confidence interval of 0 to 8.8 percent, 75 suggesting that the true percentage is 95 percent likely to fall somewhere within the interval. Sensitivity has varied across studies. In the largest study that included 407 patients, only 4 percent of those who never awakened had 92 status from myoclonus status. Extreme caution is needed in distinguishing myoclonus 105 action myoclonus (Table 9-1), given the marked differences in prognosis. Evoked potential studies have been investigated thoroughly, and bilateral median nerve somatosensory evoked potentials have become the dominant prognostic test after cardiac 74,75 Bilateral absence of a short-latency cortical response (N20) is associated with a arrest. 74,75,92,106 In a systematic review, bilateral absence of the short-latency cortical poor prognosis. response was 100 percent specific, with none of the 187 patients with this finding after cardiac arrest achieving a good outcome. Of note, exceptions exist if the somatosensory 107 evoked potentials are performed within 24 hours of arrest. In a subsequent prospective cohort study, serial somatosensory evoked potentials were performed at 24, 48, and 72 hours after resuscitation. Among the 301 patients still alive and unconscious at 72 hours, all 136 (45%) with bilaterally absent N20 at any of these times died or remained unconscious after 1 92 month. Interestingly, in nine patients, N20s were present on an initial test but lost on follow-up, and in five patients, the reverse was seen. All these patients had a poor outcome. Although treating physicians were blinded to results of the testing at 24 and 48 hours, they were informed of the results of the tests at 72 hours and advised that chances for survival or recovery of consciousness were virtually nil with bilaterally absent N20. An exception has 108 evoked been reported, which may reflect that although the reliability of somatosensory 109 potentials may be better than that for the physical examination, it is not perfect. Recommendations to improve the reliability of the test have been offered (Table 9-3). A meta-analysis based on these and other studies yielded a specificity of 99.3 percent and75a false-positive rate of 0.7 percent with 95 percent confidence interval of 0 to 3.7 percent. Unfortunately, the presence of N20 does not ensure a good outcome. Preliminary studies 110 suggest that cognitive evoked potentials hold promise in predicting good outcomes. Click here to view this table.... Imaging of the head with computed tomography (CT) and MRI may show loss of gray-white matter75differentiation, evidence of swelling, and other changes suggesting diffuse cortical injury. In one study, agreement about111the presence or absence of gray-white matter differentiation on CT was problematic. The abnormalities, especially on MRI, may be 75 dramatic (Fig. 9-5), but more work is needed to clarify the prognostic utility of such tests. Interestingly, evidence of swelling is more common among those who experienced 112 respiratory failure prior to their cardiac arrest. Later in the course, these studies may show atrophy in patients who remain unconscious. Other types of brain imaging have been studied, but only in a small number of patients, precluding any firm conclusions about their prognostic value.
12 / 18
2009.01.05. 11:58
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 9-5 Magnetic resonance imaging (MRI) after cardiac arrest. The patient was a 49-year-old woman with respiratory arrest followed by cardiac arrest. Paramedics found her cyanotic and asystolic. Initial neurological examinations showed her to be comatose with extensor posturing but intact brainstem function. MRI was performed about 32 hours after cardiac arrest. Cerebral cortical abnormalities are less obvious on fluid-attenuated inversion recovery (FLAIR) sequences (A, bright) than on diffusion-weighted imaging (B, bright) and apparent diffusion coefficient (ADC) maps (C, dark). 75,113
Several serum and cerebrospinal fluid (CSF) enzymes have been evaluated. Caution must be exercised in the interpretation of enzyme results when a mixture of brain insults has occurred because elevations are not specific to cardiac arrest, having been described with other types of injury. The highest quality evidence of predictions of outcomes after cardiac arrest exists for serum neuron-specific enolase (NSE). In the prospective cohort study 92 mentioned earlier, serial NSE was assayed at 24, 48, and 72 hours after resuscitation. Among the 231 patients still alive and unconscious at 72 hours, all 138 (60%) with an elevation above the prespecified cutoff of 33 μg/L at any time died or remained unconscious after 1 month. With this cutoff, a meta-analysis yielded a specificity of 100 percent and a false-positive rate of 0 percent with 95 percent confidence interval of 0 to 3 percent. 92,114,115 and serum NSE is often not available on Exceptions using this cutoff are now known, a timely basis, especially in the United States. Finally, NSE is present in platelets so 75 hemolysis can lead to increased serum values. Assays of creatine kinase (CK) and its isoenzymes, including the BB isoenzyme, which116 is present 117 in high concentration in the brain, are readily available, and studies in humans and animals suggest that the enzymes peak in the CSF 48 to 72 hours following global brain ischemia. The higher the value, the greater is the damage to the brain and the worse the outcome. In one retrospective study, 351 patients had CSF CK BB isoenzyme activity determined in a single laboratory. No complications from the lumbar punctures were encountered. The median CK BB isoenzyme activity in those who awakened was 4 U/L, 118 whereas in those who never awakened, it was 191 U/L. No one with a value greater than 204 U/L ever awakened, and no one with a value greater than 50 U/L ever regained independence. The assay was subsequently modified in this laboratory allowing reversibly inactivated CK BB isoenzyme to be reactivated. The revised cutoffs were 363 U/L for awakening and 89 U/L for independence. As with the somatosensory evoked potentials, the sensitivity of the CSF CK BB isoenzymes was low at 48 percent. Another study has shown that specificity can be119 maintained at 100 percent and sensitivity increased to 69 percent by increased by combining the results of several employing both tests. That sensitivity can be 92,114,120 tests has also been demonstrated by others.
Application of Prognostic Information These and other studies on prognostic tests raise several issues: some ethical, some legal, 72 and some statistical. Often when the prognosis for awakening is extremely poor, family members and clinicians will agree that the best course of action is to limit artificial life-sustaining treatments and allow the patient to die, with appropriate attention being given to end-of-life care as outlined in Chapter 63. Given that such actions, which121 can include discontinuation of artificial nutrition and hydration, uniformly result in death, a danger exists that prognostic information creates a self-fulfilling prophecy. One option to avoid this possibility is to treat maximally all patients until they die of some other cause, an option
13 / 18
2009.01.05. 11:58
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
unacceptable to most families and clinicians. Nevertheless, support is maintained in some patients, particularly younger ones, and late awakenings have been documented. For example, in the series of 459 consecutive patients from one hospital in Seattle, the last 3 individuals to awaken after cardiac arrest did so at about 56, 75, and 100 days after their 16 cardiac arrest. Of note, all these patients were severely impaired and totally dependent in their activities of daily living, as has been described in other patients who awakened late after 122,123 Another option in the evaluation of a new predictive test is to collect data cardiac arrest. without making them available to the clinicians who will make decisions about support. After outcomes have been determined, performance of the test can be evaluated without fear of its results having influenced decisions. Unfortunately, prognostic tests are correlated so findings on the physical examination may influence decisions about support even though the results of the other prognostic tests are kept secret. So despite the blinding of the treating physician to the results of the NSE in the longitudinal study already described, sup- port was more often 92 limited in those with elevated NSE compared to those without. A final option is to require some independent gold standard to assess the degree of brain damage. A quantitative neuropathological examination would serve such a purpose but is currently not readily available in humans. If a treatment is being evaluated, such as in a clinical trial, it is essential that decisions concerning the limitations of treatments are made in as standard a fashion as 37 possible and without the knowledge of treatment status so as to avoid biasing results. A standardized approach is also warranted in vegetative patients being considered as 124 non–heart-beating donors. Based on these considerations, a practical approach to prognostication after cardiac arrest is suggested. It involves serial neurological examinations to document baseline function and change. Using the simple rule in Figure 9-3, clinicians can use the initial examinations to formulate an initial impression about prognosis. These examinations should include the 57 Glasgow Coma Scale and assessment of brainstem function (Table 9-2). EEGs should be reserved for those in whom seizure activity is suspected. If the patient is not awake by 48 to 72 hours following the arrest, additional testing may help to clarify the prognosis. The tests that seem the most useful are somatosensory evoked potentials and biochemical markers of brain damage. Assays of CSF CK isoenzymes may be more widely available than assays of serum NSE, but cutoffs may not be sufficiently standardized for either. When the results of these tests are available, a meeting should be held with the patient's surrogate to review the results and to proffer a prognosis (Table 9-4). The patient's surrogates are typically family members, legal next-of-kin, or other legally appointed representatives for the patient. If the physical examination suggests a poor prognosis, especially with persistence of no pupillary light reflex and no motor responses to pain, and the results of the ancillary tests are consistent, an option of limiting medical support should be discussed. Typically, surrogates insist on limiting support when they learn that their loved one faces the prospects of a prolonged unconscious state and when they know the patient would not want aggressive treatment in such circumstances. Most surrogates, especially of elderly patients, strongly resist delaying decisions, especially for several months to a year, as has been 72,125 suggested. Click here to view this table.... These considerations raise several statistical issues about the confidence of predictions of 72 outcome. The discussion by Shewmon and De Giorgio is particularly enlightening. We strive for a prognostic model with both a specificity for predicting a poor outcome and a positive predictive value of 100 percent and a false-positive rate of 0 percent. This goal is often claimed to have been achieved when a certain number (N) of patients have a particular test result, and all (N/N = 100%) have a poor outcome, or, alternatively, none (0/N = 0%) has a good outcome. A simple rule of three (3/N) allows a reader to estimate the upper 95 percent 126 confidence interval rapidly for the proportion in which the numerator is zero. For example, none of 187 patients with bilateral absence of the short-latency cortical response of the somatosensory evoked potentials after cardiac arrest had a good outcome in a systematic 74 review. We can estimate the upper 95 percent confidence interval as 3/187 = 0.02. The lower confidence interval will always be zero. We may conclude that the results are consistent with up to 2 percent of the patients with this finding achieving a good outcome. If we want a prognostic model to exclude even remote possibilities of errors, huge numbers of patients fully supported for prolonged periods are required. Using Bayesian methodology, Shewmon demonstrated that, given N patients with a particular test result, none of whom 127 awakened, the risk of the very next patient awakening is approximately 1/(N + 2). Also, the risk of at least one person breaking the rule in the next N + 1 patients studied is approximately 50 percent. All this information suggests that the search for some infallible rule is quixotic, and exceptions will probably be found if enough patients are studied. The literature on prognostication may become less interesting for large series in which problems with self-fulfilling prophecies cannot be avoided than for reports of patients who break the
14 / 18
2009.01.05. 11:58
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp 92
rules and awaken despite absence of motor responses at 72 hours, bilateral absent N20 108 or serum NSE greater than 33 responses on somatosensory evoked potentials, 92,114,115 μg/L. In discussions with a patient's surrogate decision-maker concerning withdrawal of artificial life-sustaining treatments, the inherent uncertainty need not be masked. Uncertainty does not preclude decisions to limit support nor does certainty ensure such decisions. These concepts have been illustrated previously with decision analysis incorporating probabilities and utilities 128 of outcomes after cardiac arrest. The care provider brings to the surrogate the probabilities based on the prognostic tests described. The surrogate must estimate the utility or value of certain outcomes, especially the vegetative state. Ideally, such estimates of utility are based on the patient's previously stated opinions about living in severely neurologically impaired states and whether such states are better or worse than death. If the utility of an outcome such as a vegetative state is judged as not being worse than death, the best decision will be to continue full support even in the face of near certainty that the patient will never awaken. At the other extreme, if the utility of an outcome such as a vegetative state is judged as much worse than death, the best decision will be to limit full support even in the face of substantial uncertainty that the patient will never awaken. Many people would choose to give up the chance of awakening, especially awakening with neurological deficits, to avoid being trapped in a prolonged vegetative state. Challenges arise when the probabilities and utilities lead to a close call or when care providers and surrogates disagree about what is best for the patient because they disagree about probabilities, utilities, or both. The use of decision analysis allows a quantitative deconstructed view of what most clinicians already know, namely, that decisions can be made in the setting of uncertainty, but preferences of patients or their surrogates about outcomes are key considerations, as discussed in Chapter 63. None of these approaches incorporates the societal view, with concerns about resources. Requiring prolonged support for unconscious patients results in extensive resources being devoted to 72 these patients. Scarcity of resources may someday force society to mandate that the vegetative state is valued at worse than or equal to death. ALTERATION OF OUTCOMES
Minimizing Insult Many strategies exist to reduce brain damage from cardiac arrest. Most effective is to prevent cardiac arrest from occurring in the first place. Prevention requires delineation of the risk factors for cardiac arrest. The most common cause of cardiac arrest is atherosclerotic cardiovascular disease; thus, the two share risk factors. With identification and control of these risk factors in recent years, the incidence of cardiac arrest may be expected to decrease. Assuming that efforts at prevention fail and a patient suffers a cardiac arrest, another strategy is to limit as much as possible the severity and duration of global brain ischemia. Such is the aim of what currently is the most effective treatment for brain damage following cardiac 129 arrest, namely, cardiopulmonary resuscitation with basic and advanced life support. The most treatable condition leading to cardiac arrest is ventricular fibrillation, and the necessary treatment is electrical defibrillation. Consequently, in patients with ventricular fibrillation, the outcome is determined in large part by how quickly the patient and defibrillator can be 130 brought together. In-hospital cardiac arrests require code teams and the availability of necessary equipment, especially in areas where cardiac arrests are known to occur more frequently, such as intensive care units, operating suites, and the emergency department. For out-of-hospital cardiac arrest, success requires an emergency medical system capable of a rapid response and early defibrillation. Automatic defibrillators made available to care 131 132 made available to the public, and especially providers, automatic defibrillators 133 implantable defibrillators have led to a reduction in the time from the onset of the arrest until delivery of the first defibrillatory shock. Patients with other rhythms, such as asystole and 76–78 pulseless electrical activity, are less likely to have spontaneous circulation restored,134,135 and have efforts to improve the proportion resuscitated, such as with high-dose epinephrine, been disappointing.
Brain Resuscitation Even when cardiopulmonary resuscitation leads to restoration of spontaneous circulation, many patients will die without ever awakening. Currently, hypothermia is the only therapeutic intervention initiated after restoration of spontaneous circulation that has been shown to improve neurological outcomes after cardiac arrest in humans. Efforts to identify such treatments, which constitute brain resuscitation, have been substantial. Safar and Bircher
15 / 18
2009.01.05. 11:58
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
suggested that brain resuscitation includes both specific measures and general 136 brain-oriented intensive care. The general measures are essential and are the approach taken for any critically ill comatose patient. As mentioned, the occurrence of seizures and myoclonus tends to indicate a worse prognosis, which is not clearly improved with treatment. Brain swelling is rarely a serious problem when the mechanism of arrest is primarily cardiac, and treatments aimed at reducing swelling, such as hyperventilation, use of osmotic agents, and administration of corticosteroids, have no clear role. The efficacy of corticosteroids has not been studied in a randomized clinical trial. In two cohort studies, both of which had 137 138 concurrent nonrandomized controls, one retrospective and one prospective, outcomes were not related to the use of corticosteroids. Perhaps duration and severity of complete and incomplete global brain ischemia determine the outcome, and no manner of treatment after the insult will alter outcome. Evidence against such a nihilistic view has come from the use of experimental treatments in animal models of global brain ischemia and an expanding knowledge of the brain's response to ischemia, reperfusion, and repair. Several reviews address these topics and their implications for 139–141 In many ways, patients resuscitated from cardiac arrest represent an ideal treatment. group to evaluate treatments for brain ischemia. The condition is common, good outcomes are not rare in subgroups such as those with ventricular fibrillation, treatments can be initiated very early after restoration of spontaneous circulation, and relevant outcomes are easily determined and timed. What follows is a brief overview of this field from the perspective of a clinician. Under normal circumstances, intracellular calcium is kept quite low relative to extracellular calcium, a 10,000-fold concentration difference. During ischemia, the ability of a cell to maintain this gradient is lost, and the increase in intracellular calcium triggers a number of destructive events that lead to the cell's death, including activation of calcium-dependent enzymes. Calcium can enter the cell via a number of pathways. The initial hope was that most of the calcium entered through voltage-sensitive calcium channels and could be stopped with calcium entry blockers. As a testimony to the popularity of the hypothesis, it was subsequently tested 142 in at least four143–145 randomized clinical trials of calcium entry blockers, 146 and flunarizine. In humans, none of these agents including lidoflazine, nimodipine, has been shown to be effective in altering outcome. The 144 study of nimodipine reported by Roine and colleagues set a high standard for such trials. It included only patients with out-of-hospital cardiac arrest with ventricular fibrillation. The treatment was initiated in the field upon restoration of spontaneous circulation. Finally, the follow-up of the patients and 53 documentation of outcomes were superb. Unfortunately, no overall benefit could be detected from the drug, although patients with delayed resuscitation of more than 8 minutes 145 may have benefited. The lack of efficacy of the calcium entry blockers may be explained by calcium also entering cells by agonist-operated channels, specifically those activated by glutamate. It is an excitatory neurotransmitter that in this setting is proposed to be an excitatory neurotoxin or excitotoxin. Glutamate acts at several receptors named for the more specific agonists that bind to them, including AMPA (αamino-3-hydroxy-5-methyl-4-isoxazole propionic acid) and NMDA (N-methyl-d-aspartate). The AMPA sites mediate fast synaptic transmission, opening a channel for sodium and potassium, but not calcium. The NMDA channels are gated by magnesium and allow the flux of cations, including calcium. Despite hopes that blockage of the NMDA sites would reduce the influx of calcium and protect the brain, experimental studies of global brain ischemia have not consistently shown benefit. Interestingly, the glutamate antagonists that block the AMPA sites have been effective after global brain ischemia. By preventing rapid changes in sodium and potassium and thus excitatory synaptic transmission, these agents may prevent the cell from depolarizing. Without depolarization, calcium does not enter through the voltage-sensitive calcium channels. In addition, depolarization is necessary for clearance of magnesium from NMDA channels. Thus, even in the presence of excess glutamate, if the cell is not depolarized, magnesium blocks the channel and calcium cannot enter. Currently, none of the agents that block the AMPA receptors has been systematically studied in humans after cardiac arrest. One randomized trial of humans with a factorial design using magnesium to reduce excitation 87 and diazepam to increase inhibition showed no benefit of either agent or their combination. Barbiturates also prevent cells from depolarizing by increasing the inhibitory effects of γ-aminobutyric acid. Thiopental was studied in a randomized trial of humans and was not 147 found to be effective. This landmark study was the first major clinical trial that evaluated a treatment whose purpose was brain resuscitation. The sequence of events following ischemia and during reperfusion continues to be clarified. Free radicals probably play an important role in the brain injury following cardiac arrest. A
16 / 18
2009.01.05. 11:58
Aminoff: Neurology and General Medicine: Neurological Complicatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
number of strategies exist for dealing with oxygen free radicals, including reducing their production, increasing their removal, and blocking their effects. How nitric oxide fits into these theories of excitotoxins and free radicals remains to be defined. Coagulation may play a role in microcirculatory reperfusion disorders in animals, and a randomized trial of thrombolysis 148 during cardiopulmonary resuscitation is pending. Also, attention has turned in recent years to the reparative mechanisms and the possibility that some of the damage following global brain ischemia is a consequence of defective repair. The production of growth factors such as nerve growth factor and insulin-like growth factor, the induction of stress proteins such as heat shock proteins, and the transcription of immediate early genes such as c-fos and c-jun all are under investigation. Although necrosis has been the focus in the past, apoptosis also 149 likely plays a role. How the genetic make-up of patients who suffer cardiac arrest may modify the response to injury and thus prognosis remains largely unstudied. A better understanding of the pathophysiology of ischemic brain injury may lead to novel ways of improving the outcomes of patients after cardiac arrest.
Hypothermia To date, induced hypothermia represents the sole success in the many efforts to make brain 150 to protect resuscitation a reality. The idea is not novel, having first been used in the 1950s 151–153 The the brain initially during cardiac surgery and subsequently after cardiac arrest. precise mechanism by which hypothermia confers protection is unknown, but results in experimental animals for both global and focal brain ischemia are consistent. In 2002, two randomized clinical trials both showed improved outcome after ventricular fibrillation with 154,155 In one trial of 275 patients, external cooling with a external cooling to 32° to 34°C. specialized blanket did not begin until after hospitalization at a median of 105 minutes from return 154 of spontaneous circulation, and the target temperature was achieved at a median of 8 hours. Hypothermia was continued for 24 hours with concomitant use of midazolam, fentanyl, and pancuronium. Cooling was associated with an increased percentage of patients discharged alive without severe neurological deficits, namely from 39 percent to 55 percent, for an absolute difference of 16 percent. In the other trial of 77 patients, external cooling was initiated in the field with paramedics applying cold packs and continued in the hospital, and target temperature was achieved by about 120 minutes after return of spontaneous 155 circulation. Hypothermia was continued for 12 hours with concomitant use of midazolam and vecuronium. Again cooling was associated with an increased percentage of patients discharged alive without severe neurological deficits, specifically from 26 to 49 percent, for an absolute difference of 23 percent. Experience in patients whose initial rhythms were asystole or pulseless electrical activity is limited. In one study of 33 such patients, external cooling with a specialized helmet did not begin until after hospitalization at a median of 102 minutes from return of spontaneous circulation, and the target temperature was achieved at a median of 154 180 minutes. Hypothermia was continued for 4 hours with concomitant use of midazolam, fentanyl, and pancuronium. Cooling was associated with an increased percentage of patients discharged alive without severe neurological deficits, from 0 percent to 19 percent, for an absolute difference of 19 percent. In a meta-analysis of these three studies, benefit was 156 substantial despite delays in each of these studies in achieving the target temperature. The estimated number needed to treat with cooling to yield one more person who would survive cardiac arrest without severe neurological deficits was 6, with a 95 percent confidence interval of 4 of 13 people. No serious side effects of cooling were identified, although the trend was for an increased risk of bleeding and sepsis with cooling. Also potassium150 can decrease, and glucose can increase with cooling, both deserving special attention. Although this and other evidence was deemed sufficient for therapeutic hypothermia after cardiac arrest to earn the approval of the Advancement Life Support Task Force of the 157 International158,159 Liaison Committee on Resuscitation, such treatment is still used A common excuse for not cooling patients is that it is technically too infrequently. difficult to accomplish. Several methods that go beyond external cooling have been explored to cool patients rapidly. Appealing for its simplicity and effectiveness is the rapid infusion of cold intravenous fluids. Results from three studies have been remarkably consistent with patients having low temperatures on admission after resuscitation from out-of-hospital cardiac arrest (35.5°, 35.4°, and 35.6°C) and having them drop substantially (1.7°, 1.7°, and 160–162 In two studies, the fluids were 1.8°C) after the infusion of cold intravenous fluids. 160,161 In two studies, 4°C lactated161 administered with a pressure bag over 20 to 30 minutes. 160,162 whereas in161,162 the other, 4°C normal saline was infused. Ringer's solution was infused, 160 In two studies the amount infused was 2 liters, and in the other, it was 30 ml/kg. All protocols included paralytic agents and sedatives. The infusions have been well tolerated without deterioration noted on clinical examination, blood tests, or echocardiogram. In these patients, hypothermia in the target range of 32° to 34°C was maintained for 12 to 24 hours using cooling blankets or a more complicated endovascular device, which allowed for easy
17 / 18
2009.01.05. 11:58
Aminoff: Neurology and General Medicine: Neurological Complicatio... 162
control 163 of temperature. control.
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
External cooling devices are also available that allow for easy
Given that 164–166 hypothermia may be more effective if achieved early after return of spontaneous intravenous infusion of cold fluids is also appealing for its ability to be circulation, initiated in the field in patients resuscitated from out-of-hospital cardiac arrest. Will cooling be more effective if initiated in the field rather than being delayed until after hospital admission? This question and many others remain unanswered. Will patients with initial rhythms other than ventricular fibrillation benefit from cooling? What is the best method to induce hypothermia? What is the optimal duration of cooling? What is the best protocol for rewarming? More randomized trials are needed to answer these and other questions about 87 brain resuscitation. A factorial design is particularly appealing, given the desire to alter more than one of the many proposed pathophysiological mechanisms. Decisions about artificial life-sustaining treatments should be standardized as much as possible in clinical trials and made without knowledge of randomized treatment status. Analyses should include comparison of randomized treatment groups for various outcomes, but especially death and awakening. The times of occurrence of death and awakening can easily be determined, and time-dependent analyses should be performed and presented (Fig. 9-4). VIEW TO THE FUTURE Brain damage after cardiac arrest is the result of an imperfect technology. Prior to the advent of cardiopulmonary resuscitation and especially electrical defibrillation, virtually all patients died after cardiac arrest. With the proliferation of in-hospital code teams and prehospital emergency medical systems, an increasing proportion of these patients are resuscitated. As a consequence, patients, families, and clinicians are faced with issues of brain damage after cardiac arrest. The ability to predict outcomes has improved but will never be perfect, a fact that should not prevent clinicians from working with families to make decisions about artificial life-sustaining treatments. Currently, induced hypothermia can improve neurological outcomes after cardiac arrest, but more needs to be learned about how best to employ this treatment. Given the increasing understanding of the brain's response to ischemia, reperfusion, and repair, other treatments should follow and become an integral part of brain-cardiopulmonary resuscitation. Such treatments will find immediate use in the thousands of patients who are resuscitated from cardiac arrest each year. In the meantime, and for all time, prevention of cardiac arrest and efficient cardiopulmonary resuscitation are essential. Previous
Next
Return to Previous Page
18 / 18
2009.01.05. 11:58
Aminoff: Neurology and General Medicine: Cardiac Manifestations of...
Return to Previous Page
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Print this page
This information has been developed and provided by an independent third party source. Merck & Co., Inc., does not endorse and is not responsible for the accuracy of the content, or for practices or standards of non-Merck sources. This resource may discuss regimens that have not been approved by the FDA. For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences please see the appropriate manufacturer's product circular. View Prescribing Information for Merck products.
Table of Contents This Chapter by Chapters
Keyword Index
Michael J. Aminoff
NEUROLOGY and GENERAL MEDICINE 10 Cardiac Manifestations of Acute Neurological Lesions NERISSA U. KO • JONATHAN G. ZAROFF •
Previous
Next
HISTORICAL PERSPECTIVE ISCHEMIC AND HEMORRHAGIC STROKE Anatomy and Physiology: The Insular Cortex The Electrocardiogram QT Prolongation Repolarization Abnormalities Q Waves and U Waves Cardiac Arrhythmias Cardiac Injury and Dysfunction Plasma Markers EPILEPSY AND OTHER NEUROLOGICAL disorders CARDIAC EVALUATION CLINICAL MANAGEMENT CONCLUDING COMMENTS
Cardiac abnormalities are common after acute neurological injury. Disturbances can range in severity from transient electrocardiographic (ECG) abnormalities to profound myocardial injury and dysfunction. Evidence from animal models and clinical observations indicate that the central nervous system (CNS) is involved in the generation of cardiac arrhythmias and dysfunction even in an otherwise normal myocardium. Many studies demonstrate how neurological lesions can influence cardiovascular function and affect cardiac prognosis. Recent evidence from patients with subarachnoid hemorrhage (SAH) also suggests an association with cardiac dysfunction and adverse neurological outcomes. A better understanding of cardiac abnormalities after acute neurological injury can improve the clinical management of patients and may also have important prognostic implications. This chapter briefly outlines the cardiac manifestations after acute neurological injury, summarizes the neurophysiology and neuroanatomy of cardiac control, and discusses the clinical implications and treatment recommendations for the most common cardiac complications. HISTORICAL PERSPECTIVE At the turn of the previous century, Cushing first described hemodynamic changes after acute
1 / 14
2009.01.05. 11:59
Aminoff: Neurology and General Medicine: Cardiac Manifestations of...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
1
intracerebral hemorrhage (ICH). Subsequent clinical observations began to identify the importance of the brain–heart interaction in patients with cerebral lesions. Cardiac abnormalities were described with various CNS diseases including seizures, trauma, ischemic stroke, and ICH and less commonly with tumors, electroconvulsive therapy, and 2 meningitis.3–5More recently, an emotion- and stress-induced cardiomyopathy has been described. To date, hemorrhagic and ischemic stroke remain the best described clinical models of neurocardiogenic injury. The anatomy and physiology of the pathways involved in brain–heart interactions have been elucidated in both animal and human studies. During World War I, a series of animal experiments were conducted to identify the cause of unexpected deaths of patients undergoing surgery with chloroform anesthesia. The frequent ventricular tachyarrhythmias that occurred in cats under light chloroform anesthesia could be aborted by cardiac sympathetic denervation. The ability to reproduce the arrhythmia by6,7activation of the sympathetic nervous system suggested a neurogenic mechanism. The medulla has been described as the principal site of vagal parasympathetic and 8,9 sympathetic areas involved in cardiac control. In addition, both anatomical and 10 physiological evidence exists to implicate the hypothalamus in cardiac control. Electrical stimulation experiments suggest a posteriorly located area of cardiovascular sympathetic 11 and colleagues first control and an anterior parasympathetic control region. Beattie 12 described cardiac arrhythmias after hypothalamic stimulation. Arrhythmias from 13,14 hypothalamic stimulation were subsequently confirmed in other animal models. Areas of the cerebral cortex with connections to the autonomic nervous system can also elicit cardiac responses. The autonomic-emotional interactions with cardiovascular function have 15,16 Stimulation of the orbitofrontal, been linked to the central nucleus of the amygdala. cingulate, and temporal regions can elicit a cardiac response, but with much less frequency 17–19 The majority of evidence suggests that compared to the hypothalamus and brainstem. the insular cortex has a pivotal role in integrating autonomic responses and is strongly associated with adverse cardiac events after neurological injury. ISCHEMIC AND HEMORRHAGIC STROKE Clinical observations in patients with stroke have greatly advanced the understanding of interactions between20the brain and heart. Cardiac abnormalities occur in 60 to 70 percent of patients after stroke. The most common disturbances include ECG abnormalities, cardiac arrhythmias, and myocardial injury and dysfunction. Distinguishing cardiac abnormalities directly caused by stroke, however, remains difficult because the prevalence of preexisting 21,22 However, cardiac disease is high, particularly among patients with ischemic stroke. substantial evidence exists supporting the occurrence of cardiac disturbances after stroke even in the absence of significant coronary artery disease (CAD). More importantly, cardiac disturbances are the most common cause of death after stroke, accounting for up to 6 23 percent of unexpected deaths during the first month. Understanding the mechanisms of cardiac disturbances may prevent future cardiac complications and improve survival in these patients.
Anatomy and Physiology: The Insular Cortex The insular cortex has widespread connectivity with other areas of the brain that are known to 24 be involved in autonomic control. Both experimental and clinical evidence strongly suggests a role for the insula in cardiovascular function. Oppenheimer and colleagues first identified the insular cortex in rats as a site from which lethal cardiac arrhythmias and myocardial damage could be produced, resembling changes seen in patients after stroke and sudden death in patients with epilepsy. These microstimulation experiments in the rat posterior insular cortex produced stereotyped ECG changes from progressive atrioventricular block leading to complete heart block, interventricular block, QT interval prolongation, ST segment depression, ventricular ectopy, and finally death in asystole. These ECG changes were directly correlated with pathological changes in the myocardium called myocytolysis that were 25 thought to be induced by excess activation of intrinsic cardiac sympathetic nerves. Animal models of stroke have provided further evidence of involvement of the insula in the autonomic regulation of the heart. In a rat model of cerebral ischemia, insular infarction was associated with increased renal sympathetic nerve activity, prolongation of the QT interval, 26,27 Pathologically, cardiac myocytolysis was and elevated norepinephrine levels. 28 demonstrated only if the insular cortex was involved. Furthermore, stroke involving the insular cortex in humans abolished the normal nocturnal decline in blood pressure, prolonged the corrected QT interval, increased ventricular tachyarrhythmias, and resulted in higher
2 / 14
2009.01.05. 11:59
Aminoff: Neurology and General Medicine: Cardiac Manifestations of...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
29
plasma norepinephrine levels. Clinical observational studies among stroke patients 31 also 30 loss of nocturnal vagal dominance, and suggest a loss of cardiac parasympathetic tone, 32 increased sympathetic tone. This evidence collectively supports the belief that stroke can alter cardiovascular tone by directly damaging the insular cortex or other interrelated areas and shifting the balance toward a predominance of sympathetic activation. Although there is considerable evidence suggesting lateralization of cardiac control in animal models, the clinical impact of the laterality of insular strokes in humans has proven to be more complicated. In a rat model comparing the effects of left and right middle cerebral artery occlusion on sympathetic tone, right-sided lesions were associated with elevated plasma norepinephrine levels and prolongation of the QT interval, whereas left-sided lesions led to 26 more hypotension during urethane anesthesia. With more selective posterior insular lesions, elevated baseline heart rate and blood pressure were noted after right-sided33injury, and significantly increased baroreflex sensitivity was observed after left-sided injury. Clinical observations and more recent systematic studies have addressed the effect of lateralization in humans. In patients undergoing temporal lobectomy for the control of intractable seizures, stimulation of either insula resulted in alterations of blood pressure and heart rate, but bradycardia and decreased blood pressure occurred with greater frequency from the left anterior insular34cortex, suggesting a greater sympathetic cardiovascular representation on the right. Similarly, stimulation of the right temporal lobe tip in a schizophrenic patient induced elevations in blood pressure that were greater than with 35 stimulation on the left. Other observations during infusion of amylobarbital during the Wada test describe tachycardia after left carotid infusion and bradycardia with right internal carotid 36 infusion. Collectively, these observations support a greater sympathetic cardiovascular representation on the right and greater parasympathetic regulation on the left. However, observational stroke studies in humans have reported conflicting results. An observational study of 62 acute stroke patients indicated an increased incidence of sudden 37 death among patients with right insular strokes. In addition, right middle cerebral artery strokes were associated with a significantly increased incidence of supraventricular 38 tachyarrhythmias compared with similar left-sided strokes. When anterior left insular lesions were specifically isolated, there was increased cardiac sympathetic and decreased cardiac 39 parasympathetic tone. In contrast, left parietoinsular stroke was associated with an increased incidence 40 of new-onset atrial fibrillation, often considered a parasympathetically derived abnormality. In a prospective study of patients with stroke and transient ischemic attacks (TIAs), left insular strokes were an41independent risk factor for adverse cardiac outcome in patients without heart disease. Similarly, in a secondary analysis of the North American Symptomatic Endarterectomy Trial (NASCET), 42 long-term risk of sudden death was significantly increased in patients with left brain infarction. These observations highlight the complex interactions of the insular cortex and other autonomic centers of the brain. The relative balance of excitatory and inhibitory pathways involved in cardiovascular control can vary with the state of arousal as well as with involvement of adjacent inhibitory pathways in the frontoparietal cortex. Evidence suggests that in humans, a stroke isolated to the left anterior insula or the right frontoparietal cortex 43 sparing the insula will have similar effects on cardiovascular outcomes.
The Electrocardiogram 44
ECG abnormalities are common, occurring in 92 percent of patients with acute stroke. In 1947, Byer and colleagues first described marked QT prolongation with large T and U waves 45 on the ECG of four patients with acute stroke. Subsequently, Burch and colleagues described an ECG pattern after acute stroke consisting of large inverted T waves, prolonged QT intervals, and large septal U waves that has become distinctive of cerebrovascular injury 46 (Fig. 10-1). In the 17 abnormal ECGs reported in their study, the abnormalities were most frequently observed after SAH, followed by ICH and ischemic lesions. These early studies did not control for the incidence of concomitant or preexisting ischemic cardiac disease, but subsequent case-control studies suggest that repolarization abnormalities on ECGs are not present prior to the stroke event. Overall, there was a significantly increased incidence of ST depression, prolongation of the QT interval, T-wave inversion, and ventricular premature beats among stroke patients compared to age- and sex-matched controls. Although patients with known cardiac disease were excluded, limitations of these studies were the lack of detailed cardiac evaluations and comparison to44,47,48 antecedent ECG tracings that may not have completely excluded coexistent heart disease.
3 / 14
2009.01.05. 11:59
Aminoff: Neurology and General Medicine: Cardiac Manifestations of...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 10-1 Typical “neurogenic” electrocardiographic (ECG) changes with symmetric
deep T-wave inversions in a patient with acute subarachnoid hemorrhage. These abnormalities were transient and not associated with myocardial infarction. QT Prolongation The most common stroke-related ECG abnormality is QT prolongation, a myocardial repolarization abnormality associated with an increased risk of a characteristic 49 life-threatening cardiac arrhythmia, known as torsade de pointes (Fig. 10-2). Interestingly, congenital forms of long QT may be related to imbalance of sympathetic innervation of the 50 heart. Among acute stroke patients, prolonged QT interval is more frequently observed after hemorrhagic strokes, occurring in 45 to 7144,47,51,52 percent of patients with SAH or ICH compared to Ventricular tachyarrhythmias including 38 percent of those with ischemic strokes. sudden death and torsade de pointes are often preceded by QT prolongation in patients with 51,53 QT prolongation, accompanied by U waves and T-wave changes, often correlates SAH. 44,51 Assessment of common causes of with elevated systolic blood pressure on admission. acquired QT abnormalities accompanied by U waves and T-wave changes, such as hypokalemia, hypomagnesemia, and medication toxicity, is recommended before attributing these changes to the underlying stroke.
FIGURE 10-2 ECG changes can precede pathological arrhythmias in patients with
severe neurological injuries. A, Prolongation of the QT interval is common after subarachnoid hemorrhage. Electrolyte abnormalities or medications can also prolong the QT interval. B, Torsade de pointes is a polymorphic ventricular tachycardia associated with QT prolongation. (Courtesy of Byron Lee, MD, University of California, San Francisco.)
4 / 14
2009.01.05. 11:59
Aminoff: Neurology and General Medicine: Cardiac Manifestations of...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Repolarization Abnormalities The similarities between ECG changes due to acute myocardial ischemia and infarction and those associated with stroke are most striking with the repolarization abnormalities involving the ST segment, leading many investigators to hypothesize coexisting cardiac disease as the primary cause. ST segment changes (including ST elevations) occur in 22 to 35 percent of patients with ischemic stroke, which is complicated by the increased prevalence of cardiac 48,54 However, new T-wave abnormalities appear disease in this subgroup of stroke patients. in approximately 15 percent of patients with acute stroke, even in the absence of electrolyte 48 disturbances or primary ischemic heart disease. Inverted or flat T waves have also been reported in up to 55 percent of patients with SAH, the stroke subgroup with the lowest 55,56 More direct evidence comes from an autopsy prevalence of coexistent cardiac disease. study of five patients with ECG changes who57died after SAH. None of the autopsied patients had evidence of epicardial coronary disease. Kono and colleagues performed detailed cardiac assessments on 12 patients with acute SAH and ST elevations on the ECG. Although patients were found to have apical wall motion abnormalities on the echocardiogram, there 58 was no evidence of coronary artery stenosis or vasospasm on cardiac angiography. These findings, along with the observation that stroke-induced ECG changes are evanescent, resolving over a period of days to months with little residuum, argue against myocardial ischemia or infarction as the only cause of repolarization changes on ECG. Q Waves and U Waves New Q waves similar in morphology to those observed in acute myocardial infarction are also common after acute stroke, reported in approximately 10 percent of patients with acute 47,52 To complicate matters, Q waves may be transient or ischemic or hemorrhagic stroke. 44,48 Further cardiac proceed through the evolutionary changes seen in myocardial infarction. evaluation may be necessary in patients with Q waves and ST segment alterations, particularly if they are older than 65 years with coronary risk factors such as diabetes 59 mellitus. New U waves occur in isolation or with T waves and QT abnormalities in approximately 13 to 44,60 Isolated U waves were 15 percent of patients with acute ischemic stroke and SAH. equally distributed between ischemic and hemorrhagic strokes, but the combination of U 44 waves and QT prolongation was more common among patients with hemorrhagic strokes. There is no relationship between the presence of U waves and stroke mortality, suggesting that this ECG change should not require any specific treatment or evaluation.
Cardiac Arrhythmias Nearly every type of cardiac arrhythmia has been reported after acute stroke including bradycardia, supraventricular tachycardia, atrial flutter, atrial fibrillation, ectopic ventricular beats, multifocal ventricular tachycardias, torsade de pointes, ventricular flutter, and ventricular fibrillation. Most arrhythmias occur within the first week after stroke, occurring in 25 to 61,62 40 percent of patients with ischemic stroke or ICH, and 98 percent of patients with In retrospective case-control studies of the ECG after acute stroke, the most SAH. common arrhythmia was atrial fibrillation (14% to 21%), followed by ventricular arrhythmias 44,47 40 Transient atrial fibrillation is much more common after ischemic stroke. (5% to 13%). Without controlling for preexisting cardiac disease in these studies, rhythm disturbances may have preceded the stroke event and, in the setting of atrial fibrillation, may be causally related to the ischemic stroke. Not surprising, because the ECG is a relatively insensitive test for arrhythmia, a prospective study of ischemic stroke patients with cardiac telemetry monitoring found a higher incidence of ventricular extrasystoles, followed by atrial extrasystoles, 59 supraventricular tachycardia, and atrial fibrillation. In similar studies of hemorrhagic strokes, the incidence of ventricular arrhythmias was 10 63 percent after ICH. Location of hemorrhage appears to correlate with the rhythm disturbances. Yamour and colleagues52reported a correlation between the occurrence of brainstem bleeds and atrial fibrillation. Ventricular arrhythmias correlated with temporoparietal location, whereas sinus bradycardia and supraventricular tachycardias were seen more commonly with traumatic frontal lobe hemorrhage. Patients with SAH have even more profound rhythm disturbances that may be related to the diffuse nature of the injury and the degree of monitoring in the intensive care unit. Stober and associates described multifocal ventricular ectopy (54%), asystolic intervals (27%), sinus 64 bradycardia (23%), and atrial fibrillation (4%). Because the frequency and severity of 53,65,66 we arrhythmias are significantly higher in patients studied within 48 hours of SAH onset,
5 / 14
2009.01.05. 11:59
Aminoff: Neurology and General Medicine: Cardiac Manifestations of...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
recommend continuous cardiac monitoring in an intensive care setting for all patients with acute SAH. In one study of monitored patients, rhythm disturbances occurred in one third of patients, including asystole55and ventricular fibrillation, with 5 percent of patients suffering a life-threatening arrhythmia. In addition, torsade de pointes, a polymorphic ventricular 67,68 tachyarrhythmia that is difficult to treat, was detected in about 4 percent of SAH patients. Unlike ischemic stroke, a significant proportion of patients with SAH have normal cardiac function even though they have the highest incidence of cardiac arrhythmias. Increasing evidence supports a catecholamine-mediated myocardial injury after SAH. As previously described, the type and location of the stroke can determine the type of arrhythmia, with vasodepressor effects more common with injury to the right insula and tachycardia and 26,37,38 However, even a hypertension more common with injury of the left insular region. diffuse neurological injury like SAH can influence cardiac function and generate cardiac arrhythmias. After SAH, the most common ECG change is QT prolongation that often precedes pathological arrhythmias. More importantly, the 69 presence of arrhythmias after stroke is significantly associated with increased mortality.
Cardiac Injury and Dysfunction Evidence from autopsy series in both ischemic and hemorrhagic stroke indicate that cardiac 57,70,71 When myocardial tissue injury dysfunction can occur in the absence of underlying CAD. is present, suspicion of underlying cardiac disease increases, but pathological and functional studies of the heart suggest a mechanism distinct from coronary artery–induced ischemia. Subendocardial hemorrhages were initially described in patients dying after acute strokes and seizures. Further studies suggested that these pathological changes were secondary to 72–75 Offerhaus and Van Gool showed convincingly that 76 excessive sympathetic stimulation. following intracranial hemorrhage, there was an increase in cardiac tissue catecholamines. A broader description of these catecholamine-induced subendocardial lesions included scattered foci of swollen myocytes surrounded by infiltrating monocytes, interstitial 77 hemorrhages, and myofibrillar degeneration. Collectively, the characteristic pathological changes have been called contraction band necrosis, coagulative myocytolysis, or myofibrillar degeneration (Fig. 10-3). The pattern of myofibrillar necrosis localizing near cardiac nerves is identical to other lesions thought to be of sympathetic origin such as catecholamine infusion, “voodoo death,” hypothalamic stimulation, or reperfusion of transiently ischemic cardiac 78 muscle. In patients with CAD, myocardial necrosis typically follows a vascular distribution. The timing of the injury is also distinct from the necrosis seen in CAD, which typically occurs in a delayed fashion after progressive ischemia and muscle cell death. Neurogenic myocardial injury can be visible within minutes of onset, with appreciable differences observed on a cellular level. In myocytolysis, mononuclear infiltration predominates, 78 with early calcification, and myocardial cells in a hypercontracted state with contraction bands.
6 / 14
2009.01.05. 11:59
Aminoff: Neurology and General Medicine: Cardiac Manifestations of...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 10-3 A representative cross section of myocardium after
hematoxylin–eosin stain showing marked myocyte hypertrophy with nucleomegaly and myocytolysis. (Courtesy of Philip Ursell, MD, University of California, San Francisco.) Further evidence of a neurogenic mechanism of cardiac injury comes from studies of cardiac function after SAH, which typically affects younger patients without a history of coexistent cardiac disease. Global or regional left ventricular systolic dysfunction on echocardiogram 58,79,80 The has been described after SAH with an approximate incidence of 10 to 28 percent. severity of neurological injury is strongly associated with the presence of left ventricular 81 dysfunction. Similarly, diastolic dysfunction is also common after SAH, is associated with the severity of neurological injury, and may be the cause of pulmonary edema seen in83,84 these 82 In patients. The onset of left ventricular dysfunction occurs early in the course of SAH. the largest study to date, a regional wall motion abnormality was most likely to be present 84 within the first 2 days. The prevalence then declined during days 3 to 8 after hemorrhage. In this same study, the authors demonstrated complete or partial resolution of left ventricular dysfunction in the majority of patients during the acute hospitalization. Cardiac dysfunction 85–88 appears to be reversible in most cases and normalizes over time. There is a well-demonstrated, unique, apical-sparing pattern of regional wall motion abnormality that differentiates SAH patients from those with the typical patterns seen in CAD. The most frequently affected segments are the basal and mid-ventricular portions of the anteroseptal and anterior walls and the mid-ventricular portions of the inferoseptal and 84,89 A retrospective study of SAH patients demonstrated reversibility and anterolateral walls. both global and regional left ventricular dysfunction,90most commonly affecting the anterior and anteroseptal walls that do not involve the apex. 91Younger age and anterior aneurysm position were independent predictors of this pattern. This apical-sparing pattern of left
7 / 14
2009.01.05. 11:59
Aminoff: Neurology and General Medicine: Cardiac Manifestations of...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
ventricular dysfunction argues against an obstruction or vasospasm of coronary arteries and provides indirect evidence of neurally mediated mechanism of injury. Experimental and clinical studies have addressed a neurogenic catecholamine-mediated 92–95 In a cohort of mechanism of injury or “catecholamine hypothesis” of cardiac dysfunction. patients with SAH, we found an association between regions of contractile dysfunction and abnormalities in myocardial sympathetic innervation while demonstrating normal cardiac perfusion. We measured the degree of cardiac innervation with a scintigraphic evaluation 123 ([99m I]metaiodobenzylguanidine or MIBG), cardiac perfusion (using [ Tc]sesta-methoxyisobutylisonitrile or MIBI) and regions of myocardial dysfunction with echocardiography simultaneously in SAH patients. Patients with functional cardiac denervation had worse regional wall motion scores (RWMS) and more troponin release than patients without evidence of cardiac denervation (Table 10-1). Figure 10-4 illustrates normal perfusion and global denervation in an SAH patient whose echocardiogram showed global left ventricular systolic dysfunction. All study subjects had normal perfusion imaging, 89 excluding significant CAD and supporting a neurogenic mechanism of cardiac injury. In addition, recent data suggest that genetic polymorphisms of the adrenoceptors are 96 associated with an increased risk of cardiac abnormalities after SAH. These data support the hypothesis that cardiac dysfunction after SAH is a form of neurocardiogenic injury. Click here to view this table....
FIGURE 10-4 Normal myocardial innervation (A) and perfusion (B) in a 71-year-old man with subarachnoid hemorrhage. Global functional denervation (C) and normal perfusion, except for a nonspecific apical irregularity (D), in a 41-year-old woman with subarachnoid hemorrhage. (From Banki NM, Kopelnik A, Dae MW, et al: Acute neurocardiogenic injury after subarachnoid hemorrhage. Circulation 112:3314, 2005, with permission.)
8 / 14
2009.01.05. 11:59
Aminoff: Neurology and General Medicine: Cardiac Manifestations of...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Plasma Markers In addition to pathological data and measurements of cardiac function, elevations in cardiac enzymes provide evidence of myocardial injury after stroke. Creatine kinase (CK) and specifically the cardiac isoenzyme CK- MB are released from damaged myocardium. Elevated serum levels are seen in 10 to 45 percent of stroke patients, and there is a good correlation between elevation in CK-MB and stroke-induced ECG changes or cardiac 62 arrhythmias. Unlike acute myocardial infarction, a stroke-induced increase in serum CK-MB levels occurs more slowly and peaks at a much lower value at approximately day 4 after a 97 stroke. Elevated serum CK levels have been associated with increased mortality after stroke, but unfractionated CK levels are not specific for myocardial injury and we cannot accurately attribute the increased mortality to cardiac injury in these studies. Cardiac troponin I is a specific and more sensitive marker of myocardial damage. Elevations 98–100 The degree in troponin I have been described in 20 to 25 percent of patients with SAH. of neurological injury and female gender are strong predictors of myocardial necrosis after 100 SAH (Table 10-2). Acute troponin I elevation after SAH is associated with ECG abnormalities, left ventricular dysfunction, pulmonary edema, hypotension, and delayed 101 cerebral ischemia from vasospasm. Peak troponin I levels were associated with increased mortality and poor functional outcome at hospital discharge, providing more direct evidence of the role of cardiac injury in adverse outcomes. Click here to view this table.... Serum B-type natriuretic peptide is often used as a marker of heart failure. Elevated B-type natriuretic peptide levels after SAH have been independently associated with hyponatremia, 102 delayed ischemic neurologi cal deficits, and poor Glasgow Coma Scale score at 2 weeks. In our prospective study, we found that elevated levels were significantly correlated with systolic and diastolic dysfunction, pulmonary edema, elevated troponin I levels, and lower cardiac ejection fractions (Fig. 10-5). The predominance of cardiac abnormalities similar to heart failure suggests that although B-type103natriuretic peptide is found in heart and brain, elevated levels are likely of cardiac origin. Moreover, elevated troponin I and B-type natriuretic peptide levels are independent and strong predictors of inpatient mortality after 104 SAH. These data provide additional evidence that the degree of myocardial injury has significant implications for prognosis in these patients.
FIGURE 10-5 Plasma B-type natriuretic peptide (BNP) levels and cardiac outcomes. The
column height indicates the mean BNP level, and the error bars indicate 95 percent confidence intervals. Probability values indicate results of Wilcoxon rank-sum tests. cTi, cardiac troponin I more than 1.0 μg/L; EF, left ventricular ejection fraction less than 50 percent; RWMA, regional wall motion abnormality. (From Tung PP, Olmsted E, Kopelnik A, et al: Plasma B-type natriuretic peptide levels are associated with early
9 / 14
2009.01.05. 11:59
Aminoff: Neurology and General Medicine: Cardiac Manifestations of...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
cardiac dysfunction after subarachnoid hemorrhage. Stroke 36:1567, 2005, with permission.) EPILEPSY AND OTHER NEUROLOGICAL disorders Similar cardiac arrhythmias and ECG findings have been described in patients with epilepsy, brain tumors, head trauma, meningitis, multiple sclerosis, and spinal lesions. In all cases, a common mechanism of neurogenic cardiac injury is supported by increased sympathetic nervous system discharge, increased adrenomedullary catecholamine production, and 105 reduced parasympathetic activity. In studies of intensive cardiac monitoring after severe closed head injury, the hyperdynamic cardiac state was correlated with increased arterial 106 levels of epinephrine and norepinephrine. Autopsy case reports in young patients who died suddenly of seizures and brain tumors describe cardiac pathology identical to myocardial 43 injury from excessive sympathetic activation and catecholamine infusion. Clinical observations as well as experimental work also suggest that sympathetic activation may be important in the pathogenesis of cardiac arrhythmia and sudden death in epilepsy, which is another well-studied model of brain–heart interactions. Experimental evidence from animal models of epilepsy has elucidated the mechanism by which cortical activity can lead to cardiac arrhythmia and death. Lathers and colleagues were able to induce cortical spike activity while recording from107,108 the cardiac vagus nerve and from In their cat model of epilepsy, two different branches of the cardiac sympathetic nerve. they described ECG changes similar to those found in clinical observational studies. Their most significant finding, however, was an increase in cardiac arrhythmias that corresponded with desynchronization of firing between the vagus and sympathetic nerves and with an increase in ictal cortical discharges. With sustained cortical activity, the animals died either in asystole or in ventricular fibrillation. Furthermore, electrical stimulation studies in both animals and humans have provided direct evidence of cardiac autonomic activation from specific 34 regions of the insula. Clinical observations and more recent controlled studies of patients with epilepsy also support neurocardiogenic mechanisms of injury. More importantly, advances in cardiac monitoring have enabled better prospective studies of the changes in heart rate accompanying seizures to better understand the phenomenon of sudden unexpected death in epileptic patients. Sinus tachycardia and ECG changes are commonly associated with seizures. In studies using simultaneous ambulatory electroencephalographic (EEG)/ECG monitoring, sinus tachycardia occurring at the time of the seizure was seen in 90 percent of patients. Cardiac arrhythmias were identified in 52 percent of all seizures and most frequently comprised a marked beat-to-beat variation in the R-R interval accompanied by changes in P-wave shape. 109,110 Of note, interictal ECGs Sinus bradycardia or asystole was rare, seen in 0.5 percent. were often normal in these patients. Ambulatory ECG studies suggest that there is more sympathetic tone during seizures and 109 that no significant cardiac disturbances occur during the interictal period. However, measurements of cardiac innervation suggest baseline dysfunction in cardiac sympathetic 111 innervation in patients with chronic temporal lobe epilepsy. In 22 subjects with chronic temporal lobe epilepsy, there was a significantly lower cardiac MIBG uptake and greater heart rate variability compared to controls. All subjects had MIBI with normal myocardial perfusion. These results suggest an increase in parasympathetic activity during the interictal period. Increased parasympathetic activity has been described previously, affecting variation in blood 112 pressure and heart rate after sympathetic challenge. Ictal bradycardia and asystole were considered rare,113,114 with only two cases of sinus arrest Long-term cardiac monitoring using associated with the ictus reported in earlier studies. implantable loop recorders, however, suggests that bradyarrhythmias may be more common. Sinus tachycardia remained the most common abnormality seen in all patients. Of the 20 patients with focal epilepsy monitored over a 2-year period, more than one third had ictal bradycardia,115 and more than one half required pacemaker insertion for clinically significant arrhythmias. The association of these pathological arrhythmias with seizures has important implications for understanding the mechanisms of sudden unexpected death in epilepsy. Epilepsy is associated with an increased mortality rate compared to the general population, 116–118 The and approximately one half of seizure-related deaths are sudden and unexplained. incidence of119 sudden unexpected death in epilepsy has been estimated at between 0.05 and 0.2 percent. Risk factors for sudden unexpected death include increased seizure frequency, generalized seizures, younger age, lower concentration 118–120 of antiepileptic The etiology for medications, use of multiple medications, and duration of epilepsy. sudden death in these patients remains elusive. Cardiac arrhythmia is a potentially treatable
10 / 14
2009.01.05. 11:59
Aminoff: Neurology and General Medicine: Cardiac Manifestations of...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
cause of sudden death, but direct evidence of increased mortality with ictal arrhythmias is lacking. Recent studies have focused on ictal bradyarrhythmias and asystole as well as 121 interictal heart rate variability that may represent high risk of sudden death. Improvements in cardiac monitoring and early intervention with cardiac pacing could improve outcomes if arrhythmias are found to be a significant risk factor for sudden death. CARDIAC EVALUATION Despite the growing evidence of neurocardiogenic mechanisms for cardiac injury after acute neurological insults, proper evaluation of cardiac injury and dysfunction remains important for both cardiac and neurological prognosis. Ischemic stroke patients, in particular, are more 22 likely to have concomitant significant CAD. A strong association between cerebrovascular disease and CAD has been established in a number of clinical studies. In the longitudinal Framingham study, similar risk factors predicted both stroke and heart disease. The presence of carotid atherosclerosis had similar rates of cerebral and cardiac ischemic events 122 (annual rates of 6% and 7%, respectively). After transient ischemic attacks, the risks of myocardial infarction and sudden death (21%) and stroke (23%) were similar, but cardiac 123 events were more likely to be fatal (63%) than stroke (16%). Coronary angiography of stroke patients identified that 40 percent had significant narrowing of their coronary arteries 124 that was asymptomatic at the time of stroke presentation. Using functional testing with thallium stress imaging, significant 21 CAD was present in 45 to 60 percent of patients with transient ischemic attack or stroke. Given the higher probability of CAD, several diagnostic evaluations are recommended in the acute period for all patients with ischemic stroke including an echocardiogram and serum troponin I levels. Further functional testing with echocardiography and continuous cardiac monitoring are often initiated to determine the risk of cardiogenic source of embolic ischemic strokes. Exercise or pharmacological stress test (nuclear or echocardiographic) and coronary angiography should be performed based on the patient's risk level and functional status. The majority of patients with acute stroke would not be eligible for acute treatments for myocardial infarction, but coronary angiography may be indicated if there is a strong clinical suspicion of plaque rupture or thrombus formation that may be safely treated endovascularly. As previously described, distinguishing cardiogenic from neurogenic causes of myocardial injury can be problematic in this patient population. Integration of clinical signs of heart failure, such as cardiogenic pulmonary edema and hypotension, careful analysis of the ECG, assessment of cardiac function by echocardiography, and evaluation of myocardial necrosis by cardiac markers may help to determine the need for cardiac catheterization. The CK-MB levels are insensitive and should not be used for differentiation between neurogenic injury and cardiogenic injury. A large increase in serum troponin I levels with a significant temporal trend, along with ECG changes that correlate with the location of left ventricular systolic 125 dysfunction on the echocardiogram may be more helpful. In contrast, common “neurogenic” ECG changes, including T-wave inversion, QTc prolongation, a shorter PR interval, and the presence of U waves, may aid in differentiating neurogenic injury from 126 myocardial infarction. In hemorrhagic strokes, the frequency of cardiac arrhythmias is high and often correlates with ECG changes. Baseline ECG and continuous cardiac monitoring in this population are often performed in the intensive care unit. Patients with SAH pose a greater challenge when the complication of cerebral vasospasm arises. The typical management of these patients includes induced hypertension with pressors, hypervolemia, and hemodilution to improve 127–130 The reduction of cardiac output from cerebral blood-flow through narrowed vasculature. normally elevated levels may increase the risk of cerebral ischemia related to vasospasm and 131 increase the risk of cardiopulmonary complications. SAH patients could potentially benefit from measurement of serum troponin I and B-type natriuretic peptide levels as well as transthoracic echocardiography as part of their initial management. Moreover, a close independent relationship has been established between the severity of SAH and the probability of troponin release and could be used to anticipate greater risk of cardiac 100 abnormalities in these patients. We do not recommend coronary angiography after SAH because most patients with left ventricular dysfunction following an SAH who undergo cardiac catheterization have normal epicardial coronary arteries and no evidence of coronary 58 vasospasm. For patients with epilepsy, sudden unexpected death is the most feared complication. Growing evidence suggests that neurogenic cardiac arrhythmias may contribute to the risk of sudden death. Identifying patients at highest risk of sudden death has been challenging. In addition to identifying clinical risk factors and promoting better medication compliance, advanced cardiac monitoring with ambulatory ECG and long-term implantable loop recorders 115 could help identify patients with pathological arrhythmias. In addition, other methods for
11 / 14
2009.01.05. 11:59
Aminoff: Neurology and General Medicine: Cardiac Manifestations of...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
measuring cardiac autonomic input such as heart rate variability and spectral analysis could 132 be potentially useful. CLINICAL MANAGEMENT After identification of the common cardiac abnormalities, management should be initiated to prevent their detrimental effect on patient outcomes. The most common ECG changes generally do62not require specific treatment, but may prompt further testing and continuous monitoring. Identification of other causes or contributors to ECG changes can lead to rapid resolution. In particular, specific treatment of hypokalemia, hypomagnesemia, and medication toxicity may correct a prolonged QT interval. Antiarrhythmic (e.g., quinidine, sotalol, amiodarone) or antipsychotic (e.g., haloperidol) drugs known to affect the QT interval should be avoided in these patients, especially if their neurological injury exacerbates underlying hereditary long QT syndrome. When repolarization abnormalities occur, excluding acute myocardial infarction may be necessary. Common electrolyte abnormalities such as hyperkalemia can produce tall T waves, whereas hypokalemia is the most common cause of U waves. Correction of electrolyte abnormalities can reduce the risk of arrhythmias. It is important to recognize that cardiac rhythm disturbances after neurological injury can be complex, requiring cardiology consultation. The most important aim is to identify patients who may be hemodynamically unstable in the presence of an arrhythmia. This is a medical emergency and should be managed immediately by appropriate personnel in the intensive care unit, with the involvement of a cardiac team. In a stable asymptomatic patient, identifying the type of arrhythmia can guide management. Atrial or ventricular premature contractions generally do not require specific treatment. For sinus bradycardia or tachycardia, identification and treatment of the common underlying conditions such as fever, thyroid dysfunction, anemia, pain, sepsis, and anxiety will often correct the rhythm disturbance. Specific pharmacological treatment may be required if the patient develops stable tachyarrhythmias. A trial of adenosine can terminate supraventricular tachycardia and assist in determining the underlying rhythm disturbance. Rate control with an intravenous β-blocker, calcium-channel blocker, or amiodarone can be used in patients with atrial fibrillation or flutter, most common after ischemic stroke and ICH. Stable ventricular tachyarrhythmias can also be managed with intravenous amiodarone or lidocaine. Specific treatment of torsade de pointes includes intravenous magnesium. Any arrhythmia more complex than ectopic beats or sinus bradycardia or tachycardia should prompt a cardiology consultation. When more significant cardiac dysfunction or injury is identified from elevated serum markers or dysfunction on the ECG, several steps can be taken to improve cardiac prognosis. If CAD is present, management of atherosclerosis risk factors (diabetes, hyperlipidemia, hypertension, and smoking) and treatment with antiplatelet agents and lipid-lowering agents may help both the ischemic stroke and heart disease. β-Blockers reduce the risk of vascular events after myocardial infarction, but their role in the prevention of cardiac events in other high-risk patients with stroke is unclear. Finally, revascularization by angioplasty or coronary artery bypass grafting is beneficial for patients with symptomatic CAD, but the decision to treat must balance the risk to the patient with an acute neurological injury. The value of 22 revascularization in patients with asymptomatic CAD is less clear. In the rare event of coronary plaque rupture in a patient with SAH, coronary angioplasty along with stenting may be considered once the aneurysm is secured and the necessary anticoagulation regimen can be tolerated safely. Although further studies are needed to determine the safety of percutaneous coronary intervention and anticoagulation after successful aneurysmal intervention, patients with unsecured aneurysms should not undergo any coronary intervention given the unacceptably high risk of rebleeding. In SAH patients, the presence of cardiac injury and dysfunction often directly affects management. The decision to treat a ruptured aneurysm should not be delayed because of concerns regarding cardiac injury. Because the mechanism of neurogenic cardiac injury is likely catecholamine mediated, treatment should focus on correcting or improving the underlying neurological process. For patients with SAH, prevention of rebleeding with early aneurysm clipping or endovascular coiling has proven benefit and does not appear to affect cardiac outcomes. In our patient cohort, there was no significant difference in cardiac 133 morbidity between surgical and endovascular therapies. Management of cerebral vasospasm in the setting of significant neurocardiogenic injury is challenging and directly affects neurological prognosis. Permissive hypertension requiring pressors to improve cerebral blood-flow often leads to increased myocardial wall stress and oxygen consumption, whereas hemodilution will decrease oxygen delivery to the myocardium, predisposing to further injury. Although most patients tolerate treatment for
12 / 14
2009.01.05. 11:59
Aminoff: Neurology and General Medicine: Cardiac Manifestations of...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
cerebral vasospasm, our recent study found that phenylephrine, the most commonly used 104 pressor, is relatively ineffective in patients with a poor cardiac ejection fraction. Other studies have also suggested the use of alternative agents such as dobutamine and milrinone, 134 which may be more effective in this setting. In those patients with diastolic dysfunction, iatrogenic hypervolemia may cause increased filling pressures leading to pulmonary edema. We recommend continued aggressive therapy for vasospasm, but consider more effective pressors and volume repletion strategies in patients with concomitant cardiogenic injury. In patients with severe neurogenic cardiac injury and evidence of heart failure who are unable to tolerate medical therapy for vasospasm, placement of an intra-aortic balloon pump to 85,135,136 increase cerebral perfusion pressure has been successful. Given the potential role of excessive catecholamines in neurocardiogenic injury, β-blockers may have a role in providing cardioprotection if administered early in the hospital course. Limited evidence from two small studies has demonstrated clinical efficacy. The first study demonstrated resolution of abnormal ECG changes associated with SAH after administration 126 of 80 mg propranolol. The second study was a randomized, double-blind, placebo-controlled trial of 12 patients comparing propranolol (80 mg) and 20 mg 137 phentolamine (20 mg) with placebo given within the first 48 hours. Although there was no mortality benefit in the treatment group, necrotic myocardial lesions were present in all six patients who died in the placebo group, whereas the six patients who died in the treatment group had no necrotic myocardial lesions. The pathological correlation suggests that β-blockade may protect myocytes from the hostile environment caused by massive levels of catecholamines released from cardiac sympathetic nerve terminals following SAH. Larger studies will help to determine the role of early administration of β-blockers in patients with cardiac dysfunction following SAH. Calcium-channel blockers targeting the calcium overload preceding contraction band necrosis has not been well studied. There does not appear to be a significant cardiac benefit from nimodipine, the calcium-channel blocker already administered to patients for vasospasm prophylaxis. CONCLUDING COMMENTS Cardiac disturbances are diverse and frequent in the setting of acute neurological injury. More importantly, the presence of cardiac abnormalities has significant impact on clinical management and affects cardiac and neurological outcomes adversely. Understanding of the underlying pathophysiology and localization of the important autonomic regulatory centers involved in brain–heart interactions has progressed significantly in recent years. Animal models have been translated into important clinical research studies that have revealed further complexity in the brain regulation of cardiac function. It is widely accepted that acute brain injuries most often lead to an increase in sympathetic tone, leading to a potential role for β-blockade in these patients. Understanding certain aspects of neurocardiogenic injury has already affected clinical management. Early detection of asymptomatic CAD in ischemic stroke patients will likely improve outcomes. Prioritizing treatment of the underlying neurological condition, even in the setting of cardiac dysfunction, has led to timely aneurysm treatment after SAH and prevention of rebleeding. Close cardiac monitoring for cardiac arrhythmias after acute injuries and screening for elevated serum levels of cardiac enzymes and for echocardiographic abnormalities in high-risk patients may lead to better treatment strategies. The knowledge that the cardiac injury that occurs following SAH appears to be reversible will likely prevent unnecessary invasive testing for CAD. Echocardiography and screening for elevated troponin and B-type natriuretic peptide levels may help prognosticate and guide treatment of stroke and optimize treatment of vasospasm after SAH. In most cases, treatment of cardiac injury should be supportive. β-blockers may provide cardioprotection from the hyperadrenergic milieu around myocytes but to date have no proven mortality benefit. Improved diagnostic techniques with ECG spectral analysis should help to detect the effect of the parasympathetic and sympathetic nervous systems on the heart. These techniques may help to identify patients with epilepsy at risk of cardiac arrhythmias and sudden death. Improved biomarker assays and screening for genetic susceptibility for neurocardiogenic injury will eventually be possible. Last, for brain-dead patients, cardiac evaluation under optimal conditions may help to increase the organ donor pool. According to the United Network for Organ Sharing, in 1998 138 only 42 percent of potential donor hearts were transplanted. One main reason for this low yield was left ventricular dysfunction; in 1995,139 918 of 2,199 potential donor hearts were unused because of poor ventricular function. Current guidelines help to determine which donor hearts will have the greatest success and recommend careful evaluation and assessment of cardiac anatomy and systolic function by echocardiography and cardiac
13 / 14
2009.01.05. 11:59
Aminoff: Neurology and General Medicine: Cardiac Manifestations of...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp 140
catheterization in patients who are at higher risk of CAD. Because it is likely that left ventricular dysfunction following SAH is reversible and unrelated to CAD, initial cardiac evaluation that is obtained under suboptimal conditions may not be an accurate reflection of long-term contractile function of the left ventricle. One study demonstrated that donor hearts with left ventricular dysfunction defined by hemodynamic criteria could be functionally resuscitated in 92 percent of cases, resulting in a 30 percent increase in donor-retrieval 141 rate. Proposed guidelines that suggest evaluation during optimized conditions and more liberal criteria for cardiac catheterization, among other changes in recommendations, are being established to help increase the donor pool without compromising success following 140 transplantation. Previous
Next
Return to Previous Page
14 / 14
2009.01.05. 11:59
Aminoff: Neurology and General Medicine: Neurocutaneous Syndrome...
Return to Previous Page
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Print this page
This information has been developed and provided by an independent third party source. Merck & Co., Inc., does not endorse and is not responsible for the accuracy of the content, or for practices or standards of non-Merck sources. This resource may discuss regimens that have not been approved by the FDA. For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences please see the appropriate manufacturer's product circular. View Prescribing Information for Merck products.
Table of Contents This Chapter by Chapters
Keyword Index
Michael J. Aminoff
NEUROLOGY and GENERAL MEDICINE 11 Neurocutaneous Syndromes BRUCE O. BERG •
Previous
Next
NEUROFIBROMATOSIS TUBEROUS SCLEROSIS VON HIPPEL–LINDAU DISEASE STURGE–WEBER SYNDROME ATAXIA-TELANGIECTASIA
The diseases usually considered in the category of neurocutaneous syndromes are characterized by their dysplastic nature and tendency to form tumors. Although the skin and central nervous system (CNS) are primarily affected, other organ systems may be involved. Several of the diseases in this group were described during the nineteenth century, but in 1914 Bielschowsky first associated neurofibromatosis and tuberous sclerosis because of 1,2 their dysplastic and neoplastic features. In describing the ocular findings in these two diseases, Van Der Hoeve suggested the neologism phakomatosis (Gr. phakos, lentil, mole, birthmark)—an inappropriate term—to epitomize these diseases; he later added von 3–5 Hippel–Lindau disease and Sturge–Weber syndrome to this group. In 1941, Louis-Bar reported the clinical features of a syndrome now recognized as ataxia-telangiectasia and 6 suggested that it too belonged in this disease category. During the last several decades, a variety of other disorders, all unusual and some lacking the typical features of the neurocutaneous syndromes, have been added to the group. Some of them are summarized in Table 11-1. The five most important syndromes are discussed in detail in this chapter. Click here to view this table.... Except for Sturge–Weber syndrome, these major neurocutaneous syndromes are genetically determined, although sporadic cases can occur. They are distinct clinical entities, and although there are reports of double “phakomatoses” or “overlap,” reliable documentation of any combination of these diseases is rare, and such a combination occurs no more 7 frequently than by chance. NEUROFIBROMATOSIS Neurofibromatosis, an inherited disease transmitted as an autosomal-dominant trait, is noted for its heterogeneity of clinical expression. It may involve the peripheral and central nervous systems as well as skin and bone, and the endocrine, gastrointestinal, and vascular systems.
1 / 16
2009.01.05. 12:02
Aminoff: Neurology and General Medicine: Neurocutaneous Syndrome...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Although von Recklinghausen is credited for the initial clinical description of the disease, it 8–11 had been described earlier. Three distinct forms of neurofibromatosis have been recognized: type 1 (NF1), the most common type, is widely known as von Recklinghausen disease and is characterized by multiple hyperpigmented macules (café-au-lait spots) and neurofibromas; type 2 (NF2) is characterized by eighth-nerve tumors (schwannomas), but other intracranial and intraspinal tumors are common; and type 3 (NF3), schwannomatosis, is characterized by the occurrence of schwannomas on cranial and spinal nerves with the exception of the vestibular nerves. The diagnosis of NF1 neurofibromatosis can be made in patients with two or more of the following clinical findings: six or more café-au-lait spots with a maximum diameter of more than 5 mm during prepuberty and more than 15 mm in postpubertal patients; two or more neurofibromas of any type or one plexiform neuroma; freckling of the axillary or inguinal regions; optic glioma; two or more Lisch nodules; typical bony lesions; and a first-degree relative with the disorder diagnosed by these criteria. The diagnosis of NF2 neurofibromatosis can be made if the patient has bilateral vestibular schwannomas. The diagnosis can also be made if the patient has a first-degree relative with unilateral schwannoma before the age of 30 years or any two of the following findings: neurofibroma, meningioma, glioma, 12 schwannoma, or juvenile subcapsular lenticular opacity. The skin changes associated with neurofibromatosis are characterized by focal or diffuse lesions, or both, that are usually present before the appearance of any neurological abnormality. They include café-au-lait spots, fibroma molluscum, patchy or diffuse areas of hyperpigmentation, hypopigmented spots, and angiomas. Café-au-lait spots are usually present at birth. The number of spots and the degree of pigmentation tend to increase during the first year of life, but after that time the number of spots remains relatively stable. These spots can appear anywhere on the body (Fig. 11-1) except probably the scalp, palms, and soles. They are typically flat, with discrete borders, and vary in size from millimeters to centimeters. Crowe and associates observed that patients with six or more café-au-lait spots with a diameter of 1.5 cm have a presumptive diagnosis of neurofibromatosis; Crowe later reported that axillary freckling was also an important feature 13,14 The presence of café-au-lait spots does not necessarily establish the of the disease. diagnosis of neurofibromatosis, however, since at least 10 percent of the population have one or more hyperpigmented cutaneous macules.
2 / 16
2009.01.05. 12:02
Aminoff: Neurology and General Medicine: Neurocutaneous Syndrome...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 11-1 Typical café-au-lait spots of neurofibromatosis, located primarily on the
trunk. Fibroma molluscum, a prominent skin lesion found in the dermis or adjacent to it, consists of discrete, soft or firm papules ranging in size from a few millimeters to several centimeters. They are flat, sessile, or pedunculated and can be readily impressed into the subjacent skin. Hypopigmented spots, similar to those found in tuberous sclerosis, are sometimes present, as are discrete areas of skin hypoplasia and angiomas. Neurofibromas can occur anywhere from the dorsal root ganglion to the terminal peripheral nerve branches and can affect any organ system. They vary in size and are more often found on the trunk than on the limbs (Fig. 11-2). Plexiform neuromas are made up of interwoven elements of tumor and connective tissue that infiltrate normal tissue. They can be superficial, involving skin and subcutaneous tissues, or deep, affecting visceral and adjacent tissues. Diffuse areas of skin hyperpigmentation may overlie the plexiform neuroma. Neurofibromas are composed of a variety of cell types including Schwann cells, fibroblasts, perineurial cells, 15–18 with an incidence and mast cells. Malignant transformation of neurofibromas may occur, of 2 to 7 percent in different series. Pain, an increasing neurological deficit, and enlargement of a preexisting peripheral nerve sheath tumor indicate the need for surgical biopsy to 19 exclude such transformation.
3 / 16
2009.01.05. 12:02
Aminoff: Neurology and General Medicine: Neurocutaneous Syndrome...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 11-2 Multiple subcutaneous neurofibromas in a young adult.
Other intracranial tumors commonly found in neurofibromatosis include astrocytomas involving the cerebrum, cerebellum, or brainstem, and there is an increased frequency of 20,21 Other cranial nerves can be affected by neurofibromas or optic nerve gliomas. schwannomas, and bilateral acoustic neuromas are a characteristic feature of NF2. Although meningiomas, both solitary and multiple, are found with increased frequency in the major type of neurofibromatosis (NF1), they are more typically observed in NF2. Medulloblastomas, ependymomas, and hamartomas also occur more17frequently in patients with neurofibromatosis than in the general population. Intraspinal tumors are single or multiple, intradural or extradural. They can be accompanied by spinal anomalies such as syringomyelia. Some intraspinal tumors assume a dumbbell shape, extending through the intervertebral foramen. They are17sometimes associated with enlargement of that foramen or defect of the contiguous bone. Lisch nodules, a typical finding in neurofibromatosis, are melanocytic hamartomas found in the iris. Age-dependent and bilateral, they are found in about 10 percent of patients younger than 6 years, 50 percent of patients younger than 30 years, and almost all patients by age 50. Other ocular findings in neurofibromatosis include optic nerve gliomas (the most common CNS tumor) and congenital glaucoma. The frequency of optic gliomas in neurofibromatosis 17,18 Patients usually have symptoms of decreased visual has ranged from 15 to 20 percent. acuity or visual field defects but may initially appear with signs and symptoms of increased intracranial pressure. The tumor mass can involve the optic chiasm or hypothalamus and 20,22 Although rarely manifests as the diencephalic syndrome of infancy or precocious puberty. there is some controversy regarding the nature of the tumor, optic gliomas in children are probably congenital hamartomas, indolent and slow-growing. They are reportedly rare after the age of 6 years and progression of preexisting tumors in children with NF1 has been held to be uncommon after this age; nevertheless, late-onset or late-progressive21,23 lesions may certainly occur, mandating careful monitoring of all patients into adulthood. Congenital glaucoma, a known complication of neurofibromatosis, is commonly associated with a neurofibroma of the superior eyelid. The mechanisms underlying its cause include angle obstruction by neurofibromas, angle narrowing from neurofibromatous thickening of the ciliary body and choroid, fibrovascularization and synechial narrowing of the angle, and developmental anomalies of the angle.
4 / 16
2009.01.05. 12:02
Aminoff: Neurology and General Medicine: Neurocutaneous Syndrome...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
A variety of bony changes can occur in neurofibromatosis, including a ballooning of the middle fossa, an enlarged sella turcica, a J-shaped sella, and abnormalities of the sphenoid wing. The optic foramina are enlarged in some patients with optic glioma; bony defects of the orbit, the area of the lambdoid sutures, and other cranial bones are not uncommon. Scoliosis is reported in 10 to 40 percent of patients, although usually it is not reported before the age of 6 years; kyphosis, anterior meningocele, enlarged intervertebral foramina, bowing of the tibia and fibula, and bony overgrowth have also been reported. Pseudarthrosis is a characteristic feature of neurofibromatosis and usually involves the junction of the middle and distal third of 24,25 The bony defects associated with the tibia, although other tubular bones can be affected. neurofibromatosis are secondary to developmental abnormalities of mesenchymal tissue and are usually not the result of bone erosion by tumor. Magnetic resonance imaging (MRI) of the head may show focal areas of increased signal intensity in T2-weighted images that are associated with increased myelin water content and gliosis. The lesions are seen primarily in the basal ganglia, internal capsule, brainstem,26,27 cerebellum, and subcortical white matter and tend to involute spontaneously with age. Other features of neurofibromatosis include macrocephaly and short stature, which are reported to occur in 10 to 40 percent of patients. Mental retardation and seizures, though not necessarily related, occur in about 10 percent of patients, and about 50 percent of patients 17 have specific learning disabilities and hyperactivity. Precocious puberty has been observed in patients with a hypothalamic glioma or hamartoma or in some optic chiasmal gliomas that involve the hypothalamus. It should not be presumed, however, that precocious puberty without hypothalamic involvement by mass lesion is an integral part of the disease. Hypertension can develop from stenotic lesions or aneurysm formation at all levels of the renal arteries including intimal proliferation and fibromuscular changes of the media in parenchymal branches of the arteries, and stenotic28,29 changes of the internal carotid artery can result in moyamoya disease and ultimately stroke. A variety of tumors occur more frequently in patients with neurofibromatosis than in the general17,30–33 population, including pheochromocytoma, leukemia, neuroblastoma, and Wilms' There is an increased frequency of multiple endocrine neoplasia and medullary tumor. thyroid carcinoma. Among patients with pheochromocytomas, a significant number (4% to 23%, depending on the series) have neurofibromatosis, whereas only 1 to 2 percent of 30–33 patients with neurofibromatosis have pheochromocytomas. The frequency of neurofibromatosis, inherited as an autosomal-dominant trait, is about 1 in 12 4,000 persons for NF1 and about 1 in 50,000 persons for NF2. About one half of the cases are said to be spontaneous mutations. The factors behind the risk of developing the varied 34 complications of the disease are yet to be determined. The gene for NF1 has been mapped to a locus on chromosome 17q11.2, and it encodes a 3818 amino-acid protein, neurofibromin, which is expressed in a variety of cell types, particularly Schwann cells, 35–39 The protein contains a guanosine triphosphatase oligodendrocytes, and neurons. (GTPase) activating40–42 protein (GAP) that appears to regulate conversion of RAS-guanosine Neurofibromin is a tumor suppressor gene with respect to formation diphosphate (GDP). 43 of neurofibromas. Conversion to malignancy requires additional genetic alterations, but it is not known whether dysplasia results from tumor suppressor mechanisms or whether the expression of haploinsufficiency of neurofibromin causes the lesion. The gene for NF2 has been44,45 localized to a mutation at 22q12.2 and the protein is referred to Schwannomas are clonal tumors and the NF2 gene acts as a as schwannomin or merlin. tumor suppressor, whereas merlin is a cytoskeletal protein that functions in the control of cell growth. Schwannomatosis is characterized by the occurrence of schwannomas affecting cranial or spinal nerves except for the vestibular nerve. The disease is sporadic, and the responsible 46 gene has been localized to chromosome 22, near the NF2 locus but distinct from it. The treatment of patients with neurofibromatosis is symptomatic. Peripheral neurofibromas are generally indolent lesions that do not require surgical removal unless they are subjected to repeated trauma or show rapid growth. On occasion, plexiform neuromas are removed for cosmetic reasons. Intracranial and intraspinal tumors are treated with appropriate surgical techniques, irradiation, or chemotherapy. Optic gliomas in children are generally thought to be hamartomas; some authors recommend that they be managed conservatively by following their growth and documenting visual function, rather than by immediate surgery or radiation 47,48 therapy. TUBEROUS SCLEROSIS
5 / 16
2009.01.05. 12:02
Aminoff: Neurology and General Medicine: Neurocutaneous Syndrome...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Tuberous sclerosis complex, inherited as an autosomal-dominant trait, is characterized by a wide spectrum of clinical findings, including seizures, varying degrees of mental subnormality, and dysplastic and neoplastic changes of the skin, nervous system, and other organs. It was probably first described by von Recklinghausen in 1862,49–52 although Bourneville is appropriately Bourneville thought that cerebral credited for the initial clinical description of the disease. “scleroses” and renal tumors were associated findings but paid little attention to the facial skin lesions. Only later did he and Brissaud suggest an association of cerebral scleroses and renal tumors. In 1908, Vogt believed there was a typical triad of findings: adenoma 53 sebaceum, seizures, and mental retardation. The clinical expression of the disease depends on the patient's age and the extent of organ involvement. Seizures, the most common symptom occurring in 75 to 90 percent of patients, can appear at any time after birth. Generalized and, less commonly, partial54–58 seizures occur, The early and infantile spasms are often present during the first several years of life. onset and severity of recurring seizures is correlated with mental subnormality, and patients who have numerous cerebral tubers are prone to have greater impairment of higher cortical function. There is, however, notable variability of mental function in patients with tuberous sclerosis, and about 30 to 50 percent of patients have normal intelligence. Some affected children may develop normally during the first few years of life, but mental function deteriorates later in the first decade; between 25 and 50 percent manifest symptoms and 59,60 signs of autism spectrum disorder. Adenoma sebaceum, commonly considered to be the characteristic skin lesion in tuberous sclerosis, consists of angiofibromas that appear in patches or in a butterfly distribution about the nose, cheeks, and chin (Fig. 11-3). Observed in more than 50 percent of patients, they are rarely apparent at birth and are usually first observed between the ages of 1 and 4 years, 54,55 Hypopigmented spots can be visualized in a variety of forms: tending to enlarge with time. polygonal or “thumb-print”–shaped, in an ash-leaf configuration, or as confetti-like hypopigmented spots. The hypopigmented spots vary in size from millimeters to several centimeters (Fig. 11-4). They may be present at birth but become more prominent with time. Visualization of these hypomelanotic macules is enhanced by using a Wood light because melanin absorbs light of that frequency (360 nm), so areas deficient in melanin are accentuated.
6 / 16
2009.01.05. 12:02
Aminoff: Neurology and General Medicine: Neurocutaneous Syndrome...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 11-3 Adenoma sebaceum of tuberous sclerosis.
FIGURE 11-4 Leaf-shaped hypopigmented macule (left arrows) and adjacent small fibroma (right arrow) commonly seen in tuberous sclerosis.
In some patients, a patch of white or gray hair precedes the appearance of hypopigmented 61 spots. Other skin changes that may occur include the shagreen patch (a “leathery” cutaneous hamartomatous plaque) usually found over the lumbosacral or gluteal area), 55 café-au-lait spots, fibromas, and angiomas. Subungual or periungual fibromas (Koenen tumors) are found in about 20 percent of patients and affect the toes more than the fingers. They are usually first noted during adolescence. 62 Gingival fibromas may also occur, as may dental enamel pits. Although retinal tumors (hamartomas) are commonly present, affecting about 50 percent of patients, visual complaints are few (Fig. 11-5). These astrocytic, nodular lesions tend to calcify and may be solitary or multiple. Gray-yellow glial patches are sometimes present. Additional ocular findings include iritic hypomelanotic spots, cataracts, and colobomas of the iris, lens, and choroid.
7 / 16
2009.01.05. 12:02
Aminoff: Neurology and General Medicine: Neurocutaneous Syndrome...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 11-5 Typical retinal (mulberry) lesion observed in tuberous sclerosis.
Renal tumors are found in about 25 percent of patients with tuberous sclerosis and include angiomyolipomas and cystic lesions that are embedded in the renal parenchyma. These 63 lesions are relatively benign and only rarely require surgical intervention. Cardiac rhabdomyomas are found in at least 50 percent of patients and are solitary, multiple, or infiltrative, diffusely affecting the myocardium. They may be the cause of obstructive outflow or abnormalities of valvular function.64–66 Their demonstration has been notably improved with They are often identified prenatally and are most echocardiography and angiography. apparent during the first few years of life, subsequently undergoing spontaneous regression. Other associated abnormalities include pulmonary abnormalities that occur almost entirely in female subjects and may be manifested as lymphangioleiomyomatosis or pulmonary cysts. They may be asymptomatic or become apparent because of dyspnea, spontaneous 67–69 Hamartomas can be present in other organ pneumothorax, or pulmonary hypertension. 70–72 systems, and a variety of endocrine abnormalities have been reported. Radiographic studies can be effectively utilized to confirm the diagnosis. Intracranial calcifications, commonly observed in the region of the foramen of Monro or the periventricular region, are present on skull radiographs in about 60 percent of affected patients. Computed tomography (CT) may demonstrate cerebral hamartomas, subependymal nodules, ventriculomegaly, and areas of diffuse demyelination (Fig. 11-6). The CT findings may be abnormal in patients without clinical features of the disorder; less commonly, the findings are 73 normal in clinically affected patients. The most reliable finding on CT head scan is the demonstration of mineralized subependymal nodules. Periventricular calcification is less specific and may not be distinguishable from toxoplasmosis, cytomegalic inclusion disease, and Fahr's syndrome. MRI demonstrates with great clarity not only uncalcified subependymal 74 nodules but a marked distortion of normal cortical cytoarchitectonics (Fig. 11-7).
8 / 16
2009.01.05. 12:02
Aminoff: Neurology and General Medicine: Neurocutaneous Syndrome...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 11-6 Computed tomography (CT) scan (unenhanced axial view) of
patient with tuberous sclerosis, showing calcified tubers.
9 / 16
2009.01.05. 12:02
Aminoff: Neurology and General Medicine: Neurocutaneous Syndrome...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 11-7 Magnetic resonance imaging (MRI) of the head (axial view),
demonstrating multiple cortical and subcortical foci of increased signal intensity in tuberous sclerosis. Other typical radiographic findings include cystic rarefaction of phalanges and metacarpals, sclerotic areas of long bones, areas of increased or decreased bony density of the skull, and cerebellar calcification. Patients with pulmonary involvement may have a fine reticular infiltrate or multicystic changes on chest radiographs. Brain weight and configuration are usually normal except for the presence of cortical tubers, which may be noted anywhere in the cerebral hemisphere. Tubers are often found within the cortical gyri, although smaller nodular lesions can be observed in the region of the sulcus terminalis or basal ganglia, protruding into the ventricle. Tubers located about the foramen of Monro or the aqueduct of Sylvius may grow sufficiently to obstruct the normal circulation of cerebrospi-nal fluid (CSF), resulting in increased intracranial pressure. The microscopic appearance of the tuber is characterized by a decreased number of neurons with scattered large, bizarre, sometimes vacuolated “monster” neurons. Sections of cortex show proliferation of fibrillary astrocytes, demyelination, and abnormalities of cortical 75,76 cytoarchitectonics. The walls of some vessels may show hyaline degeneration. Subependymal nodules are fibrocellular, with round or oval cells and whorls of fibrillary glial tissue. Amyloid or calcium deposits may be present within the tuber or subependymal nodule; cerebellar calcification occurs rarely. Tuberous sclerosis is inherited as an autosomal-dominant trait with variable penetrance; the estimated frequency of the disease is 1 in 58,000. The reported sporadic rate, ranging from 50 to 75 percent is probably an overestimate because it is likely that a diagnosis of tuberous sclerosis could be established in some of the “asymptomatic” parents of children with the 77 disease if they were examined with current diagnostic techniques. It is thought that two genes are responsible for the tuberous sclerosis complex; one gene is located at chromosome 9q34, with its protein product being hamartin, and the other at chromosome
10 / 16
2009.01.05. 12:02
Aminoff: Neurology and General Medicine: Neurocutaneous Syndrome...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
16p13.3, with the gene product being tuberin. Hamartin and tuberin interact and function as 78,79 tumor suppressor molecules. Convulsive disorders are treated by administration of appropriate anticonvulsant medications; the ketogenic diet and vagus nerve stimulator have also been used. Unfortunately, the control of seizures cannot be assured. There is no specific treatment for the skin lesions unless they are subjected to frequent irritation; selected lesions can be surgically removed or treated with other dermatological measures. When the diagnosis of tuberous sclerosis is established, genetic counseling is required for all family members. Patients with tuberous sclerosis must be afforded thoughtful medical and emotional support and guidance. VON HIPPEL–LINDAU DISEASE Von Hippel–Lindau disease, inherited as an autosomal-dominant trait, is characterized by retinal and cerebellar hemangioblastomas. Other manifestations include cysts of the pancreas, liver, and spleen as well as malignant renal tumors. There are no associated skin lesions, as are found in other neurocutaneous syndromes. The retinal lesion was first80described, though not recognized as a hemangioblastoma, by Panas and Remy in 1879. In 1882, Fuchs thought the lesion was an arteriovenous malformation, and Collins in 1894 believed it originated from capillaries and had a hereditary 81,82 Von Hippel decided that83the retinal lesion was a hemangioblastoma but attached basis. the name of angiomatosis retinae. In 1926, Lindau established the association of retinal and cerebellar hemangioblastomas, but he was also aware that these patients may have other lesions, including spinal cord angiomas and cystic tumors of the pancreas, kidney, and 84 epididymis. The retinal hemangioblastoma is one of the earliest manifestations of the disorder. Though reported to occur during childhood, it is usually found initially during the third decade. The early appearance of the lesion is similar to an aneurysmal dilation of a peripheral retinal vessel; later, there are typical tortuous vessels, with an afferent arteriole and venule leading 85,86 to a small, raised retinal lesion (Fig. 11-8). Some lesions are small and easily overlooked. The retinal lesions have been divided into three categories: (1) a pinkish red vascular lesion located in the midperiphery, with visible dilated “feeder” vessels and variable exudate; (2) a pale gray lesion, with “feeder” vessels observed only on fluorescein retinal angiography; and (3) retinal lesions that are similar to diabetic microaneurysms but that are not observed to have retinal vascular connections. Patients with peripheral retinal lesions may have no significant visual impairment, but if the lesion involves the macula or optic disc, there is 87–90 progressive visual loss.
FIGURE 11-8 Typical round, white-red retinal hemangioblastoma observed in
von Hippel–Lindau disease. The diagnosis of cerebellar hemangioblastoma is usually first made during the third or fourth decade, but there are rare reports of its occurrence before puberty. The initial signs and symptoms are primarily those of cerebellar dysfunction and increased intracranial pressure.
11 / 16
2009.01.05. 12:02
Aminoff: Neurology and General Medicine: Neurocutaneous Syndrome...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Hemangioblastomas can also occur in the medulla and the91–93 spinal cord, where in about 80 Supratentorial percent of patients they are associated with syringomyelia. hemangioblastomas are uncommon but have been reported in the pituitary, third ventricle, and cerebral hemispheres. Renal lesions may be found in von Hippel–Lindau disease and include benign cysts, 94,95 Hypernephromas occur in more than half of patients angiomas, and hypernephromas. and are a prominent cause of morbidity and mortality. Benign cysts are also found in the pancreas, adrenal gland, and epididymis and are usually asymptomatic. There is an increased frequency of pheochromocytoma in patients with von Hippel–Lindau disease, 96 ranging from 3 to 17 percent. The retinal lesions are recognized by ophthalmological examination, and fluorescein retinal angiography can demonstrate the vascular characteristics of the lesion. CT and MRI delineate the structural characteristics of the cerebellar or spinal cord lesions. Intra-abdominal lesions can be demonstrated by CT, MRI, and ultrasonography. The red blood cell count may be elevated because of increased concentration of erythropoietin in the hemangioblastoma cyst fluid; the absence of polycythemia, however, does not exclude the diagnosis. Patients with CNS tumors have an elevated protein concentration in the cerebrospinal fluid. Urine collection (24-hour) for assay of epinephrine, norepinephrine, and vanillylmandelic acid is performed to screen for pheochromocytoma. The most frequent site of the tumor is the cerebellum, usually in the paramedial aspect of the cerebel lar cortex, and the tumor is associated with prominent vessels. The microscopic features of the tumor are characterized by large numbers of thin-walled, closely packed blood vessels that are lined by plump endothelial cells and separated by large, pale cells 94 incorporated into an elaborate network of reticulin fibers. Von Hippel–Lindau disease is inherited as an autosomal-dominant trait with variable penetrance. There is no sex predominance. The incidence of sporadic cases is not known. The tumor suppressor gene that causes von Hippel–Lindau has been localized to chromosome 3p26–25 by linkage analysis and encodes a protein that senses and responds 97–101 to hypoxia. Posterior fossa hemangioblastomas are treated by neurosurgical techniques to remove the cyst and associated fluid and mural nodule. Radiation therapy is of little benefit in the treatment of this tumor. Retinal hemangioblastomas are treated by a variety of methods, including laser photocoagulation and cryotherapy. STURGE–WEBER SYNDROME Sturge–Weber syndrome is characterized by a facial angioma (nevus, port-wine stain) associated with signs and symptoms of a leptomeningeal venous angioma. In 1860, Schirmer described a patient with a facial nevus and buphthalmos, but Sturge is credited with the first clinical description in 1879 of the syndrome in a102,103 young child who had a facial angioma, He suggested that the patient had an buphthalmos, and contralateral partial seizures. underlying104 cerebral nevus, but it was not until 1897 that pathological studies confirmed his prediction. Weber subsequently described the associated intracranial calcifications noted on skull 105 der Hoeve radiographs and introduced the term encephalofacialangiomatosis, and Van 106 inappropriately suggested that the disorder was the “fourth phakomatosis.” Sturge–Weber syndrome has no clear pattern of inheritance. The estimated incidence is approximately 1 in 50,000 persons. The facial angioma is congenital and unilateral (though it may be bilateral) and involves at least the upper face, superior eyelid, or periorbital region (Fig. 11-9). It may involve the nasopharynx, palate, lips, gingiva, and tongue. Although the facial angioma is commonly thought to conform to the sensory distribution of the first and possibly second or third divisions of the trigeminal nerve, there is reason to consider such a relationship fortuitous. Rather, the distribution of the facial nevus may be determined by 107 embryological development of the face. Angiomas may also be found on the neck, trunk, or extremities. Meningeal venous angiomas may occur in the absence of any facial angioma; although secondary cerebral signs and symptoms are similar to those of the Sturge–Weber syndrome, these patients are more appropriately thought to have a separate disorder, 108 referred to as meningeal angiomatosis.
12 / 16
2009.01.05. 12:02
Aminoff: Neurology and General Medicine: Neurocutaneous Syndrome...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 11-9 Facial angioma (port-wine stain) of Sturge–Weber syndrome
primarily involving the left upper face (arrows). In addition the patient manifests contralateral hemiparesis and hemiatrophy. During early infancy, most patients with Sturge–Weber syndrome experience seizures that are primarily partial motor in type, although some patients have generalized tonic-clonic seizures. There is usually a relentless progression of severity and frequency of the convulsive disorder, and any postictal Todd's paralysis often requires increasingly longer periods of time to resolve, until eventually there is a permanent hemiparesis. Other types of seizures, including infantile spasms, myoclonic seizures, and atonic attacks, occur less commonly. In earlier studies, the frequency of seizure disorders has varied from 70 to 90 percent. In a retrospective study of 102 patients evaluated between 1942 and 1986, 88 patients had one cerebral hemisphere affected and 14 patients had bilateral hemispheric involvement. Seizures occurred in 75 percent of these patients. Among 88 patients with unilateral hemispheric disease, 63 had seizures, with the mean age at seizure onset being 24 months; 13 of 14 patients with bilateral hemispheric lesions had seizure disorders, with a mean age at 109 onset of 6 months. Hemiparesis contralateral to the facial angioma occurs in about 30 percent of patients and is sometimes apparent during infancy, before the onset of seizures. The weakness is generally exacerbated by increasingly severe recurrent seizures and may be accompanied later by hemiatrophy. Bilateral hemipareses may be present in patients with meningeal angiomas affecting both cerebral hemispheres. Hemisensory deficits are less frequently documented because reliable sensory examinations are difficult to carry out in very young and in mentally subnormal patients. Homonymous hemianopia is present in about one third of patients, and glaucoma secondary to choroidal angioma is found in about one fourth. Other ocular findings include iritic heterochromia with the hyperpigmented iris ipsilateral to the facial angioma, optic atrophy, and strabismus. At least 50 percent of patients are mentally subnormal, and behavioral problems are common. As seizures of early onset increase in frequency and severity, mental function and behavior often regress. In the retrospective study noted previously, 25 of 88 patients with unihemispheric leptomeningeal involvement who did not have seizures were of average intelligence; 1 of 14 patients with bilateral hemispheric109involvement was unaffected by seizures and that patient was of average intelligence. These observations are important considerations in patient management. Electroencephalographic (EEG) studies may show decreased amplitude and frequency of electrocerebral activity over the affected hemisphere. Diffuse multiple and independent spike
13 / 16
2009.01.05. 12:02
Aminoff: Neurology and General Medicine: Neurocutaneous Syndrome...
foci are commonly present.
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
110
Intracranial calcification, demonstrated on skull radiographs, is present in more than 90 percent of patients. It is rarely observed in infants but has nevertheless been reported in the neonate and is present in most patients by the end of the second decade. The calcifications, which are usually in the occipital or parieto-occipital regions, assume a linear, parallel configuration (“tram sign”). CT scans of the head demonstrate calcifications and cerebral atrophy more readily than plain radiography and may show the calcific deposits during the first few months of life. Cerebral angiography shows decreased cerebral venous drainage and dilated deep cerebral veins. About one third of patients have a variety of vascular abnormalities, including thrombotic lesions, dural venous sinus abnormalities, and arteriovenous malformations. Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) provide a measure of the extent of cerebral metabolic impairment, and serial PET scanning can be useful with other neuroimaging techniques to document the progression of 111,112 The extent and amount of glucose asymmetry as detected by PET 112 the disease. scanning are reported to be sensitive markers of seizure severity and cognitive decline. SPECT detects asymmetries in cerebral blood-flow in infants with Sturge–Weber disease, and these asymmetries may shift with age. In particular, the cortex involved in the vascular malformation is hyperperfused during the first year of life, becoming hypoperfused 113 thereafter. Typical pathological features include thickened, hypervascularized leptomeninges involving primarily the occipital, parietal, or temporo-occipital lobes. Meningeal vessels are small and tortuous, lending a dark, purplish blue color to the cerebral surface. These abnormal vessels rarely enter the underlying atrophic hemisphere. Calcific deposits of varying size are found in the walls of some small cerebral vessels but are located primarily in the molecular and outer pyramidal cortical layers. Although some iron associated with calcific deposits has been reported, the iron content of gray and white matter is normal, whereas the calcium content is greatly increased. The pathogenesis of intracortical calcium deposition is not fully understood. Good management requires careful attention to every aspect of the patient's medical and emotional well-being. The seizure disorder is managed with anticonvulsant drugs. Adrenocorticotropic hormone (ACTH) may be required for patients with infantile spasms. It is not unusual for seizures to be recalcitrant to medical management; in selected cases, consideration must114,115 be given to the surgical removal of an affected lobe or lobes or to but there is no agreement as to the optimal time for such an hemispherectomy, 116 approach. There has been some measure of success in treating the facial angioma with administration of pulse-dye laser. Management of mental subnormality and behavioral problems requires the skilled support of the physician, psychologist, and social worker. ATAXIA-TELANGIECTASIA Ataxia-telangiectasia is a multisystem disease characterized by progressive cerebellar ataxia, oculocutaneous telangiectasis, proclivity to sinopulmonary infections, and immunoincompetence associated with lymphoreticular neoplasia. The disease is transmitted as an autosomal-recessive trait, affecting male and female subjects equally. 117
Although this condition was initially described by Syllaba and Henner in 1926, Louis-Bar believed that her 1941 report of ataxia and notable cutaneous telangiectasis in a 9-year-old boy described a118 hitherto unrecognized disease and suggested that it was one of the phakomatoses. Three independent reports of the disease were published in 1957: Boder and Sedgwick described the clinical features of the disease and named it 119 ataxia-telangiectasia ; Biemond described the clinical and pathological findings of the 120 disease and emphasized the recurring sinopulmonary infections and extrapyramidal signs ; and Wells and 121 Shy reported the disease as “familial choreoathetosis and cutaneous telangiectasis.” Affected patients appear normal until the time they begin to walk independently, usually at 12 to 18 months, at which time truncal ataxia first becomes apparent. Normal motor development continues despite the ataxia, but within several years there is little question that the child is inordinately clumsy. Abnormalities of ocular motility characterized by slow, involuntary ocular movements with erratically interspersed vertical components are common. There is a defect in the initiation of voluntary and involuntary saccades; associated eye blinking and head thrusts or jerks, 122,123 consistent with congenital oculomotor apraxia, are usually present.
14 / 16
2009.01.05. 12:02
Aminoff: Neurology and General Medicine: Neurocutaneous Syndrome...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Patients are generally hypotonic, and there is a paucity of muscle bulk. Stretch reflexes, usually normal in the younger child, are decreased or lost within a few years; plantar responses are nonreactive or flexor. Choreoathetosis is common in most patients and may increase in severity. There are generally no sensory abnormalities of note, although older patients may have posterior column dysfunction. Affected patients appear rather apathetic, if not sad, but they usually have a pleasant disposition. Although dysarthria and drooling may convey the impression of dullness, mental subnormality is not a typical feature of the disease. There appears to be a “leveling off” of the acquisition of cognitive skills rather than a deterioration of mental function. Telangiectasias become apparent later than ataxia and are usually first observed between the ages124 of 3 and 5 years, although they have been observed at birth or as late as the second decade. They are generally first noted in the lateral bulbar conjunctiva but gradually involve its entirety (Fig. 11-10). Exposed areas of skin are also affected, including the nasal bridge, ear, and antecubital and popliteal spaces. Telangiectasias become more prominent following exposure to sun. Progeric changes of skin and hair are common and are manifested by sclerodermoid and atrophic areas of skin and patches of gray or white hair.
FIGURE 11-10 Characteristic conjunctival telangiectasias seen in
ataxia-telangiectasia. Chronic blepharitis is often present. Recurring sinopulmonary infections, affecting 90 percent of patients, usually result in chronic bronchitis or bronchiectasis. Hypogonadism is frequently present, and growth retardation is notable despite normal levels of serum growth hormone. The incidence of malignant neoplasms in patients with ataxia-telangiectasia has been reported as 10 to 15 percent. Most of these neoplasms are lymphomas, reticulum cell sarcomas, histiocytosarcomas, Hodgkin's disease, or leukemias; other associated neoplasms include brain tumors, gastric adenocarcinomas, ovarian dysgerminomas, gonadoblastomas, cystadenofibromas, uterine leiomyomas, thyroid adenomas, and basal cell carcinomas. Abnormalities of both humoral and cellular immunity have been demonstrated. Most patients have absent or low serum levels of immunoglobulin A (IgA) or IgG2; serum IgE and IgM 125 levels may also be decreased. Serum levels of IgM, IgG1, and IgG3 have also been
15 / 16
2009.01.05. 12:02
Aminoff: Neurology and General Medicine: Neurocutaneous Syndrome...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
reported as normal or elevated. The humoral deficits can result in impaired antibody response to some bacterial and viral antigens. The most consistent biochemical findings, 126–128 however, are elevated serum α-fetoprotein and carcinoembryonic antigen. Impaired cellular immunity is common in older children as a consequence of abnormally developed or absent thymus gland, tonsils, adenoids, and lymphoid tissue. Other cellular features of ataxia-telangiectasia include cytoskeletal abnormalities, decreased cell life in culture, an increased incidence of spontaneous or irradiation-induced chromosomal breakage and rearrangement, defective radiation checkpoints at G1, S, and G phases of the cell cycle, and abnormalities of signal transduction pathways. A large gene found on chromosome 11q22–23 has been associated with ataxia-telangiectasia, and many different mutations in patients with 129–132 the disease have been described. Pathological studies show notable cerebellar atrophy with particular involvement of Purkinje and granular cells, although basket cells may be affected as well. Neuronal degeneration of the dentate and olivary nuclei has been described, as has neuronal loss in the substantia nigra and nuclear changes in cells of the oculomotor complex and hypothalamus. In many cases of long duration, there is degeneration of the posterior columns of the spinal cord; degenerative changes of anterior horn cells have also been observed. Bizarre dystrophic changes and nucleomegaly of satellite cells in the dorsal root ganglia and Schwann cells of peripheral nerves have been described. No characteristic vascular pathology of the nervous system has been reported. Specific treatment is not available. Patients must therefore receive vigorous supportive care, with particular attention directed to recurrent infection and pulmonary function. Attempts to improve the immunological status of patients by plasma transfusion, administration of thymosin, and fetal thymus transplants have thus far not altered the course of the disease. Previous
Next
Return to Previous Page
16 / 16
2009.01.05. 12:02
Aminoff: Neurology and General Medicine: Dermatological–Neurolog...
Return to Previous Page
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Print this page
This information has been developed and provided by an independent third party source. Merck & Co., Inc., does not endorse and is not responsible for the accuracy of the content, or for practices or standards of non-Merck sources. This resource may discuss regimens that have not been approved by the FDA. For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences please see the appropriate manufacturer's product circular. View Prescribing Information for Merck products.
Table of Contents This Chapter by Chapters
Keyword Index
Michael J. Aminoff
NEUROLOGY and GENERAL MEDICINE 12 Dermatological–Neurological Interactions KEVIN C. WANG • TIMOTHY G. BERGER •
Previous
Next
NEUROPATHIC PRURITUS Brachioradial Pruritus Notalgia Paresthetica Anogenital Pruritus Prurigo Nodularis ERYTHROMELALGIA NEUROPATHIC ROSACEA IDIOPATHIC SUDOMOTOR FAILURE
Many patients are referred to dermatologists for complaints that are primarily if not entirely neurological in nature. These include such symptoms as pruritus, pain, and paresthesias. Although dysesthesias, paresthesias, and anesthesia are common features of disorders such as postherpetic neuralgia and diabetic neuropathy (Chapter 21), they may occur as a component or as the sole symptom of various cutaneous syndromes. Characteristically, these sensations, especially pruritus, when induced by neurological disorders, cause patients to rub, scratch, or pick at their skin. A number of disease entities that are closely associated with involvement of pathways within the nervous system are discussed here. These diseases share common clinical features and have an underlying neurological basis. The term neurocutaneous dermatoses—defined as a dermatitis that arises secondary to disease located at any point along the circuitry of the nervous system—can be used to encompass these conditions. They can be further classified into three subgroups (Table 12-1): anatomical, neurovascular, and primary sudomotor, according to the underlying mechanism presumed to be responsible primarily for producing their clinical features. Click here to view this table.... NEUROPATHIC PRURITUS Persistent picking and scratching result in stereotypical changes that are easily recognized clinically. The presence of these characteristic features on physical examination should suggest an underlying neurological etiology for the cutaneous complaints. Lichenification and prurigo papules/nodules are two of the most common manifestations of the unrelenting cycle
1/8
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Dermatological–Neurolog...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
of itching and scratching. These lesions are often accompanied by skin thickening and dyspigmentation. “Lichenification” refers to hyperplasia of the skin in response to constant rubbing or scratching. The skin becomes leathery, and the normal lines in the skin become exaggerated, giving it a bark-like appearance referred to as “increased skin markings.” Lichenification occurs in patients with cutaneous conditions such as atopic dermatitis, where chronic itching causes repeated scratching and rubbing of the affected area. A related entity is lichen simplex chronicus, a condition in which one or more slightly erythematous, scaly, well-demarcated, lichenified, firm, rough plaques with exaggerated skin lines are noted (Fig. 12-1). Pigmentary changes (especially hyperpigmentation) are seen. As is the case with lichenification, rubbing plays a key role in formation of lichen simplex chronicus and is evidenced by linear scratch marks, erosions, and ulcerations from deeper scratching.
FIGURE 12-1 Lichen simplex chronicus, scrotum. Chronic persistent rubbing
and scratching resulting in a plaque of thickened and leathery skin. The lichenified plaque is often unilateral, well-circumscribed with marked accentuation of the skin creases. Pigmentary abnormalities are common, especially in patients with darker skin. Intractable localized or segmental pruritus without evidence of a primary dermatological process has been reported under various names, depending on the affected area of the body. Brachioradial pruritus, notalgia paresthetica, and anogenital pruritus are three of the more common conditions. This group of diseases is frequently a manifestation of injuries (often mechanical in nature) affecting the vertebral column or nerve roots, and the anatomical distribution of each disorder corresponds to the respective levels of injury—brachioradial pruritus to the cervical, notalgia paresthetica to the thoracic, and anogenital pruritus to the lumbosacral region. Knowledge and understanding of the anatomical pathogenesis enables the clinician to correctly diagnose and treat these disorders.
2/8
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Dermatological–Neurolog...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Brachioradial Pruritus Brachioradial pruritus is an entity of localized pruritus characterized by severe, refractory, intractable itching and secondary skin changes such as lichenification. The skin overlying the proximal heads of the brachioradialis muscles is affected, usually in association with clinical1 evidence of chronic sun damage; occasionally, the pruritus extends across the upper back. Heyt demonstrated radiographic evidence of cervical vertebral osteoarthritis in four of five patients and hypothesized that nerve injury, resulting from either lesions of the cervical spine 2 or from mechanical compression by nearby structures, was of etiological importance. Goodkin and colleagues provided further support for the belief that cervical spine disease may be an important contributing factor, since 50 percent of their patients had radiologically 3 verified cervical spine disease that correlated with the location of pruritus in each patient. Cervical root compression as a mechanism was further supported by report of a spinal cord 4 tumor causing pruritus in the C5–C6 dermatomes. Of note, none of the published reports have included magnetic resonance images (MRIs) of the cervical spine, although this is the current definitive diagnostic means of determining nerve root impingement. On the basis of these observations, brachioradial pruritus is now thought to represent a form 5 of neuropathic pruritus related to cervical disease. However, sunlight can be an eliciting factor and compression of cervical nerve roots a predisposing factor in these patients. Wallengren and Sundler compared the cutaneous innervation in biopsies from the affected skin of patients with brachioradial pruritus to normal skin from age-matched controls. Cutaneous innervation was visualized by antibodies to protein gene product 9.5, a general neuronal marker; calcitonin gene-related peptide, a marker for thin sensory nerve fibers; and 6 the VR1-receptor, a marker for capsaicin-sensitive nerve fibers. They found that pruritus was seasonal in most of their patients, and histologically the biopsy specimens displayed changes similar to those seen in skin affected by ultraviolet light. The number of nerve fibers in diseased skin, as detected by the previously mentioned nerve markers, was significantly reduced compared with controls. Interestingly, fiber counts from some patients, who served as their own controls, normalized as they became symptom free. Wallengren and colleagues argue that spinal disease alone cannot explain the symptoms of brachioradial pruritus, on the basis of their observations of symptom-free periods interspersed with relapses. Familial occurrence has suggested the presence of a hereditary form of brachioradial pruritus, with 7 either autosomal-dominant or possibly X-linked inheritance. To relieve the burning and stinging quality of their itch, patients often apply ice packs to the affected 8arm. Since sunlight is a cofactor, sunscreen may be of partial benefit in some patients. The most effective treatments, however, are those directed at the neurological cause of the disease. Significant relief has been achieved from application of topical 9,10 10 capsaicin ; amitriptyline was effective in capsaicin-refractory cases. Other treatments reported—sometimes purely anecdotally—to be effective for brachioradial15pruritus include 11–13 14 resection of a16cervical rib. Cervical gabapentin, 2,15carbamazepine, and surgical 2 and cervical manipulation and acupuncture have also been reported as physiotherapy an effective treatment. Tait and colleagues described a group of patients who were treated with cervical spine manipulation and found that 71 percent reported resolution of symptoms following manipulative treatment, including all those with documented cervical spine disease, 14 as well as some with no previous history of neck symptoms.
Notalgia Paresthetica Notalgia paresthetica is usually a unilateral sensory neuropathy found mainly in older patients 17 characterized by infrascapular pruritus, burning pain, tenderness, or hyperalgesia ; other neurological symptoms such as numbness, tingling, and formication have been described as well. Its distribution is usually in that of the T2 through T6 dermatomes. There is often no evidence of an accompanying primary dermatological lesion, although pigmented patches 18 and frictional amyloidosis (macular amyloidosis; Fig. 12-2) may arise with rubbing. The fact that the posterior rami of these five thoracic roots traverse a 90-degree course through the multifidus spinae muscle may contribute to their increased susceptibility to mechanical 19 injury.
3/8
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Dermatological–Neurolog...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 12-2 Macular amyloid. A chronic, pruritic eruption of small brown macules
distributed in a rippled, symmetric fashion on the interscapular region of the back with nonuniform pigmentation resulting in a rippled, “salt-and-pepper” appearance. It is hypothesized to result from rubbing of dysesthetic areas of notalgia paresthetica. 20
Pathogenesis is thought to involve musculoskeletal compression and resultant spinal nerve impingement of the posterior primary rami of the aforementioned spinal nerves. Thus, Raison-Peyron and associates have presented evidence of dorsal arthrosis in spinal 18 radiographs of patients with notalgia paresthetica, and Savk and colleagues offered striking correlation of the localization of notalgia paresthetica with degenerative changes in the 21 spine. In both sets of patients, the observed structural abnormalities matched precisely the expected dermatomal localization of pruritus. Some hereditary cases have occurred, mainly in young patients, associated with multiple endocrine neoplasia type 2A (MEN 2A). The associated cutaneous lesions are hypothesized 22 to be secondary to pathology in the neural crest–derived dorsal sensory nerves. To date, treatments for notalgia paresthetica for which some efficacy has been claimed 23 24 paravertebral local anesthetic blocks, cervical epidural steroid include capsaicin, 25 26 anesthetic cream (2.5% lidocaine and 2.5% prilocaine), and injection, topical 18 physiotherapy. Most of these treatment modalities act either directly or indirectly on the nervous system, lending support to the theory of a neurological etiology.
Anogenital Pruritus Anogenital pruritus is a general term used to describe itching that is virtually always limited to a defined area—the perianal or genital skin, with few or no symptoms at other anatomical sites. Cutaneous manifestations are identical to those of lichen simplex chronicus elsewhere Attacks are characterized by paroxysms of violent itching. Nocturnal on the body (Fig. 12-1). 27 pruritus is common. Specific terms used to describe chronic itching in the anogenital region include pruritus ani, pruritus vulvae, and pruritus scroti. Usually pruritus is restricted to one anatomical region with limited migration to closely adjacent sites. For example, patients with scrotal itch have no or very limited perianal itch, and vice versa. These conditions are common and are often poorly managed. Anogenital itching may be a manifestation of preexisting pathology or an idiopathic, primary condition, in which case a more severe and 27–30 A thorough and careful search for specific anatomical persistent itch is experienced. etiologic factors should always be conducted, such as for hemorrhoids or anal/genital neoplasia. 28,31
In chronic Acute anogenital pruritus is usually caused by infections or contact dermatitis. pruritus, inflammatory dermatoses and rarely malignancies are found in a significant number of cases. In idiopathic anogenital pruritus, where no demonstrable cause can be identified, the skin findings are frequently entirely absent or limited to erythema, lichenification, and
4/8
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Dermatological–Neurolog...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
excoriations. Depression, anxiety disorder, and obsessive-compulsive traits must be 32,33 Recent studies have considered in patients with intractable pruritus resistant to therapy. speculated on a possible neuropathic origin for idiopathic anogenital pruritus, with a mechanism akin to that suggested for brachioradial pruritus and notalgia paresthetica. One study of a group of patients with “idiopathic” anogenital pruritus suggested such an 34 association. Patients with anogenital pruritus were observed to have lumbosacral radiculopathy, representing nerve or nerve root compression at the level of L4 to S2 vertebrae, as evidenced by degenerative changes of the lower spine by radiography. In addition, the location of the pruritus was 34 correlated with that of the neuropathic changes observed with electrodiagnostic studies. More definitive studies are clearly needed. Treatment of anogenital pruritus usually begins with elimination of apparent exacerbating factors such as irritants and potential sensitizers, as well as modification of cleansing and toilet habits. Short courses of high-potency topical steroids, with adjunctive sedating antihistamines, can bring moderate to complete relief and limit night-time symptoms by 27 cream (0.006%) is effective in some breaking the itch–scratch cycle. Dilute capsaicin 35 cases, mostly in the pruritus ani subgroup. In cases of neuropathic anogenital pruritus (i.e., those cases possibly attributable to lumbosacral radiculopathy), paravertebral injections of corticosteroids and lidocaine may alleviate pruritus and other associated cutaneous 34 symptoms. Psychotropic agents may be required to achieve adequate sedation. Selective serotonin reuptake inhibitors such as fluoxetine, paroxetine, sertraline, and citalopram36may be required in patients refractory to treatment or with underlying psychiatric disorders.
Prurigo Nodularis Prurigo nodularis is a chronic condition occurring mainly in adults. It is characterized by numerous excoriated firm nodules, the majority of which are situated symmetrically on the extremities (with a predilection for the anterior surfaces of limbs, trunk, and other 37–39 Individual lesions or nodules, which may vary from a few to easy-to-reach areas). hundreds, are firm, several millimeters to 2 cm in diameter, often in a linear arrangement with prominent excoriations, crusting, and postinflammatory hyper- and hypopigmentation as a result of repeated scratching (Fig. 12-3). The lesions evolve slowly over time. Severe itching is the hallmark of the disorder and is characteristically paroxysmal and usually confined to the lesions themselves.
FIGURE 12-3 Prurigo nodularis. Persistent picking and scratching, usually on
the extensor aspects of the limbs, upper trunk, and buttocks, result in formation of firm, pea-sized, dome-shaped nodules, often with an eroded surface with scale and crusts. The intervening skin may be normal, or it may show changes such as erythema, scales, excoriations, lichenification, postinflammatory pigmentary changes, or scars. The etiology is unknown, although multiple factors such as atopic dermatitis, hepatic dysfunction including hepatitis C, human immunodeficiency virus infection, lymphoproliferative diseases, renal failure, pregnancy, venous stasis, insect bites, and stress
5/8
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Dermatological–Neurolog...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
38,39,40–42
have been postulated as possible contributors.37,38 Some authors have suggested that whereas others believe that it represents prurigo nodularis is related to neuronal factors, an induced reaction to particular stimuli. There is evidence to suggest that the disorder is, at least at some level, a neural-mediated entity. For example, proliferation of peripheral nerves with some disorganization, axonal swelling, and axonal dystrophy as well43as newly formed nervous tissue resembling neuromas have been observed in the lesions. Nerve bundles from the lesions show increased immunoreactivity to neuropeptides such as substance P and 44,45 when compared to normal unaffected skin. It has calcitonin gene-related peptide (CGRP) been hypothesized that neuropeptides serve as mediators of cutaneous neurogenic inflammation and pruritus by liberating histamine through interactions with mast cells and 46 nerve growth factor (NGF) receptors. Harris and colleagues demonstrated an increase in the number of nerves in the papillary dermis (so-called “hypertrophy of dermal nerves”), advocating a pathogenic neurocutaneous component with NGF as a major contributor to the 47,48 Extreme pruritus in chronic lesions can presumably be related to the neurohyperplasia. increased number of dermal nerves. Prurigo nodularis is notoriously difficult to treat. Spontaneous regression is rare, and relapse 49 37 is common. Once the cycle of pruritus–excoriation–pruritus begins, it is difficult to stop. Topical or intralesional glucocorticoids are the initial treatment but are often ineffective. Anecdotal reports support the use of liquid nitrogen cryotherapy, presumably through its 50 damaging properties on the sensory nerves. 51–53
Topical capsaicin treatment has resulted in clearing of the lesions. The mechanism is thought to involve release and prevention of the reaccumulation of neuropeptides in the unmyelinated, polymodal C and small myelinated A-delta cutaneous nerves. Unfortunately, how capsaicin modulates the interaction between the peripheral nervous system and the proinflammatory cytokines at the molecular level remains unclear. Other treatments such as 54 55 56 topical vitamin D3, cyclosporine, and phototherapy have been demonstrated to relieve pruritus and lead to resolution of skin lesions in selected patients. There has been one clinical study and many reports on the use of thalidomide, a derivative of glutamic acid, for cases of prurigo nodularis refractory to conventional treatment. Most report resolution of the pruritus within 1 to 2 months and involution of the nodular lesions in several 57–60 The mechanism of action of thalidomide is still unclear61,62 but is believed to be months. —thus, patients are at through a direct destructive effect on the proliferated neural tissues increased risk of developing a dose-dependent neuropathy. The improvement of pruritus, however, may not be totally explained by nerve damage and may be attributed 59 to the numerous immunomodulatory and anti-inflammatory properties of thalidomide. Alternatively, clinical improvement may be secondary 49,63 to thalidomide's central sedative effects and consequent interruption of the that result in reduction in peripheral stimuli perception itch–scratch cycle. ERYTHROMELALGIA Erythromelalgia, also known as erythermalgia and acromelalgia, is an extraordinary pain syndrome first described by S. Weir Mitchell in 1878. It is a rare form of paroxysmal vasodilation characterized by episodes of severe localized burning pain affecting the feet (usually bilaterally and symmetrically) and, rarely, the hands, accompanied by striking redness and warmth of the skin, often precipitated by heat or activity and terminated only with cooling of the64affected extremity. The burning spells may last anywhere from a few minutes to several days. Two forms have been described. The primary form is either a sporadic or an 65 autosomal-dominantly inherited disorder. In these cases, symptoms begin in childhood. Secondary erythromelalgia is seen in association with an underlying disease process such as diabetes mellitus, hypertension, neurological disorders (myelitis, multiple sclerosis, and peripheral neuropathy), collagen-vascular diseases, use of certain drugs, and especially myeloproliferative disorders (polycythemia, thrombotic thrombocytopenic purpura, and 66 throm-bocythemia). Treatment with pharmacological agents and targeted neurological surgery have been found to be most effective in patients with secondary erythromelalgia, in which treatment of the 67 associated disorder generally results in remission. Symptoms in the primary group may be minimized by appropriate environmental control with cooling and avoidance of heat-producing situations that would raise skin temperature above a critical thermal threshold. Calcium-channel blockers and cyclosporine have been68,69 utilized as treatments but in some cases can actually exacerbate or induce the condition. The pathophysiology is poorly understood, but there is evidence that primary and familial
6/8
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Dermatological–Neurolog...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
erythromelalgia are secondary to disorders of peripheral small-fiber (C-fiber) neurotransmission. Layzer hypothesized that erythromelalgia is a disorder of hypersensitized polymodal C-fiber receptors in the skin, in which the threshold to heat activation is lowered 66 (from 36° to 32°C). The activated C-fibers then cause vasodilation through axonal reflexes, resulting in redness, heat, and swelling; cooling brings the nociceptors below the temperature activation threshold. Along the same lines, secondary erythromelalgia may occur as a result of injuries to C-fibers, either directly in cases of neuropathy or indirectly from humoral factors released by platelets or ischemic tissues. Davis and his group have provided further support for this mechanism by noting that a high proportion of their patients with erythromelalgia had severe postganglionic sudomotor impairment, as well as 70 evidence of peripheral, especially distal, denervation without generalized autonomic failure. Their neurological assessments included electromyography, nerve conduction studies, and autonomic reflex screening, all of which demonstrated a consistent relationship between erythromelalgia and small-fiber 70 neuropathy. The presence of voltage-gated sodium channels in sensory neurons may play a crucial role in several chronic painful neuropathies. Recently, several groups have demonstrated mutations in SCN9A (or Nav 1.7), a sodium channel that is selectively expressed within nociceptive dorsal root ganglion and71,72 sympathetic ganglion neurons, in families with autosomal-dominant primary erythromelalgia. In fact, erythromelalgia is perhaps the first inherited painful neuropathic disorder to be understood at a molecular level. Similar to the concept of modulating C-fiber receptor thresholds described previously, shifts in activation/deactivation as well as an enhanced response to small stimuli in the mutant sodium channels act to 72 Furthermore, the decrease the threshold for impulses in pain-sensing neurons. 73 74 observations that sympathetic ganglion block and epidural bupivacaine can bring effective symptomatic relief for secondary erythromelalgia support the role that region-specific ion-channel disturbances play in the disorder. Erythromelalgia may resemble post-traumatic painful neurological syndromes involving the somatosensory, sympathetic, and somatomotor systems such as reflex sympathetic dystrophy 75 (RSD) and causalgia (collectively classified as complex regional pain syndromes, or CRPS). Distinguishing among the three conditions can be difficult, since patients with these conditions may all have hot, swollen, and painful limbs. Erythromelalgia has also been reported to coexist with Raynaud's phenomenon, an interesting association given that one is 76 a problem of vasodilation and the other of vasoconstriction. Erythromelalgia may be primarily a neuropathy that results in vascular phenomena, or a vasculopathy with hypoxia that results in a similar neurological phenotype. The real pathophysiological mechanism is likely distinct in individual patients, as evidenced by therapeutic success that has been reported with medications used for both neuropathy (such as gabapentin, tricyclic antidepressants, and selective serotonin reuptake inhibitors) and vasculopathy (such as 67,77 beta-blockers and calcium-channel antagonists). NEUROPATHIC ROSACEA There is a clear subset of patients seen by both neurologists and dermatologists, whose main complaints are facial pain and dysesthesias. These patients often have a history of prominent facial flushing and blushing in response to various stimuli such as emotional stress, hot beverages, alcohol, spicy foods, exercise, heat, and sun exposure. They may also have erythematous papules and pustules. This cluster of features is most consistent with a diagnosis of rosacea but, when combined with the78pain and dysesthesias, a form of complex regional pain syndrome must also be considered. In addition, some patients may have concurrent erythromelalgia and Raynaud's disease, suggesting that the etiology is perhaps more complex. 79–81
Rosacea is primarily believed to be a result of abnormalities of the facial vasculature. Histopathological studies have demonstrated that all major symptoms (erythema, 82 telangiectasia, and inflammatory papules) are likely to be vascular in origin. The vasculature is likely to be hyper-responsive, secondary to an increased excitability of its modulation by the nervous system, to both internal and external stimuli, resulting in chronic vasodilatation. It is not unreasonable to presume that a hyperexcitable neuroregulatory mechanism plays a significant role in the flushing/blushing patient with facial pain and dysesthesias. This is 79,83,84 especially in supported by reports of an85association between rosacea and migraine, postmenopausal patients. A “migraine diathesis” should be considered by those taking care of these patients. Recognition of the underlying pathophysiology in these patients is a prerequisite for a mechanism-oriented therapeutic strategy. Treatment is difficult. In patients whose major complaints center around the flushing/blushing component of the disorder, a beta-blocker
7/8
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Dermatological–Neurolog...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
86
such as propranolol may be tried for symptomatic relief. In patients suffering from facial 87 pain and dysesthesias, neuroactive agents such as gabapentin may be effective. Surgical approaches can include laser ablation of the vessels, although care must be taken with the latter option as some patients have experienced worsening of their pain after laser procedures. IDIOPATHIC SUDOMOTOR FAILURE Hypohidrosis or anhidrosis is an acquired disorder of sweating characterized by a decrease in or complete loss of sweat 88 production in response to an appropriate thermal or pharmacological stimulus. It can be generalized or segmental. Symptoms may include heat intolerance, tingling pain, nausea, and palpitations. The condition can result from poral occlusion, absence of sweat glands, sweat gland dysfunction, or impaired autonomic function 89 (Chapter 8) found in certain neurological disorders. Hypohidrosis or anhidrosis due to impaired sweat glands can be observed in patients with90Sjögren's syndrome, progressive systemic sclerosis, and systemic lupus erythematosus. Hypohidrosis or anhidrosis due to impaired autonomic function has been associated with cases of congenital insensitivity to pain; central nervous system (CNS) disorders such as Parkinson's disease, multiple sclerosis, and Shy–Drager syndrome; and peripheral neuropathies including diabetes mellitus, amyloidosis, Guillain–Barré syndrome, Fabry's disease,91and Ross syndrome (a triad of segmental progressive anhidrosis, tonic pupils, and areflexia). Occasionally, no underlying cause can be92–94 found and the condition is then termed “acquired idiopathic generalized anhidrosis.” Patients with acquired idiopathic generalized anhidrosis, usually young adults who are otherwise healthy, present with the complaint of severe prickling pain and itch whenever they are warm enough to sweat—usually when their body temperature is raised by approximately 0.5°C. The sensation is intolerable, and patients are often unable to exercise or work. When patients are given a heat stress, they develop transient, fine, skin-colored papules resembling “goose bumps” centered around eccrine orifices. The cutaneous sensations appear with the skin lesions. Cooling immediately resolves the symptoms. The pathogenesis of acquired idiopathic generalized anhidrosis is still unclear but is probably heterogeneous. Findings from skin biopsies have been inconsistent, ranging from normal eccrine glands in some to atrophic or degenerated glands in others,91,94,95 with a few showing A decrease in the infiltrates of lymphocytes and mast cells around the duct or glands. number of nerve terminals and unmyelinated axons associated with histologically normal eccrine glands has led some to implicate degeneration of postganglionic sympathetic 95 cholinergic nerves as responsible for anhidrosis. Even though an association of acquired idiopathic generalized anhidrosis with cholinergic 91 urticaria has been documented in the literature, there are clear and distinct differences between the two diseases. Patients with cholinergic urticaria, believed to be produced by actions of acetylcholine on mast cells, often complain of itching wheals surrounded by areas of erythema that appear within minutes of exertion, with increased environmental 96 temperature, after emotional disturbances, or after ingestion of spicy foods, whereas patients with acquired idiopathic generalized anhidrosis do not report identifiable triggers except heat. In patients with cholinergic urticaria, systemic symptoms of flushing, 97,98 ; however, unlike those with acquired hypotension, faintness, or asthma may occur idiopathic generalized anhidrosis, patients with cholinergic urticaria are not anhidrotic and usually enjoy a refractory period with no lesions for up to 24 hours following a provoked attack. A useful way to avoid confusion between the two is to think of acquired idiopathic generalized anhidrosis as a neurologically mediated entity and cholinergic urticaria as a nerve-stimulated mast cell phenomenon. Treatment of acquired idiopathic generalized anhidrosis is limited, and nonresponders are not uncommon. Corticosteroids produce dramatic effects in some patients, although clinical studies are93,99 difficult to evaluate because adequate control subjects have not been It is likely that the effects of corticosteroids depend on the nature of the examined. 95 pathogenetic process or the disease stage.
Previous
Next
Return to Previous Page
8/8
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
Return to Previous Page
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Print this page
This information has been developed and provided by an independent third party source. Merck & Co., Inc., does not endorse and is not responsible for the accuracy of the content, or for practices or standards of non-Merck sources. This resource may discuss regimens that have not been approved by the FDA. For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences please see the appropriate manufacturer's product circular. View Prescribing Information for Merck products.
Table of Contents This Chapter by Chapters
Keyword Index
Michael J. Aminoff
NEUROLOGY and GENERAL MEDICINE 13 Neurological Manifestations of Hematological Disorders G.A.B. DAVIES-JONES • JON D. SUSSMAN •
Previous
Next
ANEMIA Iron-Deficiency Anemia Vitamin B12 Deficiency Peripheral Neuropathy Myelopathy Encephalopathy Optic Neuropathy Disordered Eye Movements Extrapyramidal syndrome Infantile Vitamin B12 Deficiency Imerslund-Graesbeck Syndrome Folate Deficiency Sickle Cell Disease Thalassemia Hereditary Spherocytosis Paroxysmal Nocturnal Hemoglobinuria Cold Agglutinin Disease Cryoglobulinemia Kernicterus RARE NEUROLOGICAL SYNDROMES AND RED CELL ABNORMALITIES PROLIFERATIVE DISORDERS Leukemia Meningeal Leukemia Localized Leukemic Deposits Chloromas (Granulocytic Sarcoma) Intracranial Hemorrhage Cellular Hyperviscosity Infections Leukoencephalopathy and Other Encephalopathies Myelomatosis Spinal Myeloma Nerve Root Compression Cranial Myeloma
1 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Peripheral Neuropathy Neurological Effects of Metabolic Complications Neurological Effects of Immunological Complications Macroglobulinemia (Waldenström's Disease) Paraproteinemias Lymphoma Spinal Cord and Meningeal Involvement Intracranial Involvement Paraneoplastic Syndromes Other Neurological Complications Burkitt's Lymphoma Primary Intracerebral Lymphoma Intravascular Lymphoma Lymphomatoid Granulomatosis Polycythemia Cerebellar Hemangioblastoma Pseudopolycythemia Essential Thrombocythemia Myelofibrosis Eosinophilic Syndromes HEMORRHAGIC DISORDERS Hemophilia Von Willebrand's Disease Christmas Disease Other Clotting Factor Deficiencies Acquired Hemophilia Hemorrhagic Disease of the Newborn Thrombocytopenia Disorders of Platelet Function Disseminated Intravascular Coagulation Thrombotic Thrombocytopenic Purpura Hemolytic-Uremic Syndrome Gaucher's Disease COAGULATION DISORDERS Antiphospholipid Antibodies Hereditary Thrombophilia Antithrombin Deficiency Protein C Deficiency Protein S Deficiency Factor V Leiden (RQ506Q) Prothrombin G:A 20210 Mutation Hyperhomocysteinemia Factor VIII Interactions Between Inherited Thrombophilias Interactions Between Inherited and Acquired Risk Factors Thrombophilic Disorders and Arterial Thrombosis Patent Foramen Ovale
Hematological disorders can affect the central and peripheral nervous systems in a number of different ways, producing a wide range of neurological disturbances. Some of these neurological complications are well described, but others are less clearly defined. In the present chapter, neurological aspects of each of the main groups of hematological disorders are discussed. For brevity, a number of the older references have been deleted, but they can be found in earlier editions of this book. ANEMIA
Iron-Deficiency Anemia Nonspecific neurological symptoms of tiredness, fatigability, weakness, poor concentration, irritability, faintness, dizziness, tinnitus, and headache are commonly associated with anemia. Occasionally, more concrete neurological syndromes arise, and a number of case reports have drawn attention to the association of benign intracranial hypertension and cerebral 1,2 venous sinus thrombosis with iron-deficiency anemia. The benign intracranial hypertension 2 may resolve and recur with resolution and recurrence of the iron-deficiency anemia. In some patients with iron-deficiency anemia, thrombocytosis may be marked and may be so high as to suggest a myeloproliferative disorder. The increased platelet mass may be accompanied by signs and symptoms of cerebrovascular insufficiency, either as transient cerebral ischemic
2 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
attacks (TIAs) or as cerebral infarction or amaurosis fugax. Profound anemia, particularly if associated with thrombocytopenia, may produce a retinopathy comprising papilledema, cotton-wool exudates, flame-shaped hemorrhages, retinal edema, and even retinal detachment. Blindness is a rare but long-recognized complication of massive hemorrhage; swelling of the optic discs is followed within a few weeks by optic atrophy. Focal neurological signs may arise from severe anemia in conjunction with severe cerebral atherosclerosis. Symptoms may resolve completely over hours as the hemoglobin is 3 increased. 4 Severe anemia may produce signs and symptoms that mimic Guillain–Barré syndrome. Transient erythroblastopenia of childhood has been noted to present with papilledema and 5 may be associated with iron-deficiency transient hemiparesis. Restless legs syndrome 6 anemia including frequent blood donation. Iron deficiency and a strong family 7history (present in 72%) are characteristic of childhood-onset restless legs syndrome.
Vitamin B12 Deficiency Vitamin B12 deficiency may result in lesions affecting the peripheral nerves, spinal cord, optic nerves, and brain. Addisonian pernicious anemia is an important cause of vitamin B12 deficiency, but the neurological complications may also result from vitamin B12 deficiency secondary to malabsorption syndromes, gastric and ileal resections, terminal ileal removal for 8 lower urinary tract reconstruction, blind loops, infestation with fish tapeworm, and dietary deficiency, particularly in vegans. It is essential to realize that all the neurological complications of vitamin B12 deficiency may occur with no appreciable alteration in the peripheral blood picture. There may be no anemia, and erythropoiesis may even be normoblastic. Lindenbaum and colleagues confirmed that neuropsychiatric disorders due to vitamin B12 deficiency occur commonly in the absence of anemia or macrocytosis and suggested that measurements of serum methylmalonic acid and total homocysteine both 9 before and after treatment are useful in the diagnosis of these disorders. Peripheral Neuropathy The frequency of peripheral neuropathy as a complication of vitamin B12 deficiency is difficult to determine accurately, since the sensory symptoms of peripheral neuropathy may be identical to those of vitamin B12 myelopathy. However, the findings of muscle wasting and absent reflexes confirm the presence of neuropathy. Electrophysiological studies indicate that the neuropathy is secondary to a dying-back type of axonal degeneration, and neuropathological studies have demonstrated the loss of large myelinated fibers in distal sensory nerves as well as axonal degeneration in teased-fiber preparations. Paresthesias and numbness appear first in the feet and legs, accompanied by loss of reflexes, superficial sensory impairment in a stocking distribution, and impairment of vibration sense. Later, there are similar sensory changes in the hands, together with wasting and weakness of the distal leg muscles. Myelopathy Demyelination followed by axonal degeneration seems to affect the most heavily myelinated fibers first, which may explain why lesions appear first in the posterior columns and later in the lateral columns. They tend first to appear at the mid-thoracic level. The term subacute combined degeneration is appropriate for describing this process in most cases because symptoms and signs usually progress over several weeks and months. However, progression may be rapid, resulting in severe clinical disability within a week or two; or it may be much more chronic, developing over a year or more. Sensory symptoms appear first in the feet, accompanied by early and severe impairment of proprioception and vibration sense. The ankle reflexes are usually absent, owing to the invariable concomitant peripheral neuropathy, but the knee reflexes become exaggerated sooner or later, and subsequently the plantar responses become extensor. Severe sensory ataxic spastic paraparesis may be virtually the sole manifestation of vitamin B12 myelopathy. Bladder symptoms of urinary urgency leading to incontinence occur later. Pseudoathetosis of the fingers, hands, or toes due to severe loss of joint position sense can be a rare but prominent feature. Encephalopathy
3 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
The pathological changes in the brain are similar to those in the spinal cord. Multiple foci or diffuse areas of demyelination in the white matter occur with little evidence of glial cell proliferation or axonal degeneration. Changes appear most marked in the corpus callosum and in the frontal and parietal white matter. A variety of symptoms occur, consisting of disorders of mood, mental slowing, poor memory, confusion, agitation, delusions, visual and auditory hallucinations, aggression, dysphasia, and incontinence. Shorvon and associates assessed the neuropsychiatric state of 50 patients with megaloblastosis due to vitamin B12 deficiency and that of 34 patients due to folate deficiency 10 presenting to hematologists or general physicians. One third of each group had no neuropsychiatric complications. Peripheral neuropathy was the most common complication of vitamin B12 deficiency (40%). Eight patients (16%) had evidence of subacute combined degeneration of the cord, and one (2%) had optic atrophy. Organic mental change of unspecified nature occurred in 26 percent, and affective disorders in 20 percent. Response to vitamin B12 therapy is variable. Healton and associates confirmed that all 11 patients respond to some extent to treatment, and recovery was complete in virtually half. The severity score was reduced by 50 percent in 91 percent of instances. Residual long-term moderate or severe neurological disabilities were observed in 6.3 percent. The degree of neurological disability remaining after treatment was related to two factors—the nature of the neurological disability and the duration of symptoms before treatment. Optic Neuropathy Optic neuropathy due to vitamin B12 deficiency is rare. It is reputedly more common in men. It may precede, coincide, or follow the anemia or the myelopathy. The characteristic visual abnormality is a centrocecal scotoma, usually appearing earlier to red than to white, which may be associated with constriction of the periphery of the visual field leading to optic atrophy. With early and adequate treatment, recovery may be complete. Disordered Eye Movements 12
13
14
Downbeat nystagmus, paralysis of upward gaze, and internuclear ophthalmoplegia been attributed to vitamin B12 deficiency and have responded to vitamin B12 therapy.
have
Extrapyramidal syndrome Kumar described the rapid onset of a typical parkinsonian syndrome over 10 days in a man found to have vitamin B12 deficiency that showed a dramatic response to parenteral vitamin 15 B12. At 5-year follow-up there were no residual neurological signs. Infantile Vitamin B12 Deficiency Infantile vitamin B12 deficiency may result from maternal vitamin B12 deficiency causing 16 encephalopathy, epilepsy, and microcephaly. Imerslund-Graesbeck Syndrome Vitamin B12 malabsorption in the ileum has been suggested to be the underlying cause of this syndrome, which consists of megaloblastic anemia, proteinuria, and multiple neurological abnormalities. A young Saudi child with spasticity, truncal ataxia, cerebral atrophy, 17 megaloblastic anemia, and proteinuria completely recovered following vitamin B12 therapy.
Folate Deficiency In the study of Shorvon and colleagues previously mentioned, affective disorders (mostly depression) and organic mental change were the most common neuropsychiatric 10 complications of folate deficiency. Peripheral neuropathy was seen in a few patients, but there was no instance of optic atrophy or myelopathy. Subacute combined degeneration of the cord and optic atrophy occurred only in the patients with vitamin B12 deficiency. However, diet-induced folic acid deficiency with subacute combined degeneration 18 of the spinal cord that improved significantly after treatment with folic acid has been recorded. Mental and physical retardation, hypotonia, cerebral atrophy, seizures, ataxia, and athetoid movements are associated with congenital folate malabsorption; calcification of the basal
4 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
ganglia has also been reported. Allen and colleagues have associated the Kearns–Sayre syndrome—progressive external ophthalmoplegia, conduction heart block, atypical pigmentary degeneration of the retina, calcification of the basal ganglia, white matter hypodensities on cranial computed tomography (CT), and “ragged red fiber” myopathy—with 19 low cerebrospinal fluid (CSF) folate levels.
Sickle Cell Disease Most if not all of the clinicopathological complications of sickle cell anemia (Hb SS) or of sickle C disease (Hb SC) relate to the formation of sickle cells; these cells form because of the insolubility of deoxygenated hemoglobin S polymers, and they produce vascular occlusion by adhering to various receptors on the vascular endothelium, producing aggregates and thrombotic vessel occlusion. The neurological complications also result from a point mutation 20 that causes vasculopathy of both large and small vessels. In circumstances of severe hypoxemia, even patients with sickle cell trait (Hb SA) may develop vaso-occlusive disease. Factors exacerbating the sickling phenomenon include hypoxia, dehydration, acidosis, and infection. Children with sickle cell disease have a reduced level of the majority of endothelial coagulation inhibitors, which further enhances the 21 adhesive interactions between sickle cells with injured cell membranes and endothelial cells. As sickling occurs in the venous circulation, central venous Po2, not arterial Po2, is the critical factor. There is a trace of sickling in homozygous disease even when hemoglobin is 100 percent saturated with oxygen, whereas at 65 and 50 percent oxygen saturation there is 75 and 100 percent sickling, respectively. In heterozygous disease with 40 percent hemoglobin S (Hb S), sickling starts at 40 percent saturation. The critical Po2 is 30 mmHg for sickle cell disease and 20 to 30 mmHg for sickle cell trait. In the presence of circulatory stasis or reduced cardiac output, oxygen extraction may be so high that venous Po2 is reduced to dangerously low values despite normal arterial oxygen tension. In sickle cell trait, the severity of sickling depends on the actual amount of Hb S rather than the proportions of hemoglobin A (Hb A) and Hb S. The percentage of Hb S in sickle cell trait can vary from 25 to 45 percent. In vitro studies suggest that in carriers who have a high concentration of Hb S, the risk of 22 sickling is not much less than in patients with sickle cell disease. The incidence of neurological manifestations in patients with sickle cell disease approximates 25 percent, with cerebral infarction and hemiparesis being most common. Cerebral infarction tends to occur in young children, and transfusion greatly reduces the risk of a first stroke in affected children 23 who have abnormal high-velocity flow on transcranial Doppler ultrasonography. Intracranial hemorrhage is much rarer; it tends to occur more often in adults and is more commonly subarachnoid. In adults, the subarachnoid hemorrhage is usually associated with ruptured aneurysms, which frequently are multiple and commonly involve the posterior circulation. In children, it tends to be primary and possibly related to fibrotic endarteritis and fragmentation of the internal elastic lamina of the larger proximal 24 intracranial arteries. Stenosis of large extracranial or intracranial vessels may occur secondary to a vasculopathy and fibrous proliferation of the intima. Other neurological manifestations of sickle cell disease include aphasia, cranial 25 26 neuropathies, radiculopathy, ischemic mononeuropathy, radiculomyelopathy from vertebral crushing as a result of successive bone infarction, paraplegia, spinal cord infarction, hypopituitarism, ischemic optic neuropathy, optic atrophy, transient ischemic attacks, and seizures. Prengler and colleagues suggested that vasculopathy and 27 focal hypoperfusion cord infarction might be relevant to the seizures associated with sickle cell disease. Spinal 28 Subcortical is rare, and there has been only one autopsy report of this complication. 29,30 as has cerebral venous cerebral infarction31has also been described in sickle cell trait, sinus thrombosis. In contrast to homozygous sickle cell disease, cerebrovascular complications are relatively uncommon in Hb SC disease. The association of proliferative retinopathy with Hb SC disease is well known. Fabian and Peters found a significant increase in retinopathy, stupor, coma, 32 and seizures in patients with Hb SC disease compared with matched control subjects. Recurrent transient impairment of vision due to occlusion of major retinal vessels is an unusual manifestation of Hb SS disease. It is important to remember that patients with sickle cell disease may develop neurological disorders unrelated to their hemoglobinopathy and so should be investigated to exclude unrelated but treatable conditions. This is illustrated by the patient of Caprioli and colleagues who developed acute monocular visual loss with no retinal or vitreous abnormalities but who 33 had a large aneurysm of the anterior communicating artery compressing the optic nerve.
5 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Thalassemia Chronic anemias such as thalassemia are associated with extramedullary hematopoiesis, usually in the liver, spleen, or lymph nodes. There have been a few reports of extramedullary hematopoiesis in thalassemia producing spinal cord compression and paraparesis, the hematopoietic tissue presumably arising from embryonal rests in the extradural areolar tissue of mesodermal origin. Most commonly the lesion is situated in the middle to lower thoracic region of the spinal canal, and surgical decompression plus radiotherapy is curative. Treatment with corticosteroids or repeated blood transfusions together 34 with local radiotherapy to the tumor without surgical decompression has also been successful. Transfusion alone to maintain the hemoglobin level above 12.5 g/dl has been reported to relieve the signs of spinal 35 cord compression, with near-complete resolution of the extradural hematopoietic suprasellar extramedullary hematopoiesis in mass. Visual failure secondary to 36 β-thalassemia has been described. In one study, 20 percent of β-thalassemic patients were found to have clinical and 37 electrophysiological findings of a predominantly motor sensorimotor neuropathy. Severe forms of β-thalassemia are associated with an increased risk of cerebral thrombosis as well as portal and deep vein thrombosis and pulmonary 38 embolism.
Hereditary Spherocytosis There has been an isolated report of two patients with hereditary spherocytosis associated 39 with a mild spastic paraparesis for which no cause was found. Although it may have been an entirely fortuitous association, the authors deliberated about a possible common mechanism for the neurological and red blood cell abnormalities. This association has not been described since.
Paroxysmal Nocturnal Hemoglobinuria Paroxysmal nocturnal hemoglobinuria is a rare acquired hematopoietic stem-cell disorder characterized by deficiency of glycosyl phosphatidylinositol (GPI)–anchored protein. This results in deficiency in the binding of several protective red cell membrane proteins and leads to hypersensitivity to complement and hemolysis. It may occur de novo or in association with marrow hypoplasia. It is characterized by intravascular hemolysis and manifested by episodes of hemoglobinuria and venous thrombosis. Increased intravascular destruction of red cells occurs at night, which results in hemoglobinuria seen when the first urine is passed in the morning. One of the commonest complications of this disorder is large-vessel thrombosis, and its occurrence in the brain and portal system accounts for the death of 50 percent of patients. The thrombotic tendency is thought to arise from deficiency in GPI-linked proteins in platelets. Although thrombosis has been reported in most organs, it has not been detected in the vessels of the spinal cord; most of the neurological complications of paroxysmal nocturnal hemoglobinuria relate to thrombosis of intracranial vessels. Cerebral 40 arterial and venous thrombosis occurs, resulting in hemorrhagic infarction. During the crises of paroxysmal nocturnal hemoglobinuria, an occasional patient suffers TIAs that have been attributed to the hypercoagulable state induced when excess thromboplastin is released from lysing red blood cells. Increased sensitivity of the red cells to lysis by complement stimulates platelet aggregation and hypercoagulability. In the study of Hillmen and associates, a neurological cause of death was found in 10 percent of patients, including cerebral venous 41 thrombosis, subarachnoid hemorrhage, and intracerebral hemorrhage.
Cold Agglutinin Disease Cold agglutinin disease is usually associated with IgM antibodies (rarely IgG and IgA cold-reactive autoantibodies) directed against erythrocytes with binding activity that increases as the temperature approaches 0°C. Characteristically, the disease presents as anemia and a cold-induced rash. A case is reported of a man with purpura, anemia, cold agglutinins, and a sensory and autonomic polyneuropathy that resolved on treatment with corticosteroids and 42 plasma exchange.
Cryoglobulinemia Cryoglobulins are serum proteins or protein complexes that undergo reversible precipitation at low temperatures. Three main types of cryoglobulin are recognized. Type I consists of monoclonal proteins seen in association with multiple myeloma, Waldenström's macroglobulinemia, and other lymphoproliferative disorders. Type II consists of mixed immunoglobulin complexes in which the monoclonal antibody has specificity for polyclonal
6 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
IgG, and is described in association with lymphoproliferative diseases, autoimmune disorders, and hepatitis. Type III cryoglobulin is composed of polyclonal immunoglobulin and is found in infections and autoimmune disorders. Neurological complications are not unusual, with peripheral symmetric sensorimotor axonal or demyelinating polyneuropathy being the most common finding. More rarely, acute mononeuritis or cerebral ischemia or vasculitis may occur.
Kernicterus With the virtual elimination of hemolytic disease of the newborn, kernicterus is now uncommon in developed countries. It may be produced by any hemolytic process of sufficient severity in neonates and in premature infants by “physiological jaundice.” Whenever the serum unconjugated bilirubin level exceeds 20 mg/dl during the first few weeks of life, kernicterus may occur. Unconjugated bilirubin is highly lipid soluble; it enters the brain and binds to neurons, resulting in neuronal necrosis particularly in the basal ganglia and cerebellum. The neurological features include opisthotonos, convulsions, rigidity, involuntary movements, athetosis, deafness, nystagmus, and psychotic behavior. RARE NEUROLOGICAL SYNDROMES AND RED CELL ABNORMALITIES Hallervorden–Spatz disease of dystonia, dementia, and spasticity in childhood43,44 or adolescence has been associated with acanthocytosis in occasional patients. Bassen–Kornzweig disease (neuroacanthocytosis with abetalipoproteinemia) is a well-defined, recessively inherited syndrome characterized by acanthocytosis, retinitis pigmentosa, increasing cerebellar ataxia, peripheral neuropathy, steatorrhea, and complete or almost complete lack of serum β-lipoproteins, with onset during childhood. Treatment with vitamins A and E as early as possible is helpful. Chorea-amyotrophy-acanthocytosis is another rare neurological syndrome associated with peripheral blood acanthocytosis. The neurological features consist of adult-onset progressive choreiform movements of the limbs, lip and tongue biting, orofacial dyskinesia, high serum creatine kinase levels, peripheral neuropathy with amyotrophy, and normal serum 45,46 This neurological lipoproteins. These patients may also develop features of parkinsonism. syndrome without acanthocytosis but with47chronic spherocytic hemolytic anemia was seen in two brothers by Spencer and associates. At autopsy the striatum was atrophic, with iron deposition and spheroid bodies. There was degeneration of the substantia nigra and anterior horn cells of the spinal cord. These features provide an anatomical basis for the parkinsonism and motor neuron disease associated with chorea-amyotrophy-acanthocytosis. Hardie and associates reviewed 19 cases of neuroacanthocytosis in which progressive chorea, dystonia, akinetic rigidity, orofaciolingual movements, pseudobulbar dysphagia and 48 dysarthria, and lip and tongue biting occurred. Cognitive impairment and organic personality changes occurred in more than half of the cases, more than one third of patients had seizures, and frontal subcortical-type dementia was also described. Depressed or absent tendon reflexes occurred in 13, and axonal neuropathy was often found electrophysiologically. The investigators emphasized that mild acanthocytosis can easily be overlooked and that scanning electron microscopy may be helpful. A benign X-linked myopathy with acanthocytosis has also been described and is referred to as McLeod's syndrome. A progressive spinocerebellar syndrome and a sideroblastic anemia segregating together in 49 an X-linked recessive fashion was described by Pagon and co-workers. Cerebellar ataxia and dysarthria develop at an early childhood, and there is motor delay. The neurological signs 50 tend to be stable until the 40s, when slow progression may occur. A case of primary acquired sideroblastic anemia with a predominantly motor polyneuropathy responsive to 51 vitamin B6 has been documented. An autosomal-recessive axonal hereditary sensory-motor 52 neuropathy has ben associated with sideroblastic anemia. Sideroblastic anemia and mitochondrial myopathy is a rare autosomal recessive disorder of oxidative phosphorylation 53 and iron metabolism; the gene responsible maps to chromosome 12q24.33. Triosephosphate isomerase deficiency is a rare disorder characterized by chronic hemolytic anemia, progressive neurological dysfunction, and usually an increased susceptibility to infection. The neurological features consist of a dystonic-dyskinetic syndrome; gross intention tremor and rhythmical, jerky movements of the proximal parts of the limbs; generalized weakness; amyotrophy and hypotonia of the trunk and limbs; and sometimes pyramidal signs. There are electromyo-graphic (EMG) signs of denervation with normal nerve
7 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp 54
conduction velocities, suggestive of anterior horn cell impairment. It has been suggested that low triosephosphate isomerase activity leads to a metabolic block in the glycolytic 55 pathway and hence to an impairment of the cellular energy supply. PROLIFERATIVE DISORDERS
Leukemia The increased frequency of central nervous system (CNS) involvement in leukemia is related to the increased survival of patients. It is estimated to occur in between 2 and 4 percent of leukemic patients per month. CNS involvement is a poor prognostic sign if it is evident on presentation and even more so if it develops later. Involvement of the CNS in leukemia is often due to infiltration with leukemic cells, but neurological complications may occur as the result of hemorrhage, infection, drug- and radiation-induced neurotoxicity, electrolyte disturbance, and impairment of cerebral circulation from leukostasis. Leukemic cells enter the nervous system by direct seeding of circulating leukemic cells, lymphatic spread, or direct invasion from overlying meninges, or from cells with hematopoietic potential lying in relationship to arachnoidal vessels. Meningeal Leukemia The most common presenting symptoms of meningeal leukemia are headaches, nausea, and vomiting, sometimes associated with lethargy and irritability, drowsiness, coma, convulsions, and neck stiffness. Diffuse meningeal infiltration impairs the circulation of CSF and can result in obstructive or communicating hydrocephalus. Papilledema is the commonest sign, with separation of the skull sutures in young children. The leukemic deposits may compress or infiltrate the cranial nerves or spinal nerve roots and spread between the nerve fibers. The second, third, sixth, seventh, and eighth cranial nerves are the most commonly affected, but the lower cranial nerves are occasionally involved. Oculomotor palsy with pupillary sparing 56 has been described secondary to chronic lymphocytic leukemic infiltration of the meninges. The diagnosis of meningeal leukemia is confirmed by finding leukemic cells in the CSF. Increased CSF leukocyte counts are found in approximately 90 percent of cases, and cytocentrifuge preparations enable both blast cells and mitotic figures to be identified. The CSF pressure is usually elevated, but in approximately 10 percent of cases with unequivocal clinical evidence of meningeal involvement, the CSF is normal in every respect. Reduced CSF glucose and elevated protein concentrations are frequently seen but are unreliable characteristics of meningeal disease. Although meningeal leukemia is predominantly associated with acute lymphocytic leukemia and occasionally with acute nonlymphocytic leukemia, meningeal leukemia as the initial 57 presentation of B-cell chronic lymphocytic leukemia has been described. In their review of chronic lymphocytic leukemia with neurological complications, Cramer and co-workers pointed out that invasion of the CNS may produce meningitis 58 with cranial nerve palsies, confusional states, optic neuropathy, and cerebellar dysfunction. Symptomatic involvement of the CNS was comparatively rare, although infiltration of the brain and spinal cord was common at autopsy. By contrast, clinical involvement of the peripheral nervous system, including the cranial nerves, was more common. Acute myelomonocytic leukemia accompanied by pericentric inversion of chromosome 16 is a unique subtype associated with a high incidence of CNS involvement in the form of leptomeningeal deposits and granulocytic sarcoma (chloroma). Localized Leukemic Deposits Leukemic deposits may involve any part of the CNS. The symptoms and signs are therefore numerous and varied, and they depend on the extent of infiltration and the area of localization. The complete range of cranial nerve palsies has been described, as has hemiplegia, aphasia, hemianopia, ataxia, convulsions, and cortical blindness. Blindness may 59 and visual impairment from also occur from leukemic infiltration of the optic nerve head, 60 with visual blurring may be the retinal infiltration. Bilateral serous macular detachment 61 presenting symptom of acute lymphoblastic leukemia. One of the authors (GDJ) has seen
8 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
three patients with mental nerve involvement that produced sensory impairment of the lower lip and painless traumatic ulceration of the buccal mucosa, and three further cases of the numb chin syndrome as an initial symptom of acute lymphatic leukemia have been 62 reported. Hypothalamic and pituitary dysfunction are not uncommon, resulting in the hypothalamic obesity–somnolence syndrome, with excessive eating, headache, weight gain, somnolence, vomiting, and a change of behavior, usually to a more aggressive pattern. Histological examination of the hypothalamus in these cases shows diffuse infiltration by leukemic cells. This syndrome may also be associated with hydrocephalus, the hypothalamic pituitary dysfunction arising from the pressure effects of a distended third ventricle. Diabetes insipidus may occur alone or as part of the hypothalamic obesity syndrome. Clinically significant spinal cord involvement is unusual in leukemia, in contrast to intracranial, especially meningeal, involvement. The clinical syndromes relating to spinal cord involvement range from a complete cord syndrome (transverse lesion of the spinal cord with paraplegia, sensory loss below the involved segment, and urinary retention) to partial cord syndromes: anterior or posterior cord syndromes or the Brown-Séquard syndrome. Back pain, frequently with root involvement, and progressive paraparesis or quadriparesis over days or weeks is another manifestation of progressive spinal cord compression from extradural deposits, usually in the thoracic area. Cervical cord, cauda equina, and conus medullaris compression occur rarely. In their review of spinal cord leukemia, Petursson and Boggs found acute myeloid leukemia to be the most common type, followed by acute lymphoblastic and chronic 63 myeloid leukemia, with only one instance of chronic lymphatic leukemia. Cord syndromes arise from compression by extradural deposits; direct infiltration of the spinal cord and nerve roots; vascular occlusion by thrombus, leukemic cells, or a mixture of leukemic cells and thrombus; or hemorrhage. Exceptionally, an acute paraneoplastic necrotizing myelopathy may occur. Peripheral neuropathy complicating leukemia is rare. It usually results from diffuse leukemic infiltration, hemorrhage, or infarction, and it manifests by either individual or multiple nerve involvement. Proven examples of paraneoplastic neuropathy are exceptionally uncommon. Adult T-cell leukemia found among subjects born in Kyushu, Japan, may be complicated by a 64 peripheral neuropathy. Chloromas (Granulocytic Sarcoma) Chloromas are solid tumors of nonlymphatic leukemia. Occasionally, extramedullary chloromas occur in patients without any evidence of leukemia, which these tumors may precede by many months. Histologically, they are composed of poorly differentiated blast cells, almost invariably myeloblasts but occasionally monoblasts. Macroscopically, they have a distinctive green color that fades on exposure to light. Most occur subperiosteally, usually in the cranial and facial bones, especially the paranasal sinuses, mastoid air cells, or orbits; they are usually attached to the dura mater. More common in children than adults, they may present with ophthalmoplegia and exophthalmos, if orbital in origin, or with facial palsy, if they arise from the mastoid air cells. As a result of dural involvement, they may produce headaches, nausea, vomiting, papilledema, hemiplegia, or multiple cranial nerve palsies. They rarely invade cerebral tissue. Chloromas associated with the spinal dura mater result in spinal cord compression. Decompression together with radiotherapy or65chemotherapy produces resolution of the paraplegia and disappearance of the tumor. Chloromas are radiosensitive. Intracranial Hemorrhage Intracranial hemorrhage usually occurs at presentation or during relapse when the leukemic patient is unresponsive to chemotherapy. Thrombocytopenia is an almost constant concomitant of intracranial hemorrhage. It is possible, at least in some cases, that it is the result of platelet consumption due to disseminated intravascular coagulation (DIC) rather than to reduced platelet production by the bone marrow secondary to leukemic infiltration. Platelet production may also be impaired as a result of myelotoxic effects of the chemotherapy. In the absence of any other abnormality of coagulation, intracranial hemorrhage is unusual if the 3 platelet count is greater than 20,000/mm . Bleeding in the CNS is usually multifocal, affecting the meninges as well as the brain or spinal cord. Characteristically, the hemorrhages vary in size from multiple petechial hemorrhages to large, confluent ones. DIC is a prominent feature of promyelocytic leukemia. In other forms of leukemia, DIC is particularly marked in patients with high peripheral white cell counts, and it appears soon after the beginning of chemotherapy, presumably occurring because tissue thromboplastins are released from
9 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
destroyed leukocytes. The widespread distribution of hemorrhage in acute leukemia usually results in deep coma from the outset, rapidly progressing to death. If the bleeding is localized and not multifocal, the resultant syndromes depend on the part of the neuraxis involved. The cerebral hemispheres are most frequently implicated, particularly the white matter. Both acute and chronic subdural hematoma may occur; and cisternal, cervical, or lumbar puncture in a thrombocytopenic patient with acute leukemia may cause a spinal subdural hematoma and spinal cord or cauda equina compression. Cellular Hyperviscosity The hyperviscosity syndrome embraces a symptom complex of neurological dysfunction, visual disturbances, and a hemorrhagic tendency. Marked elevation of the white cell count may produce a significant increase in whole blood viscosity. All types of leukemia, acute or chronic, may produce this syndrome, but neurological symptoms may occur more readily at lower leukocyte counts in patients with myeloid leukemia than in patients with lymphocytic leukemia. This finding is probably a reflection of the larger cell size in the myelogenous leukemias. The signs and symptoms of cellular hyperviscosity are varied and include auditory and visual disturbances, headache, ataxia, profound lethargy, somnolence, impairment of consciousness, and TIAs (Fig. 13-1). It is important to recognize the possibility of this 9 syndrome in patients with massively elevated white cell counts (in excess of 200 × 10 /L), since treatment with leuka-pheresis may abolish the symptoms. It is important also to remember that blood transfusions may be hazardous in patients with high leukocyte counts because the additional red blood cells may further elevate the blood viscosity to clinically significant levels, sufficient to produce coma and even death. Hyperleukocytosis in chronic 66 myeloid leukemia may also result in deafness.
FIGURE 13-1 Cellular hyperviscosity in leukemia. Virtually complete occlusion of
cortical vessel with leukemic cells. (Hematoxylin and eosin. Original magnification 504×.) (From Davies-Jones GAB, Preston FE, Timperley WR: Neurological Complications in Clinical Haematology. Blackwell Scientific Publications, Oxford, UK, 1980, with permission.) Infections
10 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
In all leukemias, but particularly in the lymphoblastic leukemia of childhood, viruses (especially mumps, measles, and varicella) are the most common infective organisms of the CNS. Bacterial and fungal infections, especially aspergillosis, also occur. The increased incidence of involvement of the CNS with rare organisms or organisms that are normally nonpathogenic is contributed to by widespread use of corticosteroids, +chemotherapy, and broad-spectrum antibiotics. Autoimmune myositis with extensive CD8 T-cell infiltrates without any evidence of microbial infection has been described in association with large 67 granular leukocytic leukemia. Leukoencephalopathy and Other Encephalopathies Progressive multifocal leukoencephalopathy may complicate a variety of chronic diseases, including leukemias, lymphomas, carcinomas, sarcoidosis, and acquired immunodeficiency syndrome (AIDS) (Chapter 45). It is a progressive demyelinating infection caused by the ubiquitous, usually nonpathogenic JC virus in immunocompromised patients. Lysis of oligodendrocytes causes foci of myelin breakdown, which coalesce to form large areas of demyelination. Progressive disturbance in mental status, motor function, vision, and coordination results, as may focal sensory deficits. It is generally rapidly fatal, but very rarely spontaneous remission has occurred, and it may respond to treatment with cytarabine and interferon-α. Another disseminated leukoencephalopathy appears in patients with acute lymphoblastic leukemia treated with cranial irradiation and intrathecal methotrexate or in those treated with craniospinal irradiation followed by intravenous methotrexate. High-dose intravenous methotrexate produces an encephalopathy in less than 2 percent of instances; with either cranial irradiation or intrathecal methotrexate, encephalopathy develops in less than 1 percent of children. After combined intravenous methotrexate and cranial irradiation or intrathecal methotrexate and cranial68irradiation, however, the incidence increases to 15 percent and 5 percent, respectively. Pathologically, the leukoencephalopathy is characterized by demyelination, axonal degeneration, gliosis, coagulation necrosis with or without fibrinoid vascular change, mineralizing microangiopathy, and calcification. The periventricular white matter seems to be preferentially involved, but the lesions may occur anywhere in the white matter of the brain and spinal cord. The clinical manifestations of this form of encephalopathy may be delayed until several months after treatment is finished. The symptoms and signs may be varied and diffuse, reflecting the disseminated neuropathological process. Clinical features include irritability, agitation, confusion, drowsiness, ataxia, dementia, hemiplegia, quadriplegia, aphasia, and hemianopia. Cranial irradiation may produce signs of mild encephalopathy within hours of the initial dose. This usually results in somnolence but may be associated with signs of increased intracranial pressure, cranial nerve palsies, convulsions, ataxia, signs of cerebral herniation, coma, and death, especially if the patient has been given one or more injections of intrathecal chemotherapy. Cranial irradiation alone may also produce a “somnolence syndrome,” which generally occurs several weeks after treatment. Leukoencephalopathy following radiotherapy and intrathecal methotrexate may result in learning difficulties, cognitive dysfunction, and seizures in long-term survivors of childhood leukemia. Brouwers and associates showed that leukoencephalopathic patients with CT scan abnormalities of any type—calcification and cerebral atrophy—exhibited poor memory (more so for long-term retention than immediate recall) and difficulty in word-finding as compared 69 with patients who had normal CT scans. Patients with CT calcification showed greater deficits than those with cortical atrophy. Green and colleagues studied 17 adult patients with acute lymphoblastic leukemia, assessing them by neurological examination, electroencephalography (EEG), auditory evoked 70 potentials, CT scans, and magnetic resonance imaging (MRI). They concluded that there was little evidence of major CNS sequelae to the prophylactic use of cranial irradiation and intrathecal methotrexate in adults. Only minor abnormalities were found in the neurophysiological tests, psychometry, and scans in a few of the patients. Relling and associates, however, have emphasized the high incidence of malignant brainstem tumors following prophylactic craniospinal irradiation and antimetabolite treatment of acute lymphatic 71 leukemia. They stated that prophylactic radiotherapy should be given only to patients with a high risk of CNS relapse. Reddick and co-workers found that smaller white matter volumes were associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia of childhood. Those who had received chemotherapy alone had significantly larger volumes of white matter than those who had also received cranial irradiation, but their volumes
11 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp 72
remained significantly smaller than those in the control group.
Acute encephalopathy during induction therapy for acute lymphoblastic 73 leukemia occurred in 21 children in the Medical Research Council UKALL VIII study and trial. This was attributed to drug toxicity, probably from l-asparaginase, although vincristine may also have contributed. Convulsions (sometimes focal) and coma were the major features.
Myelomatosis Myelomatosis is the best-recognized expression of the plasma cell dyscrasias. These include Waldenström's macroglobulinemia, monoclonal gammopathy of unknown significance (MGUS), paraproteinemias, plasmacytoma, and plasma cell leukemia. These conditions commonly involve the nervous system. The major neurological complications can be placed into four categories: (1) compression of spinal cord, cauda equina, or solitary nerve roots; (2) cranial nerve involvement; (3) intracranial myeloma; and (4) peripheral neuropathy. Pure meningeal myeloma is rare (Fig. 13-2) and presents with confusion, altered consciousness, 74 and cranial nerve palsies. In 20 percent of cases, it is associated with plasma cell leukemia.
FIGURE 13-2 Section of hypothalamus showing meningeal infiltration by
myeloma cells. This patient had diffuse meningeal involvement by myeloma cells without parenchymatous infiltration of the brain or spinal cord. (Hematoxylin and eosin. Original magnification 504×.) (From Davies-Jones GAB, Preston FE, Timperley WR: Neurological Complications in Clinical Haematology. Blackwell Scientific Publications, Oxford, UK, 1980, with permission.) Spinal Myeloma The vertebrae are commonly infiltrated by myeloma cells, which may extend into the extradural space to form an extradural tumor and cause spinal cord compression. As a cause of cord compression, myeloma comes second to metastatic carcinoma in frequency. Vertebral body fragmentation and collapse may also produce neurological deficits from spinal cord and nerve root compression. Acute paraplegia with sensory loss due to spontaneous epidural hematoma secondary to bleeding from myeloma deposits in the thoracic vertebrae 75 has been described. Extradural myeloma tumor may occur without local bone involvement, and intradural deposits
12 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
of myeloma may arise by spread along nerve roots via intervertebral foramina. Spinal cord compression has infrequently been caused by amyloid deposits. Infiltration of the spinal cord by myeloma cells, and paraneoplastic myelopathy are rare complications. The lower thoracic area of the spinal cord is the most commonly affected area, followed by lumbar and cauda equina involvement. Cervical cord compression is relatively rare. Patients with IgA myeloma seem to be at greater risk of spinal cord compression. The neurological symptoms usually develop comparatively slowly but may do so over a week or two. Usually, back pain of several months' duration precedes any evidence of spinal cord compression, although occasionally the interval is a few weeks only. Syndromes typical of spinal cord or cauda equina compression occur, with sensory impairment below the lesion and a spastic or flaccid paraparesis progressing to complete paraplegia with urinary retention and incontinence. Nerve Root Compression Nerve root compression is produced by direct infiltration or compression by myeloma cells or by compression from vertebral collapse. The result is progressive brachialgia accompanied by sensory impairment and weakness or lumbosacral pain with sensorimotor dysfunction. Cranial Myeloma Cranial myeloma is rare. The predominant sites of occurrence are the region of the sella and cavernous sinus, the body of the sphenoid, and the apex of the petrous bones. Orbital myeloma is well recognized and presents as an orbital mass with proptosis and ophthalmoplegia. Total ophthalmoplegia may occur from amyloid infiltration of the extraocular muscles secondary to myeloma. Myeloma may infiltrate the intracranial cavity from the oropharynx or paranasal sinuses. Primary plasmacytomas may originate in the cranial vault or the dura. Direct infiltration of the brain by myeloma cells is exceptionally rare, as is diffuse meningeal involvement. Bilateral optic neuritis producing painless progressive impairment of visual acuity over 12 months and bilateral central scotomas has been described in relation to IgA lambda myeloma. The optic neuritis recovered virtually to normal over 2 months, suggesting that the optic nerve involvement was unlikely to be due to infiltration and was 76 possibly secondary to binding of IgA to myelin. Headaches and signs of raised intracranial pressure are the earliest indications of intracranial myeloma. Other signs and symptoms depend on the site of the lesion and can vary from a palpable lump over the skull vault to convulsions, hemiparesis, hemianopia, diabetes insipidus and hypopituitarism, cranial nerve palsies, brainstem syndromes, and symptoms of generalized cerebral impairment, such as confusion, disorientation, drowsiness, and coma. The pathogenesis of the latter in the setting of myelomatosis is complicated, and undoubtedly factors such as renal failure, anemia, hypercalcemia, and hyperviscosity play a part. Benign intracranial hypertension has been observed in occasional cases of IgG myeloma. 77 None of the patients showed evidence of hyperviscosity or of intracranial myeloma. Peripheral Neuropathy Four types of neuropathy have been described in association with myelomatosis: 1. Paraneoplastic neuropathy producing demyelination and axis cylinder degeneration 2. Ischemic neuropathy due to amyloid deposition in the vasa nervorum 3. Amyloid infiltration of the peripheral nerves (Fig. 13-3) 4. Infiltration of the peripheral nerves by myeloma tissue
13 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 13-3 Amyloid neuropathy in myeloma. Electron micrograph shows fibrillary deposits of amyloid adjacent to an axon. (From Davies-Jones GAB, Preston FE, Timperley WR: Neurological Complications in Clinical Haematology. Blackwell Scientific Publications, Oxford, UK, 1980, with permission.)
Neuropathy occurring in myelomatosis results in a chronic, progressive, symmetric sensorimotor disturbance that affects the legs first and, later and to a lesser extent, the arms. This is particularly so of the paraneoplastic variety, whereas infiltration by myeloma or amyloid tissue may produce an asymmetric or mononeuritic picture. Although it is a complication of the established disease in diffuse myelomatosis, the paraneoplastic type of neuropathy is usually the presenting feature of a solitary, commonly sclerotic plasmacytoma. This combination has a distinct male predominance. The neuropathy is usually sensorimotor, with the motor component predominating. The solitary sclerotic tumor may arise in the vertebrae, ribs, clavicles, scapulae, or long bones. The CSF protein concentration is increased, but the peripheral blood and bone marrow are normal; the erythrocyte sedimentation rate (ESR) is usually normal, and there is typically no identifiable paraprotein unless serum immunoelectrophoresis or immunofixation is performed. Localized radiotherapy to the bone lesion effectively arrests and usually alleviates the neuropathy. The outlook for survival is good. A progressive, symmetric sensorimotor neuropathy in patients with monoclonal gammopathy, characteristically osteosclerotic bone lesions, and circulating light-chain paraprotein has been described predominantly from Japan. It is sometimes called POEMS syndrome (plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes). This syndrome has also been described in association with 78 extramedullary plasmacytoma and occasionally with isolated dysproteinemia only.
14 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Osteosclerotic myeloma is a plasma cell dyscrasia characterized by sclerotic bone lesions, progressive demyelinating polyneuropathy, and bone marrow containing less than 5 percent plasma cells (in multiple myeloma, the bone marrow contains more than 10% plasma cells). Miralles and associates suggested that the distinction of osteosclerotic myeloma and the 79 POEMS syndrome is artificial. In their study, 84 percent of patients who fulfilled the criteria for osteosclerotic myeloma had multiorgan involvement: skin change (58%), lymphadenopathy (42%), papilledema (37%), peripheral edema (29%), hepatomegaly (24%), splenomegaly (21%), and ascites (11%). Five patients fulfilled the criteria for the POEMS syndrome, and these patients had the same clinical outcome as those with the incomplete forms. There seemed to be no benefit in differentiating POEMS syndrome and osteosclerotic myeloma. Plasma cell dyscrasia with polyneuropathy is a better all-embracing term for including the variables of these two conditions. Dispenzieri et al have proposed new criteria 80 for the diagnosis of POEMS syndrome. A particularly localized form of neuropathy due to infiltration of the carpal tunnel by amyloid deposits is well recognized. Jowitt and associates described a 81 patient who developed polymyositis 18 months after multiple myeloma was diagnosed. The stiff limb syndrome with anti-GAD antibodies has been described in a patient with multiple myeloma undergoing treatment with thalidomide by 82 Schiffer and colleagues. Neurological Effects of Metabolic Complications Neurological complications may result from hypercalcemia, uremia, and hyperviscosity (Fig. 13-4). The hyperviscosity syndrome occurs most commonly in IgA myeloma to the extent that 25 percent of patients with this form of myeloma attending the authors' hospital have at one time or another developed this complication. It occurs because the IgA myeloma molecule has an inherent tendency to form high-molecular-weight polymers.
FIGURE 13-4 Plugging of a cerebral vessel by hyperviscous protein with seepage into
the perivascular space secondary to vessel ischemia, from a case of hyperviscosity syndrome in myeloma. (Original magnification 504×.) (From Davies-Jones GAB, Preston FE, Timperley WR: Neurological Complications in Clinical Haematology. Blackwell Scientific Publications, Oxford, UK, 1980, with permission.) Hypercalcemia and uremia cause increasing headaches, confusion, disorientation, somnolence, stupor, coma, uremic convulsions, and myoclonic twitching. The hyperviscosity syndrome of myeloma is identical to that of Waldenström's macroglobulinemia. Neurological Effects of Immunological Complications
15 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Immunological incompetence is often a feature of myelomatosis. In the CNS, this is reflected by the development of meningitis (bacterial, viral, fungal) and cerebral abscess. Pneumococcal infection is particularly implicated, as is herpes zoster and, more rarely, cryptococcosis and toxoplasmosis. Profound septicemia may be complicated by cerebral DIC. Progressive multifocal leukoencephalopathy may also occur.
Macroglobulinemia (Waldenström's Disease) It has been estimated that peripheral or CNS symptoms occur in 25 percent of patients with macroglobulinemia. Although peripheral neuropathy may be associated with the hyperviscosity syndrome, this is unusual; it is unlikely, therefore, that the hyperviscosity syndrome is the cause of the neuropathy in most patients with macroglobulinemia and paraproteinemia. The neuropathy may be related to antibody binding (see later). Other mechanisms such as lymphocytic infiltration of the peripheral nerves, amyloidosis, and bleeding tendency have also been suggested as an explanation for the neuropathy. Abad and colleagues reported four patients with lymphoplasmacytic cells infiltrating meninges and nerve roots, producing progressive leg weakness from lumbar radiculopathy. Chemotherapy 83 and irradiation of the involved nerve roots led to significant improvement. Complete unilateral ophthalmoplegia has been described as the presenting manifestation 85 of 84 Waldenström's macroglobulinemia, as has an isolated lesion of the fourth cranial nerve. MRI in the latter case demonstrated an orbital apex lesion, which was not biopsied. There were no other neurological lesions. Four months after initiation of treatment with prednisolone and chlorambucil, MRI revealed complete resolution of the orbital lesion, which was probably a lymphoid infiltrate. The other neurological complications relate to hyperviscosity and bleeding tendency. Any part of the CNS may be involved, with complications presenting as strokes or other focal brain syndromes, dementia, diffuse encephalopathy, subarachnoid hemorrhage, and spinal cord symptoms from hemorrhage or infarction. Patients frequently complain of profound fatigue, lethargy, and headaches, and they develop confusion, stupor, coma, and convulsions. Visual disturbances and deafness occur and may be irreversible. Congestion, tortuosity, segmental dilation of retinal veins and bilateral central retinal venous occlusion occur, as do hemorrhages, exudates, and papilledema. The bleeding tendency results in spontaneous bruising, purpura, epistaxis, gastrointestinal hemorrhage, and oozing from venipuncture sites. Dramatic relief is frequently achieved by plasmapheresis. A case of progressive myelopathy 86 from Waldenström's disease showed a marked response to rituximab, and a 87 polyneuropathy due to it was also effectively treated with chemotherapy and rituximab. Exceptionally, Waldenström's disease is complicated by the development of primary 88 intracerebral lymphoma, progressive multifocal leukoencephalopathy, or a humorally mediated immune myopathy from IgM-kappa antibodies directed against muscle surface 89 protein.
Paraproteinemias Monoclonal gammopathy of unknown significance (MGUS), formerly termed benign monoclonal gammopathy, is characterized by low-titer (<3 g/dl) bands of IgM, IgG, or IgA. Immunoelectrophoresis or immunofixation may be required to detect smaller bands. Urine light chains are detected only rarely. The marrow contains less than 5 percent plasma cells; blood counts are normal; and lymphadenopathy, organomegaly, and skeletal lesions do not occur. Investigation may identify primary systemic amyloidosis, myeloma, macroglobulinemia, cryoglobulinemia, lymphoma, or lymphoproliferative disorder. Approximately one third of patients with MGUS will develop myeloma, macroglobulinemia, amyloidosis, or a lymphoproliferative disorder over 20 years; this is sometimes indicated by an unusually 90 rapidly progressive course of the neuropathy. Kyle and associates found the risk of progression of MGUS to multiple myeloma or related disorders to be about 1 percent per 91 year. Approximately 5 percent of patients with MGUS will develop a polyneuropathy, associated in 92 the majority with an IgM band. The median age of onset is in the sixth decade with a slowly progressive, distal, symmetric sensorimotor polyneuropathy or, less commonly, a predominantly sensory neuropathy. A presentation resembling chronic inflammatory demyelinating polyneuropathy (CIDP) is well recognized, although this condition differs from typical CIDP with more dominant sensory symptoms, a greater age at onset, and a slower, 93 more progressive course. Neurophysiological studies commonly demonstrate a mixed axonal and demyelinating picture. Predominant axonal degeneration is uncommon; pure demyelination is particularly associated with IgM MGUS. CSF protein levels may be markedly
16 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
elevated. Antibody to myelin-associated glycoprotein (MAG) may be identified in paraprotein 94 neuropathy and in as many as half of the cases of IgM MGUS. Other binding specificities are described, including GM1 ganglioside, disialosyl gangliosides, and sulfatide; however, the 95 pathogenic role of these antibodies is unclear. IgG and IgA MGUS are less likely than IgM MGUS to be associated with identifiable antineuronal antibodies. They are comparatively less 92 common, less likely to be demyelinating96or sensory, but more likely to respond to plasmapheresis than IgM neuropathies. Sural nerve biopsies in MGUS neuropathy demonstrate neuronal loss, segmental demyelination, and axonal degeneration. The characteristic changes in IgM anti-MAG neuropathy are widening of myelin lamellae at the minor dense line in the outer half of the sheath, and IgM light-chain binding to MAG, with co-localized complement components. The bound IgM is usually kappa type. The mechanism of nerve injury in many cases of MGUS neuropathy is unclear, although immune-mediated injury is probable in the presence of 96 anti-MAG disease.
Lymphoma Hodgkin's disease and the non-Hodgkin's lymphomas affect the nervous system with equal frequency, but only rarely. This usually occurs by direct spread from primary nodal and extranodal sites. Occasionally, primary Hodgkin's disease and primary non-Hodgkin's lymphoma (microglioma, reticulum cell sarcoma, histiocytic lymphoma) of the CNS are seen. Although as many as 25 percent of all non-Hodgkin's lymphomas present in extranodal sites, at most 1 percent present in the CNS. Primary lymphoma of the CNS represents about 10 97 percent of all primary tumors of the CNS. The neurological complications result from compression and direct invasion of the nervous system or from secondary paraneoplastic syndromes. Within the CNS, the cerebral hemispheres are the most frequent sites of involvement, followed by the cerebellum and brainstem. Primary lymphomas of the spinal cord are rare. CNS involvement occurs most commonly with lymphoblastic lymphoma, followed by diffuse undifferentiated lymphoma and diffuse histiocytic lymphoma. Spinal Cord and Meningeal Involvement Spinal cord and meningeal involvement are relatively common neurological complications of the lymphomas. In one study, 38 percent of patients with systemic lymphoma and CNS 98 involvement had spinal cord tumors. Extradural deposits arise as the result of direct spread from the retroperitoneal or postmediastinal spaces via the intervertebral foramina from tumor growth along nerve roots, or by direct invasion from an affected vertebral body. The tumor often extends around the lateral aspect of the spinal cord and may encircle it completely. Although the dura mater usually prevents invasion of the cord itself, intramedullary 99 metastases of lymphoblastic lymphoma is a rare but recognized complication. The segmental arterial supply may be compressed by the tumor to produce an ischemic myelopathy. Rarely, an acute necrotizing myelopathy appears as a remote paraneoplastic effect of a lymphoma. This is universally progressive. A less acute paraneoplastic myelopathy developed in a patient with pathological stage 1A Hodgkin's disease before treatment was 100 begun; it resolved substantially with intrathecal dexamethasone. With compressive lesions, back pain, frequently worse on lying down and often associated with radicular spread, is accompanied by progressive spinal cord dysfunction, producing a spastic paraparesis, sensory impairment below the lesion, and sphincter problems resulting in incontinence. Spinal cord segments C5 to T8 are most commonly implicated, although compression of the cauda equina may occur. Brown-Séquard syndrome secondary to extradural compression has been described. Nerve roots may be invaded and enlarged by the lymphoma, causing pain and sensorimotor segmental syndromes (e.g., cervical or lumbosacral radiculopathy). Intracranial Involvement Intracranial involvement usually arises from infiltration via the skull base, by direct extension from involved cervical lymph nodes as well as by lymphatic spread. On rare occasions, lymphoma of the skull bones has been known to spread to form an intracranial mass. Tumor is usually found extradurally but may occur within the dura as a subdural mass that sometimes invades underlying brain; it may even be purely intracerebral. Typically, widespread disseminated meningeal lesions occur and characteristically produce multiple cranial nerve palsies, headaches, meningism, and papilledema. The seventh cranial nerve
17 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
seems to be involved most commonly. Patients with T- and B-cell surface markers are at increased risk of cranial nerve involvement, factors also associated with increased incidence of CNS relapse. Almost all cases of lymphomatous meningitis are found in patients with diffuse non-Hodgkin's lymphoma. Lymphoblastic lymphoma, diffuse histiocytic lymphoma, diffuse undifferentiated lymphoma, and diffuse lymphocytic poorly differentiated lymphoma have a high incidence of meningeal disease. Meningeal lymphoma may have a protracted course with spontaneous remission of clinical and neuroimaging signs. A patient with spontaneous remission of a third cranial nerve palsy subsequently developed meningeal lymphoma that produced multiple lumbosacral radiculopathies a year after initial presentation. Nerve root biopsy revealed a B-cell lymphoma. Serial CSF analyses over the intervening year showed occasional atypical cells 101 that were later found to resemble closely the biopsy cell type. Intracranial deposits produce signs and symptoms of increased intracranial pressure with focal disturbances as a result of infiltration of the cerebral hemispheres, cerebellum, or brainstem. Convulsions may occur. Painful ophthalmoplegia with proptosis, together with sensory impairment of the cornea and ophthalmic division of the trigeminal nerve owing to cavernous sinus infiltration, is a recognized intracranial complication and usually occurs by invasion from the ethmoid or sphenoid bones or sinuses. Intracranial deposits seem to be associated more often with histiocytic lymphoma, and orbital deposits more commonly with lymphocytic lymphoma. Intracranial deposits are rarely seen in lymphocytic lymphoma unless leukemia has supervened. Zaman and associates reported anterior visual system involvement in non-Hodgkin's lymphoma due to lymphomatous infiltration of the optic chiasm in one patient and bilateral optic neuropathy in another who later developed progressive multifocal 102 leukoencephalopathy. 103
Younger and colleagues studied nine patients with motor neuron disease and lymphoma. They described upper and lower motor neuron signs in association with lymphoma, often accompanied by paraproteinuria. Signs suggestive of amyotrophic lateral sclerosis may also be accompanied by conduction block in peripheral nerves. Paraneoplastic Syndromes The paraneoplastic syndromes of peripheral neuropathy, encephalomyelopathy, cerebellar cortical degeneration, polymyositis, progressive multifocal leukoencephalopathy, and an acute necrotizing myelopathy have been described in association with the lymphomas (see Chapter 27). Acute dysautonomia as the only neurological association of systemic Hodgkin's 104 neuromyotonia and peripheral neuropathy, myasthenia disease has been observed, as has 105 106 opsoclonus-myoclonus, and progressive external gravis, the Guillain–Barré syndrome, 107 ophthalmoplegia. Other Neurological Complications Other neurological complications may occur as the result of radiotherapy or chemotherapy, including opportunistic infections of the CNS due to bacteria, fungi, or viruses, or from hemorrhage due to thrombocytopenia.
Burkitt's Lymphoma Burkitt's lymphoma is frequently complicated by nervous system involvement, the most common complications being paraplegia, cranial neuropathies, and pleocytosis of the CSF. Tumor spreads through the bones of the face, skull, and orbit and along cranial nerves. Spinal cord compression from extradural deposits arises from direct extension from the vertebral bodies or from paravertebral tumors infiltrating through the intervertebral foramina. Patients with facial tumors are likely to develop orbital involvement and ophthalmoplegia, or infiltration of the skull base that produces cranial nerve palsies and pleocytosis of the CSF. Ischemic myelopathy can result from compression of radicular arteries by retroperitoneal and retropleural tumor.
Primary Intracerebral Lymphoma Primary CNS lymphomas are rare, accounting for about 10 percent of primary brain tumors. Although all cytological types are observed, the most common types belong to the high-grade category of non-Hodgkin's lymphoma, the majority being clonal and of B-cell origin, as
18 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
evidenced by their monotypical expression of either kappa or lambda light-chain immunoglobulin. The tumor masses are usually multicentric and ill defined. They occur in individuals given prolonged immunosuppressive therapy, patients in receipt of organ allografts, and those with inherited immunodeficiency disorders, such as ataxia-telangiectasia and the Wiskott–Aldrich syndrome. There is a clear association between primary cerebral non-Hodgkin's lymphoma and the HIV-associated acquired immunodeficiency syndrome (AIDS) (see Chapter 45). The incidence of these tumors is increasing, and their association with AIDS only partly accounts for this. Primary CNS 108 lymphoma in immunodeficient patients is universally associated with the Epstein–Barr virus. These tumors most commonly present as discrete lesions of the cerebral cortex, corpus callosum, septum pellucidum, basal ganglia, suprasellar region, and, to a lesser extent, the cerebellum. Bilateral cerebral involvement via the corpus callosum is a feature and presents with increasing intracranial pressure, dementia, papilledema, long-tract signs, and convulsions. A case of corticosteroid-responsive primary malignant lymphoma of the optic chiasm documented by MRI and MRI-directed stereotactic biopsy was described by Gray and 109 colleagues, and Patrick and associates described a 30-year-old woman with primary cerebral lymphoma who had diabetes insipidus and otherwise minimal abnormality of 110 to metastasis from a hypothalamic pituitary function. Isolated radial nerve palsy secondary 111 primary malignant lymphoma of the brain has been described. Neuroimaging displays discrete, often large tumors with bilateral hemispheric involvement in most cases, striking enhancement with contrast media, and surrounding edema. Despite the fact that these tumors are highly radiosensitive, late morbidity and mortality may occur from radiation necrosis. Without biopsy confirmation, radiation necrosis cannot be reliably distinguished 112 from recurrent tumor. Cerebral radiation necrosis seems to be related to radiation dose and the bulk of residual tumor following diagnostic neurosurgery. Primary lymphoma of the spinal cord is exceptionally rare, as is primary lymphoma of the nerve roots. One of the authors (GDJ) has 40 investigated and cared for a patient with primary lymphoma of the cauda equina (Fig. 13-5).
FIGURE 13-5 Marked nodular thickening of the nerve roots of the cauda equina
from infiltration by primary lymphoma of the central nervous system (CNS). (From Davies-Jones GAB, Preston FE, Timperley WR: Neurological Complications in Clinical Haematology. Blackwell Scientific Publications, Oxford, UK, 1980, with permission.) Peripheral neuropathy of the paraneoplastic type has been described in association with 113 primary lymphoma of the brain.
Intravascular Lymphoma Intravascular lymphomatosis is a rarely diagnosed generalized lymphoma, usually of large B-cell type producing vascular occlusion of arterioles, capillaries, and venules. More than 50 percent of cases present with neurological symptoms, usually diffuse or focal, and suggestive of vascular disease. Dementia, stroke-like episodes, and brainstem and spinal cord syndromes predominate. Imaging demonstrates multifocal lesions in the brain suggestive of microvascular or demyelinating disease. Angiography may show a beaded appearance reminiscent of vasculitis. The CSF findings are nonspecific. Cerebral biopsy should be 114 undertaken in suspected cases.
Lymphomatoid Granulomatosis Lymphomatoid granulomatosis frequently involves the nervous system. The usual presenting symptoms are fever, weight loss, malaise, cough, dyspnea, and neurological complications.
19 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
The latter include encephalopathy, seizures, hemiparesis, cranial polyneuropathy, optic neuropathy, peripheral neuropathy, and mononeuritis multiplex. Pathologically, there is extensive infiltration of T lymphocytes and histiocytes in the meninges and cerebral vessel walls within the brain parenchyma and along nerve roots and peripheral nerves mimicking true vasculitis and resulting in vascular occlusion. Lymphomatoid granulomatosis progresses to an angiocentric T-cell lymphoma in many cases.
Polycythemia An increased incidence of thrombotic and hemorrhagic complications is a well-recognized phenomenon in polycythemia, not least in the nervous system. Approximately 15 percent of patients with polycythemia die of cerebral thrombosis, 87 percent of them after repeated episodes. Thromboembolism often continues to be a major clinical problem even after hematological control has been achieved. The high incidence of thrombosis is attributed to the increased blood viscosity, reduced perfusion, vascular engorgement, and atheromatous degeneration of vessel walls, and possibly to chronic DIC. Hemorrhage may be related to imperfect clot retraction, abnormal thromboplastin generation, and abnormalities of platelet count and function. It may be cerebral, extradural, subdural, or subarachnoid. Most of the intracranial lesions are thrombotic and involve arteries, veins, or venous sinuses. The risk of developing cerebral infarction is proportional to the hemoglobin level. Nonspecific symptoms of fullness in the head, vertigo, tinnitus, and lack of concentration are common. More specific signs such as hemiparesis, hemianesthesia, hemianopia, and aphasia depend on the site of infarction or hemorrhage. Brainstem vascular syndromes occur, as do bulbar and pseudobulbar palsy, convulsions, and coma. Amaurosis fugax, blindness, scotomas, and transient cerebral or brainstem ischemic attacks are features as well. More rarely, signs and symptoms of a progressive cerebral lesion arise because of a subdural hematoma, an expanding intracerebral blood clot, or cerebral infarction and edema. Distention and congestion of the retinal veins, central retinal venous or arterial occlusion, and papilledema may be present. Idiopathic intracranial hypertension has been reported. Aseptic cavernous sinus thrombosis associated with internal carotid artery occlusion may occur. Treatment with repeated phlebotomies and heparin resulted in resolution of the proptosis, pain, periorbital edema, lacrimation, venous congestion, ptosis, and ophthalmoplegia, and it restored the patient's sight. The one-and-a-half syndrome due to polycythemia was described 115 by Lousa and associates. Spinal cord infarction is an exceptionally rare complication; although spinal cord compression due to spontaneous subdural hematoma and extramedullary hematopoiesis 116,117 in the Chorea is proliferative phase of polycythemia have been described, this is uncommon. another rare complication. It may be of sudden onset and tends to occur in women older than 50 years. It may resolve before any significant reduction of the red cell count, but more often it resolves with the correction of the polycythemia. The chorea is generalized, with predominant involvement of the face, mouth, tongue, and arms. It is not apparently related to the rare finding of a small infarct in the caudate nucleus. Some have suggested that it may result from excess dopamine presentation to the basal ganglia by the increased number of sluggishly circulating platelets. It is discussed further in Chapter 59. Although paresthesias are not uncommon symptoms in the extremities, peripheral 118 neuropathy due to polycythemia was thought to be rare. However, Poza and co-workers in a prospective clinical and electrophysiological study of 28 patients with polycythemia identified 46 percent with clinical features of neuropathy and 71 percent with neurophysiological evidence of polyneuropathy. Oculomotor nerve paresis as a presenting sign of acute myeloblastic leukemia complicating polycythemia has been reported.
Cerebellar Hemangioblastoma Cerebellar hemangioblastoma may be associated with erythrocythemia, which arises as a response119 to erythropoietin secretion by the tumor. An incidence of 15 percent has been reported. The symptoms are those of increased intracranial pressure and “dizziness,” with either truncal and gait ataxia or ataxia of one or the other side with nystagmus. Neck stiffness and, rarely, cerebellar “fits” may occur. On examination, the symmetric or lateralized cerebellar ataxia is associated with papilledema, hemiparesis, bilateral pyramidal signs, or any combination of deficits from fifth, sixth, seventh, or eighth cranial nerve involvement. Recurrence many years after surgical treatment is typical of hemangioblastoma.
20 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Pseudopolycythemia Pseudopolycythemia is a condition in which an increased packed cell volume (hematocrit) is associated with normal red cell mass, although plasma volume may be reduced in the absence of apparent fluid loss. It is associated with hypertension, obesity, and stress, especially in middle-aged men who are smokers. In this condition, as in polycythemia, there is an increased risk of thromboembolism because the increased packed cell volume is associated with an increase in whole blood viscosity and reduced cerebral blood-flow, which predispose to vascular occlusive episodes. In patients with a packed cell volume greater than 54 percent, regular small venisections of 100 to 250 ml are recommended to reduce the packed cell volume to around 46 percent.
Essential Thrombocythemia Essential thrombocythemia is a rare disorder characterized more frequently by thrombotic than hemorrhagic complications. The condition is diagnosed on the basis of a persistently elevated platelet count without evidence of trauma, inflammation, hemorrhage, hyposplenism, or any other condition known to be associated with thrombocytosis. Amaurosis fugax, transient hemiparesis or hemianesthesia, recurrent 120 vertigo, and confusion were the characteristics of the patients studied by Preston and others. Most had evidence of circulating platelet aggregates or spontaneous platelet aggregation, and three had reduced platelet survival. Considerable clinical improvement was achieved by antiplatelet drugs and, where appropriate, by reduction of platelet count. Jabaily and colleagues have also confirmed a high incidence of121TIAs of both the anterior and the posterior cerebral circulation in essential has thrombocythemia. The incidence of cerebral ischemia in essential thrombocythemia 122 been estimated to be 180 times greater than that in a control population. It has been suggested that there is no correlation between the severity of the thrombocythemia and the 123 incidence of TIAs and completed strokes, but the numbers studied are insufficient to warrant this conclusion. Neurological complications occurred in 25 percent of 70 patients with 124 essential thromocythemia.
Myelofibrosis Myelofibrosis is an uncommon myeloproliferative disorder arising predominantly in patients older than 50 years. It is characterized by replacement of the bone marrow by fibrous tissue associated with extramedullary hematopoiesis and marked hepatosplenomegaly. The patients are anemic, may be slightly jaundiced, and have a leukoerythroblastic blood picture. Neurological complications are rare. Rutman and colleagues described a woman 125 with advanced myelofibrosis who developed a left hemiparesis and left-sided agnosia. At postmortem there were bilateral intracranial masses of hematopoietic tissue compressing both frontoparietal areas and arising from the meninges. Spinal cord compression and paraplegia from extramedullary hematopoiesis due to myelofibrosis is also very 126 uncommon. Essential thrombocythemia, polycythemia vera, and myelofibrosis with myeloid metaplasia constitute the “classic” bcr/abl-negative myeloproliferative disorders. Each represents a stem cell–derived clonal myeloproliferation. A Janus tyrosine kinase127mutation (JAK2V617F) is found in all three disorders and may be diagnostically helpful.
Eosinophilic Syndromes Eosinophilia is defined as an increase in peripheral blood eosinophil count to greater than 450 cells/μl blood, and eosinophilic infiltration is particularly observed in the tissues affected by the condition—muscle, nerve, or CSF. Eosinophilia may be observed in a wide range of conditions: connective tissue disorders; vasculitides; malignancies; allergic reactions, particularly drug reactions; infectious diseases, particularly helminth but not protozoan parasites; and the hypereosinophilic syndrome (Table 13-1). Click here to view this table.... Eosinophilic myositis is a pathological diagnosis characterized by eosinophilic infiltration of the muscle. In idiopathic eosinophilic myositis no systemic cause for the eosinophilia is apparent. Eosinophilic infiltration into skeletal muscle, although rare, has been described in a diverse group of conditions. It occurs most commonly in parasitic infection as focal eosinophilic myositis but can be a feature of systemic hypereosinophilic conditions such as eosinophilia-myalgia syndrome and idiopathic hypereosinophilic syndrome.
21 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
There are three main forms of eosinophilic neuromuscular disease. Diffuse fasciitis or Shulman syndrome can be limited to the fascia or associated with perimyositis. Eosinophilic myositis corresponds to focal muscle involvement. It is associated with skin lesions in approximately 40 percent of cases, including deep subcutaneous induration, erythema, angioedema, urticaria, and papular lesions. The overall prognosis of eosinophilic myositis/polymyositis is good, particularly when 128 muscle lesions are focal and the principal histopathological finding is perimysial infiltrates. Compound heterozygous or homozygous CAPN3 mutations have been found in a subgroup of children in the first decade with autosomal-recessive inheritance, variable peripheral eosinophilia, and elevated serum creatine kinase, but with little or no weakness. The CAPN3 gene encodes calpain-3, a muscle-specific intracellular nonlysosomal protease. Mutations in this gene are responsible for the commonest autosomal-recessive limb-girdle muscular dystrophy, calpainopathy (LGMD2A). Eosinophilia has not been identified in adults with calpainopathy. Whether this represents the well-known 129 inflammatory feature of muscular dystrophy or is a true eosinophilic myositis is uncertain. Eosinophilic polymyositis is a manifestation of the hypereosinophilic syndrome and is life-threatening. In the idiopathic hypereosinophilic syndrome there are at least 1500 eosinophils/μl in the blood for at least 6 months without any recognizable cause after a careful workup. There is evidence of multiorgan infiltration by eosinophils. Cardiac disease is common with valvular disease resulting in embolization. The systemic manifestations include eosinophilia, anemia, hypergammaglobulinemia, vascular involvement (subungual petechiae, livedo reticularis, Raynaud's phenomenon), skin rash and subcutaneous edema, pulmonary infiltrates and pleuritis, cardiac involvement (congestive heart failure, arrhythmias, heart block, pericarditis, myocardial and endocardial fibrosis), and peripheral neuropathy. One third of the patients have neurological symptoms such as encephalopathy, multiple cerebral infarcts (possibly embolic in origin), peripheral neuropathy, and mononeuropathy multiplex. The prognosis is poor, average survival being only 9 months after the onset of symptoms, although patients may respond well to corticosteroids. HEMORRHAGIC DISORDERS
Hemophilia The severity of bleeding in hemophilic patients correlates with the factor VIII level. Severely affected hemophiliacs with levels of less than 1 percent commonly have spontaneous bleeding into muscles and joints. With factor VIII levels of 1 to 5 percent, spontaneous bleeding may occur but is much less frequent. Excessive bleeding is precipitated by minor trauma, but patients with factor VIII levels greater than 10 percent can nowadays lead normal lives, as excessive blood loss occurs only after more severe trauma and surgery. Intracranial bleeding is the leading cause of death among hemophiliacs. The incidence of intracranial hemorrhage ranges from 2.2 to 13.8 percent. Bleeding tends to occur predominantly in young hemophiliacs. The most common factor associated with bleeding is trauma (53%), with hypertension an important factor in older patients. Delay in the onset of 130 symptoms following trauma is common (50%), with a mean duration of 4 ± 2.2 days. This long latent interval is most commonly associated with subdural hematoma. Bleeding may occur into the subdural, extradural, or subarachnoid spaces or into the cerebral hemispheres, cerebellar hemispheres, and brainstem. The symptoms and signs depend on the site of the hemorrhage and its extent. Prognosis in intracranial hemorrhage has been considerably improved by the early use of factor VIII concentrates, and there is now no contraindication to surgical intervention, provided that adequate control of coagulation factors is maintained. Subdural or subarachnoid bleeding carries a better prognosis than does intracerebral hemorrhage. Seizures occur in 25 percent of survivors of intracranial hemorrhage and increase the risk of further bleeding. Other sequelae include hemiparesis, aphasia, hemianopia, ataxia, and mental retardation. MRI imaging of the brain in males aged 7 to 19 with moderate to severe hemophilia 131 reportedly shows abnormalities in 20 percent of subjects. In one study, the most common acquired findings, in 11 percent of subjects, were single or multifocal nonhemorrhagic areas of high signal intensity in the white matter on T2-weighted images; cerebral atrophy and 131 hemorrhagic lesions were also be noted in some instances. Bleeding into the spinal canal is rare. With epidural hemorrhage, radicular symptoms, especially pain, are accompanied by progressive paraparesis or quadriparesis, depending on the site of the bleeding. Patients with small epidural hemorrhages and only minimal nonprogressive signs of spinal cord dysfunction may recover completely with intensive factor
22 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
VIII replacement therapy alone. With signs of more severe cord compression, surgical decompression with evacuation of the clot is also necessary. Peripheral nerve lesions are the most frequent neurological complication of hemophilia. In most instances, nerve involvement is a complication of intramuscular hemorrhage, most commonly into the iliac muscle and leading to femoral neuropathy. Median, ulnar, and radial neuropathies result from hemorrhage into the arm or forearm muscles. Nerve compression by pseudotumors (subperiosteal hemorrhages producing expanding lesions) also occurs. Severe hemophilic arthropathy of the elbow may result in ulnar nerve palsy. Intraneural hemorrhage as a cause of peripheral nerve palsy is exceptional but has been described as 132 affecting the ulnar nerve in the cubital tunnel. On exploration of the ulnar nerve, free blood escaped when the epineurium was divided; recovery was rapid and complete. In one study of 126 hemophiliacs, 34 peripheral nerve lesions were identified in 24 patients. The frequency of nerve lesions correlated with the severity of the hemophilia and with increasing age. It was not133 apparent that all mononeuropathies were caused by identifiable episodes of hemorrhage.
Von Willebrand's Disease Von Willebrand's disease consists of a family of related disorders characterized by deficiency or malfunction of von Willebrand factor, which is a carrier for factor VIII and is also required for normal platelet adhesion. Most cases are inherited as an autosomal-dominant trait. The bleeding complications of von Willebrand's disease are relatively mild, and spontaneous hemorrhage into joints and muscles does not occur. Acute onset of neurological dysfunction is not a feature of this disease. Nevertheless, serious hemorrhage may result from trauma, and patients who sustain head injuries should receive immediate factor VIII replacement therapy. The rare types 2N and 3 are inherited as autosomal-recessive traits and result in more significant hemorrhage.
Christmas Disease The neurological complications of Christmas disease are identical to those of hemophilia. Thus, peripheral nerve compression occurs as a consequence of spontaneous intramuscular hemorrhage; and intracranial hemorrhage, an important cause of death in both disorders, may occur spontaneously in severely affected patients or following trauma in less severely affected individuals. Clotting factor IX is the deficient factor requiring replacement.
Other Clotting Factor Deficiencies Spontaneous and post-traumatic hemorrhages are features of disorders resulting from deficiencies of other clotting factors. Surgical evacuation of any intracranial hemorrhage must be done under cover of replacement therapy with the relevant deficient factor or with plasma or cryoprecipitate if the specific factor is not available. Similarly, replacement therapy should probably be given routinely following head injuries.
Acquired Hemophilia Acquired hemophilia is a rare condition resulting from the production of autoantibodies in middle age that inactivate factor VIII. Both sexes are affected. Cutaneous purpura and internal hemorrhage are common, whereas extensive bleeding into the joints is not a prominent feature. The condition is associated with systemic autoimmune disorders such as systemic lupus erythematosus; rheumatoid arthritis; malignancy such as lymphoma, acute or chronic lymphocytic leukemias, and solid tumors; and pregnancy. Drugs such as the 134 penicillins, phenytoin, phenylbutazones, or chloramphenicol have also been implicated. Neurological involvement in this rare disorder is not well recognized, but a case of ulnar neuropathy has been described in association with bleeding that resulted in a compartment syndrome in an elderly woman with organ-specific autoimmunity in the form of 135 hypothyroidism associated with antithyroid antibodies. Diagnosis is based on the identification of a low factor VIII level associated with the presence of a time-dependent inhibitor in the plasma. Treatment of bleeding episodes requires the use of an activated prothrombin complex concentrate or recombinant activated factor VIII. Immunosuppression with steroids is usually effective 136 at reducing inhibitor production and bringing about a sustained rise in the factor VIII level.
23 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Hemorrhagic Disease of the Newborn Intracranial hemorrhage represents the most serious complication of hemorrhagic disease of the newborn and occurs particularly after breach deliveries. Bleeding appears to occur from capillary lesions rather than major vessels. Subdural and subarachnoid hemorrhages are the most frequent form of intracranial bleeding, and intracerebral hemorrhage is rare. CNS bleeding appears to occur earlier and with greater frequency in infants born to mothers receiving anticonvulsant therapy. This is due to interference of anticonvulsant medication with vitamin K–dependent clotting factors, as discussed in Chapter 35. Occasionally, a bleeding syndrome related to vitamin K deficiency occurs in infants beyond the neonatal period, and this is associated with a greatly increased incidence of intracranial hemorrhage. Blanchet and associates described 93 infants who developed this condition between the ages of 2 weeks and 1 year. Intracranial bleeding, particularly subdural and 137 subarachnoid hemorrhage, occurred in 63 percent.
Thrombocytopenia If platelet function9is normal, satisfactory hemostasis may be achieved with a platelet count spontaneous hemorrhage does not usually occur if as low as 80 × 10 /L. Clinically significant 9 9 the platelet count exceeds 25 × 10 /L, but below 20 × 10 /L spontaneous hemorrhage is not uncommon. Cerebral, subarachnoid, and subdural hemorrhage constitutes the most serious neurological complication of thrombocytopenia. In patients with idiopathic thrombocytopenic purpura, the risk of spontaneous intracranial hemorrhage appears to be greatest during the first 2 weeks of the onset of the disorder. Severe spontaneous intracranial hemorrhage may also occur in patients with thrombocytopenia due to aplastic anemia, DIC, and acute leukemia. The risk of cerebral hemorrhage appears to be greater in DIC and leukemia than in uncomplicated idiopathic thrombocytopenic purpura, almost certainly because of other hemostatic defects also present in these conditions. In aplastic anemia, bleeding becomes a much greater problem when infection supervenes, presumably because of the superimposed hemostatic defect or intravascular coagulation. An uncommon complication of bleeding, superficial siderosis, has been described in association with repeated intraventricular and 138 subarachnoid bleeding of a newborn infant with neonatal alloimmune thrombocytopenia. Drug-induced immune thrombocytopenias arise when the drug functions as a hapten, binding to platelets and resulting in complement fixation and intravascular lysis or removal by the reticuloendothelial system. The platelet count falls within 7 or more days after a new drug is taken or within 2 to 3 days of a repeat exposure. Commonly involved drugs include quinine, quinidine, gold salts, phenytoin, valproic acid, carbamazepine, sulfonamides, and certain cephalosporins. Heparin-induced thrombocytopenia is the commonest disorder of this type. Type I heparin-induced thrombocytopenia is characterized by a moderate reduction in platelet counts, usually 9within the first 1 to 3 days of heparin therapy. The platelet count rarely drops below 100 × 10 /L and normalizes in spite of continued heparin therapy. Type II heparin-induced thrombocytopenia is immunologically mediated. It is defined as a platelet 9 count below 100 to 150 × 10 /L for no apparent reason other than heparin administration. Up to 30 to 60 percent or more develop serious thrombotic complications, including ischemic 139 damage to limbs, CNS, myocardium, and lungs. A study of neurological complications in 120 cases of immune-mediated heparin-induced thrombocytopenia showed that 9 percent of patients developed neurological complications, including ischemic cerebrovascular events (6%), cerebral venous thromboses (2.5%), and a transient confusional state in one case. Primary intracerebral hemorrhage was not observed. Importantly, in three cases, neurological 140 complications preceded the onset of thrombocytopenia. In severe thrombocytopenia, massive intracranial hemorrhage may be instantaneous and treatment of no avail. The onset of intracranial bleeding is often heralded by headaches of varying severity. In these circumstances, platelet transfusion should be instituted without delay, as it also should be after head injury in patients who have significantly reduced platelet counts.
Disorders of Platelet Function Regardless of the platelet count, abnormal bleeding states may result from abnormalities of platelet function, that is, disorders of platelet adhesion, aggregation, secretion, and procoagulant activity, or a combination of abnormalities of number and function.
24 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Bernard–Soulier syndrome is a disorder of platelet adhesion caused by deficiency of the surface glycoprotein Ib/IX. As a result, platelets fail to stick and clump together at the site of the injury. In Glanzmann's thrombasthenia, platelets lack glycoprotein IIb/IIIa, which prevents fibrinogen bridging from occurring and thus prevents clot retraction and significantly prolongs bleeding time. The gray platelet syndrome, delta storage pool deficiency, and abnormalities of the granule secretion mechanism all result in malfunction of platelet secretion of substances required for platelet adhesion and aggregation. In Scott's syndrome, platelets fail to promote activation of the blood-clotting factors. A variety of hereditary disorders may be associated with low platelet counts or platelets of abnormal size, including Wiskott–Aldrich syndrome and Alport's syndrome. These disorders are rare, and there is a paucity of data on the risk of intracranial hemorrhage. Fatal cerebral hemorrhage has however been described in Glanzmann's thrombasthenia. In the main, bleeding due to these disorders is treated primarily with platelet transfusions. The commonest acquired disorders of platelet function arise from drugs such as aspirin, nonsteroidal anti-inflammatory drugs, and ticlopidine. A wide range of other drugs may affect platelet function, including antihistamines, some antibiotics, antidepressants, and anesthetics. Platelet function may also be affected by chronic renal failure, the use of blood-bank platelets, the leukemias, and cardiopulmonary bypass. In myelomatosis or macroglobulinemia, abnormal platelet function results from interference by circulating paraproteins, and bleeding may be readily controlled by plasmapheresis.
Disseminated Intravascular Coagulation Disseminated intravascular coagulation should not be considered as a distinct disorder but rather as indicative of the presence of an underlying disorder. The coagulation system is activated by the rapid release of thromboplastic substances into the circulation to form either soluble or insoluble fibrin. Clotting factors and platelets are consumed, and there is defective and activated fibrinolysis and impairment of the coagulation inhibition system. The clinical syndromes produced are many and varied and result from vascular obstruction giving rise to tissue ischemia or necrosis with dysfunction of organs and tissues. The overwhelming consumption of α2-antiplasmin and platelets together with the anticoagulant properties of fibrin degradation products may also result in a bleeding tendency that can vary in severity from slight oozing at venipuncture sites with purpura and spontaneous bruising, to massive uncontrollable gastrointestinal, genitourinary, or postoperative hemorrhage. Simultaneous hemorrhage and thrombosis may occur. Pathologically, fibrin-rich thrombi are seen in arterioles, capillaries, and venules. The brain, kidneys, gastrointestinal tract, and lungs are usually the most frequently and severely affected. Globules of fibrin are occasionally seen free in the circulating blood, and some are large enough to obstruct the microcirculation. In many cases, red blood cells can be forced through fine networks of fibrin strands and, in the process, become damaged and fragmented, resulting in microangiopathic hemolytic anemia. Some of the most florid cases of DIC, particularly in young people who usually have a vigorous fibrinolytic response, show only a hemorrhagic picture with little or no evidence of fibrin in vessels. In some instances, the hemorrhagic complication may be so marked that massive cerebral, intraventricular, or subarachnoid hemorrhages result. Two mechanisms underlie the association of intravascular coagulation and neurological disorder. Primary brain damage releases powerful thromboplastins into the circulation that may precipitate DIC, and already established DIC may affect the nervous system. All patients with evidence of brain damage are at risk of developing DIC. It has been described in association with status epilepticus, possibly related to widespread endothelial injury 141 secondary to seizure-induced hyper-pyrexia. When DIC affects the nervous system, the symptoms and signs are related to the thrombotic and hemorrhagic complications (Fig. 13-6) as well as the primary disorder triggering the DIC (Table 13-2). Any part of the brain may be affected, producing focal or generalized encephalopathic manifestations or a combination of the two. The symptoms and signs may fluctuate markedly with time, presumably because of the continuing deposition and lysis of fibrin, which results in intermittent obstruction of vessels and blood flow. There seems to be a level of cerebral perfusion that is sufficient to maintain the viability of neurons but, nevertheless, may produce marked neurological abnormalities, including coma. It should be noted that patients may remain in a coma for several days, but, provided that the circulation is reestablished, they may subsequently make a complete recovery.
25 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
FIGURE 13-6 Disseminated intravascular coagulation (DIC). This section of the
cerebral cortex shows multiple thrombosed small blood vessels surrounded by areas of hemorrhage. (Original magnification 220×.) (From Davies-Jones GAB, Preston FE, TimperleyWR: Neurological Complications in Clinical Haematology. Blackwell Scientific Publications, Oxford, UK, 1980, with permission.) Click here to view this table.... In DIC secondary to carcinoma, microvascular obstruction of the brain may produce signs indistinguishable from those of metastatic deposits. Neurological complications due to DIC may antedate the clinical presentation of the underlying malignancy. In the absence of a definite metabolic, infective, paraneoplastic, or metastatic cause for an encephalopathy, especially if accompanied by fleeting and fluctuating focal neurological abnormalities, DIC should be thoroughly excluded. With such a generalized and focal process, the neurological signs are numerous and varied, comprising confusion, disorientation, delirium, lethargy, stupor, coma, hemiparesis, aphasia, cortical blindness, focal or generalized seizures, cerebellar ataxia, and focal brainstem disease. The spinal cord may also be affected, for example by subdural or epidural hematoma. 142
Ischemic myelopathy due to DIC has been reported in a 39-year-old man with AIDS. He died of diffuse encephalopathy within 9 weeks of onset of the neurological syndrome. Neuropathological examination revealed multiple, usually small, frequently hemorrhagic infarcts of various ages, with fibrin thrombi in medium and small penetrating vessels and capillaries of the brain and spinal cord, characteristic of DIC. There were no inflammatory changes. No single test is available that is sufficiently sensitive or specific to permit a diagnosis of DIC. The presence of soluble fibrin in plasma has high sensitivity but low specificity for the diagnosis. The diagnosis may frequently be made using a combination of platelet count, measurement of global clotting times, measurement of one or two clotting factors and inhibitors (e.g., antithrombin), and a test for fibrin degradation products. Serial coagulation tests are often helpful and a reduced platelet count or a clear downward trend is a sensitive if not specific sign of DIC.
26 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
It is important to note that at the onset of the neurological disorder, the coagulation profile may be normal and that during pregnancy, postoperatively, following trauma, and in association with malignancy, plasma fibrinogen, an acute-phase reactant, is invariably elevated. Therefore, increased fibrinogen consumption serves only to reduce plasma fibrinogen to normal. For this reason the only laboratory evidence of DIC in this situation may be thrombocytopenia and an elevated level of fibrin degradation products. If DIC is suspected, coagulation studies should be performed at frequent intervals, and falling concentrations of the various clotting factors should be accepted as evidence of a consumptive coagulopathy. D-dimer test is the most specific and sensitive test for DIC, although inflammation and surgery may elevate levels, and false-positive results may arise in patients with elevated IgM rheumatoid factor. The International Society 143 on Thrombosis and Haemostasis has proposed a useful algorithm for the diagnosis of DIC.
Thrombotic Thrombocytopenic Purpura Thrombotic thrombocytopenic purpura is a microangiopathic hemolytic anaemia. The only consistent abnormalities are red cell fragmentation and thrombocytopenia, which are also found in other conditions. It is most common between the ages of 20 and 50 but may affect individuals of all ages. It probably affects women more commonly than men. Before the introduction of plasma exchange when the mortality rate was up to 90 percent, the diagnosis was based on the pentad of microangiopathic hemolytic anaemia, thrombocytopenia, renal and neurological abnormalities, and fever. Neurological deficits, however, may not be 144 present. As the presence of renal and neurological abnormalities and fever are no longer a requirement for the diagnosis, plasma exchange may be introduced earlier with a 145 corresponding decline in the mortality rate to less than 20 percent. There may be complete recovery. A chronic relapsing form has been described. With use of the less restrictive diagnostic criteria, care must be taken to exclude conditions that may mimic thrombotic thrombocytopenic purpura, such as DIC, disseminated malignancy, Evans syndrome, HELLP syndrome (found in 10% of cases of eclampsia and pre-eclampsia), sepsis, accelerated hypertension, eclampsia, and the catastrophic form of the antiphospholipid antibody syndrome. Thrombotic thrombocytopenic purpura results from a severe deficiency of a von Willebrand factor–cleaving protease during acute episodes, thereby causing exceptionally large multimers of von Willebrand146factor to be secreted by endothelial cells. These multimers cause platelet aggregation. Pathologically, there is hyperplasia of endothelial and adventitial cells in arterioles, capillaries, and venules associated with platelet-rich and hyaline thrombi in these vessels, in which microaneurysms may also form. Neurological features are the most frequent presenting manifestations, occurring in 60 percent of cases. As the result of involvement of any part of the CNS, there is an endless variety of neurological syndromes. However the more common neurological manifestations are headache, organic brain syndromes, coma, paresis, aphasia, dysarthria, syncope, vertigo, ataxia, visual symptoms, paresthesias, seizures, and cranial nerve palsies. These symptoms are typically transient and fluctuating and, in147 some instances, resemble TIAs. Permanent neurological complications may also occur. Involvement of the visual pathways commonly results in homonymous field defects, but ocular changes of exudative retinal detachment, retinal and choroidal hemorrhages, papilledema, anisocoria, and diplopia may occur. Prolonged coma without evidence of major structural lesions in the CNS in patients with thrombotic thrombocytopenic purpura should be treated vigorously with daily repeated plasma exchange, antiplatelet drugs, corticosteroids, and vincristine, because full recovery is possible. Exceptionally, the neurological abnormalities may precede the full syndrome by months or even years. In a typical case, there may be a variety of prodromal symptoms, including fatigue, weakness, headaches, anorexia, nausea, vomiting, abdominal distress, fever, cough, hematuria, arthralgia, tachycardia, mental change, numbness, paralysis, and gastrointestinal or vaginal bleeding. At the time of presentation, the patient is usually pale, icteric, and febrile; has petechial hemorrhages in the skin; exhibits mental changes and neurological abnormalities; and has splenomegaly, hepatomegaly, lymphadenopathy, arthropathy, and some degree of hypertension and renal insufficiency. The main laboratory abnormalities are microangiopathic hemolytic anemia, thrombocytopenia, hyperbilirubinemia, uremia, and erythroid and myeloid hyperplasia of the bone marrow with increased megakaryocytic activity. Although laboratory evidence of DIC may be present, it occurs in only a few patients.
27 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Hemolytic-Uremic Syndrome The hemolytic-uremic syndrome is a disease of children that is characterized by renal impairment, thrombocytopenia, and microangiopathic hemolytic anemia, typically preceded by abdominal pain and diarrhea. Involvement of the nervous system is found in around 30 percent of children. As with thrombotic throm-bocytopenic purpura, the diagnosis may be made on the basis of microangiopathic hemolytic anemia and thrombocytopenia. Despite its similarities to thrombotic thrombocytopenic purpura, there are important differences. Deficiency of von Willebrand148 factor–cleaving protease has not been shown in hemolytic-uremic syndrome. Furthermore, 91 percent of children with hemolytic-uremic149 syndrome survive with supportive care, and plasma exchange treatment is not indicated. Most cases arise as a complication of infection by organisms producing Shiga toxins such as Escherichia coli O157:H7 or Shigella. Sporadic, noninfectious causes resulting from idiopathic, familial, or autoimmune diseases, drugs, or tumors also occur. The non–diarrhea-associated cases occur predominantly in adults and may be idiopathic; associated with HIV, bone marrow transplant, cancer, and autoimmune diseases; or associated with use of cyclosporine, mitomycin, and other forms of chemotherapy. Familial hemolytic-uremic syndrome constitutes 5 to 10 percent of cases and is associated with deficiency of plasma factor H, which protects the host by promoting C3b cleavage. The most common neurological manifestations150 are seizures, predominantly generalized tonic-clonic convulsions but occasionally focal. Behavioral changes, diplopia, dizziness, irritability, obtundation, coma, decerebrate posturing, cerebellar ataxia, hemiparesis, hemianopia, cortical blindness, cranial nerve palsies, vitreous hemorrhages, and retinal infarction may occur. Axonal neuropathy has been151 described in a patient with E. coli serotype O157:H7–associated hemolytic-uremic syndrome. Striatal involvement due to small areas of infarction of the basal ganglia, with resultant involuntary movements, has been 152 Changes of described. MRI of the brain may show features of infarction or hemorrhage. 153 reversible posterior leukoencephalopathy have also been described. A hemorrhagic component within an acute lesion most reliably predicted residual pathological findings on follow-up imaging. Prognosis was favorable for clinical outcome and resolution of 154 imaging findings, even in patients with severe CNS involvement on acute imaging studies. There is a risk of residual hypertension and chronic renal failure, which is greatest in those children with neurological complications. Seizures, alone or as part of155 neurological involvement, were associated with mortality or long-term neurological sequelae.
Gaucher's Disease Gaucher's disease is the commonest lipid storage disorder. An autosomal-recessive disorder, it is characterized by a deficiency of glucocerebrosidase and an accumulation of glucocerebroside in lipid-laden macrophages (Gaucher cells) in various organs. Type 1 is the non-neuronopathic type. It results from accumulation in bones, liver, spleen, and lungs and is characterized by hepatosplenomegaly, bone pain and fractures, thrombocytopenia, and bleeding diathesis. It may develop at any time in childhood. It occurs worldwide in all populations, but 60 percent of cases are found in the Ashkenazi Jewish population. Type 2, the acute neuronopathic form, shows no ethnic predilection, Hepatosplenomegaly arises in the first few months of life. Characteristic brainstem abnormalities then develop with strabismus, horizontal supranuclear palsy, and opisthotonic posturing and trismus in response to noxious stimuli. There is diffuse spasticity and developmental regression, and it is usually fatal during the first 3 years of life. Type 3 Gaucher's disease, the chronic neuronopathic form, is also without ethnic predilection and is estimated to occur in 1 in 50,000 live births. The neurological symptoms are slowly progressive and appear later in childhood than the symptoms of type 2 disease. It has a more chronic course, with variable hepatosplenomegaly and the progressive development of incoordination, myoclonic seizures, and mental deterioration. The cognitive disturbance ranges from a mild memory disorder to severe dementia, which is most frequent. The seizures may be tonic-clonic, partial complex, or myoclonic. Progressive myoclonic jerking of the face, limbs, or palate may be prominent, as may pyramidal signs, cerebellar ataxia, and 156 cranial nerve palsies. Oculomotor apraxia has been described as the presenting feature. In addition, thrombocytopenia and prolonged prothrombin and partial thromboplastin times may cause a bleeding tendency. The patient may be anemic, and Gaucher cells may be found on bone marrow examination. The symptoms vary between individuals, so that some children may have cirrhosis with portal hypertension, varices, pulmonary interstitial involvement, and heart disease. Type 3 Gaucher's disease has been classified further as types 3a and 3b based on the extent of neurological involvement and the presence of progressive myotonia
28 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
and dementia (type 3a) or isolated supranuclear gaze palsy (type 3b). Norbottnian Gaucher's disease, a genetic form identified in Sweden, has features of types 2 and 3. The slowly progressive neurological symptoms may not occur until early adulthood. Bone marrow transplantation can reverse the non-neurological effects of type 1 Gaucher disease but has a high mortality rate and has been supplanted by enzyme replacement therapy. Enzyme replacement with a recombinant form of macrophage-targeted acid β-glucosidase is beneficial for types 1 and 3 Gaucher's disease, reducing liver and spleen size, improving blood counts, and reducing skeletal anomalies. It does not cross the blood–brain barrier and is not effective in the management of neuronopathic symptoms. Substrate reduction therapy with N-butyldeoxynojirimycin is available for patients unable to take enzyme replacement therapy. This compound inhibits the enzyme glucosylceramide synthase, a glucosyl transferase responsible for the first step in the synthesis of glycosphingolipids. Unlike enzyme replacement therapy, this drug does cross the blood–brain barrier, but no data are yet available on whether it has a role in neuronopathic Gaucher's disease. COAGULATION DISORDERS Thrombosis may arise from abnormalities of the blood-vessel wall, alterations in blood composition, and abnormalities in the dynamics of blood flow—Virchow's triad. The intact vessel wall modulates thrombin activity, platelet reactivity, and the release of vasodilators, and it promotes local fibrinolytic activity. Injury of a vessel wall may therefore lead to the exposure of the prothrombotic subendothelium as well as interfering with its antithrombotic properties. A number of blood components exhibit prothrombotic and antithrombotic effects, so that under normal circumstances platelet degranulation and aggregation and thrombin generation occur only at sites of tissue injury. Thrombin production is the major step in thrombosis that results in fibrin deposition. The fibrinolytic system prevents the deposition of excess fibrin, a negative-feedback process that is catalyzed by fibrin through plasmin production and that also breaks down platelet-adhesive glycoproteins, thus reducing further platelet recruitment. The balance between prothrombotic and antithrombotic activity determines the degree of thrombus progression. There are a number of well-recognized circumstances under which this balance may be altered; tissue injury may lead to increased synthesis of plasminogen activator inhibitor type 1 (PAI-1), with an increased risk of thrombosis. Congenital deficiencies in an ever-increasing range of anticoagulant proteins are also now well recognized. Antiphospholipid antibodies are associated with venous and arterial thrombosis. Pregnancy is associated with a variety of changes in hemostatic components giving rise to thrombosis or hemorrhage; increased fibrinogen production and placental production of a plasminogen activator inhibitor (PAI-2) leads to increased risk of thrombosis in the later stages of pregnancy. Cigarette smoking, estrogen use, tissue injury, infection, and inflammation result in increased production of components of the cascade, particularly fibrinogen. Diminished blood flow may lead to the local accumulation of platelets and thrombin, and if the stasis is sufficient, endothelial hypoxia may result in impairment of the antithrombotic properties of the endothelium. Blood viscosity is a significant determinant of blood flow. Under low-flow conditions, platelets have a minor role in the generation of thrombosis; stasis is the dominant factor in the pathogenesis of venous thrombosis in which activated clotting factors circulate to areas of venous stasis, where fibrin is generated. This process is exacerbated by defects in the innate anticoagulant mechanisms. In the arterial system, thrombosis usually arises from endothelial damage, commonly in association with atherosclerosis. Procoagulant mechanisms may be involved in the initiation and progression of atherosclerosis, but local platelet degranulation results in plaque growth. Plaque rupture or ulceration exposes procoagulant material with rapid formation of platelet thrombus, which may break up and embolize or become consolidated and enlarged by fibrin deposition. It follows from the physiology of thrombosis that differing risk factors are responsible for the generation of venous and arterial thrombosis. Furthermore, the multifactorial nature of thrombophilia is becoming increasingly apparent, and individuals with more than one inherited thrombophilia risk factor or those with an inherited and an acquired risk factor are particularly prone to thrombosis. The risk factors for venous thrombosis are distinct from those for arterial thrombosis and ischemic stroke. Routine evaluation for hypercoagulability such as assays for deficiencies of
29 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
coagulation inhibitors, or genetic analysis for factor V Leiden or prothrombin 20210 mutation, are not helpful in identifying risk factors for adult patients with stroke, other than in the context of a patent foramen ovale (see later). New genetic polymorphisms continue to be discovered and evaluated as risk factors for stroke.
Antiphospholipid Antibodies Lupus anticoagulant and anticardiolipin are members of a group of antiphospholipid antibodies that are directed against epitopes on phospholipid-bound proteins and are associated with venous and to a lesser degree arterial thrombosis. β2-Glycoprotein is the target for anticardiolipin antibodies, and prothrombin is thought to be the target for most lupus anticoagulant antibodies. Cardiolipin is a component of mitochondrial membrane and has been used as the antigen in solid-phase assays. The term antiphospholipid does not fully describe the target of anticardiolipin antibody assays. All assays for anticardiolipin antibodies require a source of plasma proteins to facilitate phospholipid binding. In many cases, the required plasma factor is β2-glycoprotein I. Affinity for coagulation-active negatively charged lipids is the basis for phospholipid-dependent coagulation assays for lupus anticoagulant. In systemic lupus erythematosus, predisposition to thrombosis is associated with the presence of antinuclear antibodies and antiphospholipid antibodies. The primary antiphospholipid syndrome is the association between arterial and venous thrombosis with lupus anticoagulant, anticardiolipin or other phospholipid antibodies, or both, and a history of recurrent early miscarriage and sometimes thrombocytopenia, in the absence of systemic lupus erythematosus or other connective tissue disorders. Antiphospholipid antibodies may arise de novo or may be associated with a variety of underlying disorders (Table 13-3). The risk of thrombosis is variable; antiphospholipid antibodies associated with infections and a variety of drugs are associated with a smaller risk of thrombosis than those of primary or secondary antiphospholipid syndromes. In a cohort of 1,000 patients with the antiphospholipid syndrome, 82 percent were female, primary antiphospholipid syndrome was present in 53 157 percent, and SLE was associated in 36 percent. Click here to view this table.... Patients with clinical manifestations may have lupus anticoagulant or anticardiolipin antibodies, or both, and some have antibodies that do not react in all phospholipid-dependent coagulation assays. Testing must therefore include at least two sensitive coagulation assays, usually the kaolin-cephalin clotting time (KCCT) and the dilute Russell's viper venom time (DRVVT) with a platelet neutralization step or kaolin clotting time, as well as solid-phase assays for IgG and IgM anticardiolipin antibody. Long KCCTs may arise from coagulation factor deficiency, and false-negative antiphospholipid antibody testing may arise from binding of the antibodies to platelets in samples not processed rapidly and appropriately. Antibody isotype (IgG or IgM) may be important in pathogenicity, with low titers and IgM antibody most likely to be nonpathogenic; since transient positive antibodies, particularly IgM, may follow a variety of infections, positive tests should be repeated after at least 6 to 12 weeks. Assays of β2-glycoprotein may distinguish between the β-glycoprotein–dependent anticardiolipin antibodies that are associated with infection and the β-glycoprotein–independent antibodies that are more likely to be associated with thrombosis. Anti–β2-glycoprotein I antibodies (Aβ2A) are found in approximately 30 percent of patients with systemic lupus erythematosus and are an independent risk factor for arterial and venous thromboses. Approximately 20 percent of patients with systemic lupus erythematosus who test negative for anticardiolipin antibodies will test positive for Aβ2A; Aβ2A may be more specific than anticardiolipin antibodies in predicting thrombosis, especially in adult patients 158,159 with systemic lupus erythematosus. Antiprothrombin antibodies are found in a higher percentage (50% to 60%) of patients with 160 systemic lupus erythematosus than are anticardiolipin antibodies and Aβ2A, and they also 161,162 The simultaneous constitute an independent risk factor for venous thrombosis. presence of antiprothrombin antibodies is also associated with a higher risk of thrombotic 163 events in patients with primary antiphospholipid syndrome. Annexin V is a natural anticoagulant with a high calcium-dependent binding affinity for negatively charged phospholipids, one that acts competitively with coagulation factors with inhibition of the prothrombin complex. High levels of anti-annexin V antibodies have been 164,165 but it is not yet found in 20 to 30 percent of patients with systemic lupus erythematosus, clear whether they are associated with an increased risk of thrombosis. Of the various antiphospholipid and anticofactor antibodies, anti-annexin V antibodies prove to be the greatest, if not the only, risk factor associated with recurrent pregnancy loss in women with
30 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
systemic lupus erythematosus and in women without autoimmune disease or other risk 166 the antiphospholipid syndrome have been updated, giving factors. The Sapporo criteria for 167 diagnostic significance to Aβ2A. At least one clinical and one laboratory criterion should be met. Clinical criteria include (1) one or more clinical episodes of arterial, venous, or small-vessel thrombosis, confirmed by imaging or histopathology, without significant evidence of inflammation in the vessel wall; and (2) pregnancy morbidity following defined criteria. The laboratory criteria are (1) lupus anticoagulant present in plasma on two or more occasions at least 12 weeks apart, detected according to the guidelines of the International Society on Thrombosis and Haemostasis; (2) anticardiolipin antibody of IgG or IgM isotype in serum or plasma, present in medium or high titer (i.e., >40 GPL or MPL, or >99th percentile), on two or more occasions, at least 12 weeks apart, measured by a standardized enzyme-linked immunosorbent assay (ELISA); and (3) Aβ2A of IgG or IgM isotype in serum or plasma (in titer >99th percentile), present on two or more occasions, at least 12 weeks apart, measured by a standardized ELISA, according to recommended procedures. Depression, cognitive dysfunction, psychosis, seizures, chorea, and transverse myelitis have been associated with the presence of antiphospholipid antibodies, although there is evidence that not all arise from ischemia. An interaction between antibodies and CNS cellular elements may account for some of these manifestations. Sneddon's syndrome of cerebral thrombosis in association with livedo reticularis is strongly associated with the presence of antiphospholipid antibodies. In systemic lupus erythematosus, the risk of168thrombosis is increased two- to fivefold in subjects who have the lupus anticoagulant. Venous thrombosis is seen most commonly, 169,170 but arterial thrombosis may also occur in the absence of other recognized risk factors. A study of epilepsy in patients with the antiphospholipid syndrome reveals a prevalence of 8.6 percent. Multivariate logistic regression analysis found CNS thromboembolic events as the most significant factor associated with epilepsy, with an odds ratio of 4.05 (95% confidence interval, 2.05 to 8), followed by systemic lupus erythematosus (OR 1.4, 95% CI 1.2 to 4.7), 171 and valvular vegetations (OR 2.87, 95% CI 1 to 8.27). The cumulative clinical features during the evolution of the disease have been described in 157 1,000 patients with antiphospholipid syndrome. Neurological manifestations included migraine (20.2%), stroke (19.8%), transient ischemic attack (11.1%), epilepsy (7.0%), amaurosis fugax (5.4%), multi-infarct dementia (2.5%), retinal artery thrombosis (1.5%), chorea (1.3%), acute encephalopathy (1.1%), optic neuropathy (1.0%), retinal vein thrombosis (0.9%), transient amnesia (0.7%), cerebral venous thrombosis (0.7%), cerebellar ataxia (0.7%), transverse myelopathy (0.4%), and hemiballismus (0.3%). Many studies have examined the association between antiphospholipid antibodies and stroke, but with inconsistent conclusions as a result of the use of differing patient groups and a selective range of test methods. A study of unselected adults presenting with stroke suggested that the 172,173 but does presence of anticardiolipin antibodies is an independent risk factor for stroke not predispose to subsequent thrombotic events, although other studies failed to confirm 174 this. Another study showed that presence of an antiphospholipid antibody (either lupus anticoagulant or anticardiolipin) among patients with ischemic stroke did not predict either increased risk of subsequent vascular occlusive events over 2 years or a differential response to aspirin or warfarin therapy. Routine screening for antiphospholipid175 antibodies in unselected adults with ischemic stroke has therefore not been recommended. With the introduction of assays for antibodies directed specifically against β2-glycoprotein I, however, a 176 relative risk of stroke of 2 to 3 has been suggested. Studies of a wider range of antiphospholipid antibodies in the pathogenesis of cerebral ischemia suggest a relevant role for a combination of antiphosphatidylserine IgG and anti–β2-glycoprotein I IgA in stroke 177 etiology. A consensus is forming that one or a number of the antiphospholipid antibodies have an association with stroke in adults. Whether this is a risk factor for recurrent vascular events is uncertain, and whether specific treatment is required is quite unclear. Among younger patients, the association appears stronger, with antiphospholipid antibodies present in 46 percent of subjects younger than 50 years who present with stroke or a transient ischemic attack (TIA) compared with 8 percent in matched control subjects with 178 nonthrombotic neurological disease. In young adults, the presence of antiphospholipid antibodies, particularly lupus anticoagulant, has been identified as an independent risk factor 179 for first and possibly also for recurrent ischemic stroke, although a prospective study of young patients with recent TIAs or ischemic stroke suggested that antiphospholipid 180 antibodies are not a strong risk factor for recurrent stroke or TIA. Prothrombotic abnormalities181have been identified in 20 to 50 percent of children presenting with acute ischemic stroke.
31 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
Hereditary Thrombophilia The inherited thrombophilias are a group of disorders in which a defect or deficiency in the natural anticoagulant mechanisms predisposes to the development of venous thrombosis. Within the cerebral venous system, the superior sagittal and transverse sinuses are frequently involved, whereas cavernous sinus thrombosis is much less common. Antithrombin, protein C, and protein S deficiencies, factor V Leiden, the G20210A prothrombin gene mutation and MTHFR C677T mutation resulting in hyperhomocysteinemia predispose to thrombosis, although it is uncertain whether other inherited disorders, such as deficiency of heparin cofactor 2, plasminogen, tissue plasminogen activator, factor XII, or prekallikrein, also result in thrombosis. In homocystinuria, homozygotes are susceptible to arterial and venous thromboses. Genetic or acquired predisposing factors can be identified in 182 as many as 80 percent of patients who develop cerebral venous sinus thrombosis. A genetic risk factor is now identifiable in up to 50 percent of unselected patients with venous 183 thromboembolism, although a lower incidence of inherited thrombophilia of 15 to 19 percent is reported in patients with cerebral venous sinus thrombosis in studies undertaken 184,185 Investigation in before the identification of the 20210A prothrombin gene mutation. potentially inherited disorders must include assessment of family members. Antithrombin Deficiency Antithrombin is a plasma glycoprotein that inhibits thrombin and other activated serine proteases, including factors IXa, Xa, XIa, XIIa, and kallikrein. Heterozygous antithrombin 186,187 and may arise as a new deficiency affects 1 in 2,000 to 5,000 of the population mutation. Deficiency of antithrombin is associated with sagittal sinus and cerebral venous 188 189 thrombosis, and is an under-recognized cause of neonatal seizures. A rarer disorder is recognized in which a nonsense mutation results in a dysfunctional variant of antithrombin 190 causing recurrent venous thrombosis. Acquired antithrombin deficiency associated with cerebral thrombosis may also arise from reduced antithrombin synthesis in liver disease or 191 increased loss in nephrotic syndrome, oral contraceptive use, DIC, protein malnutrition, and heparin therapy. A retrospective cohort family study that assessed the risk of venous thromboembolism in individuals with thrombophilia suggested that individuals with antithrombin deficiency might have a higher risk of thrombosis than that with the other genetic 192 defects. Protein C Deficiency Protein C is a vitamin K–dependent protein that binds to thrombomodulin, an endothelial cell surface protein, and is converted to an active protease by the action of thrombin. In conjunction with protein S, protein C proteolyses factors Va and VIIIa, thereby reducing thrombin formation as well as promoting fibrinolysis. Inheritance of protein C deficiency is usually autosomal dominant, although in some families, heterozygotes with plasma concentrations of less than 50 percent of normal remain asymptomatic, giving an autosomal recessive–like pattern of inheritance. Dysfunctional molecules present in normal levels have been described. Sagittal sinus and cerebral venous thromboses are recognized in 193 association with deficiency of protein C. Population studies suggest that 1 in 200 to 300 subjects have levels of protein C consistent with congenital deficiency, although the incidence of protein C deficiency and venous thromboembolism suggests a prevalence of 1 in 194 30,000. This represents 4 percent of subjects with venous thromboembolism presenting before the age of 45 and demonstrates that other inherited and acquired risk factors are frequently required for thrombosis to occur. Protein S Deficiency Protein S is a vitamin K–dependent glycoprotein that acts as a cofactor for activated protein C. Approximately 60 percent of it is protein bound, so that total and free protein S must be measured. Only the unbound protein is biologically active, and since its level may fall in acute disease, repeat measurement and the demonstration of a persistently reduced level is required to prove association with disease. In the presence of factor V Leiden, functional assays of protein S may give a falsely low reading. Sagittal sinus and cerebral venous 195 thromboses are reported in association with deficiency of protein S. Factor V Leiden (RQ506Q) Factor V Leiden is a point mutation in factor V at Arg 506, where protein C cleaves and
32 / 35
2009.01.05. 12:03
Aminoff: Neurology and General Medicine: Neurological Manifestatio...
http://www.merckmedicus.com/pp/us/hcp/printpage.jsp
inactivates the Va procoagulant. This results in a poor response to the anticoagulant activity of activated protein C, a key enzyme in the downregulation of blood coagulation, resulting in a predisposition for a hypercoagulable state. It is the most common inherited prothrombotic 196 accounting for at least 90 percent of the cases with resistance to activated protein state, 197 C. The mutation is inherited as an autosomal-dominant trait and has a prevalence of 2 to 10 percent in the general white population. A number of clinical studies, using different inclusion criteria, show a prevalence of activated protein C resistance of 20 to 60 percent among patients with venous thromboembolism at any site, and 20 to 25 percent for cerebral venous thrombosis. The actual thrombotic risk is moderate, with an odds ratio of 5:7, but its high prevalence makes it by far the most important inherited risk factor known today, exceeding184,197–199 the sum of contributions from inherited deficiencies of antithrombin, protein C, and protein S. Activated protein C resistance, which is not due to factor V Leiden and which appears to be acquired, is also a risk factor for venous thrombosis. A decreased response to activated protein C is common during pregnancy and during the use of oral contraceptives, although the clinical relevance of these findings remains unclear. Thrombotic events often occur in the presence of inherited and circumstantial risk factors. Noninherited factors predisposing to cerebral venous thrombosis (e.g., oral contraceptive intake, pregnancy, puerperium, trauma, or prolonged immobiliza